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Abstract 
Background This thesis involved the development and evaluation of a contraceptive 
behavioural intervention delivered by mobile phone for young people in Tajikistan, Palestine 
and Bolivia.  
 
Methods The intervention was developed using behavioral science and evaluated by 
randomised controlled trial in each country. Outcome data were self-reported at four 
months. The primary outcome was acceptability of at least one method of effective 
contraception (N = 570 in Palestine and Tajikistan). In Bolivia, a co-primary outcome was use 
of effective contraception (N = 1310). Secondary and process outcome data were collected. I 
conducted a post-hoc change from baseline to follow-up analysis in Tajikistan and Bolivia. 
Interviews with trial participants were also conducted. 
 
Results Intervention development: the results of the intervention development were similar 
across the countries. The interventions consist of short messages delivered over four months 
and include the same ten behaviour change methods. Tajikistan trial: 573 were enrolled and 
82% (n = 472) completed follow-up. Intervention content was included on the app, causing 
contamination. Acceptability: 66% intervention vs 64% control; adjusted OR 1.21 95% CI .80-
1.83, p = 0.36. Increase in acceptability from baseline to follow-up: 2% to 65%, p < 0.001. 
Palestine trial: 578 were enrolled and 80% (n = 464) completed follow-up. Acceptability: 31% 
intervention vs 17% control; adjusted OR 2.34, 95% CI 1.48-3.68, p < 0.001. Bolivia trial: 640 
were enrolled and 67% (n = 429) completed follow-up. Use: 37% intervention vs 33% control; 
adjusted OR 1.19, 95% CI .80-1.77, p = 0.40. Acceptability: 71.92% intervention vs 62.56% 
control; adjusted OR 1.49, 95% CI .98-2.28, p = 0.06. Increase in acceptability from baseline to 
follow-up: 9% to 67%, p < 0.001. Interviews: interviewees highly valued the intervention.  
 
Conclusion The interventions were well-specified, theory-based and tailored to each country. 
It is likely that the intervention delivered by short messages improves attitudes towards 
effective contraception.  
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1 Introduction 
1.1 Global unintended pregnancy 
Worldwide between 2010-2014, an estimated 44% of all pregnancies were unintended, with 
56% of these ending in abortion during this period (1). A range of negative consequences are 
associated with unintended pregnancy. Women with unintended pregnancies can experience 
decreased psychological well-being (2-10). They initiate antenatal care later than those with 
intended pregnancies (4, 10-14) and access care less frequently (4, 11, 14). The risk of low 
birth weight and pre-term birth is higher among children born of unintended pregnancies (15, 
16). These children can exhibit behavioural problems more often than children born of 
intended pregnancies (17). Unintended pregnancy can delay or prevent educational and 
career advances, which can affect the financial security of the family (18). Unsafe abortions 
are a consequence of unintended pregnancy where access to safe abortion is limited (19, 20). 
While unintended pregnancy exists in all countries among women in every socio-economic 
group, young people in LMIC are at particular risk, with half of pregnancies among women 
age 15-19 in these regions estimated to be unintended (21). Tajikistan, Bolivia and Palestine, 
the countries where the research in this thesis was conducted, are three LMIC where 
adolescents are at risk of unintended pregnancy. The measurement of pregnancy intention, 
however, is challenging (22, 23) and studies evaluating unintended pregnancy’s effects on 
maternal and child health outcomes are methodologically limited (23). Despite this, it is clear 
that unintended pregnancy persists as a global health problem (24), with research in low and 
middle income countries (LMIC) lacking (4, 23).  
 
Meeting unmet need for effective contraception is essential in decreasing unintended 
pregnancy. A woman who has an unmet need for modern contraception is: of reproductive 
age (15-49); legally married, cohabiting, in a consensual union or unmarried and sexually 
active; is not using a modern method of contraception; is fecund and does not want to have a 
child (or another child) in the next two years or at all (25, 26). Modern contraceptive methods 
include oral contraceptives, injectables, intra-uterine device (IUDs), implants, the patch, the 
ring, male and female sterilization, male and female condoms and other barrier methods,  
modern fertility-awareness methods and emergency contraception (27). ‘Effective’ 
contraceptive methods are methods with less than 10% typical use failure rate at 12 months, 
i.e. all modern methods besides condoms, other barrier methods and modern fertility 
awareness methods (28-30). While effective methods are available in Tajikistan, Bolivia and 
Palestine, there remain barriers to use. Despite increasing availability of a variety of 
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contraceptive methods, thirty-eight million women aged 15-19 in LMIC are sexually active 
and do not want a child in the next two years, yet 23 million have an unmet need for modern 
contraception (21). It is estimated that meeting adolescents’ unmet need for contraception 
would reduce unintended pregnancies by six million each year (21). 
 
1.2 Health interventions delivered by mobile phone 
Worldwide, there were an estimated 7.7 billion mobile phone subscriptions at the end of 
2017, with 6.1 billion in the developing world (31). The ubiquity of mobile phones creates the 
opportunity for broad intervention delivery. Regarding health intervention delivery, they are 
now a popular and widely established vehicle and there is growing evidence that 
interventions delivered by mobile phone can be effective at improving a range of health 
behaviours (32-47). Health support delivered by mobile phone can be received at a time of 
the recipient’s choosing, which may be important for young people, especially with sensitive 
topics such as sexual and reproductive health. Because the content of interventions delivered 
by mobile phone can be standardised and pre-specified, these interventions can be delivered 
with high fidelity. Such interventions may be more convenient and cheaper to deliver than 
face-to-face support. Mobile phone interventions can be delivered through a variety of 
different ways, for example, through voice and text messages (SMS, short message service), 
mobile applications, instant messages that include videos and images, bi-directional 
communication with professionals via SMS or a live voice call. Despite the potential to reach 
many people, systematic reviews have highlighted a lack of high quality efficacy studies 
evaluating health interventions delivered by mobile phone in LMIC (38, 48, 49). 
 
1.3 The three country project 
In 2014, the International Planned Parenthood Federation’s (IPPF) Innovation Programme 
Round 1 put forth a thematic initiative for their Member Associations (MA) titled, “Can you 
think of a new way to broaden the contraceptive method mix to young people?”. Three MAs 
included a mobile phone element in their proposal: the Tajik Family Planning Association 
(TFPA), the Palestinian Family Planning and Protection Association (PFPPA), and the Centro de 
Investigacion, Educacion y Servicios (CIES, Bolivia). Viewing this as an opportunity to create a 
cross-country project, IPPF refined the aim of Round 1 when seeking a research partner, to 
focus on developing and evaluating an intervention delivered by mobile phone to broaden 
contraceptive method choice among young people in each country. In December 2014 I 
wrote a research proposal in response to this call, as a member of staff at the London School 
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of Hygiene & Tropical Medicine (LSHTM), under the supervision of Professor Cari Free. In 
January of 2015, my application was successful, and we began a three year collaboration with 
IPPF and the three MAs. My thesis is based on this project. 
 
1.4 Roles 
IPPF conceived of the aims of the project (to develop and evaluate an intervention delivered 
by mobile phone to broaden contraceptive method choice in each country) and chose the 
target population (‘young people’). I identified and executed the methods to achieve these 
aims. During the project, IPPF’s role was largely to facilitate good collaboration and to 
monitor and ensure compliance with the research grant agreement. I led the project as a full 
time staff member at LSHTM. I was responsible for all the research activities (broadly, the 
study design, research governance, data collection, data analysis and dissemination). I 
managed the research activities of the local staff working on the project, which involved 
frequent remote training, monitoring and planning meetings along with field visits. I trained 
staff in the field and remotely in qualitative research methods and trial conduct and I 
monitored the conduct of the trials day to day. I wrote the intervention development and 
trial protocols and statistical analysis plans, modified the trial database and randomisation 
system, managed the data, conducted the analysis and interpreted the results.  
 
1.5 Aims and objectives of the thesis 
The overall aim of this thesis is to develop and evaluate a contraceptive behavioural 
intervention delivered by mobile phone for young people in Tajikistan, Palestine and Bolivia.  
 
Specific objectives of this thesis are to: 
1. Review the literature on the factors that influence contraceptive use in LMIC 
2. Describe the context in each country regarding contraceptive and mobile phone use  
3. Review the evidence from trials evaluating individual level interventions for 
contraception delivered by mobile phone 
4. Develop an intervention for contraception delivered by mobile phone in each 
country, using a systematic approach grounded in behavioural science 
5. Evaluate the effect of the intervention by conducting a randomised controlled trial in 
each country 
6. Conduct interviews with trial participants regarding their views of the intervention  
16 
 
7. Discuss the results across the countries to draw conclusions about the efficacy of the 
intervention 
 
1.6 Structure of the thesis 
My thesis is written as a combination of book style and research paper style. My research 
papers cover the intervention development and evaluation (Chapters 3 and 5-8). Five out of 
seven of the research papers have been published in peer-reviewed journals (50-54). I have 
written the other chapters of my thesis in book style. 
 
Chapter 2 provides a background for the research activities. The intervention development 
approach and results were similar, which is why I published this work in one publication 
(Chapter 3). In Chapter 4, I describe the theoretical basis of the intervention. The evaluation 
methods were similar and consisted of a randomised controlled trial in each country. I 
considered designing one trial stratified by country, but fundamental differences in the trial 
designs in each country (such as differences in the primary outcome, eligibility and 
comparison group) precluded this. Consequently, I published one trial protocol for each 
country. To avoid unnecessary repetition in this thesis, I present the trial protocols combined 
in Chapter 5, and highlight the differences between the countries. Chapter 5 also presents 
additional material that was not included in the published protocols. Chapters 6, 7 and 8 
present the evaluation results in each country. Chapter 9 presents additional analyses. In 
Chapter 10 I present a descriptive analysis of the interviews. Finally, in Chapter 11, I 
summarise the thesis and discuss the challenges, limitations and cross-country implications. 
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2 Background 
2.1 Factors that influence contraceptive use in LMIC 
Reasons for contraceptive non-use in LMIC have been well documented across different 
settings in surveys, quantitative analyses of observational data, qualitative studies and 
reviews (21, 26, 55-74). These factors can be thought as resting within the individual, such as 
attitudes, or can be environmental, such as the influence of friends, family and society as well 
as structural factors. Often, the individual factors are a result of environmental influences.  
 
Lack of access to services and methods (71), family planning education and information (73), 
and limited choice constrains women’s decision-making abilities (62). Pressure to conform to 
traditional gender roles and value systems where being a wife and mother determines 
women’s status in society can stigmatise contraceptive use (75, 76) and influence 
contraceptive decision-making (58, 63). For some, attending services constitutes admission of 
sexually activity, which can threaten reputations and social status (73). These social 
pressures, including the pressure to bear children soon after marriage, can limit women’s 
self-efficacy in accessing and using contraception (58). Environmental factors such as law, 
social practices, traditions, religious and cultural constructs can interact with each other, to 
prevent women from realising their reproductive intentions (22, 77). 
 
Concern about the side effects or health risks of contraception, such as menstrual 
irregularities and fear of infertility, remain one of the most often cited reasons for not using 
modern contraception (21, 55, 57, 59, 61-65, 67, 70). The concerns that women have can be 
due to either their own experience (61), the experiences of those close to them or 
misinformation (59). Concerns that stem from personal experience, are often responses to 
side-effects that occur as a result of the way in which the methods work (61). For example, 
most hormonal methods alter hormone levels to prevent ovulation. While ovulation 
suppression is the desired effect, some users may experience undesired side-effects 
associated with some methods such as bleeding changes, nausea, headaches, breast 
tenderness, mood changes and weight changes (78).  
 
While experienced side-effects are not uncommon, perceptions of side-effects based on 
misinformation can lead to a generalised fear of contraception (57, 59, 62, 67, 70). 
Misperceptions about contraceptive methods are beliefs about the effects or purpose of 
methods that are not supported by current best evidence (59). Common misperceptions that 
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women express are that contraception causes infertility and cancer and that bleeding 
changes associated with some methods are harmful to health (59, 63, 73). These beliefs, 
whether misperceptions or accurate, can be powerful influences on use (61). While there is 
some indication that lack of awareness of methods has decreased in LMIC (57), lack of 
accurate knowledge (55, 58, 63, 64, 66), particularly among young people (74), still remains a 
barrier to use and can likely reinforce misperceptions.  
 
Misperceptions can also be reinforced through provider bias, which can limit women’s choice 
(59, 60). For example, providers may not offer long acting methods to young people based on 
the misperception that they are contraindicated in this group (59, 60). Restricting women’s 
method options limits their choice which may result in the choice of a less acceptable 
method, which in turn could lead to discontinuation. Provider bias prevents women from 
receiving accurate and comprehensive information on the full range of available methods and 
opportunities to switch if needed. 
 
Perceived risk of pregnancy can also influence the decision to use contraception. Infrequent 
sex is a common reason women with an unmet need, particularly younger women, give for 
contraceptive non-use (21, 26, 57). Post-partum amenorrhea, breast feeding or both are also 
common reasons women with an unmet need provide (26, 57). 
 
Communication and joint decision making has been shown to be associated with greater 
contraceptive use in both lower income (68, 69) and higher income (72) settings. However, 
oppositional attitudes towards contraception, either the user’s or someone close to them, is 
a common reason women with an unmet need provide for not using it (26). While some 
oppositional attitudes are based on previous experience, survey data reveals that many 
women hold oppositional beliefs before ever trying a method (26). 
 
The above factors and influences on contraceptive use, in varying degrees, have been 
documented across a wide range of LMIC. The cross-cultural similarities mean that that 
countries can learn from each other’s efforts to tackle the causes of unintended pregnancy 
(74). 
 
2.2 Context 
In this section I report key data on contraceptive use and the fertility rates in each country. 
Published data on abortion was only available for Tajikistan, the only country of the three 
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where abortion is legal on request. It is important to note that abortion is known to be 
underreported in surveys, even in contexts where abortion is legal (79, 80) and published 
data should interpreted with caution.  
 
2.2.1 Tajikistan 
Figure 2.1 Map of Tajikistan 
 
 
The civil war that followed Tajikistan’s independence from the Soviet Union in 1991, had 
devastating effects on the Tajik economy and health system (81, 82). While economic 
hardship continues, fundamental reforms to the healthcare system have instigated 
progressive initiatives, such as the adoption of the Strategic Plan for Reproductive Health in 
2004 (83). Despite various reproductive health governmental policy initiatives and strategies, 
it is still a challenge for Tajik young people to gain accurate information about contraception 
(84, 85). Women and their partners have limited knowledge about reproductive health and 
rights and face pressures from family members (85). Provision of reproductive health services 
is impeded by factors such as lack of access to adequate care, limited health professional 
capacity and widespread stigma and discrimination (85). 
 
The most reliable source of information about contraceptive use is the 2017 Tajikistan 
Demographic and Health Survey (DHS), which was published in November of 2018 (all data 
from the 2017 DHS survey unless referenced otherwise) (86). The survey sample was 
nationally representative and followed a two-stage design. The first stage involved the 
selection of 366 clusters (with a probability proportional to their size within each sampling 
stratum). The second stage involved the selection of 22 households from each cluster (with 
an equal probability systematic selection process). The final sample included interviews with 
10,718 women aged 15-49 in all selected households (a 99% response rate). The sample 
represents all areas of Tajikistan- urban and rural and for all five regions (Sughd, Dushanbe, 
Khation, Districts of Republican Subordination and Gorno-Badakhshan Autonomous Oblast). 
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Awareness contraceptive methods is widespread among women: with 98% of married 
women aged 15-49 aware of at least one method and married women have heard of an 
average of seven methods. The top three most well-known methods are the IUD (96%), pill 
(89%) and the male condom (85%). 
  
The total fertility rate is 3.8 births per woman compared to the total wanted fertility rate of 
3.5. Childbearing increases from 54 births per 1,000 women in the 15-19 age group to a peak 
of 303 births per 1,000 women in the 20-24 age group (Figure 2.2). Age-specific fertility rates 
are higher among rural women compared to urban women for most age groups.  
 
Figure 2.2 Age-specific fertility rates, 2017 (Tajikistan) 
 
Compared to the 2012 survey, contraceptive use in the 2017 changed minimally, whereas 
there were relatively large changes from the 2005 to the 2012 survey. In the 2012 DHS 
survey, contraceptive use among married women decreased by around 10% compared to the 
previous survey conducted in 2005 (from 38% to 28%) (83, 87). Between the two surveys, use 
of the IUD among all married women decreased by almost 8%. One reason suggested for this 
decrease is the outward migration of young men into countries such as Russian looking for 
work; women whose husbands are away may be less likely to use contraception, as they 
perceive their risk of pregnancy as low. The 2012 survey estimated that that 23% of all 
married women and 8% of married 15-24 year olds use effective contraception, with the IUD 
being the most common method used. The contraceptive prevalence rate (CPR) among 
married women aged 15-49 in the 2017 survey is 29%, with 27% using modern methods. 
Among all women aged 15-49, the CRP is 21%, with 20% using modern methods. The IUD is 
the most commonly used method among married women (18%), all women (13%) and in all 
age groups. Use of contraception increases with age and peaks at 46% among women aged 
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35-39. The IUD is the most commonly used method in all age groups except those aged 15-
19, where LAM and the male condom are the most popular.   
 
Figure 2.3 Contraceptive use among all women by age and method, 2017 (Tajikistan) 
 
Unmet need for contraception peaks in the 30-34 age group among all women and married 
women. Unmet need is greatest among married women aged 30-34 (29%), with this age 
group seeing the largest jump from the previous age group in unmet need for limiting. In the 
2012 survey, holding oppositional attitudes towards contraception was the most common 
reason women with an unmet need provide for not using contraception; 36% of women with 
an unmet need cited their own opposition and 13% cited their partner’s opposition as the 
reason for not using contraception (26). The next most common reasons were infrequent/no 
sex (28%) and side effects/health risks/inconvenience (15%) (26).  
 
Figure 2.4 Women with unmet need for contraception by age group and marital 
status, 2017 (Tajikistan) 
 
0
5
10
15
20
25
30
35
40
45
15-19 20-24 25-29 30-34 35-39 40-44 45-49p
ro
p
o
rt
io
n
 o
f 
w
o
m
en
 u
si
n
g 
m
et
h
o
d
Age group
Female sterilisation Pill IUD Injectables Implants Male condom LAM Withdrawal
10
12
14
16
18
20
22
24
26
28
30
15-19 20-24 25-29 30-34 35-39 40-44 45-49
p
er
ce
n
ta
ge
  o
f 
w
o
m
en
Age group
married women all women
22 
 
Abortion is legal on request in Tajikistan. Eleven percent of women aged 15-49 have had an 
induced abortion and the total abortion rate (TAR) 0.5 per woman. In the 2012 DHS survey, 
the TAR was also 0.5 and 10% of women had had an abortion, indicating stability of the rates 
in the country (83). The TAR is 0.4 in urban and 0.5 in rural areas. Failure of contraception 
accounts only for 5% of induced abortions and the main reasons women provided for their 
decision to have an abortion were concerns about their health (37%) and that the pregnancy 
was unwanted (36%). The abortion rate increased with age, at 1 per 1,000 among women 
aged 15-19 and peaking at 28 per 1,000 among women aged 30-34 (Figure 2.5).  
 
Figure 2.5  Abortions per 1,000 women by age group, 2017 (Tajikistan) 
 
2.2.2 Palestine 
Figure 2.6 Map of the Occupied Palestinian Territories 
 
 
The conflict in the Occupied Palestinian Territories (the West Bank, East Jerusalem and the 
Gaza Strip, hereafter referred to as ‘Palestine’) has negatively impacted the health and 
wellbeing of Palestinians (88-92). More than 20% of communities in Area C have limited 
access to health facilities, (93), largely due to mobility restrictions imposed upon Palestinians 
as a result of the conflict (94). The conflict has also had negative effects on reproductive 
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health and rights in Palestine (22, 94) which has political implications in this context (22, 94). 
The population is young, with 41% of the population under age 15 and 30% aged 15-29 (95).  
 
The Palestinian Multiple Indicator Cluster Survey (MICS) 2014 provides the most recent data 
regarding reproductive health (the new survey is due to be completed by the end of 2019), 
with data regarding contraception available for married women only (96). (All data in this 
section is from the 2014 MICS unless referenced otherwise.) The MICS was conducted by the 
Palestinian Central Bureau of Statistics and the Ministry of Health, with support by the United 
Nations Children’s Fund. The sample frame was the Population Housing and Establishment 
Census 2007 and the Household Listing 2013. There were three questionnaires: household, 
women and children under five (data in this section relate to the women’s questionnaire). 
From March to April 2014, 13,964 women sampled were eligible and 13,367 were 
interviewed, representing a 96% response rate.   
 
The total fertility rate in 2014 was 4.1 (3.7 for the West Bank and 4.5 for Gaza). The 
adolescent fertility rate had decreased substantially over the past 20 years, but the current 
rate of 48 per 1,000 women aged 15-19 remains high for the region (96, 97). The rate in Gaza 
is almost twice as high as the rate in the West Bank (66 per 1,000 women vs 35 per 1,000 
women respectively) (96, 97). The adolescent fertility rate is highly associated with wealth 
index, with the rate at 86 per 1,000 in the poorest quintile vs 19 per 1,000 women aged 15-19 
in the richest quintile. The age-specific fertility rates (ASFRs) by region are presented in Figure 
2.7, which reflect a pattern of early childbearing. Fertility is low among adolescents and then 
sharply rises and peaks to 244 births per 1,000 among women age 25-29. 
 
Figure 2.7 Age-specific fertility rates by region, 2014 (Palestine) 
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Among married women aged 15-49, the CPR is 57% and modern CRP is 44%. Among married 
women aged 15-24, the modern CPR is 24% and the effective CPR in the same group is 
estimated to be 17%. The IUD is by far the most commonly used method among married 
women of all age groups (Figure 2.8). Married adolescents are the least likely of all age 
groups to use any form of contraception, with only 15% using any method (10% modern, 6% 
traditional).  
 
Figure 2.8 Contraceptive use among married women by age and method (Palestine) 
 
 
In 2014, total unmet need for contraception among married women was highest among 
women aged 20-24, at just over 15% (Figure 2.9) (96). Unmet need for spacing is also highest 
in this age group, at close to 15%. Unmet need for limiting surpasses unmet need for spacing 
in the 30-34 age group. A 2013 study indicated that unmet need is influenced by the 
availability and quality of services (particularly weak counselling), the availability of a female 
provider and provider negative attitudes towards family planning (95).  
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Figure 2.9 Married women with unmet need for contraception by age group 
(Palestine) 
 
The Palestinian Family Survey 2010 found that among married women not using 
contraception and not reporting wanting to have a child, the main reasons given for not using 
contraception were fear of side effects, inconvenience of methods and their husband’s 
opposition (98, 99). Further analysis of this survey data indicates that women are more likely 
to use contraception and are more likely to use modern contraception when couples agree 
about using it (98, 99). Spousal communication also increases the odds of contraceptive use 
(69). Lack of accurate and comprehensive information about contraceptive methods, lack of 
spousal communication regarding contraception, disapproval of peers and relatives 
(particularly husbands and mother-in-law), societal pressure to childbear and inadequate 
family planning services also influence contraceptive use (69, 100-103). Education is also an 
important factor in this context as Palestinian women who spend more time in education 
report fewer unintended pregnancies (104).  
 
Data regarding unintended pregnancy in Palestine generally comes from household surveys 
where married women are asked if their current or last pregnancy was intended at the time 
that they became pregnant, likely to underestimate the true proportion (104). A 2006 survey 
estimated that 38% of pregnancies in Palestine are unintended (104, 105). A non-
representative study in 2014 and found that 55% of women aged 15–49 years from a 
community sample (from underserved areas) said that their pregnancy was unintended 
(‘unwanted’) and, of these, 26% said that this was because it ‘was not their choice’. In a client 
sample (from service-delivery points), 40% reported unintended pregnancy, with 32% saying 
that it ‘was not their choice’ (93).  
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Abortion in Palestine is criminalised and is legal only to save a woman’s life (103, 106). Data 
on lifetime abortions among married women were collected for married women in the 2014 
MICS but are not published. Though there are no reliable estimates of the public health 
impact of unsafe abortion in Palestine, research conducted by the Safe Abortion Action Fund 
and PFPPA found that unsafe abortions are “numerous” (103). A qualitative interview study 
among Palestinian women revealed that limitations to safe abortion access included the legal 
restrictions, negative social consequences from one’s family and community if an abortion is 
discovered and differential access to abortion depending on location (107).     
 
2.2.3 Bolivia 
Figure 2.10 Map of Bolivia  
 
 
Bolivia is classified as a lower middle-income country, with 60% under the age of 29 (108).  
While the country has experienced recent economic growth, in 2015 around 39% of people 
were living below the national poverty line (109). Income inequality is high (109), with 
substantial inequality between indigenous and nonindigenous populations (110). Although 
there has been steady improvement, family planning progress in Bolivia has lagged behind 
other Latin American countries (111). In 2008, there were an estimated 2.4 million people 
aged 10-19, which equated to 21% of the population (112).  
 
The latest DHS survey is the Encuesta Nacional de Demografía y Salud 2008 (112), which was 
conducted by the Ministerio de Salud y Deportes, Programa Reforma de Salud and Instituto 
Nacional de Estadística with technical assistance from Macro International. Data from this 
survey is nationally representative and used a two-stage sample design: the first stage 
involved the systematic selection of primary sampling units with probability proportional to 
their size (the number of households) and the second involved selection of 20 households 
within each primary sampling unit. Data were collected from February to June 2008 from 
19,564 households. Complete interviews were conducted with 16,939 women aged 15-49 (a 
96% response rate) and 6,054 men aged 15-64 (a 91% response rate). A more recent Bolivian-
lead survey has since been conducted- the Encuesta de Demographia y Salud 2016 (113). The 
27 
 
2016 surveys maintains that the sample design is similar to the 2008 survey to achieve 
comparability. Data for this survey were collected from May to September 2016. Interviews 
were conducted with 11,814 women aged 15-49 (a 97% response rate) and 4,975 men aged 
15-64 (a 95% response rate). Data in this section are from the latest survey where they were 
collected.  
 
The total fertility rate in 2016 was estimated to be 2.9 births per woman (113). World Bank 
indicators (2015) report the adolescent fertility rate to be 70 per 1,000 women aged 15-19 
(109) and the 2016 survey reported found a similar rate at 71 per 1,000 (113). The adolescent 
fertility rate is higher than the rate in Tajikistan and Palestine, at 71 births per 1,000 women 
and significantly higher among rural women in this age group at 109 births per 1,000 women 
(113) (Figure 2.11). Sexual abuse is often a factor in adolescent pregnancies, particularly in 
girls under age 15 (108).   
 
Figure 2.11 Age-specific fertility rates, 2016 (Bolivia) 
 
In 2008, the modern CPR was 35% (40% urban, 28% rural) (112, 114). The 2016 survey found 
that among unmarried, sexually active women aged 15-19, an estimated 34% were not using 
any method of contraception (113), which was down from 52% in the 2008 survey (112). The 
2008 survey also found that 84.8% of unmarried sexually active women age 15-19 reported 
not wanting a pregnancy in the next two years, yet only 49% of them reported using any 
method of contraception. The main reasons these women gave for not using a method were 
that they were not married (51.5%), had infrequent sex (54.7%) or are not having sex (22.6%). 
Male condoms and the injection were the most common modern methods reported by this 
group (19.6% and 6.2% respectively), with 2% reporting that they use withdrawal and 13% 
using periodic abstinence. According to the 2008 DHS, among women who were married or 
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have a partner, unmet need for contraception was 20% overall and 38% among women aged 
15-19 (112, 114). A 2019 analysis of the 2008 DHS data found that among women of all age 
groups, use of long acting reversible contraceptive (LARC) methods was highest in the richest 
wealth quintile at 16% and lowest in the poorest wealth quintile at 2%, an indication of wide 
inequality (115).  
 
Figure 2.12 Modern and traditional contraceptive use among all women by age group, 
2016 (Bolivia) 
 
In December 2017 there was brief success in broadening the circumstances in which women 
can access legal abortion in Bolivia (116). At the time of writing however, abortion in Bolivia is 
still illegal except in cases of rape, incest and danger to the health of the woman (117). There 
are no official figures but research suggests that there are likely 100 illegal abortions 
conducted per day, the majority of which are likely to be unsafe due to the legal restrictions 
(114).  
 
2.2.4 Mobile phone use in the three countries 
While national telecommunication agencies exist in Palestine (the Ministry of 
Telecommunication and Information Technology) and Bolivia (Autoridad de Regulación y 
Fiscalización de Telecomunicaciones y Transportes), official and reliable data regarding age-
specific mobile phone ownership and usage does not appear to be available in English for the 
two countries. The 2017 Tajik DHS estimates that 21% of women ages 15-19 and 42% of 
women aged 20-24 own a mobile phone (86). This project’s local partners observed high 
usage among young people, which is why their original project proposals included a mobile 
phone component. The International Telecommunications Union (ICU) is the United Nation 
specialised agency for Information and Communication Technology. ICU data shows a steady 
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and sharp increase in mobile phone subscriptions in the three countries, particularly from 
2007 (Figure 2.13) (118). 
 
Figure 2.13 Mobile phone subscriptions per 100 people (2000-2017) 
 
 
2.3 Theory and evidence-based approaches to intervention 
development  
Best practice is to develop behaviour change interventions systematically (119-121), allowing 
for the intervention to be clearly defined. If the determinants of behaviour that an 
intervention targets and the methods used to alter these determinants are adequately 
described, it is easier to assess whether the methods are appropriate (122). This transparency 
also helps with the interpretation of the evaluation and makes adapting effective 
interventions to different contexts less challenging. Despite this, many descriptions of 
behaviour change interventions are limited (122). A context-specific, participatory approach 
to developing family planning interventions for young people makes it more likely that 
interventions address the specific determinants of the behaviour of the target group (58). 
Regarding interventions delivered by mobile phone, guidelines have recently been developed 
to standardise the reporting of the interventions (123). 
 
Along with clear descriptions of the components of interventions and the development 
process, theories can help explain how interventions work by describing the factors that have 
been altered to achieve change (124). Though the association between the effectiveness of 
interventions and the use of theory in their development is unclear (125), theory is 
recommended as a key component of the development process for this reason (120, 124, 
126).  
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When reviewing what interventions ‘work’, it is important to not only consider the results of 
the evaluation, but also to appraise the intervention development and content. This is 
especially important with interventions delivered by mobile phone because the intervention 
delivery mechanism (the mobile phone) is often mistakenly considered the active 
component, with less attention placed on the actual content of the intervention. For 
example, an intervention delivered by SMS may be effective in one context, but this does not 
mean that all interventions delivered by SMS are effective; the mobile phone is simply the 
vehicle for which to reach the target group. If the intervention is well-developed and the 
active components are well-specified, effective interventions can be adapted and may have a 
greater chance of being effective in different contexts.  
 
Along with face-to-face interventions, interventions delivered by mobile phone can be 
theory-based, with some researchers proposing theories or models specifically for ‘behaviour 
change technology’ (127-130). Interventions delivered by mobile phone can also include 
behaviour change methods (general techniques or processes that have been shown to be 
able to change determinants of behaviour), adapted for delivery by mobile phone (122, 124). 
While important in the development of all interventions, target group participation in mobile 
phone intervention development is especially important. This is because the delivery 
mechanism must be acceptable to the target population and aligned with how they use the 
technology in order for the intervention to be received as it is intended to be received (131). 
While mobile phones offer an alternative avenue in which to deliver interventions, greater 
emphasis is needed on their development, particularly in LMIC (49). 
 
2.4 Mobile phone interventions for contraception: a review of 
their development, theoretical basis and efficacy 
In this section, I review individual-level interventions delivered by mobile phone to improve 
contraceptive-related outcomes that were evaluated by randomised controlled trial. 
‘Individual-level’ health interventions are interventions that aim to create measurable change 
in a specific person (132). To identify trials, I started with Smith 2015’s Cochrane review 
“Mobile phone-based interventions for improving contraception use” (133) (see Appendix 1 
for the search strategy). The search terms would identify trials of interventions for 
contraception delivered by phone. The authors excluded trials if they did not include a 
contraceptive use-related outcome and if they could potentially be delivered by landline 
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phone. This resulted in five trials that fit their inclusion criteria (134-138). A LSHTM colleague, 
Dr Melissa Palmer, completed a literature search for a grant proposal using Smith et al’s 
search terms for the period 1 Jan 2015-8 Sept 2017.  Dr Palmer identified an additional five 
trials (44, 139-143) (Trent 2015, was the full publication of a trial that Smith identified, Trent 
2013). I ran the same search for the period 1 Sept 2017- 20 September 2018 and identified an 
additional two trials, one of which was the full publication (144) of a conference abstract 
identified by Dr Palmer (139) (144, 145). Dr Palmer and I included trials that evaluated a 
wider range of contraceptive-related outcomes. For example, I included the additional 
analysis of Castaño 2012 (Hall 2013) as it included knowledge of contraception as an 
outcome. Smith reports that only one trial was excluded because the outcome measure was 
not relevant, and this trial would have also been excluded by Dr Palmer and me (the outcome 
was not related to contraception) (146). In addition, I reviewed four additional Cochrane 
reviews (147-150), which did not result in the identification of additional trials. Below I 
present a narrative review the development, theoretical basis and reported results of the 11 
trials.  
 
Bull 2016 conducted a cluster RCT in Denver, Colorado, USA to evaluate the effect a mobile 
phone SMS program called ‘Youth all engaged!’ (YAE) when delivered alongside a face-to-face 
program for preventing adolescent births (‘Teen Outreach Program’, TOP) (44). TOP was 
delivered by a trained facilitator and consisted of 25 weekly 1-hour sessions covering 
psychological and behavioural topics such as values clarification, relationships, goal-setting, 
decision-making, human development and sexuality and community service learning (46). 
The content of YAE was developed through an iterative consultation process using FGDs with 
29 females and 30 males aged 14-18, piloting YAE with 96 participants and post-pilot exit 
interviews with 12 recipients (46). The authors provide a ‘theoretical framework’ that depicts 
how YAE is intended to influence its recipients, e.g. by increasing self-efficacy for 
contraceptive use and increasing future aspirations. They also provide a table that links the 
YAE message content to the TOP curriculum and the ‘theoretical base’ (contraceptive use, 
future aspirations, etc.). In the trial, YAE + TOP was compared to TOP alone. The authors did 
not specify the use of behaviour change methods. The behavioural primary outcomes were 
condom use, contraceptive use, access to care and pregnancy. Analyses were conducted 
according to randomised arm. There were no statistically significant differences between the 
groups. Sexually active participants were more likely to be lost to follow-up. The authors 
identify this as a potential source of bias because YAE or YAE + TOP may be more effective in 
participants who are at higher risk. 
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At a Planned Parenthood clinic in Brooklyn, New York, USA, Castaño 2012 conducted a trial of 
an educational SMS intervention providing information about the oral contraceptive pill (OC) 
among women under 25 who were using it (134). In the trial, 962 participants attending the 
clinic were randomised to receive either the intervention messages (one daily message 
delivered over 180 days) plus routine care or the control, routine care only. The messages 
were derived from an existing educational information handout that targeted oral 
contraceptive knowledge regarding the risks, benefits, side effects, use, effectiveness and 
mechanisms of action. The authors did not report using theory to inform the content of the 
intervention, suggest why providing information could influence change or report the use of 
behaviour change methods. The outcomes were various self-reported measures of OC 
continuation (use at follow-up, no OC interruptions, no missed pills in the past month and OC 
use at last intercourse). The intervention messages were compared to standard care (clinic 
contraceptive counselling plus educational handout). The analysis was conducted according 
to the intention-to-treat principle. The authors used logistic regression to adjust for 
predictors of continuation. Twenty-nine percent of the trial participants were lost to follow-
up. At six months, intervention participants were more likely than control participants to 
continue use of OCs (adjusted odds ratio 1.44, 95% CI 1.03 to 2.00) and to report that they 
avoided an interruption in OC use longer than seven days (odds ratio 1.53, 95% CI 1.13 to 
2.07) (134, 151). A separate analysis of the trial data showed a very modest improvement in 
knowledge about contraception among participants receiving the intervention. Knowledge 
was measured by a 41-item questionnaire covering the following dimensions regarding 
contraception: mechanism of action, effectiveness, use, side effects, risks, and benefits. 
Questions were coded 1 for a correct response and 0 for an incorrect response. The mean 
knowledge score was 23.7 in the control group vs 25.5 in the intervention group (p < 0.001) at 
six months (152).  
 
Harrington 2018’s thesis at the University of Washington, USA included the evaluation of 
family planning-focused post-partum SMS intervention delivered to pregnant, HIV-negative 
women over the age of 14 years in Kenya (study information from the university website 
abstract in the absence of published research and response from researchers after attempted 
contact) (145). The messages were delivered weekly from enrolment to six months post-
partum and the platform enabled bidirectional communication with a nurse. The abstract 
does not provide information regarding the intervention development, inclusion of behaviour 
change methods or theoretical basis. In the trial, the intervention was compared to ‘no SMS’ 
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and the primary outcome was self-reported highly effective contraceptive use. Ninety-eight 
percent (254/260) of trial participants were included in the analysis. Participants randomised 
to receive the intervention were more likely to use highly effective contraception at six 
months post-partum (adjusted risk ratio 1.26, 95% CI 1.04-1.52, p = 0.02).  
 
Hebert 2018 evaluated ‘miPlan’, a contraceptive counselling mobile app among African 
American and Latina women aged 15-29 attending four family planning clinics in a ‘large 
Midwestern city’ (144). The app content was developed with young African American and 
Latina patients using a ‘human-centred design’, where the target group was consulted 
throughout the app development process (153). The authors state that the Transtheoretical 
Model of Behavioural Change and the Theory of Planned Behaviour informed the app 
content, which targeted attitudes, norms and intention regarding contraceptive use, but do 
not specify the use of behaviour change methods. Participants were randomised to have 
access to miPlan in the clinic waiting room or to receive the contraceptive clinic visit alone. 
The study was powered for the outcome ‘interest in discussing LARC’ (an outcome measured 
immediately post intervention). Baseline interest was based on a previous pilot study, which 
was estimated at 25.8%. The authors chose a sample size of 220 participants, which would 
provide 80% power to detect an absolute increase in interest of 19.2% at the 5% significance 
level. Outcomes measured at three months were knowledge of contraceptive effectiveness, 
intention to use LARC and LARC uptake. Two hundred and seven participants were 
randomised and there was 19% loss to follow-up (the authors did not account for lost to 
follow-up in the target sample size). The analysis was per protocol. Besides LARC use, which 
was measured by chart review, all outcomes were self-reported. There were no differences 
between the groups in any of the outcomes besides in one knowledge question regarding the 
IUD effectiveness, which more intervention participants answered correctly (52.3% vs 30.8%, 
p=.001).  
 
A daily SMS stating, “Please remember to take your birth control pill”, was the intervention 
evaluated in Hou 2010’s trial conducted at a Planned Parenthood clinic in Boston, USA (136). 
The authors do not describe how the intervention was developed, whether it contains any 
behaviour change methods or whether it has any theoretical basis. Eighty-two sexually active 
women choosing OCs were randomised to the intervention or control (no SMSs). The sample 
size of eight-two was based on detecting a 1.6-pill improvement on an average of 2.6 missed 
pills per cycle. The average missed pills per cycle was derived from a previous study that 
found 2.6 pills on averaged were missed per cycle as measured by an electronic monitoring 
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device. The outcome was OC adherence measured by electronic monitoring devices with 
wireless data collection. The analysis was by intention-to-treat and 89% of participants 
(73/82) had complete outcome data at follow-up. There was no evidence for a difference in 
mean number of missed pills between the groups.  
 
Mobile for Reproductive Health (m4RH) is an SMS intervention that provides information on 
the benefits, disadvantages and side effects of nine family planning methods as well as 
addresses misconceptions about them (142, 154, 155). The authors do not report an explicit 
theoretical base for the intervention or specify the use of behaviour change methods. 
However, recipients of m4RH can request to receive ‘role model’ content- stories about how 
a person dealt with a particular sexual or reproductive health issue, which could be 
considered the behaviour change method ‘cultural similarity’ (‘using characteristics of the 
target group in source, message and channel’ (122)). The content was developed based on 
best practices for health communication programs and is based on the World Health 
Organization (WHO) Family Planning Handbook. A trial was conducted among male and 
female new consumers of m4RH in Kenya. New consumers were assigned to either a full-
access group or a limited-access group on a rolling basis (each new consumer was assigned to 
the opposite group that the previous new consumer was assigned to). The authors 
considered this process effectively random due to the high number of consumers and the 
large variation in SMS delivery times in Kenya as a result of differences in network coverage 
and speed. The full-access group had access to all m4RH’s components. The limited-access 
group had access to a clinic locator and general motivational messages about a variety of 
health topics and no information about family planning methods or role model content. 
Follow-up data was self-reported, collected by SMS in three ‘waves’- 24 hours, six days and 
three months after the consumer first accessed m4RH. The primary outcome was the number 
of family planning knowledge questions answered correctly (out of 5), which were asked at 
the six day follow-up wave. Other outcomes were contraceptive use, communication and 
service attendance, measured at the three month follow-up wave. The authors did not 
prespecify a sample size, presumably because the recruitment process would generate many 
potential recipients to provide follow-up data. Over 13 thousand (n = 13,629) new consumers 
were randomised. Follow-up response was low with 5,164 (39%) analysed regarding the 
knowledge questions and 2,863 (21%) analysed regarding the behavioural outcomes. There 
was a high proportion of missing data within survey waves, which the authors dealt with 
using multiple imputation. Participants randomised to receive full access of m4RH had a 
mean knowledge score of 2.19 compared to a mean score of 1.92 in the limited-access arm (p 
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< .001), which represents a 14% difference. There were no significant differences in the 
behavioural outcomes.  
 
In Accra, Ghana, Rokicki 2017 conducted a three arm cluster randomised trial among 756 
female students aged 14-24 years at 38 schools (140). The schools were randomised to a 
unidirectional SMS intervention, an interactive SMS intervention and control for 12 weeks. 
The unidirectional intervention consisted of one reproductive health SMS sent once a week. 
The interactive intervention consisted of one multiple choice question sent by SMS once a 
week. When participants responded to the question, they were immediately sent a SMS 
saying if they answered correctly along with the correct answer and information that 
corresponded with the unidirectional intervention content. Interactive intervention 
participants were sent mobile phone credit for every two correct responses. The intervention 
participants were also sent messages about the benefits of communicating with partners 
about reproductive health. Participants randomised to the control were sent messages once 
a week about malaria. Intervention content was developed through focus groups with young 
people to understand ‘the most popular sexual health topics of interest’. The authors do not 
provide information on the use of theory in the development of the intervention or specify 
the use of behaviour change methods. The primary outcome of the trial was reproductive 
health knowledge at three and 15 months, measured by a 24 item quiz. Secondary outcomes 
were pregnancy, sexual activity and contraceptive use measured at 15 months. All outcomes 
were self-reported. Follow-up was 95% at both time points and the analysis was by intention 
to treat. Knowledge was adjusted for the following baseline covariates: knowledge, age, 
religion, ethnicity, parental completion of secondary school and school size. At three months, 
average knowledge scores were significantly higher in both intervention groups compared to 
the control group. At 15 months, the interactive group only had significantly higher mean 
knowledge score than the control. There were no significant differences in secondary 
outcomes in the full sample, but both interventions decreased self-reported pregnancy 
among sexually active participants.  
 
Smith 2015 conducted a trial involving 500 women older than 17 years who sought an 
induced abortion at Marie Stopes clinics in Cambodia (135). The trial evaluated a mobile 
phone voice message and counselling intervention to support use of post-abortion 
contraception (the ‘MOTIF’ intervention) (156). The authors provide a conceptual framework 
based on the literature on the determinants of contraceptive use that drew on the COM-B 
(capability, opportunity and motivation) behavioural system (156-158). MOTIF was developed 
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by 1) reviewing the literature on contraceptive behavioural interventions 2) conducting 15 
interviews and 4 focus group discussions with the target group and 3) consultation with 
clinicians and organisations involved in mHealth activities in Cambodia (156, 157). The 
authors do not report the explicit use of behaviour change methods. The intervention 
consists of six automated, interactive voice messages with counsellor phone support sent 
three months after an abortion. Participants were allocated to groups by minimisation (by 
urban or rural clinic) to receive MOTIF or standard post-abortion care, which included post 
abortion family planning counselling at the clinic. The primary outcome was self-reported use 
of effective contraception at 4 and 12 months post abortion. Secondary behavioural 
outcomes were use of LARC, pregnancy, abortion, effective contraceptive use during the 
study, all self-reported using a questionnaire. Follow-up data was collected for 86% of 
participants at four months and 66% at 12 months. The results demonstrated an increase in 
self-reported use of effective contraception at four months in the intervention group 
compared to the control group (64% vs 46%, RR 1.39, 95% CI 1.17–1.66) and an increase in 
LARC use at four (29% vs 9%, RR 3.35, 95% CI 2.07-5.40) and 12 months (25% vs 12%, RR 2.08, 
95% CI 1.27-3.42). 
 
Trent 2015’s trial with women aged 13-21 using the injection at a medical practice in 
Baltimore, USA evaluated the Depotext intervention. Depotext consisted of daily SMS 
injection reminders that started three days before the appointment date plus additional 
health related messages (143). Control participants received standard care- “patient-initiated 
support and contact for missed appointments”. No details regarding the intervention 
development, theory or methods for changing behaviour were provided. The researchers set 
the minimum target sample size to 100 because they needed to conduct the recruitment and 
follow-up within a nine month period. This number was considered practical and would 
demonstrate feasibility and acceptability. The primary outcome was injection appointment 
attendance, which was monitored by an electronic tracking database. Participants 
randomised to receive the Depotext intervention attended closer to their scheduled 
appointments compared to participants randomised to the control arm for the first injection 
(B = -.75; 95% CI -1.4 to .06 p = .03) but not for the second and third. There was no overall 
difference in receiving the injection within the on-time window between the intervention and 
control groups. The authors mention that no overall difference was seen because participants 
who missed their appointments received additional telephone outreach.  
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Tsur 2008’s intervention consisted of two text messages providing information about the 
teratogenic risk associated with isotretinoin aimed to increase awareness and contraceptive 
use among women taking the drug. The authors did not provide information regarding the 
development or theoretical basis of the intervention and did not mention the use of 
behaviour change methods. Women aged 16-24 who were taking isotretinoin and called a 
drug consultation centre seeking advice were randomised by computer-generated random 
numbers kept in sealed envelopes to receive only the information in the initial phone 
consultation (control) or mailed written information and the two text messages one and two 
months after the initial phone consultation (137). The primary outcome was self-reported 
contraceptive use at three months. The sample size of 100 was based on the ability to detect 
a 30% absolute increase in use of contraception in the intervention group compared to the 
control group at the 5% level of significance, with 80% power. Follow-up data was available 
for 95% of participants (103/108). This small trial in Israel (n = 108) found no evidence for a 
difference in contraceptive use between the groups.  
 
Sridhar 2015 conducted a trial at the University of California Los Angeles (UCLA) Obstetrics 
and Gynecology clinic to evaluate Plan A Birth Control (Plan ABC) (141). Plan ABC is a mobile 
app that displays information about the non-permanent contraceptive methods. The content 
was adapted from three patient information resources used in the clinic, reviewed by family 
planning academics at UCLA and pilot tested with 40 patients for usability and clarity. There is 
no explicit theoretical basis for Plan ABC but one of the resources the content is based on 
mentions motivational interviewing as a component, otherwise, the authors do not mention 
the use of behaviour change methods. Women aged 18-45 not using contraception were 
recruited from the clinic waiting room before their appointment. Participants were 
randomised to receive contraceptive information from a health educator or from Plan ABC. 
The primary outcome of the trial was the effectiveness of the chosen method. The method 
chosen was verified by a review of medical records. Secondary outcomes were knowledge of 
the chosen method and patient satisfaction with counselling. The authors state that 120 
participants would provide 80% power detect a 20% absolute increase in the choice of a very 
effective contraceptive method (40% in the control and 60% in the intervention) at the 5% 
level of significance. There were no significant differences between the groups in any of the 
outcomes.   
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2.4.1 Summary  
Out of the 11 trials, eight evaluated interventions delivered primarily by SMS (44, 134, 136, 
137, 140, 142, 143, 145), two evaluated interventions delivered by mobile phone app (141, 
144) and one evaluated a mobile phone voice message intervention (135). The use of theory 
was mentioned in the development of only three of the interventions (44, 135, 144) and none 
mentioned the explicit use of behaviour change methods (although some interventions may 
have included them, e.g. m4RH). The content of four interventions was developed through 
iterative consultation with the target group (46, 140, 153, 156). Four trials (135, 140, 142, 
145) were conducted in a LMIC.  
 
The primary outcome was knowledge in two trials (140, 142), contraceptive use-related in 
eight trials (44, 134-137, 141, 143, 145) and ‘interest in discussing LARC’ in one (144). Six 
trials reported a beneficial effect of the intervention on the primary outcome compared to 
the control (134, 135, 140, 142, 143, 145). Only three trials had an objective measure as the 
primary outcome (136, 141, 143). (Herbert 2018 used chart review to determine LARC use, 
however outcomes were not specified as primary or secondary and the trial was powered for 
‘interest in discussing LARC’.) Of the five trials where knowledge of contraception was an 
outcome (134, 140-142, 144), four showed a beneficial effect of the intervention compared 
to the control. Both trials where knowledge of contraception was the primary outcome 
showed a beneficial effect (140, 142). All trials included a use-related outcome, however only 
three showed a beneficial effect (134, 135, 145). 
 
The evidence suggests that providing accurate information about contraception by mobile 
phone can increase knowledge about contraception. The evidence regarding contraceptive 
use is mixed, however, which could be due to the variability in the quality of the intervention 
development, the content of the intervention and trial methodology. The target group may 
not have been adequately consulted in the development, which would decrease the 
likelihood that the content was relevant and acceptable to them (for example, the 
development details regarding Harrington 2018’s intervention are not known). However, 
adequate consultation with the target group does not guarantee that the intervention will be 
efficacious, as in Hebert 2018. Heterogeneity in the comparators used in the trials makes it 
difficult to generalise about the efficacy of the interventions on contraceptive use. For 
example, Bull 2016’s comparator was a very comprehensive evidence-based face-to-face 
programme (the intervention group received this program plus an additional text message 
programme) and Castaño 2012’s comparator was standard care (clinic contraceptive 
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counselling plus educational handout). There was no significant difference in use in the Bull 
trial but there was in the Castaño trial. Despite ample global evidence demonstrating the 
existence of widespread negative attitudes towards contraception, none of the trials 
evaluated the effect of the intervention on attitudes towards contraception. 
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3 Intervention development  
3.1 Introduction 
This chapter is the research paper that presents the development of the intervention in 
Tajikistan, Palestine and Bolivia. This work was published in BMC Public Health as an open 
access article in May 2018 (50) (Appendix 2). 
 
Citation: 
(50) McCarthy OL, Wazwaz O, Osorio Calderon V, Jado I, Saibov S, Stavridis A, López Gallardo 
J, Tokhirov R, Adada S, Huaynoca S, Makleff S, Vandewiele M, Standaert S, Free C. 
Development of an intervention delivered by mobile phone aimed at decreasing unintended 
pregnancy among young people in three lower middle income countries. BMC Public Health. 
2018; 18(576). 
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3.2 Research paper 
3.2.1 Abstract 
Background: Unintended pregnancies can result in poorer health outcomes for women, 
children and families. Young people in low and middle income countries are at particular risk 
of unintended pregnancies and could benefit from innovative contraceptive interventions. 
There is growing evidence that interventions delivered by mobile phone can be effective in 
improving a range of health behaviours. This paper describes the development of a 
contraceptive behavioural intervention delivered by mobile phone for young people in 
Tajikistan, Bolivia and Palestine, where unmet need for contraception is high among this 
group.  
 
Methods: Guided by Intervention Mapping, the following steps contributed to the 
development of the interventions: (1) needs assessment; (2) specifying behavioural change to 
result from the intervention; (3) selecting behaviour change methods to include in the 
intervention; (4) producing and refining the intervention content.  
 
Results: The results of the needs assessment produced similar interventions across the 
countries. The interventions consist of short daily messages delivered over four months 
(delivered by text messaging in Palestine and mobile phone application instant messages in 
Bolivia and Tajikistan). The messages provide information about contraception, target 
attitudes that are barriers to contraceptive uptake and support young people in feeling that 
they can influence their reproductive health. The interventions each contain the same ten 
behaviour change methods, adapted for delivery by mobile phone.  
 
Conclusions: The development resulted in a well-specified, theory-based intervention, 
tailored to each country. It is feasible to develop an intervention delivered by mobile phone 
for young people in resource-limited settings. 
 
3.2.2 Background 
In developing regions in 2017, an estimated 89 million pregnancies were unintended, that is, 
were pregnancies that occurred too soon or were not wanted at all (159). Unintended 
pregnancy is associated with a range of negative health and social consequences, for 
example, poorer access to antenatal care, increased risk of low birth weight and pre-term 
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birth, delays in women’s educational and career achievements and unsafe abortion (2-20). 
Women aged 15-24 in low and middle income countries (LMIC) are at particular risk and are 
more likely to have an unmet need for contraception compared to older women (26). 
Women with an unmet need for modern contraception are those who want to avoid a 
pregnancy but currently use no method or use a traditional method (21). It is estimated that 
meeting adolescents’ unmet need for modern contraception would reduce unintended 
pregnancies by six million each year (21).  
 
Tajikistan, Palestine and Bolivia are three LMIC where women are at high risk of unintended 
pregnancy. In Tajikistan, women have 0.5 more children than desired, with the total wanted 
fertility rate at 3.3 births per woman compared to the actual of 3.8 (83). Unmet need for 
contraception among married 15-24-year-old women is estimated to be 26%, with unmet 
need for birth spacing the highest among women in this age group compared to women in 
other age groups (83). In Bolivia, family planning progress has lagged behind other Latin 
American countries (111). In 2008, unmet need for contraception among women aged 15-19, 
was estimated to be 38% (112, 114). Among unmarried, sexually active women aged 15-19, 
51.9% are not using a method of contraception. Among these women, 84.8% reported not 
wanting a pregnancy in the next two years, yet only 48.8% of them reported using any 
method of contraception. In Palestine in 2006, an estimated 38% of pregnancies were 
unintended (104, 105). In 2014, unmet need for contraception was highest among women 
aged 20-24, at 15% (96). While the adolescent fertility rate had decreased substantially in 
Palestine over the past 20 years, the current adolescent fertility rate of 48 per 1,000 women 
aged 15-19 remains higher than most other countries in the region (96, 97).  
 
The non-permanent ‘effective’ contraceptive methods have less than 10% typical use failure 
rate at 12 months, i.e. oral contraceptives, injectables, intra-uterine device (IUDs), implants, 
the patch and the ring (IUDs and implants being the most effective) (28-30). While effective 
methods are available in Tajikistan, Bolivia and Palestine, there remain barriers to use. In 
Tajikistan, oppositional attitudes towards contraception is the most common reason women 
with a Demographic and Health Surveys-defined (DHS) unmet need (25) provide for not using 
contraception; 36% of women with an unmet need cite their own opposition and 13% cite 
their partner’s opposition as the reason for not using contraception (26). The next most 
common reasons are infrequent/no sex (28%) and side effects/health risks/inconvenience 
(15%) (26). In Bolivia, the main reasons unmarried, sexually active adolescent women who 
report not wanting a child in the next two years provide for not using a method are 
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infrequent sex (54.7%) or not married (51.5%) (112, 114). Among married women in Palestine 
not using contraception and not reporting wanting to have a child, the main reasons given for 
not using contraception were fear of side effects, inconvenience of methods and their 
husband’s opposition (98, 99).  
 
Mobile phones are now a popular and widely established vehicle to deliver health 
interventions. There is some evidence from trials that mobile phone-based interventions can 
improve knowledge about contraception (152, 160) and contraceptive-related behaviours 
(134, 135, 143, 147, 151, 161). However, all but two of these trials (135, 160) were conducted 
in the United States and none had low risk of bias (133) according to the Cochrane 
Collaboration’s tool for assessing risk of bias in randomised controlled trials (162). 
 
In January 2015, the London School of Hygiene and Tropical Medicine (LSHTM) started a 
collaboration with the International Planned Parenthood Federation’s (IPPF) Member 
Associations in Tajikistan, Bolivia and Palestine to develop and evaluate an intervention 
delivered by mobile phone to enhance contraceptive choice among young people in each 
country. At this development stage of the project, we included both young women and men 
because women in these settings have reported that their male partners’ attitudes influence 
their use of contraception. To the best of our knowledge, this research is the first to develop 
such an intervention for young people in these countries. This project helps fill the research 
gap regarding the development of mobile phone interventions for contraception in LMIC. 
 
3.2.3 Methods  
Intervention development approach 
Intervention Mapping (IM) guided the development of the interventions (122, 124). IM is a 
protocol for the systematic development of health behaviour change interventions. It is a 
cumulative process that often necessitates moving back and forth through the following 
steps: (1) needs assessment; (2) specifying behavioural change to result from the 
intervention; (3) designing the intervention components by selecting behaviour change 
methods; (4) producing and refining the intervention content; (5) planning intervention 
implementation and (6) planning intervention evaluation. This paper describes steps 1-4 and 
compares the results across the countries.  
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1. Needs assessment 
The needs assessment aimed to understand unintended pregnancy and contraceptive use in 
each context. Activities included 1) establishing a project planning group 2) a literature search 
3) focus group discussions (FGDs) and interviews with the target group and 4) interviews with 
local service providers.  
 
Each country’s project planning group was a collaboration between the local partner, the 
research partner and the three IPPF Regional Offices. The local partners consisted of the 
Executive Director, Research Assistants, and various other employees of the organisation that 
contributed to the development process in different capacities. The research partner 
designed and managed the research. Staff from Regional Offices attended meetings and 
facilitated communication about the research between the research partner and the local 
partner.  
 
Relevant articles were identified through the research partner’s existing knowledge, 
recommendations by the local partners, a Google search for grey literature and a search of 
MEDLINE. The results of the literature search informed the discussion guide used in the FGDs 
and interviews. Remote meetings were held from February to September 2015 to plan and 
organise the field research, which took place in July 2015 in Tajikistan, August/September 
2015 in Bolivia and October 2015 in the West Bank, Palestine.  
 
The FGDs and interviews with the target group explored their knowledge of and attitudes 
toward contraceptive methods, perceived barriers in using and confidence in communicating 
about them (see Appendix 3 for the Target group discussion guide). This information was 
used to better understand the personal, socio-cultural and socio-economic factors involved in 
contraceptive use in each setting. The consultations also aimed to understand how amenable 
young people are to trying new contraceptive methods, their patterns of mobile phone use, 
preferences for intervention content and views on privacy regarding receiving contraceptive 
information on their mobile phone. The interviews with providers explored similar topics 
from a provider perspective (see Appendix 4 for the Provider discussion guide). The research 
partner trained local research staff in FGD and interview facilitation and research ethics. The 
number of groups and interviews estimated (up to ten of each) was based on previous 
intervention development experience (163, 164).  
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Target group participants were identified by convenience sampling through the local 
partners’ youth volunteer network and services in Dushanbe and Vahdat (Tajikistan), El Alto 
(Bolivia) and Ramallah, East Jerusalem, Hebron and Bethlehem (Palestine). Women and men 
were eligible if they were legally able to give independent informed consent (age 14 in 
Tajikistan, 18 in Bolivia and 18 in Palestine). There was no upper age limit but each local 
partner focused on recruiting younger participants as this most closely matched the target 
group ‘young people’ (165, 166). Providers were affiliated with each local partner.  
 
Each FGD and interview was conducted by a research staff member who was a native speaker 
of the local language (and in most cases also spoke English) and was attended by a bilingual 
(English and local language) research staff member who took detailed notes. Immediately 
after, the facilitator/interviewer relayed the information to the research partner who made 
detailed notes in English. The FGDs were comprised of participants of the same gender and 
facilitated by a staff member of the matching gender. The FGDs and interviews were held at 
the service or at a location hired specifically for this purpose. The FGDs and interviews were 
audio recorded. The FGDs lasted up to 90 minutes and the interviews lasted up to 60 
minutes. Resources allowed only for the FGDs in Bolivia to be transcribed and translated into 
English. We conducted a descriptive thematic analysis of the FGDs and interviews by 
examining the discussion notes related to each theme in the discussion guide. An information 
technology partner consultant based in the United Kingdom reviewed the local mobile phone 
operators and identified local technology partners.  
We depicted the results of the needs assessment visually in a ‘logic model of the problem’.  
 
2. Specifying behavioural change 
The needs assessment led to the specification of the desired behaviours for target group to 
accomplish as a result of the intervention (behavioural outcomes) and of the desired changes 
in the environment to occur as a result of the intervention (environmental outcomes). The 
performance objectives for the behavioural outcomes were then specified by identifying the 
smaller actions that are logically required to perform the outcome. The determinants of these 
actions were specified from the literature search and insights from the FGDs and interviews 
and behaviour-oriented theories (124). Mapping these against one another in a matrix 
enabled the identification of the most immediate behaviours that the intervention aims to 
alter in the individual (change objectives). While the environmental outcomes were specified, 
it was beyond the scope of the project to develop an intervention to target these conditions 
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therefore the performance objectives and determinants for the environmental outcomes 
were not specified. 
 
3. Designing the intervention  
This step involved choosing theory-informed behaviour change methods to include in the 
intervention and deciding how to deliver them (122, 124, 167). Potential methods were 
identified by considering: 1) authors’ report of the methods used in existing effective 
interventions for contraception (151, 168, 169) and 2) the methods shown to modify each 
determinant according to the IM taxonomy (122). (The IM taxonomy describes the behaviour 
change methods that have been shown to modify different types of behavioural 
determinants.)  Throughout the process, the conditions under which the methods can be 
effective were considered (the ‘parameters for effectiveness’) (122, 124).  
 
4. Producing and refining the intervention content 
The intervention content was written when behavioural change was specified, and the 
methods and theoretical basis of the intervention were identified. The research partner 
wrote the initial content. It was then reviewed by the local partner for cultural 
appropriateness and amended with the research partner. Next, the target group was 
consulted for their views on the tone, acceptability and comprehensibility of the content. The 
content was refined with the target group after each consultation and tested until it was 
acceptable to them.    
 
3.2.4 Results 
1. Needs assessment 
The factors reported in the published literature that influence contraceptive use and reasons 
for unmet need in LMIC and in Tajikistan, Bolivia and Palestine are summarised in the 
Background.  
 
Focus group discussions and interviews with the target group 
Eight FGDs each were conducted in Tajikistan and Bolivia and five were conducted in 
Palestine; one user interview was conducted in Tajikistan, two in Bolivia and four were 
conducted in Palestine (see FGD and interview demographics in Table 3.1). In Tajikistan and 
Bolivia, we stopped the FGDs and interviews when no new data emerged in relation to the 
themes in the discussion guides. The FGDs and interviews coincided with the escalation in 
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conflict in the West Bank in the first few weeks of October 2015. Due to logistical challenges 
related to this, we were unable to conduct more than five FGDs in Palestine. 
 
Table 3.1  Focus group discussion and interview demographics 
 Tajikistan 
n = 78 
n (%) 
Bolivia 
n = 64 
n (%) 
Palestine 
n = 35 
n (%) 
Number of participants     
FGD1 10 5 10 
FGD2 8 8 Not attended 
FGD3 10 10 Not attended 
FGD4 8 5 4 
FGD5 15 10 3 
FGD6 9 10 7 
FGD7 9 7 7 
FGD8 8 7 Not attended 
Interviews 1 2 4 
Age    
15-19 37 (47.4) 26 (40.6) 2 (5.7) 
20-24 37 (47.4) 36 (56.3) 26 (74.3) 
25-30 4 (5.1) 2 (3.1) 5 (14.3) 
Missing 0 0 2 (5.7) 
Gender    
Male 33 (42.3) 28 (43.8) 13 (37.1) 
Female 45 (57.7) 36 (56.3) 22 (62.9) 
Missing 0 0 0 
Residential area    
City 50 (64.1)  
not collectedb 
10 (28.6) 
Othera  28 (35.9) 24 (68.6) 
Missing 0 1 (2.9) 
Occupation    
Working 20 (25.6) 4 (6.3) 5 (14.3) 
Unemployed 8 (10.3) 0 3 (8.6) 
Full-time parent 1 (1.3) 0 3 (8.6) 
In education or training 49 (62.8) 60 (93.8) 19 (54.3) 
Missing 0 0 5 (14.3) 
Pregnancy intention (current)    
Avoid  11 (14.1) 38 (59.4) 13 (37.1) 
Unsure/not avoid/do not mind 29 (37.2) 14 (21.9) 18 (5.1) 
Not sexually active 30 (38.5) 12 (18.8) 2 (5.7) 
Missing 8 (10.3) 0 2 (5.7) 
Current method    
Nonec 51 (65.4) 20 (31.3) 13 (37.1) 
Condoms only 22 (28.2) 31 (48.4) 3 (8.6) 
Withdrawal only 0  1 (1.6) 3 (8.6) 
Condoms and withdrawal 2 (2.6) 0 0 
Calendar-based only 0  5 (7.8) 2 (5.7) 
Effective methodd 3 (3.8) 5 (7.8) 8 (22.9) 
Condoms and calendar-based 0 1 (1.6) 1 (2.9) 
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 Tajikistan 
n = 78 
n (%) 
Bolivia 
n = 64 
n (%) 
Palestine 
n = 35 
n (%) 
Lactational amenorrhea method only 0 0 1 (2.9) 
Condoms and lactational amenorrhea 
method 
0 0 1 (2.9) 
Missing 0 1 (1.6) 3 (8.6) 
a ’Other’ in Tajikistan is Vahdat, a large town 10 km outside of the capital Dushanbe; ‘Other’ in 
Palestine is village or refugee camp 
b Participants from El Alto, La Paz or close surrounding areas 
c Includes participants not sexually active 
d Oral contraceptives, injectables, intra-uterine device (IUDs), implants, the patch or the ring 
 
Use of mobile phones 
Use of mobile phones was nearly ubiquitous in all three countries but there was some 
variation in terms of the types of phones used and mobile Internet access. Most participants 
owned a smart phone, and if not, they owned a feature phone. Around five female 
participants in Vahdat, Tajikistan said that they did not have a mobile phone at all. In 
Tajikistan and Bolivia, it was more common to have regular mobile Internet access than in 
Palestine.  Of those who owned a smart phone, Android phones were the most popular, with 
participants in Bolivia saying iPhones were for people of “high status”. Participants in 
Tajikistan and Bolivia accessed the Internet through their phones. A few participants in 
Tajikistan said that access was sometimes restricted due to insufficient funds to support 
Internet connectivity. In the rural areas of Tajikistan, mobile Internet connection is expensive, 
and electricity is restricted to three to five hours a day in the winter, restricting the ability to 
charge the battery. In Bolivia, participants said that they do not have Internet access on their 
phones all the time and buy the smallest data package possible to support use of Facebook 
and WhatsApp. In Palestine, many did not have regular Internet access on their phones and if 
they did, most access the Internet by Wi-Fi only; those who sometimes access the Internet 
though their mobile data said that it is common for the connection to be lost. 
 
Contraception support 
Participants in all three countries were very enthusiastic about receiving information about 
contraception on their phone. Participants in Tajikistan thought that acquiring accurate 
information would improve young people’s attitudes towards contraception. In Bolivia, 
participants expressed very strongly the need for more information and talked about the 
convenience of being able to look at their phones for contraceptive information without 
having to ask anyone. In Palestine, while most young people wanted contraceptive 
information delivered on their mobile phones, female participants were more supportive of 
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the idea than the male participants. A group of male participants said that they may read the 
information and benefit from it, but it would be considered a joke and not taken seriously. A 
male participant said that contraceptive information delivered to phones is new in Palestinian 
society and that it is important that the information be given in a respectful way as “people 
feel shame about these issues”. 
 
Intervention delivery preferences and privacy 
Participants expressed a range of mobile phone media ideas for intervention delivery, such as 
videos, pictures and animations. In general, participants preferred to receive contraception 
support through short message. In Tajikistan, participants thought it was helpful to save the 
messages to read later at a convenient time and because messages are easy to delete if they 
want to prevent others seeing them. However, a few were less comfortable receiving support 
by short message because they were perceived as less private. Bolivian participants, while 
interested in a variety of intervention delivery modes, preferred information to be sent by 
simple instant messaging through an app or text messaging. Palestinian participants 
preferred text messages for intervention delivery, with some saying that they wanted 
messages delivered by app instant messaging. 
  
Most participants reported that they do not share their phones. Participants in Tajikistan said 
that if they do share their phone, they lend their phone to friends or family to take photos, 
play games, listen to music and browse social networks. One female participant in Palestine 
said that sometimes she asks her children to check her phone when she is busy, and she was 
concerned that they would see the messages. Another Palestinian participant said that she 
would share her messages with her husband to “educate him”. A few participants mentioned 
concerns about others seeing the messages and having information about contraception on 
their phone, but the majority were not concerned if they can password protect the phone.  
 
Intervention content 
Preferences for intervention content were similar across the countries, with some context-
specific preferences. In all countries, participants wanted to hear about other people’s 
experiences, particularly “success stories”, with using contraception. In Bolivia, participants 
thought that hearing real stories or “testimonies” from people who have had experience 
using different contraceptive methods would make them feel confident in trying new 
methods.  Some participants in Tajikistan however, did not want information in the form of 
stories because they value the advice from a specialist over advice from a peer. In Palestine, 
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participants said that they would trust “scientific” information. Participants in all countries 
wanted clear and concise information about the advantages and disadvantages of the 
different methods, how to use them and where they can obtain them. Tajik participants said 
that the content should not contain difficult terminology and the ‘voice’ should not be young, 
as this would be perceived as less trustworthy. A female group in Bolivia said that they 
wanted “little messages” giving advice and not telling them what to do. In terms of 
frequency, Tajik participants thought that one to two brief messages a day is acceptable, 
Bolivian participants wanted 1-3 messages a day and Palestinian participants said that they 
wanted around three messages per day. 
 
Knowledge about contraception 
Across the countries, there was a good level of awareness of the effective methods, but a lack 
of comprehensive knowledge such as the efficacy, advantages and disadvantages of the 
methods, how to use them and how they work. Participants agreed that young people do not 
have adequate information about contraception and were curious to know more about the 
range of methods available. 
 
Attitudes and beliefs towards contraception 
Across the countries, participants expressed a range of negative beliefs about effective 
contraception. Common beliefs were that hormonal contraception (including the non-
hormonal IUD) is damaging to the health of the women, not effective in preventing 
pregnancy, causes heavy and irregular bleeding (IUD), infertility and weight changes. In 
Bolivia, participants mentioned that the IUD can rust in the uterus and causes cancer and that 
hormonal contraception makes people “stop being normal”. Tajik participants mentioned 
that the IUD can grow into the skin. A few female participants in Palestine spoke favourably 
of the IUD but most thought that the metal in the IUD is harmful and causes an irregular 
menstrual cycle. A female group in Palestine though that the pill causes anxiety and 
nervousness.  
 
In Tajikistan and Palestine, most participants approved of the concept of family planning and 
thought that society did as well. This was mainly because they believed that it helps families 
plan and assess their economic situation. Palestinian participants thought that it is better to 
use “natural” methods in the first year of marriage, with a male group saying that using 
contraception in early marriage will create problems. 
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Communication about contraception 
In Tajikistan and Bolivia, participants expressed a lack of confidence communicating about 
contraception with partners, parents and providers. Participants in Palestine thought that it 
was possible to talk to close friends and mothers about contraception. A female Palestinian 
participant said that it is common for partners to talk about sex before marriage (it was not 
clear if this was discussion about contraception or just sex). In Tajikistan, a group of male 
participants said that it can be difficult to talk about contraception with a partner that they 
have been in a relationship with for a while because they fear that their partner would take 
offense. A Tajik female group thought that it is difficult to negotiate contraceptive use if they 
did not want a pregnancy at the time and their partner did. Bolivian participants said that 
they are confident talking to close friends (friends of opposite gender must be very close) but 
not confident talking to partners unless they know them very well and trust them. They said 
that talking about contraception usually happens after they begin a sexual relationship and if 
a discussion about contraception were initiated too early with a partner, the partner would 
judge them as promiscuous. 
 
In all countries, participants were not confident talking to providers about contraception 
because of the cultural stigma surrounding sex before marriage, concerns about 
confidentiality and fear of being judged. In Bolivia, many participants spoke of negative 
experiences at services.  
 
Environmental factors 
In Tajikistan and Palestine, participants expressed that the strong stigma surrounding sex 
before marriage in their cultures creates concerns about confidentiality and prevents them 
from accessing services. In Bolivia, this stigma was implicit, with participants talking about 
fear of being judged for seeking sexual and reproductive health information and services. 
Many participants in Bolivia spoke of experiences of being given “bad looks” for attending 
services (pharmacies and reproductive health services) and fear of feeling embarrassed and 
ashamed. There was a very strong fear in Tajikistan and Bolivia that others (people in the 
community) will know that they attended, judge them and spread “rumours”. There was 
general agreement across the discussions in Palestine that unmarried people accessing 
services is not accepted and is highly stigmatised. A female group in Palestine felt that they 
would be judged by providers and they will be asked if they are married or not if they attend 
a service. They also felt that they would be judged by their community if they went to a 
service and were not married.  
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In Palestine and Tajikistan, participants spoke of pressure to begin childbearing soon after 
marriage (Tajik participants mentioned nine months after). If they do not, they fear that they 
will be judged and considered unhealthy. Many participants in Palestine talked about the 
societal pressure from their mother-in-law, friends and neighbours to conceive soon after 
marriage. If a married woman in Palestine prefers to complete her university degree, 
participants said that she is pressured to conceive and if she does not, the community 
assumes that she has fertility problems. A group of female participants in Palestine 
mentioned that it can be difficult to reach the service because of checkpoints.  
 
Partners and the educational system are environmental agents that also contribute to the 
problem. This is apparent from participants’ report of the lack of partner communication 
about contraception before sexual activity and their lack of comprehensive knowledge about 
contraception. 
 
Interviews with service providers 
Six interviews with service providers were conducted in Tajikistan (5 doctors and 1 nurse 
outreach worker) and five were conducted in Bolivia (1 health advisor, 1 educator, 1 nurse 
and 2 doctors). Due to logistical challenges as a result of the escalation in conflict in the West 
Bank, only one provider interview was conducted in Palestine.  
 
Providers in all countries said that young people are generally aware of the range of methods. 
However, many said that they do not know how they work or how to use them and want 
more information on these topics. In Bolivia, lack of information and misinformation is what 
most providers viewed as the greatest barrier for young people using new methods, along 
with the cost of contraception. 
 
Providers in Tajikistan and Bolivia thought that young people are eager for more information 
about contraception and that providing this would help more young people use methods. 
Bolivian providers also said that more young people would use methods if they were 
affordable. The Palestinian provider said that in the pre-marital counselling sessions that she 
conducts, young people ask questions that make it obvious that they are already sexually 
active. Her perception is that young people want more information because many are having 
sex before marriage. She thought that providing young people with other people’s success 
stories would help young people try new methods. 
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Providers in Tajikistan thought that attitudes towards reproductive health are changing and 
that people are thinking about the consequences of sexual activity before engaging in it. One 
provider said that young people have a positive attitude towards contraception. Providers 
said there is a lot of misinformation among young people in Bolivia and that they fear the 
perceived side effects, such as the infertility they associate with oral contraceptives. The 
Palestinian provider said that that young people think that the IUD makes them nervous and 
infertile. 
 
Tajik providers commented on how religion does not accept sexual activity before marriage 
and that the mother-in-law has a great amount of influence on her daughter-in-law’s 
contraceptive use. Providers said that young people (particularly young unmarried people) do 
not even try to attend services covertly because they are too concerned that someone will 
find out. A provider in Bolivia said that barriers stem from problems with the family and that 
these women are more at risk for early sexual debut. Some providers in Bolivia also 
mentioned machismo as a barrier in that if a woman is using contraception, men will perceive 
her as “horny”, which is threatening to their masculinity. See Figure 3.1 for the Logic model of 
the problem. 
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Figure 3.1 Logic model of the problem 
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2. Specifying behavioural change: results 
Behavioural outcomes 
Based on the needs assessment results, we specified the key behavioural and environmental 
outcomes (Table 3.2).  
 
Table 3.2  Behavioural and environmental outcomes 
Behavioural 
1. Young people use effective 
contraception 
2. Young people access 
reproductive health services 
3. Young people 
communicate with 
partners about 
contraception before 
sexual activity 
Environmental* 
1. Sex before 
marriage is less 
stigmatised 
2. Young people 
have access to 
comprehensive 
and accurate 
sexual and 
reproductive 
health education 
3. Partners 
discuss 
contraception 
before a sexual 
relationship has 
begun 
4. Providers do 
not judge 
young people 
who access 
services 
5. Young 
people are 
not 
pressured 
into 
childbearing 
*Not targeted by the mobile phone intervention 
 
Theory, performance objectives and determinants 
The Integrated Behavioural Model (IBM) (170) is the overarching framework for the 
intervention This project’s IBM was adapted to include knowledge as a fundamental 
determinant of behaviour, as in the Information Motivation-Behavioural Skills Model (171) 
(Chapter 4, Figure 4.2). 
 
Table 3.3 presents the behavioural outcomes, performance objectives and determinants. The 
literature supports the determinants knowledge (21, 55, 58, 59, 62-64, 66, 71, 73, 74) and 
attitudes (21, 55, 57, 59, 61-67, 70), as important influences on contraceptive use. It was clear 
from the needs assessment that accurate information about effective contraception was low. 
Providing accurate information in a context where there is none or very little, may change 
people’s beliefs. Attitudes and intention were verified by behaviour-oriented theory (170, 
172, 173). Personal agency (174) in the IBM is comprised of efficacy (170, 175, 176) and 
control beliefs (170, 177). The addition of perceived control acknowledges that while a 
member of the target group may feel confident in using a contraceptive method, they may 
not feel that they have control over whether they use it.  
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While intention was identified as a determinant, the intervention does not influence it 
directly, rather, the intervention aims to influence the behavioural (attitudinal), efficacy and 
control beliefs identified in the needs assessment, which all influence intention.  
 
Table 3.3  Behavioural outcomes, performance objectives and determinants 
Behavioural 
outcomes 
Performance objectives Determinants 
 
 
 
 
Use effective 
contraception 
 
 
po1.1 Choose a method Knowledge about the effective methods 
Attitude towards using effective methods 
Intention to use effective methods 
Personal agency in choosing an effective 
method 
po1.2 Acquire the method Knowledge of where to get effective 
contraception 
Attitudes about acquiring effective 
contraception 
Intention to acquire effective 
contraception 
po1.3 Use the method 
correctly 
 
Knowledge about how to use effective 
contraception correctly 
Intention to use effective contraception 
correctly 
Personal agency in using effective 
contraception correctly 
 
 
 
Access 
reproductive 
health services 
 
po2.1 Locate a service 
 
Knowledge of where to get effective 
contraception 
Attitudes about acquiring effective 
contraception 
Intention to locate a service 
po2.2 Travel to the service Intention to travel to a service 
Personal agency in traveling to a service 
po2.3 Communicate 
effectively with providers 
Personal agency in communicating with 
providers 
 
 
 
Communicate 
with partners 
about 
contraception 
before sexual 
activity 
po3.1 Initiate conversation 
with partner about 
contraception 
Attitudes towards partner’s approval of 
contraception 
Intention to initiate conversation about 
contraception 
Personal agency in initiating a 
conversation about contraception 
po3.2 Clearly state own 
preferences regarding  
contraception to partner 
Intention to clearly state contraceptive 
preferences to partner 
Personal agency in clearly stating 
contraceptive preferences to partner  
po3.3 Listen to partner’s 
preferences regarding 
contraception 
Intention to listen to partner’s 
contraceptive preferences 
Personal agency in listening to partner’s 
contraceptive preferences 
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Change objectives 
Crossing the behavioural outcomes, performance objectives and determinants, it was 
possible to specify the most immediate behaviours that the intervention aims to alter (see 
Table 3.4 for a partial matrix and Appendix 5 for the complete matrix). The change objectives 
for all countries were the same, except for a2.1.3, which only applies to Bolivia, because this 
was a specific cultural norm that emerged from the needs assessment. 
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Table 3.4  Partial matrix of change objectives 
Performance objective Determinants 
 Knowledge Attitudes Intention Personal agency 
Young people will… Behavioural outcome 1: Use effective contraception 
po1.1 Choose a method k1.1.1 Name the effective 
methods 
 
k1.1.2 Describe how the 
effective methods work 
 
k1.1.3 List the risks & benefits 
of the range of effective 
methods  
 
 
 
a1.1.1 Express positive attitudes 
towards the effective methods 
 
a1.1.2 Recognise that hormonal 
methods are not less healthy than 
non-hormonal methods  
 
a1.1.3 Differentiate between real 
potential side-effects and 
misconceptions  
 
a1.1.4 Recognise that an 
experience of side-effects in one 
method may not occur in another 
method 
i1.1.1 Assess options 
 
i1.1.2 Express intention to 
choose effective 
contraception 
pa1.1.0 Express personal 
agency in choosing an 
effective method despite fears 
of being judged by society 
(married or not married) 
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3. Designing the intervention components: results 
Practical application of the methods 
After the needs assessment, through frequent discussions, the project planning groups 
decided that the intervention would be delivered through short, one-way messages.  
 
Behaviour change methods  
Descriptions of the methods used in the effective contraceptive interventions, were limited 
(134, 135, 143, 161, 178-181). Two of these trials (182, 183) reported using motivational 
interviewing, which could not be successfully delivered though automated messages.  
 
Using the IM taxonomy, we identified methods previously shown to be effective in modifying 
the determinants (knowledge, attitudes, personal agency) and considered their use for the 
intervention. Because the methods had to be delivered through short instant message, they 
required adaptation and there were only two methods from the initial list whose parameters 
for effectiveness (the conditions under which the methods can be effective) could be fully 
satisfied (belief selection and tailoring). While the parameters for most methods could not be 
fully satisfied, they were used if they could partially or potentially be satisfied. The final 
methods included in the intervention are (122): belief selection, facilitation, anticipated 
regret, guided practice, verbal persuasion, tailoring, cultural similarity, arguments, shifting 
perspective and goal setting (see Appendix 6 for details regarding the behaviour change 
methods).  
 
4. Producing and refining the intervention content: results 
The initial message sets were largely similar across the countries given the similar results of 
the needs assessment. Feedback from the Tajik partner on the initial set of messages was 
regarding specifics about the methods available in the country. Feedback from the Bolivian 
partner was regarding the meaning of some of the messages, which was clarified through 
discussion. The Palestinian partner’s initial feedback was them seeking clarification for the 
rationale behind some of the messages and suggesting a few changes to maintain cultural 
sensitivity.  
 
In Tajikistan, thirty-four young people (17 female and 17 male, the majority of whom were 
volunteers at the organisation) tested the intervention over four rounds. The Bolivia 
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intervention was also tested over 4 rounds and involved 47 young people (29 female and 18 
male) who were a mix of the organisation’s ‘young leaders’, university students who were 
non-service users and women who were sexually active and did not report using effective 
contraception. The intervention in Palestine was tested over three rounds with 17 people 
(eight female and nine male) five of whom were volunteers in the organisation and 12 of 
whom were non-service users.  
 
In general, feedback across the countries was that the messages were helpful, and they were 
enthusiastic about the intervention. There were no clear differences in acceptability of the 
messages by gender. The Tajik volunteers wanted more clarification about how the methods 
work, which appeared to be for reassurance that they were safe to use. They also said that in 
general, they wanted the messages to be more “interesting and joyful”. Target group 
feedback in Bolivia was that the messages should be more light-hearted, contain emojis 
within the messages, “curiosities” about contraception and messages about “pop stars”. This 
contrasted with Palestine, where the target group preferred messages that were “scientific”. 
Palestinian volunteers reported that the messages overall were reassuring and socially 
acceptable. There were some messages that they said sounded too negative and they 
suggested rewording to sound more reassuring. The research partner incorporated feedback 
after each round of testing and tested a revised set of messages in the following round.  
 
Final intervention 
The fundamental structure of the intervention is the same across the countries. Each 
intervention is designed to target the belief-based constructs identified in the needs 
assessment (instrumental attitude, self-efficacy and perceived control) in relation to 
contraception use, access to services and communication with partners about contraception. 
Each intervention provides accurate information about the effective contraceptive methods 
available in the country and aims to support young people in believing that they can influence 
their reproductive health. The messages are mapped to their corresponding change 
objective/s, behaviour change method and behavioural outcome (however, not all messages 
address a change objective, contain a behaviour change method or target a behavioural 
outcome). 
 
The interventions contain the same ten behaviour change methods and similar content, with 
minor contextual variations resulting from the testing (see Table 3.5 for a sample of the 
intervention messages) 
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The messages are tailored according to marital status (a proxy for sexual activity) and gender 
in Tajikistan and Palestine (male messages in Bolivia were not developed due to an early 
decision that the intervention would be evaluated with women only). The message sets start 
with 6-7 days of messages with information about what they will receive over the next 120 
days, how to stop the messages, who to contact if they change their number, how to keep 
the messages private and information about who to call if they feel unsafe as a result of 
someone reading the messages. Over the next 112-113 days, intervention recipients receive 
0-3 messages a day covering the following: accurate information about the effective 
methods; short quotes derived from real quotes from the target group regarding their views 
and experiences using each method; messages targeting specific misconceptions about 
contraception identified in the needs assessment; messages providing support for 
communicating with partners about contraception; messages that aim to reassure recipients 
that it is a provider’s job to maintain confidentiality; information about the cost of the 
different methods and where to obtain contraception and messages emphasising the 
importance of method switching rather than discontinuation. On day 119 and 120, the 
message sets include two messages that indicate that the messages have ended and provide 
reassurance that the information that they provide is confidential.  
 
Table 3.5  Sample intervention messages 
Tajikistan Bolivia Palestine 
Specialists have tested 
hormonal contraceptives 
many times and found them 
to be safe. 
Some people think that 
hormonal methods are less 
healthy than non-hormonal 
methods. Hormonal 
methods are safe. 
Some people think that 
hormonal methods are less 
healthy than non-hormonal 
methods. Hormonal 
methods are safe under 
medical supervision. 
The most effective methods 
are: pills, IUD, implant and 
injection. These methods 
are over 99% effective if 
used correctly. 
The most effective methods 
are: pills, t-
copper (intrauterine 
dispositive), implant, 
injection & patch. If used 
correctly, less than 1 out of 
100 women will get 
pregnant in a year if they 
use one of these.  🔒 
The most effective and 
available methods in 
Palestine are: pills, IUD, 
implant, injection, patch. 
These methods are 99% 
effective if used correctly. 
Some woman may not have 
a period when on the 
injection. Some people say 
that they like not having 
periods because they can be 
painful and inconvenient. 
Bleeding may change or 
even stop with the 
injection. Some people like 
not having a period. 
The bleeding cycle may 
change or even stop with 
the injection. Some people 
like not having a period. 
63 
 
Tajikistan Bolivia Palestine 
Making decision about 
contraception with a 
partner makes it more likely 
that you will avoid an 
unintended pregnancy. 
Making decision about 
contraception with a 
partner makes it more likely 
that you will avoid an 
unintended pregnancy. 
Making a decision about 
family planning with your 
husband helps you avoid an 
unintended pregnancy. 
Providers see young people 
with different kinds of 
lifestyles choose 
contraception. 
Providers see young people, 
married and not-married, all 
day and help them choose 
contraception. They want to 
help rather than judge.    
Providers help people of 
different lifestyles regarding 
family planning. 
Some young people worry 
that providers will judge 
them. Remember, it’s about 
your health and you can 
choose what is right for you. 
Some young people worry 
about being judged by other 
people too. Your health is 
what’s important. It’s your 
body and your right.  😃.  
 
Remember it's about your 
health and you have the 
right to choose what is right 
for you regardless of how 
others think and feel. 
Think about your situation 
and what is right for you. If 
you decide to use 
contraception without your 
partner knowing, the IUD 
and implant are easy to 
hide. 
If you are worried, there are 
methods that you can use 
without others knowing.            
If your husband 
disapproves, talk to him 
about why you believe that 
it's a good decision for you. 
 
The IUD and implant are 
easy to keep private. 
 
3.2.5 Discussion 
Main results 
The application of Intervention Mapping resulted in one intervention, tailored for Tajikistan, 
Bolivia and Palestine. The interventions are well specified, with each step in the development 
process documented. The needs assessment revealed that mobile phone ownership is 
widespread in each country and that young people are eager to receive contraceptive 
support on their mobile phone. Young people lacked comprehensive knowledge about 
contraception and expresses a range of negative beliefs about effective methods. They 
expressed a lack of confidence communicating about contraception and mentioned various 
environmental barriers to use. This study demonstrates that it is feasible to develop an 
innovative, comprehensible, acceptable intervention delivered by mobile phone with and for 
young people in resource-limited settings.  
 
Strengths and limitations 
A strength of the development is the participatory design. Young people were an integral part 
of the process and strengthened the intervention. Target group participants were a 
heterogeneous group, particularly in terms of age, gender and residential area. This is the 
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only study we are aware of that has used the same approach to develop, in parallel, 
interventions delivered by mobile phone in three different contexts. Because the intervention 
content is mapped to the corresponding change objectives and behaviour change methods, it 
is well specified.  
 
While there were strengths in conducting this multi-country research, it was also a challenge 
to spread our resources across the three countries. We conducted a pragmatic study using 
qualitative methods to explore the key themes related to unintended pregnancy and 
contraceptive use identified in the literature, to inform the development of the intervention. 
Working in one country would have allowed greater time and resources to conduct a more in 
depth qualitative study. It is possible that a more in depth, inductive approach could have 
produced a slightly different intervention. However, it is reassuring that our findings are in 
line with the global literature. 
 
The needs assessment revealed that there are powerful environmental influences, such as 
stigma surrounding young people using contraception and pressure to child bear soon after 
marriage. While not mentioned explicitly by young people, this cultural stigma is likely a 
result of religious belief that maintains sexual activity is reserved for marriage (Islam in 
Tajikistan and Palestine and Christianity in Bolivia). A potential limitation of this project is that 
the delivery mechanism was pre-specified. Targeting these important environmental 
conditions would likely require a broader intervention than messages delivered by mobile 
phone.  
 
Another limitation is that the target group was defined at the start of the project. The needs 
assessment revealed that unmet need is greatest in all three countries in a slightly older age 
group, i.e. 19-30. Due to funding restrictions, the focus group discussions in Tajikistan and 
Palestine were not transcribed and translated into English. The research partner who wrote 
the first draft of the intervention relied on the report of the trained facilitators and note 
takers.  
 
In Palestine, the increase in conflict that coincided with the fieldwork meant that some FGDs 
were not well attended and only one provider interview was conducted. A consequence of 
this is that the views of younger people may not have been adequately explored because only 
two participants were aged 15-19. However, the message testing provided reassurance that 
the intervention was appropriate and acceptable.     
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In Bolivia and Tajikistan, participants in the FGD were members of the youth network or 
recruited by the youth network.  It may be that this group was more informed than people 
not connected with services in any way. Still, there were widespread negative beliefs and low 
levels of comprehensive knowledge about contraception. Another way that this may have 
hindered the development is that this group may be more likely to find a mobile phone 
intervention for contraception acceptable because they had greater exposure to the topic 
and therefore may be more comfortable with it. In addition, young people who have no 
connection with services may have greater confidentiality concerns. 
 
Most participants were either employed or in education or training. The project could have 
benefitted from the inclusion of more participants in other occupational categories.   
 
It was only possible for the research partner to train each local team remotely in the testing 
procedures. The research partner relied on their report of the results, some of which were 
more detailed than others. It is not clear if this variability was due to the testing facilitators, 
the target population or both. If the project had more time and resources, we would have 
tested the intervention with a wider range of people (e.g. more at-risk groups and people 
who were not connected to the youth networks).  
 
Intervention Mapping provides a comprehensive guide for developing complex health 
interventions targeting both individuals and environmental agents. This project, however, is 
smaller in scope and targets individuals only. The determinants were not quantitatively 
verified (184) and their importance or changeability was not assessed. The adaption of the 
behaviour change methods for delivery by mobile phone and lack of fully accounting for the 
parameters for effectiveness is likely to result in some loss of meaning (124). While there are 
various modes in which to deliver content via mobile phones, strictly speaking, it is counter to 
Intervention Mapping to rule out non-mobile phone options from the start. Despite this, a 
mobile phone intervention emerged as highly acceptable and appropriate mode of 
intervention delivery.   
 
Although participants in Bolivia mentioned that cost was a barrier to contraceptive use, the 
intervention could not address this. Even if the intervention is successful in improving 
attitudes towards the methods, uptake may not be improved if cost remains a barrier. 
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Comparisons with existing research 
The results of the consultation with the target group align with existing research regarding 
the attitudinal factors that influence contraceptive use, i.e. that concern about the side 
effects or health risks are the most commonly expressed beliefs (21, 55, 57, 59, 61-65, 67, 
70). Consistent with other research (58, 63, 73, 75, 76), this study confirms similar 
environmental barriers to contraceptive use, such as stigma regarding sex before marriage 
and the societal value around family and childbearing. Other research involving young people 
has shown that participants are willing and eager to receive contraceptive information on 
their mobile phone (134, 136, 143, 154, 155). While there was variation in mobile Internet 
access among participants, mobile phone use was nearly ubiquitous. This reflects the global 
growth of mobile phone subscriptions, which has been slower in LMIC compared to higher 
income countries but is rising (185).   
  
Implications 
The fact that the beliefs identified in the needs assessment were similar to the beliefs in the 
literature suggests that the intervention is likely to be somewhat generalizable. The approach 
that we used to develop the intervention was successful in three culturally different settings, 
which highlights its broad applicability. Adaptation of the intervention to different settings 
could be more straightforward than usual, because the intervention is well specified.  
 
Conclusions 
The intervention development process resulted in one intervention, tailored to three 
contexts. The process exhibited how similar factors contribute to contraceptive use across 
three geographically and culturally unique LMIC settings. This project contributes to the field 
of contraception intervention development and mobile health. It has taken forward the 
practice of adapting behaviour change methods for delivery by mobile phone. This 
contribution highlights the importance of developing interventions using a systematic 
approach. The intervention has been evaluated by randomised controlled trial among men 
and women aged 16-24 in Tajikistan (54), women aged 18-24 in Palestine (52) and women 
aged 16-24 in Bolivia (53). 
 
Ethical approval 
Ethical approval was granted from the London School of Hygiene and Tropical Medicine 
Observational Research Ethics Committee on 27 April 2015 (reference number 9148), the 
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Tajik National Scientific and Research Centre on Paediatrics and Child Surgery on 8 June 2015, 
the State of Palestine Ministry of Health on 1 July 2015 and the Bolivian National Committee 
of Bioethics on 4 August 2015 (Appendix 7). Participants were given verbal and written 
information about the study by the FGD facilitator or interviewer. Participants provided 
written informed consent before providing demographic data and before the focus group 
discussions and interviews began. 
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4 The Integrated Behavioural Model 
I chose the Integrated Behavioural Model (IBM) as the overarching theory to conceptualise 
the factors that affect contraceptive use in the three countries (Montaño and Kasprzyk 2015). 
I chose the IBM because, after reviewing various other models and theories, considering the 
factors that influence contraceptive that use from my literature review and consultation with 
the target group, my view was that the constructs included in the IBM most closely 
represents the determinants of contraceptive use in the three countries. In the IBM and in 
the models and theories from which it is derived (Theory of Planned Behaviour, Theory of 
Reasoned Action, Reasoned Action Approach, Social Cognitive Theory), intention is the 
closest psychological construct to the behaviour. Intention is determined by attitude, 
perceived norm and personal agency (comprised of self-efficacy and perceived behavioural 
control) (170). Attitude, perceived norm and personal agency are aggregates of attitudinal, 
normative, efficacy and control beliefs. There are four additional factors that are important in 
determining if an intention can result in behavioural performance: knowledge and skills to 
perform the behaviour, salience of the behaviour, habit and environmental constraints 
(Figure 4.1) 
 
69 
 
Figure 4.1 The Integrated Behavioural Model 
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The intervention is designed to target the IBM belief-based determinants. These are: 
instrumental attitude, self-efficacy and perceived behavioural control. These determinants 
are aggregates of the beliefs related to contraception use, access to services and 
communication with partners about contraception. These beliefs were identified in the focus 
group discussions, interviews and my review of the literature.  
 
Instrumental attitude is cognitively-based (as opposed to experiential attitude, which is an 
emotional response) and is determined by beliefs about the outcomes of performing a 
behaviour, e.g. “Using hormonal contraception would make me infertile”. The literature is 
clear that attitudes influence use of contraception. Attitudinal beliefs, such as concerns about 
weight gain and infertility due to hormonal contraceptive use, were identified in the 
consultation with the target group. The intervention is designed to target the specific beliefs. 
 
Personal agency in the IBM follows Bandura’s definition- ‘bringing one’s influence to bear on 
one’s own functioning and environmental events’ (174). In the Integrated Behavioural Model, 
personal agency includes perceived control and self-efficacy, which are similar but distinct. 
Self-efficacy, from Social Cognitive Theory (175, 176), is an individual’s ‘degree of confidence 
in performing a behaviour’ (170), e.g. “I am certain that I can talk to my partner about 
contraception”. Perceived control is an individual’s ‘perception of the degree to which various 
factors make it easy versus difficult’ to perform a behaviour’ (170, 177), e.g. “If my partner 
disapproved of using contraception, it would be difficult for me to use it”. The intervention 
provides support in using contraception, talking to a partner about contraception and 
attending services for contraception, in order to increase self-efficacy in and control over 
these behaviours.  
 
I have adapted the Integrated Behavioural Model to include knowledge as an equally 
important construct that is a fundamental determinant of behaviour, as in the Information-
Motivation-Behavioural Skills Model (171). In the focus group discussions and interviews, it 
was clear that accurate information about effective contraception was low. Providing 
accurate information in a context where there is none or very little, may change people’s 
beliefs. The intervention provides accurate information about the different effective 
methods. 
 
Figure 4.2 illustrates this project’s adapted IBM (the green boxes are the constructs that the 
intervention targets):   
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Figure 4.2 This project’s Integrated Behavioural Model 
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The intervention content specifically targets the determinants as developed through the 
Intervention Mapping process. While I have retained perceived norm in the model, the 
intervention does not target this determinant directly. Perceived norm is composed of 
injunctive and descriptive norm. Injunctive norm is belief about what others think one should 
do and descriptive norm is the perception of what others are doing. While the target group 
expressed normative beliefs about others’ expectations and behaviour, it was clear that some 
perceptions were likely to be accurate (such as the cultural norm of childbearing soon after 
marriage). I decided that targeting these perceived norms could decrease the credibility of 
the intervention. However, as the intervention includes real quotes from the target group it is 
possible that the intervention could influence perceived norms. 
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5 Evaluation methods 
5.1 Introduction 
This chapter is based on the three published trial protocols for the evaluation of the 
intervention in Palestine, Tajikistan and Bolivia. It also contains additional methodological 
detail, which was not included in the publications. I combined the publications in one chapter 
to avoid repetition because the methodological approach across the countries is largely the 
same. I have outlined the differences between the countries in the relevant sections. The 
Tajikistan protocol was published in BMJ Open in September 2017 (51) (Appendix 8) the 
Palestine protocol was published in Trials in October 2017 (52) (Appendix 9) and the Bolivia 
protocol was published in the Journal of Medical Internet Research- Research Protocols in 
December 2017 (53) (Appendix 10). All articles are open access.  
 
Citations: 
(51) McCarthy OL, Leurent B, Edwards P, Tokhirov R, Free C. A randomised controlled trial of 
an intervention delivered by app instant messaging to increase the acceptability of effective 
contraception among young people in Tajikistan: study protocol. BMJ Open. 2017;7(9). 
 
(52) McCarthy OL, Wazwaz O, Jado I, Leurent B, Edwards P, Adada S, et al. An intervention 
delivered by text message to increase the acceptability of effective contraception among 
young women in Palestine: study protocol for a randomised controlled trial. Trials. 
2017;18(1):454. 
 
(53) McCarthy OL, Osorio Calderon V, Makleff S, Huaynoca S, Leurent B, Edwards P, Lopez 
Gallardo J, Free C. An Intervention Delivered by App Instant Messaging to Increase 
Acceptability and Use of Effective Contraception Among Young Women in Bolivia: Protocol of 
a Randomized Controlled Trial. JMIR Res Protoc 2017;6(12):e252. doi:10.2196/resprot.8679  
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5.2 Methods 
5.2.1 Study design 
In each country, I conducted a parallel-group, individually randomised superiority trial with a 
1:1 allocation ratio to evaluate the effect of the intervention in each country. The objective 
was to establish the effect of the intervention on attitudes towards effective contraception in 
each country. In Bolivia, an added objective was to establish the effect of the intervention on 
use of effective contraception.  
 
5.2.2 Eligibility 
Tajikistan eligibility 
Women and men aged 16-24 who owned a personal Android mobile phone, lived in Tajikistan 
and could read Tajik or Russian will be eligible to take part. 
 
Palestine eligibility 
Women aged 18–24 years, who did not report using effective contraception, owned a 
personal mobile phone, lived in the West Bank and could read Arabic were eligible to take 
part. The lower age limit of 18 years was chosen because it is the age in Palestine where 
people can provide independent informed consent to take part in research.  
 
Bolivia eligibility 
Women aged 16 to 24 years who own a personal Android mobile phone and live in La Paz or 
El Alto and who reported an unmet need for contraception (i.e. were sexually active, not 
using effective contraception and wanted to avoid a pregnancy) and could read Spanish were 
eligible to take part. 
 
The upper age limit of 24 years was chosen because this most closely matched the target 
group ‘young people’ (165), which was identified by the funder. Participants in all countries 
must also have been willing to receive messages about contraception on their mobile phone. 
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5.2.3 Recruitment 
Tajikistan recruitment 
The trial was promoted through the distribution of flyers through TFPA’s volunteers and 
youth partner organisation, TFPA’s website and social media sites. Potential participants were 
provided the link to the enrolment pages of the secure online trial database and 
randomisation system, where they could read the information sheet and provide informed 
consent. If they did not have adequate internet access, youth organisation volunteers 
provided it. Participants had the option of completing the paper-based version of the consent 
form.  
 
Palestine recruitment 
The trial was promoted through PFPPA’s service delivery points through outreach sites, the 
PFPPA website, the distribution of trial promotional material via flyers and social media sites. 
PFPPA service-delivery points provide: contraceptive methods; counselling for women in 
psychological, legal and social matters; laboratory tests for both men and women; maternal, 
antenatal and post-natal care and infertility services (186). The promotional material included 
brief information about the trial (e.g. who was conducting it, who may be eligible, what 
participation would involve) with a link to the secure trial database and randomisation 
system where they could read the information sheet and provide informed consent.  
 
Bolivia recruitment 
To achieve a diverse sample, the trial was promoted through a variety or routes: CIES’s 
service delivery points in La Paz and El Alto, the CIES website, flyers distributed through CIES’s 
youth network and social media sites. Potential participants were provided the link to the 
enrolment pages of the secure online trial database and randomisation system, where they 
read the participant information sheet and provide informed consent. If they did not have 
adequate Internet connectivity, youth network volunteers provided this. Participants also had 
the option of completing the paper-based version of the consent form. 
 
Pre-trial recruitment training 
To maximize the chance of recruiting to target, I conducted a pre-trial training in Dushanbe, 
Bethlehem and La Paz to train local staff on all recruitment procedures. The training included 
discussions about the practicalities of recruitment with a view to developing the most 
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appropriate strategies. CIES conducted a similar training with their youth volunteers, who 
promoted the trial. 
 
All participants also had the option of completing a paper-based version of the consent form. 
See Appendix 11 for the Information sheets and Appendix 12 for the Consent forms.  
 
5.2.4 Intervention 
Similarities in the intervention between the countries  
The intervention is informed by the Integrated Behavioural Model (170) and consists of short 
mobile phone messages providing contraceptive support delivered over four months. The 
intervention messages provide information about contraception, target beliefs identified in 
the development phase that influence contraceptive use (e.g. misconceptions about the side 
effects and health risks of contraception, belief that non-hormonal methods are better 
because they are not harmful to health) and aim to support young people in believing that 
they can influence their reproductive health. The intervention contains the following 
behaviour change methods, adapted for delivery by mobile phone (122): belief selection, 
facilitation, anticipated regret, guided practice, verbal persuasion, tailoring, cultural similarity, 
arguments, shifting perspective and goal setting. 
 
Differences in the intervention between the countries 
Tajikistan 
The intervention was sent through TFPA’s ‘healthy lifestyles’ app. The app itself was to 
contain basic information about contraception, how to have a ‘healthy lifestyle’, youth 
friendly service point locations and no behaviour change methods. The app and the 
intervention messages were available in Tajik or Russian, according to participants’ 
preference, which they indicated at enrolment. 
 
The messages were tailored according to marital status and gender, resulting in four sets of 
intervention messages: 1) female-married 2) female-not married 3) male-married 4) male-not 
married. Most of the messages in the four sets overlap, with minor tailoring so that the 
messages are relevant to marital status and gender. Marital status was used a proxy for 
sexual activity because the target group and TFPA considered it inappropriate to ask directly 
about sexual activity. Based on the development work with the target group, participants 
received 0-3 messages per day (135 messages for female-not married, 155 messages for 
female-married, 135 messages for male-not married and 146 messages for male-married) for 
80 
 
120 days. Included in the messages that intervention recipients received were seven control 
messages about the importance of their participation and reminding them to contact the 
project coordinator if they change their number. 
 
The message sets started with 6-7 days of messages (11 female-married, 12 female-not 
married, 12 male-married and 13 male-not married) with general information about the 
study, such as what they will receive over the next 120 days, how to stop the messages, how 
to choose specific times to receive the messages, who to contact if they change their number, 
how to keep the messages private and information about who to call if they feel unsafe as a 
result of someone reading the messages (women only). On the final 2-3 days, the message 
sets included four messages that indicated that the messages have ended, provided a link to 
the database to complete the follow-up questionnaire, reassurance that the information that 
they provide is confidential and a final message stating that their participation helps to 
determine the best ways to provide reproductive health services in Tajikistan.  
 
Palestine 
The intervention was sent by text message and was tailored according to marital status, 
resulting in two sets of intervention messages: (1) female-married and (2) female-not 
married. Most of the messages in the two sets overlap, with minor tailoring so that the 
messages are relevant to marital status (a proxy for sexual activity as in Tajikistan). 
Participants allocated to the intervention group received zero to three messages per day (113 
messages for female-not married and 120 messages for female-married) for 120 days. 
 
The message sets started with 6 days of messages (10 messages for married women and 11 
for not-married women) with general information about the study, such as information about 
what they will receive over the next 120 days, how to stop the messages, who to contact if 
they change their number, how to keep the messages private and information about who to 
call if they feel unsafe as a result of someone reading the messages. Included in the 
intervention messages that the intervention recipients receive were seven control messages 
about the importance of their participation and reminding them to contact the project 
coordinator if they change their number. On days 119 and 120, the message sets included 
four messages that indicate that the messages have ended, provided information on how to 
complete the follow-up questionnaire, reassurance that the information that they provide is 
confidential and a final message stating that their participation helps to determine the best 
ways to provide reproductive health services in Palestine.  
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Bolivia 
The intervention messages in Bolivia were sent through the Tú decides app. The app 
contained standard family planning information and no behaviour change methods. 
Participants allocated to the intervention group received zero to three messages per day (a 
total of 183 messages) for 120 days. Included in the 183 messages that intervention 
recipients receive were seven control messages about the importance of their participation 
and reminding them to contact the project coordinator if they change their number. The 
message sets started with 6 days of messages with general information about the study, such 
as information about what they will receive over the next 120 days, how to stop the 
messages, who to contact if they change their number, how to keep the messages private 
and information about who to call if they feel unsafe as a result of someone reading the 
messages. On day 119 and 120, the intervention included 4 messages: one that indicated that 
the messages have ended, one that provided a link to the database to complete the follow-up 
questionnaire, one that gave reassurance that the information that they provide is 
confidential and a final message stating that their participation helps to determine the best 
ways to provide reproductive health services in Bolivia.  
 
5.2.5 Control 
Similarities in the control between the countries 
Control participants in all three countries received 16 messages about trial participation over 
120 days. The first four days included six messages that introduce the study, as well as 
provided information about what they will receive over the next 120 days, how to stop the 
messages and who to contact if they change their number. They then received two messages 
a month for three months: one about the importance of their participation and one 
reminding them to contact the project coordinator if they change their number. On day 105, 
they received one message about the importance of their participation. On day 120, 
participants received three messages: one that provided information on how to complete the 
follow-up questionnaire, one that gives reassurance that the information they provide is 
confidential and a final message stating that their participation helps to determine the best 
ways to provide reproductive health services in the country. 
 
Differences in the control between the countries 
Tajikistan 
The control messages were sent through TFPA’s Healthy Lifestyles app.  
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Palestine 
The control messages were sent by text messages through the local platform. 
 
Bolivia 
The control messages were sent through CIES’s Tú decides app.  
 
All participants received usual care (the normal care that a young person would receive if 
they attended a service in each country) and were free to seek any other support, whether 
existing or new.  
 
5.2.6 Outcomes 
The acceptability primary outcome  
In Palestine and Tajikistan, the primary outcome was the proportion of participants reporting 
that at least one method of effective contraception was acceptable at four months after 
randomisation (‘acceptability’). I chose acceptability as the primary outcome for the following 
reasons. Sexual activity before marriage is highly stigmatised in all three countries. There is 
strong cultural pressure to childbear soon after marriage, particularly in Palestine and 
Tajikistan. I predicted that a significant proportion of participants in the Palestine and Tajik 
trial sample would be either not married (and not sexually active or not willing to admit that 
they are) or newly married. Because of this, an objective primary outcome of effective 
contraceptive use would not be advisable as powering a study for an outcome with a small 
number of events would make the sample size prohibitively large. In not married/not sexually 
active young people, the intervention aimed to increase acceptability of the effective 
methods for when they may want to limit or space their families and could benefit from 
finding a range of methods acceptable.  
 
In the IBM, intention is the most proximal predictor of behaviour. Apart from measuring the 
behaviour itself, choosing intention as the primary outcome would have been the best 
option. However, my view was that intention would have been too abstract for young people 
in Tajikistan and Palestine, many of whom I thought would not have been sexually active (or 
not willing to admit that they were). I did not choose personal agency as the primary 
outcome for similar reasons. Therefore, I chose to measure ‘acceptability’ as the primary 
outcome. Acceptability is a composite of the attitudinal beliefs about contraception identified 
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in the literature and formative work; these are the immediate beliefs that the messages 
target (instrumental attitude, see this project’s IBM, Figure 4.2)  
 
The acceptability of each method was measured by the following stems: Using the [method] 
…causes infertility, …causes unwanted side effects, …is easy, …is a good way to prevent 
pregnancy and I would recommend the [method] to a friend. The IUD and implant include an 
additional stem: The [method] insertion would not be a problem. The response options for 
each scale were: strongly disagree, disagree, not sure, agree, strongly agree and I do not 
know what the [method] is. A method was acceptable if participants reported ‘agree’ or 
‘strongly agree’ for all scales except for ‘…causes infertility’ and ‘…causes unwanted side 
effects’ stems, for which ‘disagree’ or ‘strongly disagree’ denoted acceptability.  
 
Co-primary outcome in Bolivia 
In Bolivia, a co-primary outcome was self-reported current use of effective contraception. 
The formative work in Bolivia indicated that, while sex before marriage is stigmatised as it is 
in Tajikistan and Palestine, young people were having sex before marriage (or were more 
willing to admit that they were compared to the other countries). 
 
Secondary outcomes 
In Palestine and Tajikistan, a secondary outcome was the proportion reporting current use of 
effective contraception, which was a co-primary outcome in Bolivia. Secondary outcomes 
shared across the countries were, for each contraception methods, the proportion reporting 
that each effective contraception method is acceptable (acceptability of individual methods); 
the proportion reporting use (or partner’s use in Tajikistan) of effective contraception at any 
time during the four months (discontinuation); the proportion reporting attending a sexual 
health service during the four months (service uptake); the proportion reporting that they 
became pregnant (or partner in Tajikistan) and they did not want to become pregnant during 
the study (unintended pregnancy); and the proportion reporting having an abortion (or 
partner in Tajikistan) during the study (induced abortion).  
 
Process outcomes 
The process outcomes were: knowledge of effective contraception; perceived norms in 
relation to using and communicating with partners about contraception; personal agency in 
using (women only) and communicating with partners about contraception; intention to use 
effective contraception (women only) and intervention dose received. 
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Measuring the Integrated Behavioural Model constructs 
[This section was not included in the published protocols.] 
I first reviewed the existing validated scales measuring psychological constructs related to 
contraception but did not find any that were suitable (187). For example, the “Contraceptive 
Attitude Scale” (in Fisher 2010 (187), p179) includes items that do not reflect the aim of the 
messages and with 32 items, was prohibitively long. Likewise, the “Contraceptive Utilities, 
Intention and Knowledge Scale” and the “Contraceptive Self-efficacy Scale” (in Fisher 2010 
(187), p180 and p188) do not measure what the intervention targeted. In most of the 
measures that I identified, many items were also not culturally appropriate. Therefore, in the 
absence of existing validated measures, I constructed the scales used to measure 
instrumental attitude (the acceptability primary outcome), perceived behavioural control, 
self-efficacy, injunctive norm and descriptive norm in relation to use, accessing services and 
communicating with partner, based on guidelines for measuring IBM constructs (170, 188, 
189).  I used the method for measuring ‘generalised intention’ because this is most 
commonly used in research involving individual’s health behaviour (188). I kept intention to 
just one item (intention to use contraception) and did not include every change objective in 
the questionnaires in the interest of keeping the questionnaire as short as possible.  
 
For instrumental attitude (acceptability), I listed the most common perceived advantages and 
disadvantages of performing each behaviour (use, accessing services and communicating with 
partners) (Table 5.1). For perceived norms, I considered the most important people or groups 
of people who would approve or disapprove of each behaviour. The sources of normative 
influence that I identified were: parents, siblings, family, friends, neighbors, mother-in-law, 
family-in-law. I could not include an item for each, so I chose the most important. I had 
originally included the wording ‘most people like me’ but testing in Tajikistan suggested that 
‘my friends’ would be better. For perceived behavioural control, I identified the perceived 
barriers or facilitating factors that could make performing each behaviour easier or more 
difficult. For self-efficacy, I determined the perceived factors that would make people more 
confident in performing each behaviour. I chose the main constraints that apply to all the 
countries. Being newly married did not come up strongly in Bolivia, but I included it in the 
Bolivian questionnaire for consistency across the countries. 
 
I worded the scales in accordance with the IBM guidelines, however it was necessary to adapt 
the wording for measuring instrumental attitude (acceptability) so that it also applied to men 
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as well as women. For example, I changed “If I used the pill, it would cause fertility problems” 
to “The pill causes fertility problems”. I included the common belief across the countries, that 
contraception causes infertility, as its own item. I grouped the other various negative beliefs 
about contraception into “harmful side-effects” to make the measure applicable across the 
three countries. I did not include the belief that hormones cause weight gain because the 
messages say “most” women do not gain weight, and this item therefore would be difficult to 
interpret. 
 
We tested the scales for face validity with the target group in each country. The project 
coordinators asked young people to complete the scales and then asked them why they 
answered how they answered. They also asked them if they had any difficulty answering any 
items and how to reword if necessary. The items were translated from English to Tajik, 
Russian, Arabic and Spanish by native speakers and then back translated into English.  
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Table 5.1  Specific issues regarding the IBM constructs identified in needs assessment  
 Use Access services Communication 
(Attitude) 
Positive or 
negative beliefs 
about the 
behaviour 
- Hormones cause weight gain, menstrual changes and infertility 
- Natural methods are better because they don’t have side-effects 
- The pill contains harmful chemicals, causes anxiety and 
nervousness 
- The IUD makes women nervous, causes heavy bleeding, 
infertility, causes an irregular menstrual cycle, back pain 
- The metal in the IUD is harmful 
- The injection causes weight gain 
- If you use contraception, you will worry less if you have sex 
- Should not use if not married 
- Using contraception in early marriage will cause problems 
Providers judge young 
people 
Should be a shared 
decision between 
partners to use 
contraception 
(Norms)  
Sources of 
normative 
influence about 
the behaviour 
- Parents 
- Siblings 
- Family 
- Friends 
- Neighbors 
- Mother-in-law 
- Family-in-law 
- Provider  
- Society/community 
- Village/neighbours will find 
out 
- Pharmacists make YP feel 
uncomfortable, providers 
at clinic more relaxed 
- Partner 
- Society/ 
community 
(Personal agency) 
Factors that 
make it easier or 
harder to perform 
the behaviour 
(facilitators and 
constraints) 
- Being newly married can make it difficult to use contraception 
- Hearing about other’s positive experiences would facilitate use 
- If friends have used a method and report that it does not affect 
health (including fertility), this would facilitate use 
- Having accurate information would facilitate use 
- Feeling of being judged by 
providers (mainly 
pharmacists)  
- People in village will judge 
you if not married 
- Partner doesn’t approve 
If newly married, 
could cause problems 
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5.2.7 Data collection 
Baseline data 
At baseline, we measured the acceptability of effective contraception and collected the 
following personal and demographic data: full name; mobile phone number; email address; 
date of birth; marital status; number of children; ethnicity; occupation; education level; 
current pregnancy intention; current method of contraception and how they heard about and 
enrolled in the study. In Palestine, ‘residence’ was used instead of ethnicity in because 
PFPPA’s believed that most people in Palestine would consider themselves ‘Palestinian’ and 
that ‘residence’ is a more meaningful demographic indicator. In Palestine we also asked 
participants what the time that they preferred to receive the messages. See Appendix 13 for 
the baseline questionnaires. 
 
Follow-up data 
At four months, we measured the primary, secondary and process outcomes and collected 
the following data via the follow-up questionnaire: if participants report using an effective 
method, where they obtained it; current pregnancy intention; whether they knew someone 
else who took part in the study and if so, whether they read each other’s messages 
(contamination); whether they experienced physical violence since being in the study and 
whether anything good or bad happened as a result of receiving the messages. We collected 
data on physical violence because the intervention involves a sensitive topic and is delivered 
in a context where intimate partner violence is a public health concern. If participants did not 
complete the questionnaire themselves, local research staff unaware of participants’ 
allocation contacted them to collect their data. See Appendix 14 for the follow-up 
questionnaires. 
 
Methods to improve follow-up data collection 
I conducted training regarding the follow-up procedures with relevant staff in each country. 
The training emphasised the importance of ensuring that participants understand that 
participation involves completing a four month questionnaire and to potentially receiving 
daily messages about contraception for four months. The control messages, also sent to 
participants allocated to the intervention, were an effort to keep participants engaged. Staff 
contacted non-responders multiple times for their follow-up data. Follow-up ended six 
months after the last participant was randomised or after staff attempted to contact all non-
responders at least three times, whichever came first. 
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Building the trial database and randomisation system 
[This section was not included in the published protocols.] 
The trial database and randomisation system was used in the three trials. While the 
architecture of the system was built, it required modifications to fit each trial. I completed all 
the non-coding work myself (the coding work was completed by the systems developer). This 
involved extensive content management, testing and reformatting to include the following 
pages for each country in each local language (in Cyrillic script for Tajik and Russian in 
Tajikistan and Arabic script for Palestine): landing, eligibility, information sheet, consent, 
baseline questionnaire and follow-up questionnaire.  
 
5.2.8 Allocation and protecting against bias 
Randomisation occurred immediately after baseline data was submitted on the trial database 
and randomisation system. The allocation sequence was generated by the remote computer-
based randomisation software, ensuring that investigators are unaware of allocation before 
participants are randomised. Due to the nature of the intervention, participants would have 
been aware of the allocation soon after they started receiving the messages. Local research 
staff collecting outcome data were not made aware of allocation unless this was revealed to 
them by the participant. I was masked to treatment allocation until after all analyses were 
conducted. 
 
5.2.9 Intervention delivery 
Palestine 
After randomisation, the trial database and randomisation system sent the local SMS 
platform the following information: allocation, time slot (participants could choose to receive 
messages from 10:00 to 13:59, 14:00 to 18:59, or both), mobile phone number and marital 
status. The platform sent the intervention or control messages, according to allocation. 
Messages sent were recorded by the local platform and were monitored by me and a 
colleague at LSHTM. 
 
Tajikistan and Bolivia 
After participant baseline data was entered, a confirmation of enrolment screen provided 
instructions on how to install the app. When participants installed the app, they were 
prompted to enter the mobile phone number they entered on the baseline questionnaire. In 
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Tajikistan, the trial database and randomisation system then sent the local app platform the 
following information: gender, marital status, language preference, allocation and date of 
enrolment. In Bolivia, the system sent only the allocation to the local app platform. 
Participants then had access to the app and received either the control or intervention 
messages, according to their allocation. Within the app, participants could choose when they 
wanted to receive the messages and they could also stop the messages. If participants 
installed the app after 13:00 in Tajikistan, they received the first message the following day. 
Otherwise, they received the first message on the day of enrolment. In Bolivia, participants 
received the first message the day after they install the app. 
 
5.2.10 Sample size 
Palestine and Tajikistan 
The Palestine and Tajik trials were powered to detect a 15% increase in acceptability of 
effective contraception in the intervention group compared with the control group. Other 
studies have found smaller increases in behaviour with similar interventions, for example, 
Castaño et al (134). Because attitudinal change is likely to be easier to achieve than 
behavioural change, we decided to power the trial to detect a larger difference. Four hundred 
and fifty-four participants would have allowed for 90% power to detect a 15% absolute 
increase in acceptability, assuming 50% acceptability in the control group (i.e., 50% in the 
control vs 65% in the intervention, an odds ratio of 1.86). Fifty per cent baseline acceptability 
was used in the absence of published data on acceptability in these contexts. If the actual 
baseline acceptability was higher or lower than 50%, the trials would still be sufficiently 
powered to detect an absolute difference of 15%. For example, if the proportion in the 
control arm was 75%, there would be 90% power to detect an absolute difference of 12% 
(corresponding to 87% acceptability in the intervention group and an odds ratio of 2.23). 
Allowing for 20% loss to follow-up, we aimed to randomised 570 people in Palestine and 570 
in Tajikistan. 
 
Bolivia 
Smith et al’s trial evaluating a post abortion mobile phone intervention using voice messages 
and counsellor support found that 18% more women in the intervention arm than in the 
control arm were using effective contraception at 4 months (64% versus 46%, relative risk 
1.39, 95% CI 1.17–1.66) (135). If Smith and colleagues’ trial observed a larger increase in 
contraceptive uptake, as it involved women who had just had an abortion, we powered our 
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trial to detect a smaller absolute difference of 10% uptake in effective contraception at four 
months. The proportion of women aged 16 to 24 years in a partnership living in La Paz or El 
Alto using effective contraception was estimated to be around 44% (190). A total of 1048 
participants would provide 90% power to detect a 10% increase in effective contraception, 
assuming 44% use in the control group (i.e. 44% in the control vs 54% in the intervention, 
corresponding to an odds ratio of 1.49). Allowing for 20% loss to follow-up, we aimed to 
randomise 1310 people.  
 
5.2.11 Data management 
I did not convene a data monitoring and ethics committee, as the intervention provided 
support and was unlikely to produce adverse effects. I convened a PhD trial steering 
committee, who agreed to take on the monitoring of ethical aspects of the trials.  
 
Personal details entered onto the trial database and randomisation system were stored on 
LSHTM’s secure server. Personally identifiable information exported from the database was 
stored separately from anonymized research data. Participant mobile phone numbers, but no 
other personal details, were stored in the local platform that sends the messages through the 
app. Any signed paper consent forms and questionnaires were kept in a local data enclave. All 
data arising from the study was kept confidential and accessible only to researchers directly 
involved in it. Personally identifiable data was not kept longer than necessary and was 
deleted within three months following study completion. I will retain primary research data 
for ten years following study completion.  
 
Data export and analysis preparation 
[This section was not included in the published protocols.] 
The data entered onto the trial database was stored on LSHTM’s server. I exported the data, 
which was in the local script, into excel spreadsheets. I then imported the data into Stata 15 
and wrote do files to translate the Cyrillic script (both Tajik and Russian), Arabic and Spanish 
data into English. When this was complete, I labelled and coded all variables the same across 
the countries.  
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5.2.12 Analysis 
General statistical considerations 
The analysis of the data in each country followed the plan specified below. There were no 
interim analyses and therefore no stopping rules. I analysed participant data according to the 
arm that they were allocated to and included only participants with complete outcome data 
in the primary analysis (a complete case analysis). All statistical tests were two-sided. I 
reported all effect estimates with a 95% confidence interval and associated p-value. 
Statistical significance was considered at the 5% level, (but interpreted with caution in Bolivia 
considering the two primary outcomes). I used Stata 15 for analyses. 
 
Loss to follow-up 
To investigate whether loss to follow-up differed by arm in each country, I reported this 
descriptively and used a chi-squared test. I used logistic regression to compare baseline 
characteristics of participants who completed four month follow-up against participants who 
did not. I reported predictors of loss to follow-up and investigated whether the effect of 
these differed by arm by testing for an interaction.   
 
Assumptions about missing data 
The complete-case analysis assumes that missing data for participants who did not complete 
follow-up are similar to data from participants who completed follow-up, conditionally on 
baseline covariates included in the analysis model (i.e. that data are missing at random) 
(191). If participants who completed follow-up are more likely to use effective contraception 
and to find an effective method acceptable compared with those who are lost to follow-up, 
the observed proportion may overestimate use and acceptability (191).  
 
It is reasonable to assume that participants who did not complete follow-up would be similar 
to participants that did not find a method acceptable at four months. For example, a 
participant that resides in a Bedouin camp typically has inadequate access to services and 
education, which are likely associated with whether or not they complete follow-up (they 
may be more difficult for staff to reach over the phone due to poor mobile phone 
connectivity in certain areas and/or they may find it more difficult to travel to service to 
complete the paper follow-up questionnaire). In turn, this demographic may also be less 
likely to find a method acceptable than participants that reside in the city as they may have 
more firmly held misconceptions about hormonal contraception due to less exposure to 
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sexual and reproductive health education. In this case, the overestimation would be modest 
(191). 
 
Missing data on the acceptability outcome scales 
[The following paragraph was not included in the published protocols.] 
The acceptability of each method (pill, IUD, injection, implant and patch) was measured by 
five-six ordinal scales. If data was missing on any scale associated with a method, that 
method could not be acceptable. In this case, acceptability for the method was coded as 
missing. The acceptability outcome was complete if all scales for each method were complete 
or if there was missing data for some methods but at least one method was acceptable. For 
example, if a participant had missing data for all methods except for one, and this method 
was acceptable, the primary outcome would be complete. The acceptability outcome was not 
complete if there was missing data for some methods, complete data for at least one 
method, but this method was unacceptable. 
 
Missing covariates 
The database required all items on the baseline questionnaire to be submitted to proceed to 
the random allocation. Therefore, there were no missing baseline covariates.  
 
Principal analyses 
Descriptive analysis 
I reported a flow diagram of trial participation, as recommended in the Consolidated 
Standards of Reporting Trials (CONSORT) guidelines (192). I reported the baseline 
characteristics by treatment arm. I also explored the baseline factors associated with 
retention (see loss to follow-up section above).  
 
Analysis of the primary outcome 
The primary outcome acceptability of at least one method of effective contraception and co-
primary outcome use (Bolivia) were binary. I reported the crude proportion who reported 
that at least one method was acceptable in each group and the crude proportion who 
reported using effective contraception in each group. I estimated the difference between the 
groups using logistic regression and reported the odds ratio along with the 95% confidence 
interval and p-value for evidence against the absence of intervention effect from the model. I 
adjusted the primary analysis regression for baseline covariates likely to be associated with 
the outcome in order to improve the efficiency of the analysis and avoid chance imbalances 
93 
 
(193). The pre-specified covariates that I adjusted for were: use (Tajikistan only, using 
effective contraception/not using effective contraception); pregnancy intention (Palestine 
and Tajikistan only, wants to avoid a pregnancy/other); gender (Tajikistan only, female/male) 
age (16-19 years/20-24 years in Tajikistan and Bolivia and 18-19 years/20-24 years in 
Palestine), number of children (0/≥1), highest education level completed (university/other) 
and acceptability of effective contraception at baseline (at least one method acceptable/no 
methods acceptable). In Bolivia, the primary outcomes were analysed individually, and no 
formal multiplicity correction was applied, but interpretation took into account the multiple 
tests if only one of the two outcomes reached the 5% significance level. I also reported the 
crude odds ratio between arms. 
 
Analysis of the secondary outcomes 
The analysis of the secondary outcomes was similar to the analysis of the primary outcome. I 
estimated the difference between the groups using logistic regression, reported odds ratios 
with 95% confidence intervals and p-values. All regressions were adjusted for the pre-
specified covariates as above (although with the acceptability of individual methods, the 
outcome at baseline replaced acceptability of effective contraception). 
 
Analysis of the process outcomes 
The process outcomes perceived norms, personal agency and intention were comprised of 
ordinal scales. I analysed each scale individually using ordered logistic regression to estimate 
proportional odds ratios. For knowledge, each correct answer received one point. The points 
were summed, and an overall score was produced. I used linear regression to test for a 
difference in mean scores between the arms.  
 
To assess the ‘dose’ of the intervention that the intervention participants received, I analysed 
the number of messages that participants reported to have read (all, most, some, none) and 
whether they stopped the messages. I reported this descriptively. 
 
Additional analyses 
Sensitivity analyses 
I conducted sensitivity analyses regarding the missing data. In the first sensitivity analysis, I 
considered that data are not missing at random; that participants lost to follow-up did not 
find at least one method acceptable and that participants lost to follow-up were not using an 
effective method of contraception (Bolivia). In the second, I adjusted for the main baseline 
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predictors of missingness. Sensitivity analyses were adjusted for the pre-specified covariates 
as above. 
 
Subgroup analyses 
Recognising that the trials are not powered to detect effect differences in subgroups, I 
conducted an exploratory subgroup analyses for the primary outcomes to determine whether 
the intervention effect varied by baseline characteristics. The pre-specified subgroups were: 
gender (Tajikistan only, female/male) age (split at the median); marital status (married/not 
married); number of children (0/≥1); ethnicity (Tajikistan only, Tajik/other); residence 
(Palestine and Tajikistan, city/other) geographical location (El Alto/La Paz); occupation (in 
education/other) and highest education level completed (university/other). Within the pre-
specified subgroups, I assessed heterogeneity of treatment effect with a test for interaction 
(194-198). I presented interaction test p-values, but I interpreted them with caution, due to 
the exploratory nature, the multiple tests performed and the low power of the interaction 
test. I estimated odds ratios along with 95% CIs for each subgroup without p-values. As these 
were exploratory analyses of potentially influential characteristics that are not justified a 
priori, I did not hypothesize effect directions.  
 
Contamination 
To assess the potential for contamination, I reported the proportion of control group 
participants that read another participant’s messages and the proportion of intervention 
participants whose messages were read by another participant. 
 
5.2.13  Ethical approval 
The trials were granted ethical approval by the LSHTM Interventions Research Ethics 
Committee on 16 May 2016, by the Tajik National Scientific and Research Centre on 
Paediatrics and Child Surgery under the Ministry of Health on 15 April 2016, by the State of 
Palestine Ministry of Health Primary Health Care and Public Health Directorate on 9 May 
2016 and by La Comisión de Ética de la Investigación del Comité Nacional de Bioética on 20 
September 2016 (Appendix 15). 
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6 Tajikistan evaluation results 
6.1 Introduction 
This chapter is the research paper that presents the results of the randomised controlled trial 
in Tajikistan. This work was published in Reproductive Health as an open access article in May 
2018 (54) (Appendix 16). 
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intervention delivered by mobile phone app instant messaging to increase the acceptability 
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6.2 Research paper 
6.2.1 Abstract  
Background  
Unintended pregnancy is associated with poorer health outcomes for women and their 
families. In Tajikistan, around 26% of married 15-24 year old women have an unmet need for 
contraception. There is some evidence that interventions delivered by mobile phone can 
affect contraceptive-related behaviour and knowledge. We developed an intervention 
delivered by mobile phone app instant messaging to improve acceptability of effective 
contraceptive methods among young people in Tajikistan.  
 
Methods  
This was a randomized controlled trial among Tajik people aged 16-24. Participants allocated 
to the intervention arm had access to an app plus intervention messages. Participants 
allocated to the control arm had access to the app plus control messages. The primary 
outcome was acceptability of at least one method of effective contraception at four months. 
Secondary outcomes were use of effective contraception at four months and during the 
study, acceptability of individual methods, service uptake, unintended pregnancy and 
induced abortion. Process outcomes were knowledge, perceived norms, personal agency and 
intention. Outcomes were analysed using logistic and linear regression. We conducted a pre-
specified subgroup analysis and a post-hoc analysis of change in acceptability from baseline 
to follow-up.  
 
Results  
573 participants were enrolled. Intervention content was included on the app, causing 
contamination. 472 (82%) completed follow-up for the primary outcome. There was no 
evidence of a difference in acceptability of effective contraception between the groups (66% 
in the intervention arm vs 64% in the control arm, adjusted OR 1.21, 95% CI .80-1.83, p=0.36). 
There were no differences in the secondary or process outcomes between groups. There was 
some evidence that the effect of the intervention was greater among women compared to 
men (interaction test p=0.03). There was an increase in acceptability of effective 
contraception from baseline to follow-up (2% to 65%, p<0.001). 
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Conclusions  
The whole intervention delivered by instant messaging provided no additional benefit over a 
portion of the intervention delivered by app pages. The important increase in contraceptive 
acceptability from baseline to follow-up suggests that the intervention content included on 
the app may influence attitudes. Further research is needed to establish the effect of the 
intervention on attitudes towards and use of effective contraception among married/sexually 
active young people. 
 
Trial registration: Clinicaltrial.gov NCT02905513   
 
Date of registration: 14 September 2016 
 
Key words 
Randomized controlled trial, Tajikistan, Contraception, Smart phone, Reproductive health, 
Young adults 
 
Plain English summary 
Unintended pregnancy is associated with poor health and social outcomes for women and 
their families. Despite wide availability of contraception, many women globally face barriers 
in realizing their fertility desires. A woman has an unmet need for modern contraception if 
she wants to avoid a pregnancy but currently uses no method or a traditional method. In 
Tajikistan, unmet need for contraception is approximately 26% among married 15-24 year 
olds. Oppositional attitudes towards contraception (both their own and others’) is a common 
reason women provide for not using contraception.   
  
We developed an intervention delivered by mobile phone to increase the acceptability of 
effective contraception among young people in Tajikistan. The intervention was developed 
with young people using an established approach grounded in behavioural science. We 
conducted a randomized controlled trial to evaluate the effect of the intervention on 
acceptability of effective contraception. Participants allocated to the intervention group had 
access to an app plus the intervention messages. Participants allocated to the control group 
had access to the app plus control messages. The app contained a proportion of the 
intervention messages that targeted knowledge of and attitudes towards effective 
contraception. This was different from what was planned in the trial protocol.  
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The intervention instant messages did not have an added benefit over the app with regards 
to any of the outcomes. When data from both groups were analysed together, there was a 
large increase in acceptability of effective contraception from baseline to follow-up (2% at 
baseline to 65% at follow-up). While we cannot attribute this increase unequivocally to the 
intervention content, it suggests that providing accurate information and targeting beliefs 
that influence contraceptive use may be sufficient in changing attitudes towards these 
methods among young people in Tajikistan. Further research is needed to reliably establish 
the effect of the intervention on attitudes towards and use of effective contraceptive 
methods among married/sexually active young people.  
 
6.2.2 Background 
Unintended pregnancy persists as a global health problem, with people in lower income 
countries experiencing them at a higher rate (24). Unintended pregnancy is associated with a 
multitude of negative health and economic outcomes for women and their families (3, 4, 7, 
10, 12, 15, 16, 18, 199, 200). It is estimated that modern contraceptive use currently prevents 
307 million unintended pregnancies each year in developing regions (159). Satisfying unmet 
need for modern contraception in these regions would reduce unintended pregnancies by 
74% (159). A woman has an unmet need for modern contraception if she wants to avoid a 
pregnancy but currently uses no method or a traditional method (201).   
 
Despite a number of governmental policy initiatives and strategies aimed at improving 
reproductive health in Tajikistan, young people in the country face challenges in gaining 
accurate information about contraception and in accessing services (84, 85). The 2012 
Tajikistan Demographic and Health Survey is the most reliable resource for family planning 
data in the country at present (83). The survey estimates that Tajik women have an average 
of half a child more than their desired number, implying that if unintended pregnancies were 
avoided, the total fertility rate would be 3.3 births per woman rather than the actual 3.8 (83). 
The effective contraceptive methods available in Tajikistan are oral contraceptive pills (OCs), 
intrauterine devices (IUDs), injectables and implants (‘effective methods are methods with a 
less than 10% typical use failure rate at 12 months (28-30)). Though these methods are 
available, around 26% of married 15-24 year old women have an unmet need for 
contraception (83). Unmet need is the highest between the ages of 20 to 29 (26). The main 
reason women with an unmet need provide for not using contraception are oppositional 
attitudes towards contraception, both their own and others’ (26). The next common reasons 
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relate to low perceived pregnancy risk and negative attitudes about the methods, such as 
fear of side-effects (26).  
 
Over the past few decades, the dramatic global increase in mobile phone ownership has 
engendered enthusiasm amongst researchers and health care providers regarding the use of 
mobile phones for health care delivery (32-41, 43, 47). Trials have provided some evidence 
that interventions delivered by mobile phone can improve contraceptive-related behaviours 
(134, 135, 143, 161) and knowledge (140, 142, 152), however others have failed to find an 
effect (44, 136, 137, 202). The London School of Hygiene and Tropical Medicine (LSHTM) and 
the Tajik Family Planning Association (TFPA), a Member Association of the International 
Planned Parenthood Federation (IPPF) collaborated to develop and evaluate an intervention 
delivered by mobile phone to improve attitudes towards the effective contraceptive methods 
among young people in Tajikistan.  
 
To evaluate the intervention, we conducted a randomized controlled trial from November 
2016 to July 2017. This paper reports the results of the trial. To the best of our knowledge, 
this is the first trial to evaluate a contraceptive behavioural intervention delivered by mobile 
phone in Tajikistan. The results contribute to an understanding about how to help young 
people in Tajikistan avoid unintended pregnancies.  
 
6.2.3 Methods  
The methods reported in this section were first published in the trial protocol (51) and the 
statistical analysis plan (203). 
 
Study design and participants 
This was a parallel group, individually randomized superiority trial with a 1:1 allocation ratio. 
The aim of this trial was to assess the effect of the intervention on the acceptability of 
effective contraceptive methods among young people in Tajikistan. Participants were eligible 
to take part in the trial if they were between the ages of 16 and 24, owned a personal 
Android mobile phone, lived in Tajikistan, could provide informed consent and could read 
Tajik or Russian. Participants must also have been willing to download a mobile phone app 
and receive instant messages about contraception through the app. Participants provided 
informed consent though the secure online trial database and randomization system. All 
participants received usual care (the normal care that a young person would receive if they 
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attended a sexual and reproductive health service in Tajikistan) and were free to seek any 
other support.  
 
Intervention and control 
The intervention was developed with young Tajik people in 2015-2016 guided by an 
established approach grounded in behavioural science (124). It consisted of short mobile 
phone instant messages delivered through TFPA’s ‘healthy lifestyles’ app over four months. It 
was informed by the Integrated Behavioural Model (IBM) (170) and contained 10 behaviour 
change methods (BCM) (belief selection, facilitation, anticipated regret, guided practice, 
verbal persuasion, tailoring, cultural similarity, arguments, shifting perspective and goal 
setting) (122), adapted for delivery by mobile phone. The messages provided information 
about contraception, targeted beliefs identified in the development phase that influence 
contraceptive use and aimed to support young people in believing that they can influence 
their reproductive health.  
 
The messages are tailored according to marital status and gender, resulting in four sets of 
messages (female-married, female-not married, male-married and male-not married). The 
majority of the messages in the four sets are the same, with minor tailoring so that the 
messages are relevant to these groups. (Marital status was used as a proxy for sexual activity 
because the target group and TFPA considered it inappropriate to ask directly about sexual 
activity.) Further details about the intervention are presented in the trial protocol (51) and in 
a forthcoming intervention development publication. 
 
Contamination 
Participants allocated to the intervention arm had access to the app plus the intervention 
instant messages. Participants allocated to the control arm had access to the app plus control 
instant messages about trial participation. Contrary to what was planned in the trial protocol 
(51), the app contained intervention content. The app was intended to contain only basic 
information about contraception and no behaviour change methods. This contamination 
occurred due to a misunderstanding between the partners collaborating in the research.  
 
The app contraception pages included just under a third of the intervention content. 
Specifically, 57% of the female-married intervention messages that provide accurate 
information about the effective contraceptive methods and 36% of the messages that use the 
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BCM ‘belief selection’ were included on the app. Forty-four percent of the female-married 
intervention content included on the app used the same words as the intervention messages 
(56% did not use the same words but was very similar and conveyed the same meaning). The 
intervention content included on the app aimed to help individuals: name the effective 
methods, describe how the effective methods work, list services that provide effective 
contraception, list the risks and benefits of the effective methods, describe how methods are 
used, express positive attitudes towards the effective methods and differentiate between 
real potential side-effects and misconceptions about the methods.  
 
Allocation and intervention delivery  
After providing informed consent, participants completed the baseline questionnaire through 
the database and randomization system. The allocation sequence was generated by the 
remote computer-based randomization software. Randomization occurred immediately after 
baseline data was submitted. All participants downloaded the app immediately after they 
submitted their baseline data. The delivery of the intervention (and control) instant messages 
began on the same day if participants downloaded the app before 13:00 and the following 
day if they downloaded it after 13:00.   
 
Protecting against bias 
Due to the nature of the intervention, participants would have been aware of the allocation 
soon after they started receiving the messages. Local research staff collecting outcome data 
were masked to allocation unless the participant revealed it to them. Researchers that 
analysed the data were masked to treatment allocation. 
 
Outcomes 
Primary outcome 
The primary outcome was the proportion of participants reporting that at least one method 
of effective contraception was acceptable at four months post randomization. The primary 
outcome measure was constructed based on guidelines for measuring IBM constructs (170, 
188, 189) and tested for face validity with the target group. The acceptability of each method 
was measured by the following stems: Using the [method] …causes infertility, …causes 
unwanted side effects, …is easy, …is a good way to prevent pregnancy and I would 
recommend the [method] to a friend. The IUD and implant include an additional stem: The 
[method] insertion would not be a problem. The response options for each scale were 
strongly disagree, disagree, not sure, agree, strongly agree and I do not know what the 
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[method] is. A method was acceptable if participants reported ‘agree’ or ‘strongly agree’ for 
all scales except for ‘…causes infertility’ and ‘…causes unwanted side effects’ stems, for which 
‘disagree’ or ‘strongly disagree’ indicated acceptability.  
 
Secondary outcomes 
Secondary outcomes were: use (or partner’s use) of effective contraception; acceptability of 
individual methods; use (or partner’s use) of effective contraception at any time during the 
four months; service uptake; unintended pregnancy and induced abortion. 
 
Process outcomes 
The process outcomes were: knowledge of effective contraception; perceived norms in 
relation to using and communicating with partners about contraception; personal agency in 
using (women only) and communicating with partners about contraception; intention to use 
effective contraception (women only) and intervention dose received. Details about the 
scales used to measure knowledge, perceived norm, personal agency and intention are 
reported in the trial protocol (51). 
 
Data collection 
Data was collected at baseline and at four months post-randomization using questionnaires. 
At baseline, we collected personal and demographic data and acceptability of at least one 
method of effective contraception (using the same scales as the primary outcome measure). 
All baseline data was entered onto the trial database system by the participant on their 
mobile phone. At four month follow-up, we collected all outcomes and the following data: if 
participants report using an effective method, where they obtained it; current pregnancy 
intention; whether they knew someone else that took part in the study and if so, if they read 
each other’s messages; if they stopped the messages; if they experienced physical violence 
since being in the study and if anything good or bad happened as a result of receiving the 
messages. An instant message that included a link to the database to complete the follow-up 
questionnaire was sent to all participants through the app four months after downloading the 
app. If participants did not complete the follow-up questionnaire themselves, local research 
staff contacted them by telephone to collect their data. 
  
Sample size 
The trial was powered to detect a 15% increase in acceptability of effective contraception in 
the intervention group compared with the control group. Four hundred and fifty-four 
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participants allowed for 90% power to detect a 15% absolute increase in acceptability, 
assuming 50% acceptability in the control group (i.e. 50% in the control vs 65% in the 
intervention, an odds ratio of 1.86). Allowing for 20% loss to follow-up, we aimed to 
randomize 570 people.  
 
Statistical analysis  
The trial protocol was accepted for publication on 21 July 2017 (51) and the statistical 
analysis plan was publicly released on 16 August 2017 (203). The analysis was conducted 
using Stata 15. Analyses were according to randomized arm and only participants with 
complete outcome data were included in the principal analysis. All statistical tests were two-
sided and considered significant at the 5% level. Unmasking occurred on 29 August 2017, 
after the analyses outlined within the analysis plan were complete. 
 
Loss to follow-up and missing data 
We used a chi-squared test to investigate whether loss to follow-up differed by arm. We used 
logistic regression to compare baseline characteristics of participants that completed follow-
up against participants that did not. We investigated whether predictors of loss to follow-up 
differed by arm by testing for an interaction.  
 
6.2.4 Principal analysis 
Analysis of the primary outcome 
We compared the proportion that reported that at least one method was acceptable in each 
group using logistic regression. We report the crude and adjusted odds ratio (OR) along with 
the 95% confidence interval (CI) and p-value. We adjusted the primary analysis regression for 
the following pre-specified baseline covariates: pregnancy intention (wants to avoid/other); 
gender (female/male); age (16-19/20-24); highest education level completed 
(university/other) and acceptability of effective contraception (at least one method 
acceptable/no methods acceptable) (51, 203). 
 
Analysis of the secondary outcomes 
The analysis of the secondary outcomes was similar to the analysis of the primary outcome. 
We estimated the difference between the groups using logistic regression and report odds 
ratios with 95% CIs and p-values. Regressions were adjusted for the baseline covariates 
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pregnancy intention, gender, age, education level and acceptability (of at least one method 
or with acceptability of individual methods, of the corresponding method). 
 
Analysis of the process outcomes 
The process outcomes perceived norms, personal agency and intention were comprised of 
ordinal scales. Each scale was analysed individually using ordered logistic regression to 
estimate proportional ORs. For knowledge, each correct answer received one point. The 
points were summed and an overall score was produced. We used linear regression to test 
for a difference in mean scores between the arms. To assess the ‘dose’ of the intervention 
that the intervention participants received, we analysed the number of messages that 
participants reported to have read (all, most, some, none) and whether they stopped the 
messages.  
 
Additional analyses 
Sensitivity analyses 
We conducted two sensitivity analyses regarding the missing data. In the first, we considered 
that participants lost to follow-up did not find at least one method acceptable. In the second, 
we adjusted for the main baseline predictors of missingness. Both sensitivity analyses were 
adjusted for the baseline covariates pregnancy intention, gender, age, education level and 
acceptability. 
 
Subgroup analysis  
We conducted an exploratory subgroup analysis for the primary outcome to determine if the 
intervention effect varied by baseline characteristics. The pre-specified subgroups were 
gender (female/male); age (split at the median); marital status (married/not married); 
number of children (0/1+); ethnicity (Tajik/other); occupation (in education/other); highest 
education level completed (university/other) and pregnancy intention (wants to avoid/other). 
Within the subgroups, we assessed heterogeneity of treatment effect with a test for 
interaction (194-198). We estimated ORs along with 95% CIs for each subgroup.  
 
Contamination 
To assess the potential for contamination, we report the proportion of control group 
participants that reported that they read another participant’s messages and the proportion 
of intervention participants that reported that their messages were read by another 
participant. 
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Change from baseline 
In addition to the analyses specified in the statistical analysis plan, we tested for a change in 
the primary outcome from baseline to follow-up, using McNemar’s 2 test for paired data. 
This post hoc non-randomized analysis was conducted to explore the increase in acceptability 
overall, as the app included intervention content (see discussion). 
 
6.2.5 Results 
Recruitment, randomization, exclusions 
Between 16 November 2016 and 1 March 2017, there were 580 randomizations. During the 
analysis, we discovered that five participants enrolled and were randomized twice. For the 
three participants that were allocated to the same arm on both randomizations, we kept 
them in the analysis using the baseline data from their first record. For the two participants 
that were allocated to different arms, we excluded them from the analysis. This resulted in 
573 participants included in the trial (see discussion). 
 
Two hundred and seventy-five participants were allocated to the intervention arm and 298 
participants were allocated to the control arm (Figure 6.1). No participants withdrew from 
the trial after allocation.  
 
Baseline characteristics 
Baseline characteristics of trial participants are reported in Table 6.1. Mean age was 20 years, 
and 53% were male. Ninety-four percent were not married (259/573), and only 2% (13/573) 
found at least one method of effective contraception acceptable. Characteristics were similar 
between the two groups. 
 
Table 6.1  Baseline characteristics (Tajikistan) 
 Control 
N = 298 
% (n) 
Intervention 
N = 275 
% (n) 
All participants 
N = 573 
% (n) 
Age mean [sd] 20.00 [2.41] 19.93 [2.24] 19.98 [2.33] 
16-19 53.02 (158) 56.73 (156) 54.80 (314) 
20-24 46.98 (140) 43.27(119) 45.20(259) 
Gender female 45.97(137) 47.27 (130) 46.60 (267) 
male 54.03 (161) 52.73 (145) 53.40 (306) 
Marital status married 6.71 (20) 5.82 (16) 6.28 (36) 
not-married 93.29 (278) 94.18 (259) 93.72 (537) 
Number of children 0 95.64 (285) 97.09 (267) 96.34 (552) 
1 2.01 (6) 2.18 (6) 2.09 (12) 
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 Control 
N = 298 
% (n) 
Intervention 
N = 275 
% (n) 
All participants 
N = 573 
% (n) 
2 or more 2.35 (7) 0.73 (2) 1.57 (9) 
Ethnicity Tajik  92.62 (276) 93.82 (258) 93.19 (534) 
Russian 2.35 (7) 0.36 (1) 1.40 (8) 
Uzbek 5.03 (15) 5.45 (15) 5.24 (30) 
other 0 (0) 0.36 (1) 0.17 (1) 
Occupation school  17.79 (53) 17.09 (47) 17.45 (100) 
university 68.46 (204) 70.55 (194) 69.46 (398) 
working 10.74 (32) 10.55 (29) 10.65 (61) 
training 0.67 (2) 0 (0) 0.35 (2) 
parent 0.34 (1) 0 (0) 0.17 (1) 
not working 1.68 (5) 1.82 (5) 1.75 (10) 
university & 
working 
0.34 (1) 0 (0) 0.17 (1) 
Highest level of 
education 
completed 
primary 12.75 (38) 13.09 (36) 12.91 (74) 
secondary 66.11 (197) 59.64 (164) 63.00 (361) 
university 19.46 (58) 25.82 (71) 22.51 (129) 
other 1.68 (5) 1.45 (4) 1.57 (9) 
Current pregnancy 
intention 
(‘Do you want a 
pregnancy now?) 
yes 3.02 (9) 4.00 (11) 3.49 (20) 
no 12.42 (37) 5.82 (16) 9.25 (53) 
unsure 1.01 (3) 0.73 (2) 0.87 (5) 
not married* 83.56 (249) 89.45 (246) 86.39 (495) 
Baseline method none 31.88 (95) 29.45 (81) 30.72 (176) 
male condom 2.01 (6) 1.09 (3) 1.57 (9) 
IUD** 0.67 (2) 0 (0) 0.35 (2) 
not married* 65.10 (194) 69.09 (190) 67.02 (384) 
LAM*** 0 (0) 0.36 (1) 0.17 (1) 
other 0.34 (1) 0 (0) 0.17 (1) 
At least one 
effective method is 
acceptable 
yes 2.68 (8) 1.82 (5) 2.27 (13) 
no 97.32 (290) 98.18 (270) 97.73 (560) 
Pill acceptability yes 1.34 (4) 0.73 (2) 1.05 (6) 
no 98.66 (294) 99.27 (273) 98.95 (567) 
IUD acceptability yes 1.34 (4) 0 (0) 0.70 (4) 
no 98.66 (294) 100 (275) 99.30 (569) 
Injection 
acceptability 
yes 0.67 (2) 1.45 (4) 1.05 (6) 
no 99.33 (296) 98.55 (271) 98.95 (567) 
Implant 
acceptability 
yes 0.34 (1) 0.73 (2) 0.52 (3) 
no 99.66 (297) 99.27 (273) 99.48 (570) 
*The response ‘not married’ was used as a proxy for not being sexually active.  
**IUD = intrauterine device 
***LAM = Lactational amenorrhea method 
 
Loss to follow-up 
Four hundred and seventy-six participants total (83%) contributed follow-up data. Four 
hundred and seventy-two participants (82%) completed the trial follow-up for the primary 
outcome (intervention, n = 228; control, n =244) (Figure 6.1). 
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Retention did not differ between the arms (83% in the intervention vs 82% in the control, 
p=0.75). The main predictors of retention were male gender (OR 1.78, p=0.01), Tajik ethnicity 
(OR 2.22, p=0.03) and having completed a level of education lower than university at 
enrolment (OR 1.79, p=0.02). The effect of these predictors did not differ by arm (interaction 
test p-values: gender, p=0.72; ethnicity, p=0.41; education level, p=0.98). Detailed 
characteristics of follow-up completers and non-completers are reported in Appendix 17. 
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Figure 6.1 CONSORT diagram (Tajikistan) 
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Primary outcome 
In the intervention arm, 66% (151/228) reported that at least one method of contraception 
was acceptable compared to 64% (156/244) in the control arm (Table 6.2). There was no 
evidence of a difference in acceptability between the groups (crude OR 1.11, 95% CI .76-1.62, 
p = 0.60; adjusted OR 1.21, 95% CI .80-1.83, p = 0.36).  
 
Table 6.2  Primary outcome (Tajikistan) 
 
 
Control 
N = 244 
% (n) 
Intervention 
N = 228 
% (n) 
OR (95% CI) p-value 
 
At least one effective 
method is acceptable* 
 
63.93 (156) 
 
66.23 (151) 
 
1.21 (.80-1.83) 
 
0.36 
*adjusted for pregnancy intention, gender, age, education level and acceptability at baseline 
 
Secondary outcomes 
There were no significant differences in any of the secondary outcomes between the groups 
(Table 6.3). 
 
Table 6.3  Secondary outcomes (Tajikistan) 
 
 
Control 
% (n/N) 
Intervention 
% (n/N) 
OR (95% CI) p-value 
 
Use of effective 
contraception* 
 
3.66 (9/246) 
 
1.30 (3/230) 
 
.35 (.06-1.42) 
 
0.18 
 
Pill acceptability** 
 
56.56 (138/244) 
 
60.53 (138) 
 
1.32 (.88-2.00) 
 
0.18 
 
IUD acceptability** 
 
52.87 (129/244) 
 
51.32 (117/228) 
 
1.00 (.67-1.50) 
 
0.98 
 
Injection acceptability** 
 
54.51 (133/244) 
 
55.26 (126/228) 
 
1.14 (.76-1.70) 
 
0.52 
 
Implant acceptability** 
 
48.77 (119/244) 
 
48.68 (111/228) 
 
1.08 (.73-1.59) 
 
0.71 
Effective contraceptive 
use  
during the 4 months* 
 
2.88 (7/243) 
 
1.76 (4/227) 
 
.61 (.13-2.42) 
 
0.62 
Service uptake+ 
(attended a service one 
or more times) 
 
10.29 (25/243) 
 
7.93 (18/227) 
 
.76 (.39-1.46) 
 
0.41 
 
Unintended pregnancy+ 
 
0 (0) 
 
0 (0) 
 
- 
 
- 
 
Induced abortion+ 
 
0 (0) 
 
0 (0) 
 
- 
 
- 
*based on unadjusted exact logistic regression, due to small numbers 
**adjusted for pregnancy intention, gender, age, education level and the corresponding method 
acceptability at baseline  
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+adjusted for pregnancy intention, gender, age, education level and acceptability at baseline 
 
Process outcomes 
There were no significant differences in any of the process outcomes between the groups 
(Table 6.4).
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Table 6.4  Process outcomes (Tajikistan) 
 
 
Control 
% (n/N) 
Intervention 
% (n/N) 
proportional OR* 
(95% CI), p-value 
Knowledge of effective contraception  
 
Mean = 4.00 
[sd = 2.04] 
Mean = 4.08 
[sd = 2.02] 
.08** 
(-.29-.44), 0.69 
My friends would use the pill, IUD, injection or implant if they 
wanted to prevent pregnancy 
strongly disagree 3.70 (9/243) 1.33 (3/226)  
1.40  
(.97-2.01), 0.07 
disagree 4.53 (11/243) 5.31 (12/226) 
not sure 17.28 (42/243) 16.37 (37/226) 
agree 64.61 (157/243) 59.29 (134/226) 
strongly agree 9.88 (24/243) 17.70 (40/226) 
My friends would talk to their husband/wife about contraception if 
they wanted to prevent a pregnancy 
strongly disagree 1.23 (3/243) 1.33 (3/226)  
1.09  
(.76-1.57), 0.64 
disagree 5.35 (13/243) 6.64 (15/226) 
not sure 16.05 (39/243) 15.93 (36/226) 
agree 65.02 (158/243) 59.29 (134/226) 
strongly agree 12.35 (30/243) 16.81 (38/226) 
If you wanted to use the pill, IUD, injection or implant, how easy 
would it be for you to use it? (women only) 
very difficult 7.62 (8/105) 5.83 (6/103)  
1.43  
(.87-2.34), 0.16 
difficult 17.14 (18/105) 9.71 (10/103) 
not sure 27.62 (29/105) 29.13 (30/103) 
easy 38.10 (40/105) 43.69 (45/103) 
very easy 9.52 (10/105) 11.65 (12/103) 
If you wanted to talk to your husband/wife about contraception, 
how easy would it be for you to talk to him/her? 
very difficult 3.70 (9/243) 3/10 (7/226)  
1.22  
(.86-1.73), 0.26 
difficult 6.17 (15/243) 7.52 (17/226) 
not sure 14.81 (36/243) 14.16 (32/226) 
easy 60.49 (147/243) 53.10 (120/226) 
very easy 14.81 (36/243) 22.12 (50/226) 
If you wanted to use the pill, IUD, injection or implant, how certain 
are you that you could use it? (women only) 
very certain I could not 2.86 (3/105) 5.83 (6/103)  
.99  
(.60-1.63), 0.96 
 
certain I could not 6.67 (7/105) 7.77 (8/103) 
not sure  38.10 (40/105) 32.04 (33/103) 
certain I could 40.00 (42/105) 41.75 (43/103) 
very certain I could 12.38 (13/105) 12.62 (13/103) 
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Control 
% (n/N) 
Intervention 
% (n/N) 
proportional OR* 
(95% CI), p-value 
If you wanted to talk to your husband/wife about contraception, 
how certain are you that you could talk to him/her? 
very certain I could not 1.23 (3/243) 2.65 (6/226)  
1.10  
(.78-1.53), 0.60 
certain I could not 13.17 (32/243) 12.39 (28/226) 
not sure  16.46 (40/243) 16.81 (38/226) 
certain I could 50.62 (123/243) 44.25 (100/226) 
very certain I could 18.52 (45/243) 23.89 (54/226) 
I intend to use the pill, IUD, injection or implant strongly disagree 4.76 (5/105) 2.91 (3/103)  
1.37  
(.84-2.25), 0.21 
disagree 10.48 (11/105) 12.62 (13/103) 
not sure 31.43 (33/105) 25.24 (26/103) 
agree 39.05 (41/105) 34.95 (36/103) 
strongly agree 14.29 (15/105) 24.27 (25/103) 
Number of messages read 
 
all  32.16 (73/227)  
most  43.61 (99/227) 
some  18.50 (42/227) 
none 5.73 (13/227) 
Proportion of intervention participants that stopped the intervention 
 
  
29.07 (66/227) 
 
*estimated from ordered logistic regression 
**mean difference 
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Potential for contamination 
Three percent (8/243) of control participants said that they read the messages of someone 
else in the study. Nine percent (21/227) of intervention participants said that someone else in 
the study read their messages. 
 
Participants’ report of physical violence during the study 
Overall, 0.85% (4/470) reported that they experienced physical violence since being in the 
study (0.41% in the control and 1.32% in the intervention, Pearson’s chi2 p = 0.28). 
 
Sensitivity analyses 
The effect of the intervention on the primary outcome observed in the principal analysis did 
not change when we considered participants lost to follow-up did not find at least one 
method acceptable (OR 1.20, 95% CI .84-1.73, p=0.31) or when we adjusted the model for the 
predictors of missingness (OR 1.21, 95% CI .80-1.85, p=0.35). 
 
Subgroup analysis 
There was some evidence that the effect of the intervention was greater among women 
compared to men (interaction test p=0.03) (Figure 6.2). 
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Figure 6.2 Intervention effect on acceptability of effective contraception, by subgroups (Tajikistan) 
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Change from baseline analysis 
Among the 472 participants who completed follow-up 2% (n=10) thought that at least one 
method was acceptable at baseline, which increased to 65% at follow-up (n=307, p<0.001) 
(Figure 6.3). Acceptability for the individual methods increased from 1% at baseline to 49%-
58% at follow-up (p<0.001). 
 
Figure 6.3 Method acceptability at baseline and follow-up (Tajikistan) 
 
6.2.6 Discussion 
Main results 
Contrary to what was planned in the trial protocol, the app contained intervention content. 
Both intervention and control participants received intervention content targeting knowledge 
and attitudes towards effective contraception, including the BCM ‘belief selection’. The trial 
therefore evaluated the effect of the whole intervention with all ten BCMs (belief selection, 
facilitation, anticipated regret, guided practice, verbal persuasion, tailoring, cultural similarity, 
arguments, shifting perspective and goal setting) delivered by instant messaging, compared 
to a proportion of the intervention delivered on the app pages with the BCM belief selection.  
 
The trial found no evidence of a difference in acceptability of at least one effective 
contraceptive method between the intervention and control groups. There was also no 
evidence of a difference in any of the secondary and process outcomes between the groups 
(use of effective contraception, service uptake, knowledge, perceived norms, personal agency 
and intention to use effective contraception). This indicates that the intervention content 
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attitudes and personal agency) did not have an additional benefit over the app regarding 
these outcomes. The subgroup analysis suggests that the intervention delivered by instant 
messaging could be more effective among women compared to men. When data from both 
groups were analysed together, there was a large statistically significant increase in 
acceptability from baseline to follow-up.  
 
Comparisons with other research 
Trials that have evaluated interventions delivered by mobile phone to improve contraceptive-
related outcomes have had mixed results (44, 134-137, 140, 142, 143, 152, 161, 202). We are 
conducting trials in Bolivia and Palestine that are evaluating the effect of interventions similar 
to the Tajik intervention on acceptability and use of effective contraception (52, 204). The 
results of the three trials together should contribute to a better understanding of the effect 
of the intervention evaluated in this Tajik trial.  
 
Our trial shows no additional benefit on the outcomes from the nine BCMs deliver by instant 
messaging. No previous research reports the effectiveness of these BCMs aimed at improving 
contraceptive-related outcomes delivered by mobile phone (133).  
 
Ongoing trials of interventions delivered by mobile phone to improve reproductive health are 
measuring participants’ experience of violence during their participation in the trial (52, 204, 
205). In this Tajik trial, we found no association between the intervention and experience of 
violence. While this is reassuring, both groups had access to the app, so we are unable to 
assess the effect of the app on partner violence.   
 
Strengths and limitations 
The trial conduct has a number of strengths. We recruited our target number of participants 
and were able to collect follow-up data for an acceptable proportion of them, given that the 
sample size allowed for 20% loss. We developed and tested a remote trial database and 
randomization system, which successfully generated and concealed the allocation sequence 
and achieved well-balanced groups. An important limitation is that the app included 
intervention content, as discussed above. This constitutes a protocol deviation and the trial 
was therefore not able to answer the primary question it aimed to answer. Because the self-
reported acceptability scales were collected by telephone by the research staff, participants 
may have been more likely to report positive attitudes than they were at baseline where they 
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completed the questionnaire by themselves on their phones. Regarding the large increase in 
acceptability from baseline to follow-up, we cannot rule out the possibility that at least a 
portion of this increase was due to participation in the trial as opposed to the intervention 
itself; participants were aware that the trial involved changing attitudes towards 
contraception. Five participants enrolled and were randomized twice. 
 
There were inconsistencies in participants’ self-reporting of marital status. The proportion 
that responded ‘not married’ to the current pregnancy intention (495/573, 86%) and the 
baseline method question (384/573, 67%) is lower than the proportion that responded ‘not 
married’ when asked directly about their marital status (537/573, 94%). We cannot say why 
these inconsistencies occurred. However, we can speculate that some participants who 
responded ‘not married’ to the marital status question were sexually active and responded to 
the other two questions with responses other than ‘not married’.  
  
Thirty six percent of people assessed for eligibility (328/908) were excluded from the study. 
The reason for ineligibility was not recorded for 85 people, which could limit the 
generalizability of the trial findings. While the recording of this information was not 
complete, of those that are known, the majority appear to have been excluded because they 
did not have an Android phone (n = 99). If those who did not own a smartphone were less 
likely to find at least one method of effective contraception acceptable, this could have 
affected the generalizability of the results. Smartphone ownership is rapidly increasing 
however, and ownership could be an option for a greater proportion of young people across 
different socioeconomic communities in the near future.  
 
Implications of the findings 
The finding that the intervention instant messages did not have an additional benefit over the 
app along with the large increase in acceptability from baseline to follow-up suggests that 
participants read the app contraception pages. It may be that in a context such as Tajikistan, 
where young people have limited access to information and support about reproductive 
health, they are willing to read static app pages about this topic. In comparison, a trial in the 
United Kingdom found that young people did not engage heavily with a sexual and 
reproductive health website (206, 207). In contexts such as the United Kingdom where 
information and support are more accessible, interventions delivered on app pages and 
websites may be utilized less frequently than in contexts such as Tajikistan.  
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Because the intervention content included on the app aimed to improve knowledge of and 
attitudes towards effective contraception, it is not surprising that there was no evidence of a 
difference between the groups regarding these outcomes. Though the large increase in 
acceptability from baseline to follow-up cannot be unequivocally attributed to the 
intervention content, an increase this large suggests that the intervention content included 
on the app at least was partially effective in improving attitudes towards the effective 
methods. Because the intervention is well-specified, we were able to identify the 
components of the intervention that may have been effective in producing this change 
(accurate information and targeting beliefs using the BCM belief selection) (122, 124).  
 
Despite the contamination that occurred, intervention participants received content that 
control participants did not. The secondary outcomes use and service uptake and the process 
outcomes personal agency and intention are related to the content that only intervention 
participants received. There are a number of potential explanations for why we did not 
observe a difference between the groups in these outcomes. The first is that the BCMs 
targeting these outcomes did not work. This could have been because the conditions under 
which the methods have been shown to be effective were not fully satisfied (122, 124). In 
addition, because a large proportion of meaning comes from visual cues in face-to-face 
interaction (124), some of the meaning of the BCMs may have been lost when delivered by 
mobile phone. For example, the BCM ‘guided practice’ requires skill demonstration, 
enactment and individual feedback. While the intervention messages demonstrated and 
provided instruction, we were not able to observe the participant enacting the behavior or to 
provide individual feedback. This may have resulted in a loss of effectiveness of the BCM. 
Another explanation is that intervention could be more effective on these secondary and 
process outcomes with people where the behaviour is salient, such as with those who are 
married/sexually active or soon to be. In this trial however, only 6% (36/573) were 
married/sexually active, which was too small to explore this possibility. Alternatively, the app 
alone may have been effective in influencing these secondary and process outcomes; in the 
Tajik context, providing accurate information from a credible source and targeting the pre-
identified beliefs may be sufficient. Finally, these secondary and process outcomes could 
have be so strongly influenced by environmental conditions (e.g. stigma regarding sexual 
activity before marriage and pressure to bear children) that they were not amenable to 
change by a mobile phone intervention only.  
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While caution is necessary in interpreting the results of the subgroup analysis, it suggests that 
the whole intervention delivered by instant messaging could be more effective among 
women compared to men. The trials in Bolivia and Palestine involve women only so the 
results should provide additional evidence of the intervention’s effectiveness in women.  
 
We are currently conducting qualitative interviews with trial participants to explore their 
experiences in receiving the intervention and app content. If participants were positive about 
receiving the intervention messages, this could support the delivery of the messages with the 
download of the app. The fact that the intervention is already developed and therefore 
inexpensive to deliver, plus the fact that it does not appear to cause harm, also supports the 
delivery of the messages with the download of the app. 
 
Conclusions 
This trial demonstrated that the whole intervention delivered by app instant messaging 
provided no additional benefit over a portion of the intervention delivered by the app pages. 
An analysis of participants randomized to the control and intervention groups together 
showed a large significant increase in acceptability from baseline to follow-up. Further 
research is needed to establish the effect of the intervention on attitudes towards and use of 
effective contraceptive methods among married/sexually active young people. 
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7 Palestine evaluation results 
7.1 Introduction 
This chapter includes the results of the Palestine randomised controlled trial. I submitted the 
manuscript to Trials on 24 August 2018. At the time of thesis submission in November 2018, 
the manuscript was under review.
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7.2 Research paper 
7.2.1 Abstract 
Background 
Research has shown that mobile phone contraceptive behavioral interventions can increase 
knowledge and use of contraception, but other studies have failed to demonstrate a 
beneficial effect. The objective of this trial was to estimate the effect of a contraceptive 
behavioral intervention delivered by mobile phone text message on young Palestinian 
women’s attitudes towards effective contraception.   
 
Methods 
We conducted a randomized controlled trial among women aged 18-24 years not using an 
effective method of contraception living in the West Bank. The intervention group received 
the intervention messages. The control group received messages about trial participation. 
The primary outcome was acceptability of at least one method of effective contraception at 
four months. Secondary outcomes were use of effective contraception at four months and 
during the study, acceptability of individual methods, service uptake, unintended pregnancy 
and abortion. Process outcomes included knowledge, perceived norms, personal agency and 
intention. We analyzed the outcomes using logistic and linear regression. 
 
Results 
578 participants were enrolled and 464 (80%) completed follow-up at 4 months. Intervention 
group participants were more likely to find at least one method of effective contraception 
acceptable (31% in the intervention group vs. 17% in the control group, adjusted OR 2.34, 
95% CI 1.48-3.68, p < 0.001). They had a higher mean knowledge score, were more likely to 
find individual methods acceptable, to agree that their friends would use an effective method 
and to intend to use an effective method compare to participants in the control group. 
 
Conclusions 
The intervention can improve attitudes, knowledge perceived norms and intention to use 
effective contraception among young women in Palestine. Future implementation research is 
needed. 
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7.2.2 Background 
Unintended pregnancy continues to be a global health problem (24). Women with an unmet 
need for modern contraception account for an estimated 84% of all unintended pregnancies 
in developing regions (159). Satisfying unmet need for modern contraception is essential in 
avoiding unintended pregnancies and identifying the barriers that prevent people from using 
the methods can help achieve this (26, 201).   
 
Sexual and reproductive health in the State of Palestine (the West Bank, East Jerusalem and 
the Gaza Strip, hereafter referred to as ‘Palestine’) has been negatively affected by the 
conflict (22, 94). It is estimated that 38% of pregnancies are unintended (104), with unmet 
need for contraception peaking among women aged 20-24, at 15% (96). While the adolescent 
fertility rate had decreased substantially over the past 20 years, the current adolescent 
fertility rate of 48 per 1,000 women aged 15-19 remains higher than most other countries in 
the region (96, 97). The Palestinian Family Survey 2010 found that among married women 
not using contraception and not reporting wanting to have a child, the main reasons given for 
not using contraception were fear of side effects, inconvenience of methods and their 
husband’s opposition (98, 99). 
 
Mobile phones are commonly used to deliver health behavioral support (36-41, 43). In 
Palestine, delivering contraceptive support by mobile phone may be an advantageous mode 
by which to reach people in the substantial area that is underserved with regard to sexual 
and reproductive health services (93). There is some evidence from trials that interventions 
delivered by mobile phone can improve contraceptive use (134, 135, 143, 161) and 
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knowledge (140, 142, 152), however other trials have not found a beneficial effect (44, 136, 
137, 202). 
 
The London School of Hygiene and Tropical Medicine (LSHTM) and the Palestinian Family 
Planning and Protection Association (PFPPA) developed a contraceptive behavioral 
intervention in Palestine delivered by mobile phone (50). This paper reports the results of the 
evaluation of the intervention.  
 
7.2.3 Methods 
The methods are summarized in this section. Detailed methods are published in the trial 
protocol (52) and the statistical analysis plan (208).  
 
Aim, study design and participants 
This was a parallel group, individually randomized trial with a 1:1 allocation ratio. The aim 
was to assess the effect of the intervention on attitudes towards the non-permanent 
effective contraceptive methods (28-30) available in Palestine (oral contraceptive pills (OCs), 
intrauterine devices (IUDs), injectables, implants and the patch). Women were eligible to take 
part if they were between 18 and 24 years, did not report using an effective method of 
contraception, owned a personal mobile phone, lived in the West Bank and could read 
Arabic. We recruited participants through PFPPA’s service delivery points and outreach sites 
in Jerusalem, Bethlehem, Halhoul and Ramallah.  
 
Intervention and control 
The intervention consisted of short mobile phone text messages, tailored to marital status, 
delivered over four months (50). The intervention messages contained information and 10 
behavior change methods (BCM) (122), adapted for delivery by mobile phone. Participants 
allocated to the intervention group received the intervention text messages and participants 
allocated to the control group received control messages about trial participation. Details 
regarding the development of the intervention can be found in the intervention development 
publication (50) and the trial protocol (52).  
 
Allocation and intervention delivery 
The online trial database and randomization system generated the allocation sequence and 
randomization occurred immediately after the baseline data were submitted by clinic 
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research staff. The system sent the Palestinian texting platform the allocation, preferred time 
slot for message delivery, mobile phone number and marital status.  
 
Protecting against bias 
Participants would have been aware of the allocation after they started receiving the 
messages. Research staff collecting outcome data were masked to allocation unless the 
participant revealed it to them. Researchers who analyzed the data were masked to 
treatment allocation. 
 
Outcomes  
Primary outcome 
The primary outcome was the proportion of participants reporting that at least one method 
of effective contraception was acceptable at four months post randomization. The 
acceptability of each method was measured by the following stems: Using the [method] 
…causes infertility, …causes unwanted side effects, …is easy, …is a good way to prevent 
pregnancy and I would recommend the [method] to a friend. The IUD and implant include an 
additional stem: The [method] insertion would not be a problem for me. The response 
options for each stem were: ‘strongly disagree’, ‘disagree’, ‘not sure’, ‘agree’, ‘strongly agree’ 
and ‘I do not know what the [method] is’. A method was acceptable if participants reported 
agree or strongly agree for all stems except for …causes infertility and …causes unwanted 
side effects, for which disagree or strongly disagree indicated acceptability (52).  
 
Secondary outcomes 
Secondary outcomes were: use of effective contraception at four months and during the 
study; acceptability of individual methods; service uptake, unintended pregnancy and 
abortion.  
 
Process outcomes 
The process outcomes were: knowledge of effective contraception; perceived norms and 
personal agency in relation to using and communicating with partners about contraception; 
intention to use effective contraception and intervention dose received. 
 
127 
 
Data collection 
At baseline, we collected personal and demographic data and the primary outcome via self-
completed paper questionnaire. At four-month follow-up we collected all outcomes. Staff 
masked to treatment allocation collected the follow-up data verbally by telephone. 
 
Sample size  
The trial was powered to detect a 15% absolute increase in acceptability of effective 
contraception in the intervention group compared to the control group. Four hundred and 
fifty-four participants would provide 90% power to detect a 15% absolute increase in 
acceptability, at the 5% significance level, assuming 50% acceptability in the control group. 
We allowed for 20% loss to follow-up and aimed to randomize 570 participants.  
 
Statistical analysis 
The trial protocol was accepted for publication on September 14, 2017 (52) and the detailed 
statistical analysis plan was publicly released before conducting the data analysis, on 
November 7, 2017 (208). Analyses were conducted according to randomized group and only 
participants with complete outcome data were included in the principal analysis. All statistical 
tests were two-sided and considered significant at the 5% level. The analysis was conducted 
using Stata 15. Unmasking occurred on February 6, 2018, after the analyses outlined within 
the analysis plan were completed on masked data.  
 
Loss to follow-up and missing data 
We used a chi-squared test to investigate whether loss to follow-up differed by trial arm. We 
used logistic regression to compare baseline characteristics of participants who completed 
follow-up with participants who did not. We investigated whether predictors of loss to 
follow-up differed by trial arm by testing for an interaction.  
 
Principal analysis 
Analysis of the primary outcome 
We compared the proportion of participants that reported that at least one method was 
acceptable in each trial arm using logistic regression. We report the crude and adjusted odds 
ratio (OR) along with a 95% confidence interval (CI) and p-value. We adjusted the primary 
analysis regression for pre-specified baseline covariates (52, 208).   
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Analysis of the secondary outcomes 
The analysis of the secondary outcomes was similar to the analysis of the primary outcome, 
although with acceptability of the individual methods, the acceptability of that method at 
baseline replaced the acceptability of at least one method at baseline as a covariate.  
 
Analysis of the process outcomes 
The process outcomes perceived norms, personal agency and intention were each comprised 
of ordinal scales. Each scale was analyzed individually using ordered logistic regression. For 
knowledge, we used linear regression to assess the difference in the mean scores between 
the groups. To quantify the ‘dose’ of the intervention that the intervention participants 
received, we analyzed the number of messages that participants reported to have read (all, 
most, some, none) and whether they stopped the messages, along with our monitoring data.  
  
Additional analyses 
Sensitivity analyses 
We conducted two sensitivity analyses to account for missing data. In the first, we considered 
that all participants lost to follow-up did not find at least one method acceptable. In the 
second, we adjusted for the main baseline predictors of missingness. Both sensitivity analyses 
were adjusted for the baseline covariates as above.  
 
Subgroup analysis  
We conducted an exploratory subgroup analysis for the primary outcome with pre-specified 
subgroups (208). Within the subgroups, we assessed heterogeneity of the estimated 
treatment effect with a test for interaction (197, 198). We estimated ORs with 95% CIs for 
each subgroup. 
 
Contamination 
We report the proportion of control group participants that reported that they read another 
participant’s messages and the proportion of intervention participants that reported that 
their messages were read by another participant. 
 
Report of physical violence 
We report the proportion of participants in each group that reported experiencing physical 
violence during the study. 
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7.2.4 Results 
Recruitment, randomization, exclusions 
Between December 8, 2016 and July 22, 2017, there were 586 randomizations by the system. 
During the trial follow-up, we discovered that four participants enrolled and were 
randomized twice. For the two participants who were allocated to the same group on both 
randomizations, we kept them in the trial using the baseline data from their first record (the 
system allowed only one follow-up record). We excluded the two participants who were 
allocated to different groups from the analysis.  
 
In addition, one record was excluded because the participant’s incorrect mobile number was 
entered onto the database (the correct record and number was kept) and another record was 
excluded because the participant was recruited in error (the participant was using the IUD 
and was therefore ineligible). This resulted in 578 participants included in the trial (Figure 
7.1). Two hundred and eighty-nine participants were allocated to the intervention group and 
to the control group. No participants withdrew from the trial after allocation.  
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Figure 7.1 CONSORT diagram (Palestine) 
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Baseline characteristics 
Baseline characteristics of trial participants are reported in Table 7.1. Mean age was 21 years, 
and 71% (409/578) were aged 20-24 years. Sixty percent were not married (259/573) and 
only 8% (47/578) found at least one method of effective contraception acceptable. 
Characteristics were largely similar between the two groups, however, almost twice as many 
participants in the control group reported that at least one method of effective contraception 
was acceptable at baseline compared to the intervention group (10.38% in the control vs 
5.88% in the intervention, see discussion).  
 
Table 7.1  Baseline characteristics (Palestine) 
 Control 
N = 289 
% (n) 
Intervention 
N = 289 
% (n) 
All participants 
N = 578 
% (n) 
Age mean [sd] 21.36 [1.77] 21.18 [1.75] 21.27 [1.76] 
18-19 25.95 (75) 32.53 (94) 29.24 (169) 
20-24 74.05 (214) 67.47 (195) 70.76 (409) 
Marital status married 40.48 (117) 38.75 (112) 39.62 (229) 
not-married 59.52 (172) 61.25 (177) 60.38 (349) 
Number of 
children 
0 72.32 (209) 79.58 (230) 75.95 (439) 
1 16.26 (47) 10.73 (31) 13.49 (78) 
2 or more 11.42 (33) 9.69 (28) 10.55 (61) 
Residence city 46.71 (135) 47.75 (138) 47.23 (273) 
village 48.10 (139) 46.71 (135) 47.40 (274) 
camp  4.15 (12) 4.84 (14) 4.50 (26) 
Bedouin community 1.04 (3) 0.69 (2) 0.87 (5) 
Occupation 
 
 
school  1.73 (5) 0.35 (1) 1.04 (6) 
university 48.44 (140) 52.60 (152) 44.64 (258) 
working 5.19 (15) 3.46 (10) 4.33 (25) 
training 14.88 (43) 15.92 (46) 15.22 (88) 
parent 22.49 (65) 20.07 (58) 20.59 (119) 
not working 5.88 (17) 6.57 (19) 6.23 (36) 
university & working 0.35 (1) 0.35 (1) 0.35 (2) 
university & parent 0.69 (2) - 0.35 (2) 
school & parent 0.35 (1) 0.35 (1) 0.35 (2) 
working, training & 
parent 
- 0.35 (1) 0.17 (1) 
Highest level of 
education 
completed 
primary 0.69 (2) 0.69 (2) 0.69 (4) 
secondary 22.84 (66) 21.11 (61) 21.97 (127) 
university 66.09 (191) 66.44 (192) 66.26 (383) 
technical 10.38 (30) 11.76 (34) 11.07 (64) 
Current pregnancy 
intention 
(‘Do you want a 
pregnancy now?) 
yes 16.26 (47) 20.07 (58) 18.17 (105) 
no 25.61 (74) 24.57 (71) 25.09 (145) 
unsure 4.15 (12) 1.38 (4) 2.77 (16) 
not married a 53.98 (156) 53.98 (156) 53.98 (312) 
Baseline method none 39.45 (114) 41.52 (120) 40.48 (234) 
male condom 0.69 (2) 0.69 (2) 0.69 (4) 
not married a 53.63 (155) 54.33 (157) 53.98 (312) 
calendar 1.04 (3) 0.35 (1) 0.69 (4) 
LAM b 3.11 (9) 1.38 (4) 2.25 (13) 
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 Control 
N = 289 
% (n) 
Intervention 
N = 289 
% (n) 
All participants 
N = 578 
% (n) 
withdrawal 2.08 (6) 1.38 (4) 1.73 (10) 
other - 0.35 (1) 0.17 (1) 
At least one 
effective method 
is acceptable 
yes 10.38 (30) 5.88 (17) 8.13 (47) 
no 89.62 (259) 94.12 (272) 91.87 (531) 
Pill acceptability yes 3.81 (11) 3.11 (9) 3.46 (20) 
no 96.19 (278) 96.89 (280) 96.54 (558) 
IUD c acceptability yes 4.50 (13) 1.73 (5) 3.11 (18) 
no 95.50 (276) 98.27 (284) 96.89 (560) 
Injection 
acceptability 
yes 1.38 (4) 1.38 (4) 1.38 (8) 
no 98.62 (285) 98.62 (285) 98.62 (570) 
Implant 
acceptability 
yes 3.11 (9) 1.73 (5) 2.42 (14) 
no 96.89 (280) 98.27 (284) 97.58 (564) 
Patch 
acceptability 
yes 0.69 (2) 0.35 (1) 0.52 (3) 
  no 99.31 (287) 99.65 (288) 99.48 (575) 
a the response ‘not married’ was used as a proxy for sexual activity 
b LAM Lactational amenorrhea method 
c IUD Intrauterine device 
 
Loss to follow-up 
Four hundred and sixty-four participants (80%) completed the trial follow-up for the primary 
outcome (control, n = 235; intervention, n = 229) (Figure 7.1). Retention did not differ 
between the groups (81% in the control and 79% in the intervention group, Pearson’s chi 
squared test p = 0.53). The main predictor of retention was completion of university at 
enrolment (OR 1.80, 95% CI 1.18-2.73, p = 0.01). The effect of this predictor of retention did 
not differ by group (interaction test p = 0.78). Detailed characteristics of follow-up 
completers and non-completers are reported in Appendix 18. 
 
Primary outcome 
In the intervention group, 31% (71/229) reported that at least one method of contraception 
was acceptable compared to 17% (40/235) in the control group (Table 7.2). Participants in the 
intervention group had 2.34 times the odds of finding at least one method of effective 
contraception acceptable compared to participants in the control group (adjusted OR 2.34, 
95% CI 1.48-3.68, p < 0.001; crude OR 2.19, 95% CI 1.41-3.40, p < 0.001). 
 
Table 7.2  Primary outcome (Palestine) 
 
 
Control 
N = 235  
% (n) 
Intervention 
N = 229 
% (n) 
adjusted OR 
(95% CI) 
p-value 
  
17.02 (40) 
 
31.00 (71) 
  
< 0.001 
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At least one effective 
method is acceptable* 
2.34 (1.48-
3.68) 
*adjusted for pregnancy intention, age, number of children, education level and acceptability at 
baseline 
 
Secondary outcomes 
The odds of finding the IUD, injection, implant, patch and a LARC method were greater in the 
intervention group compared to the control group and were statistically significant (Table 
7.3). The odds of using effective contraception was also greater in the intervention group, 
however this could likely have occurred by chance. 
 
Table 7.3  Secondary outcomes (Palestine) 
 
 
Control 
% (n/N) 
Intervention 
% (n/N) 
adjusted OR (95% 
CI) 
p-value 
 
Use of effective 
contraception* 
 
8.51 (20/235) 
 
8.73 (20/229) 
 
1.42 (.66-3.07) 
 
0.37 
 
Pill acceptability** 
 
4.68 (11/235) 
 
6.11 (14/229) 
 
1.39 (.61-3.16) 
 
0.44 
 
IUD acceptability** 
 
6.38 (15/235) 
 
13.97 (32/229) 
 
2.76 (1.41-5.40) 
 
0.003 
 
Injection acceptability** 
 
1.70 (4/235) 
 
5.68 (13/229) 
 
3.16 (.99-10.08) 
 
0.05 
 
Implant acceptability** 
 
5.53 (13/235) 
 
11.79 (27/229) 
 
2.46 (1.19-5.07) 
 
0.02 
 
Patch acceptability** 
 
2.55 (6/235) 
 
10.04 (23/229) 
 
4.17 (1.63-10.64) 
 
0.003 
 
LARC acceptability** 
 
11.91 (28/235) 
 
23.14 (53/229) 
 
2.49 (1.48-4.18) 
 
0.001 
Effective contraceptive use  
during the 4 months* 
 
8.09 (19/235) 
 
10.04 (23/229) 
 
1.95 (.90-4.25) 
 
0.09 
Service uptake* 
(attended a service one or 
more times) 
 
37.02 (87/235) 
 
42.79 (98/229) 
 
1.38 (.94-2.04) 
 
0.10 
 
Unintended pregnancy* 
 
3.11 (9/289) 
 
2.42 (7/289) 
 
.75 (.27-2.10) 
 
0.59 
 
Induced abortion* 
 
2.55 (6/235) 
 
1.31 (3/229) 
 
.47 (.11-1.95) 
 
0.30 
*adjusted for pregnancy intention, age, number of children, education level and acceptability at 
baseline 
**adjusted for pregnancy intention, age, number of children, education level and the corresponding 
method acceptability at baseline  
 
Process outcomes 
Participants in the intervention group had a higher mean knowledge score, were more likely 
to agree that their friends would use an effective method and were more likely to respond 
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that they intend to use an effective method compare to participants in the control group 
(Table 7.4). 
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Table 7.4  Process outcomes (Palestine) 
 
 
Control 
% (n/N) 
Intervention 
% (n/N) 
proportional OR a 
(95% CI), p-value 
Knowledge of effective contraception  
 
Mean = 2.13 
[sd = 1.42] 
Mean = 2.63 
[sd = 1.66] 
0.50 b 
(0.22-0.78), 0.001 
My friends would use the pill, IUD, injection or implant if they 
wanted to prevent pregnancy 
strongly disagree 0.85 (2/235) 0.44 (1/229)  
 
1.46 (1.00-2.13), 0.05 
disagree 9.36 (22/235) 5.68 (13/229) 
not sure 21.70 (51/235) 17.03 (39/229) 
agree 62.13 (146/235) 70.74 (162/229) 
strongly agree 5.96 (14/235) 6.11 (14/229) 
My friends would talk to their husband about contraception if 
they wanted to prevent a pregnancy 
strongly disagree - -  
 
0.92 (0.63-1.34), 0.66 
disagree 2.55 (6/235) 2.62 (6/229) 
not sure 18.30 (43/235) 19.65 (45/229) 
agree 66.38 (156/235) 65.94 (151/229) 
strongly agree 12.77 (30/235) 11.79 (27/229) 
If you wanted to use the pill, IUD, injection or implant, how 
easy would it be for you to use it?  
very difficult 0.85 (2/235) 1.31 (3/229)  
 
1.26 (0.89-1.78), 0.19 
difficult 9.79 (23/235) 8.73 (20/229) 
not sure 48.94 (115/235) 41.05 (94/229) 
easy 35.32 (83/235) 46.29 (106/229) 
very easy 5.11 (12/235) 2.62 (6/229) 
If you wanted to talk to your husband about contraception, 
how easy would it be for you to talk to him? 
very difficult 1.28 (3/235) 1.75 (4/229)  
 
0.83 (0.59-1.17), 0.29 
difficult 7.23 (17/235) 9.61 (22/229) 
not sure 17.87 (42/235) 17.47 (40/229) 
easy 51.49 (121/235) 52.84 (121/229) 
very easy 22.13 (52/235) 18.34 (42/229) 
If you wanted to use the pill, IUD, injection or implant, how 
certain are you that you could use it?  
very certain I could not 1.28 (3/235) 0.87 (2/229)  
 
1.19 (0.84-1.68), 0.33 
certain I could not 4.68 (11/235) 4.37 (10/229) 
not sure  43.40 (102/235) 39.74 (91/229) 
certain I could 43.83 (103/235) 47.16 (108/229) 
very certain I could 6.81 (16/235) 7.86 (18/229) 
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Control 
% (n/N) 
Intervention 
% (n/N) 
proportional OR a 
(95% CI), p-value 
If you wanted to talk to your husband about contraception, 
how certain are you that you could talk to him? 
very certain I could not - -  
 
1.05 (0.73-1.50), 0.80 
certain I could not 2.55 (6/235) 3.49 (8/229) 
not sure  18.72 (44/235) 11.79 (27/229) 
certain I could 53.62 (126/235) 63.32 (145/229) 
very certain I could 25.11 (59/235) 21.40 (49/229) 
I intend to use the pill, IUD, injection, implant or patch strongly disagree 2.13 (5/235) 2.62 (6/229)  
 
1.85 (1.29-2.65), 0.001 
disagree 13.62 (32/235) 4.37 (10/229) 
not sure 24.68 (58/235) 18.34 (42/229) 
agree 51.06 (120/235) 63.76 (146/229) 
strongly agree 8.51 (20/235) 10.92 (25/229) 
Number of messages read 
 
all  62.88 (144/229)  
most  21.83 (50/229) 
some  11.35 (26/229) 
none 3.93 (9/229) 
Proportion of intervention participants that stopped the intervention  3.93 (9/229)  
a estimated from ordered logistic regression 
b mean difference 
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Potential for contamination 
Seventeen percent (39/235) of control participants said that they read the messages of 
someone else in the study. Seventeen percent (40/229) of intervention participants said that 
someone else in the study read their messages. 
 
Report of physical violence  
In the intervention group, 0.87% (2/229) reported that they experienced physical violence 
since being in the study vs 2.13% (5/235) in the control group (Fisher’s exact test p=0.45). 
 
Participants’ report of anything good or bad that happened during the study 
Most intervention participants that answered this question (193/229) said that they 
benefitted from the messages, mainly from the increase in information and awareness about 
the methods. No participants reported any serious negative events that happened during the 
study. 
 
Sensitivity analyses 
The effect of the intervention on the primary outcome observed in the principal analysis 
(adjusted OR 2.34, 95% CI 1.48-3.68, p < 0.001) moved slightly towards the null when we 
considered participants lost to follow-up did not find at least one method of effective 
contraception acceptable (OR 2.13, 95% CI 1.37-3.30, p = 0.001).  
 
The strongest baseline predictor of retention was having completed university. This was 
already adjusted for in the primary analysis and the sensitivity analysis model was the same 
as the primary analysis.  
 
Subgroup analysis 
The effect of the intervention was greater among participants who did not want to avoid a 
pregnancy at baseline (includes participants who are not married/not sexually active, unsure 
about their pregnancy intention and who report wanting a pregnancy) at baseline compared 
to participants that did (interaction test p = 0.02) (Figure 7.2). 
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Figure 7.2 Intervention effect on acceptability of effective contraception, by subgroups (Palestine) 
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Intervention delivery 
After the trial commenced, there were two technical problems with the local platform that 
resulted in participants not being sent the full intervention. Based on the data available from 
the local platform, 40% of intervention participants were sent 90% or more of the 
intervention messages and 8% of intervention participants were sent less than 70% of the 
messages.  
 
7.2.5 Discussion 
Main results 
The results of this trial demonstrated that the intervention improved young women’s 
attitudes towards effective contraception in Palestine. The trial results also suggest that the 
intervention moderately improves knowledge about effective contraception, perceived 
norms about friends using effective contraception and intention to use effective 
contraception. The subgroup analysis suggests that that the intervention may be more 
effective among women who do not report wanting to avoid a pregnancy.  
 
Comparisons with other research 
The results of this Palestine trial are in line with research that has found mobile phone 
interventions can increase contraceptive knowledge (140, 142, 152). Previous research has 
demonstrated that interventions delivered by mobile phone can improve contraceptive use 
(134, 135, 143, 161). This current trial did not find evidence for a difference in use between 
the groups, although this study did not have enough statistical power for this outcome. This is 
the first trial that we are aware of that has shown that a contraceptive behavioral 
intervention delivered by mobile phone messaging can increase intention to use effective 
contraception. A similar intervention was evaluated by trial in Tajikistan (54) and Bolivia with 
young people (manuscript in preparation). A post hoc change from baseline to follow-up 
analysis of all participants in Tajikistan demonstrated a large increase in acceptability (54). 
 
Strengths and limitations 
An important strength of this trial is that we recruited to target and achieved greater than 
80% follow-up for the primary outcome. Our trial database and randomization system 
concealed the allocation sequence and achieved well-balanced groups overall. There was, 
however, some imbalance in acceptability at baseline, but this was adjusted for in the 
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primary analysis and had little effect on the results when not controlled for.  The sensitivity 
analysis confirmed that our results were robust to different missing data assumptions. 
 
The main limitation of the trial is that the whole intervention was not delivered to all 
participants due to technical problems with the local platform, so our result can only tell us 
the effect of partial receipt of the intervention. The self-reported primary outcome collected 
by telephone by research staff may have meant that participants were more likely to report 
positive attitudes at follow-up compared to baseline where they provided data by paper 
questionnaire. Most participants were university-educated. The inclusion participants from a 
wider range of socio-economic backgrounds would have improved the generalizability of the 
results.  
 
Meaning and implications of the findings 
The intervention effect estimated in this trial is likely to be conservative due to the moderate 
level of potential contamination and the fact that an estimated 60% of intervention 
participants were not sent the full intervention.  
 
The finding that the intervention may be more effective among women who do not explicitly 
want to avoid a pregnancy compared to those who do, could relate to exposure to 
information about contraception. Women who explicitly want to avoid a pregnancy at 
baseline may already have formed positive attitudes towards the effective methods. Indeed, 
the level of acceptability at baseline was higher among participants wanting to avoid a 
pregnancy compared to those who did not want to avoid a pregnancy or were unsure (12% vs 
7%), reducing the potential for improvement.  
 
Acceptability among intervention participants remained relatively low, at 31%. Further 
analysis of the individual scales that comprise the primary outcome measure and the 
qualitative work could help clarify why the intervention did not improve acceptability to a 
greater extent. 
 
The results indicate that implementation of the intervention in Palestine could be beneficial. 
More research is needed to understand how implementation would work in a non-trial 
context. If the intervention is made available, the local platform will need regular monitoring 
and maintenance to ensure that the intervention is delivered as intended.  
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7.2.6 Conclusions 
This trial demonstrated that the intervention more than doubled the odds of finding at least 
one method of effective contraception acceptable. This result along with the lack of evidence 
that it is associated with any harm, supports the implementation of the intervention in 
Palestine. Future research is needed to determine how to enable successful implementation 
and to evaluate the efficacy of the intervention on use of effective contraception and 
unintended pregnancy in Palestine.
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8 Bolivia evaluation results 
8.1 Introduction 
This chapter includes the results of the Bolivia randomised controlled trial. I finished 
preparing this manuscript in September 2018. Because I reference the Palestine trial results 
in the discussion, I plan on submitting the manuscript to the Journal of Medical Internet 
Research when the Palestine trial paper is accepted for publication.    
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8.2 Research paper 
8.2.1 Abstract 
Background 
Unintended pregnancy is associated with poorer health outcomes for both women and their 
children. Fulfilling unmet need for contraception is essential in avoiding unintended 
pregnancies. Although the most effective methods of contraception are available in Bolivia, 
unmet need among women aged 15-19 is estimated to be 38% (2008) and the adolescent 
fertility rate is 71 per 1,000 women (2016). Mobile phones are a popular mode by which to 
deliver health behaviour support. The London School of Hygiene & Tropical Medicine and the 
Centro de Investigación, Educación y Servicios in Bolivia developed a contraceptive 
behavioural intervention for young Bolivian women delivered by mobile phone. The 
intervention development was guided by behavioural science and consists of short instant 
messages sent through an app over four months. 
 
Objective 
The objective of this trial was to evaluate the effect of the intervention on young Bolivian 
women’s use of and attitudes towards the effective contraceptive methods available in 
Bolivia (oral contraceptive pills, intrauterine devices, injectables, implants and the patch). 
 
Methods 
This was a parallel group, individually randomised superiority trial with a 1:1 allocation ratio. 
Women were eligible if they were aged 16-24, owned a personal Android mobile phone, lived 
in La Paz or El Alto, reported an unmet need for contraception (i.e. are sexually active, not 
using effective contraception and want to avoid a pregnancy) and could read Spanish. The 
target sample size was 1310 participants. Participants allocated to the intervention arm had 
access to an app with standard family planning information plus intervention messages. 
Participants allocated to the control arm had access to the same app plus control messages. 
Co-primary outcomes were use of effective contraception and acceptability of at least one 
method of effective contraception at four months. Secondary outcomes were use of effective 
contraception during the study, acceptability of the individual methods, service uptake, 
unintended pregnancy and abortion. Process outcomes included knowledge, perceived 
norms, personal agency and intention. Outcomes were analyzed using logistic and linear 
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regression. We also asked participants if they experienced physical violence since joining the 
study. 
 
Results 
640 participants were enrolled and 67% (n= 429) contributed follow-up data for the co-
primary outcome, use of effective contraception. There was no evidence that use differed 
between the groups (33% in the control arm vs 37% in the intervention arm, adjusted OR 
1.19, 95% CI 0.80-1.77, p = 0.40). There was a borderline significant effect regarding the 
acceptability outcome (63% in the control arm vs 72% in the intervention arm; adjusted OR 
1.49, 95% CI 0.98-2.28, p = 0.06). There were no statistically significant differences in any of 
the secondary or process outcomes. Intervention dose received was low. In the control 
group, 3% reported experiencing physical violence compared to 2% in the intervention group 
(Fisher’s exact test p=0.75). 
 
Conclusions 
This trial was unable to provide definitive conclusions regarding the effect of the intervention 
on use and acceptability of effective contraception due to under recruitment. While we 
cannot strongly recommend implementation, the results suggest that it would be safe and 
may increase acceptability of effective contraception if the intervention messages were 
offered alongside the download of the app. 
 
Trial registration: ClinicalTrials.gov Identifier NCT02905526 
  
Date of registration: 14 September 2016 
 
Keywords: Bolivia, Contraception, Mobile phone, Cell phone, Reproductive health, Young 
adults 
 
8.2.2 Introduction 
Unintended pregnancy is associated with numerous poorer health outcomes for both women 
and their children (2, 4, 12, 15, 16). Satisfying unmet need for contraception is essential in 
helping women avoid unintended pregnancies, which requires an understanding of the 
barriers to use in specific settings (26). In Bolivia, a 2008 survey reported that 84% of sexually 
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active women between the ages of 15-19 wanted to avoid a pregnancy, yet only 49% of these 
women reported using any contraceptive method (112). A more recent survey (2016) 
reported that the adolescent fertility rate was 71 per 1,000 women (113). While ‘effective’ 
contraceptive methods are available in Bolivia (methods with less than 10% typical use failure 
at 12 months) (28-30), unmet need among women aged 15-19 was estimated to be 38% in 
2008 (112, 114). The (non-permanent) effective methods available in Bolivia are oral 
contraceptive pills (OC), intrauterine devices (IUD), injectables, implants and the patch.  
 
The option of delivering health interventions by mobile phone has gained popularity, 
particularly over the last decade (32-43). Randomised controlled trials have provided 
evidence that interventions delivered by mobile phone can improve contraceptive use (134, 
135, 145) and knowledge (134, 140, 142, 144). Other trials however, have not found a 
beneficial effect (44, 136, 137, 141, 143). 
 
The London School of Hygiene & Tropical Medicine and the Centro de Investigación, 
Educación y Servicios (CIES) in Bolivia developed a contraceptive behavioural intervention for 
young Bolivian women delivered by mobile phone (50). We developed the intervention 
guided by an established approach grounded in behavioural science (124). The intervention is 
informed by the Integrated Behavioural Model (170) and consists of short instant messages 
sent through CIES’s ‘Tú decides’ application (app) over four months. In this report we present 
the results of the evaluation of the intervention by randomized controlled trial. The aim of 
the trial was to establish if the intervention increases young Bolivian women’s use and 
acceptability of the effective contraceptive methods.  
 
8.2.3 Methods 
The methods reported in this section were first published in the trial protocol (53) and the 
statistical analysis plan (209).  
 
Study design and participants 
This was a parallel group, individually randomized superiority trial with a 1:1 allocation ratio 
that evaluated the effect of the intervention delivered by CIES’s app. Women were eligible to 
take part if they were aged 16-24, owned a personal Android mobile phone, lived in La Paz or 
El Alto, reported an unmet need for contraception (i.e. are sexually active, not using effective 
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contraception and want to avoid a pregnancy) and could read Spanish. Participants must also 
have been willing to download the app and receive messages about contraception on their 
mobile phone. Participants provided informed consent though the secure online trial 
database and randomization system.  
 
Intervention and control 
The intervention was developed with young Bolivian people in 2015-2016 (50). The 
intervention provided accurate information about contraception, targeted the beliefs 
identified in the development phase that influence contraceptive use, and aimed to support 
young women in believing that they can influence their reproductive health. The messages 
contained 10 behaviour change methods, adapted for delivery by mobile phone (122): belief 
selection, facilitation, anticipated regret, guided practice, verbal persuasion, tailoring, cultural 
similarity, arguments, shifting perspective and goal setting (please see the protocol (53) and 
the intervention development publication (50) for a detailed description of the intervention). 
The Tú decides app itself contained standard family planning information and no behaviour 
change methods. Participants allocated to the intervention arm had access to the app plus 
the intervention instant messages. Participants allocated to the control arm had access to the 
app plus control instant messages about trial participation. All participants received usual 
care were free to seek any other support, whether existing or new.  
 
Allocation and intervention delivery 
After providing informed consent, participants completed the baseline questionnaire through 
the database and randomization system. The allocation sequence was generated by the 
remote computer-based randomization software. Randomization occurred immediately after 
baseline data were submitted. All participants downloaded the app immediately after they 
submitted their baseline data. The messages commenced within 24 hours after participants 
downloaded the app. 
 
Protecting against bias 
Due to the nature of the intervention, participants would have been aware of the allocation 
soon after they started receiving the messages. Local research staff collecting outcome data 
were masked to allocation unless the participant revealed it to them. Researchers who 
analyzed the data were masked to treatment allocation. 
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Outcomes  
Co-primary outcomes 
The co-primary outcomes at four months post randomization were: 1) self-reported current 
use of effective contraception and 2) the proportion of participants reporting that at least 
one method of effective contraception was acceptable. The primary outcome measure was 
constructed based on guidelines for measuring IBM constructs (170, 188, 189) and tested for 
face validity with the target group. The acceptability of each method was measured by the 
following stems: “Using the [method] …causes infertility, …causes unwanted side effects, …is 
easy, …is a good way to prevent pregnancy” and “I would recommend the [method] to a 
friend”. The IUD and implant include an additional stem: “The [method] insertion would not 
be a problem for me”. The response options for each stem were “strongly disagree”, 
“disagree”, “not sure”, “agree”, “strongly agree” and “I do not know what the [method] is”. A 
method was acceptable if participants reported “agree” or “strongly agree” for all scales 
except for “…causes infertility” and “…causes unwanted side effects” stems, for which 
“disagree” or “strongly disagree” indicated acceptability (53).  
 
Secondary outcomes 
Secondary outcomes were: use of effective contraception during the study; acceptability of 
individual methods; service uptake; unintended pregnancy and abortion. 
 
Process outcomes 
The process outcomes were: knowledge of effective contraception; perceived norms and 
personal agency in relation to using and communicating with partners about contraception; 
intention to use effective contraception and intervention dose received. 
 
Data collection 
Data were collected at baseline and at four months post-randomization using questionnaires. 
At baseline, we collected personal and demographic data and the co-primary outcome 
acceptability. At follow-up we collected all outcomes plus the following: if participants report 
using an effective method, where they obtained it; current pregnancy intention; whether 
they knew someone else that had also participated in the study and if so, if they read each 
other’s messages; if they have experienced physical violence since being in the study and if 
anything good or bad happened as a result of receiving the messages. An instant message 
that included a link to the database to complete the follow-up questionnaire was sent to all 
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participants through the app four months after downloading the app. If participants did not 
complete the follow-up questionnaire themselves, local research staff unaware of 
participants’ allocation contacted them by telephone to collect their data. 
 
Sample size  
The trial was powered to detect a 10% absolute difference in use of effective contraception 
between the intervention and control group at four months. One thousand and forty-eight 
participants provided 90% power to detect a 10% absolute difference, at the 5% significance 
level, assuming 44% use in the control group vs 54% in the intervention group (corresponding 
to an odds ratio of 1.49). Allowing for 20% loss to follow-up, we aimed to enrol and 
randomize 1310 people.  
 
Statistical analysis 
The trial protocol was accepted for publication on November 3, 2017 (53) and the detailed 
statistical analysis plan was publicly released on November 7, 2017 (209). Analyses were 
according to randomized arm and only participants with complete outcome data were 
included in the principal analysis. All statistical tests were two-sided and were considered 
significant at the 5% level. The analysis was conducted using Stata 15. Unmasking occurred on 
February 6, 2018, after the analyses outlined within the analysis plan were complete on 
masked data. 
 
Loss to follow-up and missing data 
We used a chi-squared test to investigate evidence for whether losses to follow-up differed 
by trial arm. We used logistic regression to compare the baseline characteristics of 
participants who completed follow-up with those participants who did not. We investigated 
whether predictors of loss to follow-up differed by trial arm by testing for an interaction.  
 
Principal analysis 
Analysis of the co-primary outcomes 
We compared the proportion that reported using a method of effective contraception or 
finding at least one method acceptable between the groups using logistic regression. We 
report the crude and adjusted odds ratio (OR) along with the 95% confidence interval (CI) and 
p-value. The primary analysis was adjusted for the following pre-specified baseline covariates: 
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age (16-19/20-24), number of children (0/≥1), education level (university/other) and 
acceptability of effective contraception at baseline (at least one method acceptable/no 
methods acceptable) (51, 203). 
 
Analysis of the secondary outcomes 
The analysis of the secondary outcomes was similar to the analysis of the primary outcome, 
although for the acceptability of the individual methods, the acceptability of that method at 
baseline replaced the acceptability of at least one method at baseline as a covariate.  
 
Analysis of the process outcomes 
The process outcomes comprised ordinal scales. Each scale was analyzed individually using 
ordered logistic regression to estimate proportional ORs. For knowledge, each correct answer 
received one point. The points were summed, and an overall score was produced for analysis. 
We used linear regression to test for a difference in the mean scores between the trial arms. 
To assess the ‘dose’ of the intervention that the intervention participants received, we 
analyzed the number of messages that participants reported to have read (all, most, some, 
none) and whether they stopped the messages. 
  
Additional analyses 
Sensitivity analyses 
We conducted two sensitivity analyses allowing for the missing data. In the first analysis (an 
‘extreme case’ analysis), we considered that all participants lost to follow-up did not use an 
effective method of contraception or did not find at least one method acceptable. In the 
second analysis, we adjusted for the main baseline predictors of missingness. Both sensitivity 
analyses were adjusted for the baseline covariates, as above.  
 
Subgroup analysis  
We conducted an exploratory subgroup analysis for each co-primary outcome to determine if 
the intervention effect varied by baseline characteristics. The pre-specified subgroups were: 
age (split at the median); marital status (married/not married); number of children (0/≥1); 
geographical location (El Alto/La Paz); occupation (in education/other) and education level 
(university/other). Within the subgroups, we assessed heterogeneity of treatment effect with 
a test for interaction (194-198). We estimated ORs with 95% CIs for each subgroup.  
 
  
151 
 
Contamination 
To assess the potential for contamination, we report the proportion of control group 
participants that reported that they read another participant’s messages and the proportion 
of intervention participants that reported that their messages were read by another 
participant. 
 
Report of physical violence 
We report the proportion of participants in each group that reported experiencing physical 
violence during the study. 
 
8.2.4 Results 
Recruitment, randomization, exclusions 
Between March 1, 2017 and July 29, 2017, there were 645 randomizations by the system. 
Follow-up ended on February 8, 2018. During the trial follow-up, we discovered that three 
participants enrolled and were randomized twice. For the one participant that was allocated 
to the same arm on both randomizations, we kept this participant in the analysis using the 
baseline data from their first record. For the two participants that were allocated to different 
arms, we excluded them from the analysis. This resulted in 640 participants included in the 
trial. 
 
Three hundred and twenty-one participants were allocated to the intervention arm and 319 
participants were allocated to the control arm (Figure 8.1).  
 
Baseline characteristics 
Baseline characteristics of trial participants are reported in Table 8.1. Mean age was 20 years. 
Ninety percent (579/640) did not have children and only 8% (26/640) found at least one 
method of effective contraception acceptable. Characteristics were similar between the two 
groups. 
 
Table 8.1  Baseline characteristics (Bolivia) 
 Control 
N = 319 
% (n) 
Intervention 
N = 321 
% (n) 
All participants 
N = 640 
% (n) 
Age mean [sd] 20.42 [2.56] 20.27 [2.58] 20.35 [2.57] 
16-19 47.02 (150) 51.40 (165) 49.22 (315) 
20-24 52.98 (169) 48.60 (156) 50.78 (325) 
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 Control 
N = 319 
% (n) 
Intervention 
N = 321 
% (n) 
All participants 
N = 640 
% (n) 
Marital status married 4.39 (14) 5.61 (18) 5.00 (32) 
not-married 95.61 (305)  94.39 (303) 95 (608) 
Number of 
children 
0 91.85 (293) 89.10 (286) 90.47 (579) 
1 5.02 (16) 6.54 (21) 5.78 (37) 
2 or more 3.13 (10) 4.36 (14) 3.75 (24) 
Indigenous 
origin 
(ethnicity) 
Aymara 56.74 (181) 55.76 (179) 56.25 (360) 
Guarani 0.31 (1) 0.93 (3) 0.63 (4) 
Quechua  4.08 (13) 1.87 (6) 2.97 (19) 
other 3.13 (10)  3.12 (10) 3.13 (20) 
none 35.74 (114) 38.32 (123) 37.03 (237) 
Occupation 
 
 
school  19.12 (61) 18.07 (58) 18.59 (119) 
university 55.17 (176) 56.39 (181) 55.78 (357) 
working 9.40 (30) 11.21 (36) 10.31 (66) 
training 5.96 (19) 5.30 (17) 5.63 (36) 
not working 1.25 (4) 1.25 (4)  1.25 (8) 
working & 
studying 
 9.10 (29) 7.79 (25)  8.44 (54) 
Highest level 
of education 
completed 
primary 5.96 (19) 4.05 (13) 5.00 (32) 
secondary 71.16 (227) 73.21 (235) 72.19 (462) 
university 21.32 (68) 19.31 (62) 20.31 (130)  
technical 1.57 (5) 3.43 (11) 2.50 (16) 
Baseline 
method 
none 75.24 (240) 80.06 (257) 77.66 (497) 
male condom 14.42 (46) 11.21 (36) 12.81 (82) 
female condom 2.82 (9) 1.25 (4) 2.03 (13) 
other 7.52 (24) 7.48 (24) 7.5 (48) 
At least one 
effective 
method is 
acceptable 
yes 8.15 (26) 8.10 (26) 8.13 (52) 
no 91.85 (293) 91.90 (295) 91.88 (588) 
Pill 
acceptability 
yes 0.63 (2) 1.56 (5) 1.09 (7) 
no 99.37 (317) 98.44 (316) 98.91 (633) 
IUD a 
acceptability 
yes 1.88 (6) 1.25 (4) 1.56 (10) 
no 98.12 (313) 98.75 (317) 98.44 (630) 
Injection 
acceptability 
yes 2.82 (9) 1.87 (6) 2.34 (15) 
no 97.18 (310) 98.13 (315) 97.66 (625) 
Implant 
acceptability 
yes 1.57 (5) 3.12 (10) 2.34 (15) 
no 98.43 (314) 96.88 (311) 97.66 (625) 
Patch 
acceptability 
yes 3.45 (11) 2.49 (8) 2.97 (19) 
no 96.55 (308) 97.51 (313) 97.03 (621) 
a IUD Intrauterine device 
 
Loss to follow-up 
Four hundred and twenty-nine participants (67%) completed the trial follow-up for the co-
primary outcome use (control, n = 215; intervention, n = 214) and 406 (63%) completed 
follow-up for the co-primary outcome acceptability (control, n = 203; intervention, n = 203) 
(Figure 1). Retention did not differ between the arms (66.64 % in the control and 63.24% in 
the intervention arm, p = 0.92). Among participants who completed the use co-primary 
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outcome, the strongest predictor of retention was being aged 20-24 (OR 1.33, 95% .96-1.86, 
p = 0.09). There was some evidence that the effect of this predictor differed by arm 
(interaction test p = 0.09). Detailed characteristics of participants who completed follow-up 
and those that did not are reported in Appendix 19. 
 
  
154 
 
Figure 8.1 CONSORT diagram (Bolivia) 
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Primary outcomes 
In the intervention arm, 37.38% (80/214) reported use of effective contraception compared 
to 33.49% (72/215) in the control arm (Table 8.2). There was no evidence of a difference in 
use between the groups (crude OR 1.19, 95% CI .80-1.76, p = 0.40; adjusted OR 1.19, 95% CI 
.80-1.77, p = 0.40).  
 
In the intervention arm, 71.92% (146/203) reported that at least one method of 
contraception was acceptable compared to 62.56% (127/203) in the control arm (Table 8.2). 
There was borderline evidence of a difference in acceptability between the groups (crude OR 
1.53, 95% CI 1.01-2.33, p = 0.05; adjusted OR 1.49, 95% CI .98-2.28, p = 0.06).  
 
Table 8.2  Co-primary outcomes (Bolivia) 
 
 
Control 
N = 215 
% (n/N) 
Intervention 
N = 214 
% (n/N) 
adjusted OR 
(95% CI) 
p-value 
 
Use of effective 
contraception* 
 
33.49 (72/215) 
 
37.38 (80/214) 
 
1.19 (.80-1.77) 
 
0.40 
 
At least one effective 
method is acceptable* 
 
62.56 (127/203) 
 
71.92 (146/203) 
 
1.49 (.98-2.28) 
 
0.06 
* adjusted for age, number of children, education level and acceptability at baseline 
 
Secondary outcomes 
There were no significant differences in any of the secondary outcomes between the groups 
(Table 8.3). 
 
Table 8.3  Secondary outcomes (Bolivia) 
 
 
Control 
% (n/N) 
Intervention 
% (n/N) 
adjusted OR 
(95% CI) 
p-value 
 
Pill acceptability** 
 
25.24 (52/206) 
 
28.50 (59/207) 
 
1.19 (.76-1.85) 
 
0.45 
 
IUD acceptability** 
 
20.87 (43/206) 
 
26.70 (55/206) 
 
1.37 (.86-2.19) 
 
0.18 
 
Injection acceptability** 
 
37.98 (79/208)  
 
44.93 (93/207) 
 
1.30 (.88-1.94) 
 
0.19 
 
Implant acceptability** 
 
30.58 (63/206) 
 
31.71 (65/205) 
 
1.03 (.68-1.58) 
 
0.89 
 
Patch acceptability** 
 
45.67 (95/208) 
 
52.40 (109/208) 
 
1.31 (.89-1.93) 
 
0.17 
 
LARC acceptability** 
 
51.96 (106/204) 
 
58.54 (120/205) 
 
1.31 (.88-1.93) 
 
0.18 
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Control 
% (n/N) 
Intervention 
% (n/N) 
adjusted OR 
(95% CI) 
p-value 
Effective contraceptive use  
during the 4 months* 
 
36.19 (76/210) 
 
35.44 (73/206) 
 
.94 (.62-1.40) 
 
0.76 
Service uptake* 
(attended a service one or 
more times) 
 
52.38 (110/210) 
 
45.37 (93/205) 
 
.74 (.50-1.10) 
 
0.14 
 
Unintended pregnancy 
 
0.31 (1/319) 
 
0 (0/321) 
 
- 
 
- 
 
Induced abortion*** 
 
1.44 (3/209) 
 
0.49 (1/205) 
 
.34 (.01-4.24)*** 
 
0.64 
* adjusted for age, number of children, education level and acceptability at baseline  
** adjusted for age, number of children, education level and the corresponding method acceptability at 
baseline  
*** unadjusted exact logistic regression 
 
Process outcomes 
There were no significant differences in any of the process outcomes between the groups 
(Table 8.4).
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Table 8.4  Process outcomes (Bolivia)  
 
 
Control 
% (n/N) 
Intervention 
% (n/N) 
proportional OR* 
(95% CI), p-value 
Knowledge of effective contraception  
 
Mean = 4.31 
[sd = 1.86] 
Mean = 4.48 
[sd = 1.79] 
.17** (-.19-.53), 0.36 
 
My friends would use the pill, IUD, injection or implant if they 
wanted to prevent pregnancy 
strongly disagree 0.98 (2/205) 0 (0/202)  
 
1.17 (.73-1.88), 0.51  
disagree 3.41 (7/205) 0.99 (2/202) 
not sure 14.15 (29/205) 15.35 (31/202) 
agree 77.56 (159/205) 79.70 (161/202) 
strongly agree 3.90 (8/205) 3.96 (8/202) 
My friends would talk to their partner about contraception if they 
wanted to prevent a pregnancy 
strongly disagree 0.49 (1/205) 0 (0/202)  
 
1.33 (.91-1.94), 0.15 
disagree 8.29 (17/205) 6.93 (14/202) 
not sure 38.54 (79/205) 33.17 (67/202) 
agree 51.22 (105/205) 58.42 (118/202) 
strongly agree 1.46 (3/205) 1.49 (3/202) 
If you wanted to use the pill, IUD, injection or implant, how easy 
would it be for you to use it?  
very difficult 1.95 (4/205) 0.99 (2/202)  
 
.98 (.64-1.51), 0.93 
difficult 11.71 (24/205) 12.38 (25/202) 
not sure 8.29 (17/205) 8.42 (17/202) 
easy 72.68 (149/205) 73.76 (149/202) 
very easy 5.37 (11/205) 4.46 (9/202) 
If you wanted to talk to your partner about contraception, how 
easy would it be for you to talk to him? 
very difficult 0.49 (1/205) 3.47 (7/202)  
 
.71 (.48-1.06), 0.09 
difficult 10.73 (22/205) 13.37 (27/202) 
not sure 16.10 (33/205) 12.38 (25/202) 
easy 62.44 (128/205) 67.33 (136/202) 
very easy 10.24 (21/205) 3.47 (7/202) 
If you wanted to use the pill, IUD, injection or implant, how certain 
are you that you could use it?  
very certain I could not 0.98 (2/205) 0.99 (2/202)  
 
1.01 (.66-1.55), 0.97 
certain I could not 0.98 (2/205) 0.99 (2/202) 
not sure  16.59 (34/205) 17.82 (36/202) 
certain I could 73.66 (151/205) 70.79 (143/202) 
very certain I could 7.80 (16/205) 9.41 (19/202) 
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Control 
% (n/N) 
Intervention 
% (n/N) 
proportional OR* 
(95% CI), p-value 
If you wanted to talk to your partner about contraception, how 
certain are you that you could talk to him? 
very certain I could not 0 (0/204) 1.98 (4/202)  
 
.87 (.58-1.30), 0.49 
certain I could not 4.41 (9/204) 2.97 (6/202) 
not sure  22.55 (46/204) 22.28 (45/202) 
certain I could 64.22 (131/204) 67.82 (137/202) 
very certain I could 8.82 (18/204) 4.95 (10/202) 
I intend to use the pill, IUD, injection, implant or patch strongly disagree 1.47 (3/204) 0.99 (2/202)  
 
.74 (.50-1.10), 0.14 
disagree 6.86 (14/204) 7.92 (16/202) 
not sure 8.82 (18/204) 14.85 (30/202) 
agree 65.69 (134/204) 61.88 (125/202) 
strongly agree 17.16 (35/204) 14.36 (29/202) 
Number of messages read 
 
 
all  6.31 (13/206)  
most  19.42 (40/206) 
some  45.63 (94/206) 
none 28.64 (59/206) 
Proportion of intervention participants that stopped the intervention  11.22 (23/205)  
*estimated from ordered logistic regression 
**mean difference 
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Potential for contamination 
One percent (2/209) of control participants said that they read the messages of someone else 
in the study. Four percent (8/205) of intervention participants said that someone else in the 
study read their messages. 
 
Report of physical violence  
Three percent (6/207) of participants in the control group and 2% (4/202) in the intervention 
group reported that they experienced physical violence since being in the study (Fisher’s 
exact test p = 0.75). 
 
Intervention dose 
Twenty-six percent of intervention reported that they read all or most of the intervention 
messages, with 29% stating that they read none of the messages. Eleven percent reported 
that they stopped the intervention messages. Reasons intervention participants provided for 
not reading the messages or deinstalling the app were: concerns about confidentiality, the 
app took up too much space on their phone, there were too many messages and some 
messages were repetitive. Nineteen percent (39/206) of the intervention participants that 
answered the open-ended question “Did anything good or bad happened as a result of 
receiving the messages?” said that they did not receive any messages. 
 
Participants’ report of anything good or bad that happened during the study 
Almost half of intervention participants that answered this question (97/206) reported 
something positive about the messages. The most common comment was that they learned 
new information. One participant said that they got pregnant and another said that they had 
‘a scare due to carelessness’. 
 
Sensitivity analyses 
When we considered that participants who were lost to follow-up did not use an effective 
method or find an effective method acceptable, the effects observed in the principal analysis 
were reduced (use: OR 1.14 95% CI .79-1.64, p = 0.48, acceptability: OR 1.26, 95% CI .92-1.74, 
p = 0.15). 
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The strongest predictor of retention was being aged 20-24. Age was a baseline covariate so 
the model in the second sensitivity analysis (adjusting for the main baseline predictors of 
missingness) is the same as the primary analysis model. 
 
Subgroup analysis 
There was no evidence that the effect of the intervention differed within the different levels 
of the subgroups (Figure 8.2 and Figure 8.3).
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Figure 8.2  Intervention effect on use of effective contraception, by subgroups (Bolivia) 
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Figure 8.3  Intervention effect on acceptability of effective contraception, by subgroups (Bolivia) 
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8.2.5 Discussion 
Principal results 
The trial was underpowered to detect a difference in contraceptive use. While use was higher 
in the intervention group, the difference was not statistically significant. There was a 
borderline significant effect regarding the acceptability co-primary outcome, which favored 
the intervention group. No statistically significant differences between the groups in any of 
the secondary or process outcomes were observed. The intervention dose received was low, 
based on participants’ report.  
 
Strengths and limitations 
The main limitations of this trial were that we did not recruit to target and achieved less than 
80% follow-up completion. While effect estimates or both primary outcomes favored sending 
the intervention messages with the Tú decides app, the differences between the groups were 
smaller than we expected. The recruitment and follow-up challenges meant that the trial was 
underpowered and therefore unable to produce unequivocal estimates regarding the effect 
of sending the intervention messages in addition to the app (with 429 participants, the trial 
had 54% power to detect a 10% absolute difference in use of effective contraception 
between the groups). 
 
The low dose of the intervention is likely to have reduced the effect estimates. Only 26% of 
the participants reported that they read all or most of the intervention messages, with 29% 
reporting that they read none of the messages. This could have contributed to the smaller 
than anticipated observed differences.   
 
Despite the limitations, this study had several strengths. Our trial database and 
randomization system generated and concealed the allocated and achieved well-balanced 
groups. There was no evidence that the intervention was associated with an increase in self-
reported violence. However, we cannot determine the effect of the app on partner violence 
because both groups had access to it. Despite this, it is reassuring that the self-reported 
prevalence in this trial was low (2%). 
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Comparisons with existing research 
Trials evaluating contraceptive behavioural interventions delivered by mobile phone have 
had mixed results (44, 134-137, 140-145), with some showing an improvement in 
contraceptive use (134, 135, 145) and knowledge (134, 140, 142, 144). The results of this 
current trial are consistent with our trials of similar intervention among young people in 
Tajikistan (54) and Palestine (52). In the Palestine trial, participants who received the 
intervention were more than twice as likely to find at least one method of contraception 
acceptable (OR 2.34, 95% CI 1.48-3.68, p < 0.001). There were also improvements in 
knowledge, acceptability of individual methods, perceived norms about friends using 
contraception, and intention to use contraception compared to the control group (trial 
publication under review). In the Tajikistan trial there was contamination between the 
intervention and control group and no differences found between the groups. Because of 
this, we conducted a post hoc change from baseline analysis, which showed a large 
statistically significant increase in acceptability from baseline to follow-up (2% at baseline to 
65% at follow-up, p < 0.001). Although we cannot infer causality from this analysis, the results 
are consistent with the intervention content being at least partially effective at changing 
attitudes towards effective contraception in Tajikistan. The Tajik and Palestinian trials also did 
not suggest that the intervention was associated with an increase in violence.  
 
Implications of the findings 
The uncertainty regarding the efficacy of the intervention means that we cannot strongly 
recommend implementation in Bolivia. However, the results suggest that the intervention 
messages increase acceptability of effective contraception if they were offered alongside the 
download of the Tú decides app and would not cause harm if done so.  
 
Conclusions 
This trial was unable to determine unequivocally if the intervention was effective at 
increasing use and acceptability of effective contraception among young women with an 
unmet need in Bolivia. The intervention messages when delivered in addition to an app 
providing standard family planning information may moderately improve acceptability.  
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9 Additional analyses 
9.1 Internal consistency and predictive validity of the 
acceptability measure 
In the sections, ‘The acceptability primary outcome’ and ‘Measuring the Integrated 
Behavioural Model constructs’ of the Methods chapter, I detail the process of how I 
constructed the acceptability primary outcome measure and tested it for face validity with 
the target group. To summarise- I first reviewed the existing validated scales but did not find 
one that was suitable. In the absence of a pre-existing scale, I constructed scales based on 
guidelines for measuring the Integrated Behavioural Model construct, instrumental attitude 
(170, 188, 189). I tested the scales for face validity with young people in each country. In this 
section, I present an assessment of the measure’s internal consistency and predictive validity.  
 
To assess the internal consistency of the measure, I computed Cronbach’s alpha for the 
acceptability of each method using follow-up data for the three countries combined. I used 
the follow-up data because a large proportion of participants at baseline responded that they 
did not know what the methods were (pill 30%; IUD 26%; injection 38%; implant 48%; patch 
46%). I recoded the response ‘I do not know what the method is’ to the midpoint on the 
scale. The Cronbach’s alpha for each method acceptability was the following: pill = .73; IUD = 
.85; injection = .84; implant = .84 and patch = .86. 
 
I also conducted analyses to give an indication of the predictive validity of the acceptability 
measure. In the absence of a gold standard measure of acceptability of effective 
contraception,  I assessed whether the measure was associated with intention to use and 
current use of effective contraception. As with the data used to compute Cronbach’s alpha, I 
analysed the follow-up data for the three countries combined, however included only women 
in these analyses (because only women were asked about intention to use contraception in 
the Tajik trial and the Palestine and Bolivia trials only included women). Participants who 
found at least one method of acceptable had 3.76 times the odds of reporting that they 
intend to use an effective method (p < 0.001, 95% CI 2.82-5.01). Participants who found at 
least one method of acceptable had 5.45 times the odds of reporting that they currently use 
an effective method (p < 0.001, 95% CI 3.81-7.80).  
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These two analyses indicate that the acceptability outcome measure demonstrates internal 
consistency and predictive validity.       
 
9.2 Bolivia secondary analysis of trial data 
I conducted a change from baseline analysis for the co-primary outcome acceptability using 
McNemar’s χ2 test for paired data. I conducted this post-hoc non-randomised analysis in 
addition to the analyses specified in the trial protocol 1) because the low recruitment and 
follow-up produced equivocal results and 2) so that it could be compared to the Tajik trial, 
which also was not conducted as the protocol specified. Among the 406 participants that 
completed follow-up for the co-primary outcome acceptability, 9% (n = 36) thought that at 
least one method of effective contraception was acceptable at baseline. At follow-up, this 
increased to 67% (n = 273, p < 0.001). Acceptability of each of the individual methods also 
increased from baseline to follow-up (Figure 9.1). 
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Figure 9.1 Method acceptability at baseline and follow-up (Bolivia) 
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9.3 Cost analysis 
Table 9.1 displays the estimates of developing, maintaining/monitoring and sending the 
intervention. The cost of developing each county’s intervention is based on the amount that 
each local partner was provided for the project ($200,000 USD) plus the amount provided to 
LSHTM to develop the intervention (approximately $200,000 USD, which is half of the total 
provided for the entire project), divided by three. This cost is a one-off, upfront cost that 
other settings would not incur if they adapted the existing intervention. The cost of 
maintaining and monitoring the intervention is based on our experience of the annual cost of 
maintaining an app/web-based texting platform.  
 
I then compared these costs to the difference between the control and intervention groups in 
the proportion who found at least one method acceptable and the proportion who reported 
using an effective method at four month follow-up. Based on this difference, I estimated the 
cost per user.  
 
Table 9.1  Cost analysis 
(Figures are in US dollars) TFPA PFPPA CIES 
Estimated cost of developing the 
intervention1 
$267,000 $267,000 $267,000 
Estimated cost of maintaining & 
monitoring the intervention per 
year2 
$5,000 $5,000 $5,000 
Estimated cost of sending the 
intervention messages per recipient 
n/a $2.973 n/a 
 
Difference 
between the 
groups at four 
month follow-up 
at least one 
method 
acceptable4 
2% 
(int. = 66%,  
control = 64%) 
14% 
(int. = 31%, 
control = 17) 
9% 
(int. = 72%, 
 control = 63%) 
use5 of an 
effective 
method 
n/a6 
(int. = 1%,  
control = 4%) 
.22% 
(int. = 8.73%, 
control = 8.51%) 
4% 
(int. = 37%,  
control = 33%) 
 
Potential number 
of people who 
would benefit 
per 1,000 
intervention 
recipients; 
cost per person 
acceptability of 
effective 
contraception 
20 
$250 per 
person 
140 
$39 per person 
90 
$56 per person 
use of effective 
contraception 
n/a6 
 
2.2 
$2,276 per person 
40 
$125 per person 
 
Potential number 
of people who 
would benefit 
acceptability of 
effective 
contraception 
200 
$25 per 
person 
1400 
$6.57 per person 
900 
$5.60 per person 
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per 10,000 
intervention 
recipients; 
cost per person 
 
use of effective 
contraception 
n/a6 22 
$230 per person 
400 
$12.50 per person 
 
Potential number 
of people who 
would benefit 
per 100,000 
intervention 
recipients; 
cost per person 
acceptability of 
effective 
contraception 
 
2,000 
$2.50 per 
person 
14,000 
$3.33 per person 
9,000 
$0.56 per person 
use of effective 
contraception 
n/a6 
 
220 
$25.69 per person 
 
4,000 
$1.25 per person 
1 Calculated using the amount provided to each local partner (200,000 USD) plus the amount provided 
to LSHTM to develop the intervention (200,000 USD, which is half of the total provided for the entire 
project), divided by three 
2 Calculated based on our experience of the annual cost of maintaining an app/web-based texting 
platform  
3 Palestine incurs the additional cost of sending the messages via SMS. There are approximately 110 
messages per recipient. It costs approximately $272 USD to send 10,000 messages ($0.027 USD per 
message)  
4 Caveat: While in the direction of benefit, the trial results did not demonstrate that the intervention 
increased acceptability of effective contraception in Tajikistan or Bolivia  
5 Caveat: While in the direction of benefit in Palestine and Bolivia, the trial results did not demonstrate 
that the intervention increased contraceptive use in any of the countries 
6 The proportion reporting use of effective contraception at follow-up was higher in the control group 
in Tajikistan, so not meaningful to calculate the costs 
 
 
Estimating the cost per user was relatively straightforward in Palestine because the control 
group only received messages about trial participation. In Tajikistan and Bolivia however, the 
control group received information about contraception on the app. This has limited the 
additional benefit of the intervention, which would not be the case if it was compared to a 
population who received no information. This means that the cost estimates provided are 
conservative (i.e. that the actual cost is less per person). The cost per person is contingent on 
scale; the more people who are sent the intervention, the lower the cost per person who 
would benefit. 
 
These illustrations assume that the intervention is effective, although the trial results only 
found the intervention to be effective in Palestine (in improving the acceptability of effective 
contraception). While acceptability was in the right direction in Tajikistan and Bolivia, the 
results could have occurred by chance. Likewise with regard to use of effective contraception, 
while it was in the direction of benefit in Palestine and Bolivia, the trial results did not 
demonstrate that the intervention increased contraceptive use in any of the countries.  
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10 Interviews with trial participants 
10.1 Aim 
In this chapter I present a basic, descriptive report of the semi-structured interviews 
conducted in each country. The aim of the interviews was simply to gather participant views 
of the intervention (see Appendix 20 for the discussion guides).  
 
10.2 Methods 
10.2.1 Eligibility  
Participants were eligible for the interview study if they had consented at enrolment to be 
contacted about being interviewed and if they had either completed follow-up or had all 
follow-up attempts and were considered non-responders.  
 
10.2.2 Participants 
I designed a purposive sample in each country by first listing potential selection criteria in 
Tajikistan (because the Tajik interviews were completed before the Palestine and Bolivia 
interviews) and why I was considering each variable (210). The initial criteria that I considered 
were: age, gender, ethnicity, occupation, education level, intention at baseline, method at 
baseline, number of children, marital status and acceptability outcome at follow-up (Table 
10.1). 
 
Table 10.1 Purposive sample initial selection criteria for Tajikistan 
Criteria Why considered  
Age to ensure a balanced demographic sample 
Gender  to ensure balance and because attitudes towards 
contraception are likely to be influenced by gender 
Ethnicity  hypothesised that acceptability may be influenced by 
ethnicity or residence; to ensure balanced sample 
Occupation hypothesised that people in school or university may find the 
methods more acceptable because they want to delay 
Education level hypothesised that people who completed university may find 
methods more acceptable; to ensure balanced sample 
Intention at baseline hypothesised that people who want to avoid a pregnancy at 
baseline are more likely to find methods acceptable 
Method at baseline people already using (or partner using in Tajikistan) effective 
contraception may be more likely to find at least one 
acceptable 
Number of children hypothesised that people who have had at least one child 
may be more likely to find at least one acceptable 
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Criteria Why considered  
Marital status being married may influence acceptability  
Outcome to gain views about the intervention from participants who 
found at least one acceptable and those that found none 
acceptable 
 
Next, I prioritised the criteria by listing the variables in order of importance (Table 10.2). 
 
Table 10.2 Selection criteria in order of importance 
Primary importance Secondary importance Tertiary 
importance 
Age  
(16-19/20-24) 
Number of children*  
(0/1+) (proxy for marital status) 
Ethnicity 
Gender  
(female/male) 
Occupation** 
(in education/other) (proxy for education) 
Method at 
baseline 
Outcome  
(acceptable/not acceptable) 
Intention at baseline  
(wants to avoid/other) 
 
* In Tajikistan, education level and occupation were correlated  
** In Tajikistan number of children and marital status were correlated 
 
I decided on a sample size of up to 20 interviews in each country. This was based on my 
previous experience conducting interviews with trial participants that indicated that around 
20 would be sufficient to better understand participant experiences (211) and a pragmatic 
decision given the time and resource constraints of the project. I based the selection criteria 
for Palestine and Bolivia on the selection criteria for Tajikistan, but in Palestine number of 
children replaced gender (because the trial included women only) and Bolivia included only 
age and the acceptability outcome because few participants in the sample were married or 
had children. I then created a sample matrix for each country.  
 
Tajikistan  
Because of the contamination in the trial, I decided that it would be beneficial to interview 
control participants as well as intervention participants. Since most of the interviews were 
conducted after I discovered the contamination, I amended the discussion guide to 
understand how intervention participants viewed the effect of the messages compared to the 
contraception information on the app. This included questions about what intervention 
participants learned from the app pages, if the app pages influenced them in any way and 
how the app pages and messages differed. I also created a control discussion guide that was 
based on the intervention guide but did not include questions regarding the messages 
(Appendix 20). 
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Table 10.3 Trial interview sample (Tajikistan) 
 
Intervention 
 
Control 
   At least one  
acceptable 
None  
acceptable 
At least one  
acceptable 
None  
acceptable 
 Female Male 
 
Female Male Female 
 
Male Female Male 
16-19 2 2 1 
 
2  
 
 1 1 
20-24 1 1 2 
 
1 1 2 1  
Other 1 female, 16-19, randomised twice to 
different arms, received intervention, 
not followed-up 
1 male, 20-24, non-responder 
 
Palestine 
All interviews in Palestine were conducted with intervention participants. This was because 
control participants only received messages about trial participation. 
 
Table 10.4 Trial interview sample (Palestine) 
   At least one  
acceptable 
None  
acceptable 
 0 children 1+ children 
 
0 children 1+ children 
 
18-19 3 0 5 
 
0 
20-24 3 3 3 
 
3 
 
Bolivia 
My intention was that the interview sample in Bolivia would include 75% intervention 
participants and 25% control participants. I wanted to interview control participants as well 
to explore whether the standard family planning information provided on the app itself 
influenced control participants’ attitudes, knowledge, agency, behaviour and intention. 
 
Generating a list of participants to interview 
Based on the selection criteria, I generated a list of potential interviewees in each country. At 
this point, I was still masked to treatment allocation in Palestine and Bolivia, so I generated 
two lists, by masked allocation group (e.g. group D, group C). I assigned each trial 
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identification number an interview identification number. My unmasked colleague Dr Palmer 
then labelled the groups to control or intervention, password protected the spreadsheet and 
sent the list to the interviewers, so that I remained masked.  
 
10.2.3 Interviews 
I conducted remote interview trainings with the research staff member conducting the 
interviews in each country. The training included obtaining informed consent, interviewing 
techniques such as probing and use of non-verbal listening skills. The interviewers provided 
verbal and written information about the study (see the Interview information sheet in 
Appendix 21) and then the interviewees provided written informed consent (Appendix 22). 
The interviewers audio recorded the interviews, made notes in English from listening to the 
recording, and sent the notes to me, identifying participants only by their interview 
identification number. I gave feedback to the interviewers regarding the quality of their 
report and then sent another batch of interview participant IDs to complete using the 
procedure described above with Dr Palmer. The goal was for the interviews in all three 
countries to be completed by the end of November 2017. Tajikistan and Palestine completed 
20 and Bolivia had completed five by this date. In addition, the interviewer in Bolivia left the 
organisation around the time my maternity leave commenced in December 2017, meaning 
that the new interviewer had not received my training (although had access to my training 
documents) and did not receive the feedback that I was able to provide the interviewers in 
Tajikistan and Palestine. I did not receive the additional interviews from Bolivia until March 
2018, while I was still on maternity leave. 
 
10.2.4 Analysis 
By country, I grouped the interview data in a spreadsheet according to discussion guide 
theme. I then reported the data for each theme.  
 
10.3 Results 
10.3.1 Tajikistan 
Receiving the messages and confidentiality 
All intervention participants were positive about receiving the messages. One participant said 
that she liked the way that the information was divided into different parts so that it is easier 
to memorise. Most participants thought that the number and frequency of the messages was 
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just right, with a few saying that there should be more, sent for longer than four months. 
Participants said that they saved the messages to reread later. The only non-positive 
comment was that the message content about efficacy of the different methods was 
repetitive. Most control participants liked having the app on their phones. One control 
participant said that he found it boring to read the text on the app pages.  
 
Most intervention and control participants were not concerned about confidentiality. Four 
participants did not want their parents or friends to know that they had the app on their 
phone. Three of these participants said that they had positive discussions with their parents 
about contraception. For example, one participant said that her mother was interested in the 
pill, so she showed her the messages. Her mother then had a “positive attitude toward her 
daughter and the app” (my quotes of interviewer’s notes).  
 
Knowledge  
All participants said that they learned a lot about the methods. All control participants said 
that they read the app contraception pages. Many participants, both intervention and 
control, said that the new information improved their beliefs about contraceptive methods. 
 
Attitudes  
Most participants said that the accurate knowledge they gained from the app or the app and 
messages improved their attitudes towards contraception. Participants mentioned that the 
content (both on the app and the messages) made them realise the importance of talking to 
their partner about contraception. They said that the messages helped them distinguish 
between facts and myths. A few participants said that they were not aware of the different 
methods before the study, so they had no attitudes towards them. Most however, said that 
they had basic awareness of the different methods and had heard of the various myths about 
them and that the information on the app and in the messages improved their attitudes 
towards them.   
 
“Before participation at the study, I had negative attitude about some kinds of 
contraception and thought they are more likely harmful than useful” Intervention 
participant, id 15703, female, aged 20, no methods acceptable at follow-up 
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Agency  
Most participants said that the new knowledge they gained helped them feel more confident 
either in using or communicating about contraception.  
 
Behaviour and intention  
No participants said that their behaviour changed as a result of the app or messages but 
reiterated that they improved their attitudes towards contraception. Most said that the 
content changed their intention or “future behaviour”, in that they intend to use 
contraception and talk to future wives/husbands about family planning. 
 
Environment 
Nine participants said that there were no barriers to taking care of their reproductive health. 
Other participants talked about husbands and relatives being barriers to using contraception. 
One participant held a rather pessimistic view regarding environmental barriers in Tajik 
society: 
 
“The main barrier in reproductive sphere is the society and its influence to the 
individual. Society somehow does not let people to do what they want to do with 
regard to their reproductive health. For example, I want to go to a service, but I 
cannot, because I am worried about what others will think of me. This barrier cannot 
be overcome. We cannot change society’s attitude”. Intervention participant, id 
15855, female, aged 17, at least one method acceptable at follow-up  
 
The contraception app content vs the messages 
Views on the differences between the app and the messages were very mixed. Some 
participants preferred the content on the app because it provided more information than the 
messages. Others appreciated the short daily messages and thought it convenient to read 
little by little each day. These participants wanted the messages to continue for longer than 
four months. Participants said that the messages reminded them about the app and that 
without them, they would forget that the app was on their phone. However, another 
participant said that the fixed page was more convenient because they didn’t have to wait for 
the messages. One participant said that the app contraception content read like a brochure 
and seemed boring. This same participant said that the messages were the same as the app 
but contained stories, which made her prefer the messages.  
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Other 
Most participants said that the app and messages should be available to all young people in 
Tajikistan. One participant said however, that it would be difficult for the app to be accepted 
in Tajik society: 
 
“This application is useful and I think each young person has to has access to this 
application. However, if to take into account our mentality, it would be difficult to 
some young people to use it, as their parents will be against of this kind of 
application, if they discover it.” Intervention participant, id 15528, aged 19, male, at 
least one method acceptable at follow-up 
 
10.3.2 Palestine 
Receiving the messages and confidentiality  
Besides the few participants that mentioned receiving too many messages at once due to the 
period where there were technical problems with the texting system, participants were very 
enthusiastic about receiving the messages and spoke of waiting eagerly to receive the 
messages.  
 
“I used to read the messages right away even if I’m with people. I read all the 
messages and I used to wait eagerly to receive them." id 15394, aged 24, 2+ children, 
at least one method acceptable at follow-up 
 
“I loved the messages very much, it was an important source to get information from. 
I was longing to know and receive more messages and information. I didn’t face any 
trouble. And the number of them were appropriate and each method was explained 
appropriately, and clarified. I used to read the messages right away. And I used to 
read each method in one package when all received.” id 20114, aged 20, 1 child, no 
methods acceptable at follow-up 
 
A few participants said that they deleted the messages after reading them but most 
mentioned saving the messages to reread later. Some even wrote the messages elsewhere:  
 
"All the messages I received are still in my mobile, and I wrote all of them in my 
special notebook." id 15296, aged 24, 0 children, no methods acceptable at follow-up 
 
All participants said that they had no confidentiality concerns with receiving the messages. 
The interviews indicated that most parents were aware that their daughter was participating 
in the study. Participants said that they discussed the messages with a wide range of people 
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(e.g. husband, mother and father, mother-in-law, husband’s sister, wife of husband’s brother, 
aunt, sister, cousin, brother’s wife and friends).  
 
“Once my husband read a message and I felt that he become happy because the 
messages raised his awareness about the topics. My husband and I took a discussion 
on a message received about the IUD; if it’s the best option or not to use. As a result, 
we took a decision to choose the IUD, but I still need more information about it.” id 
16373, aged 21, 1 child, no methods acceptable at follow-up 
 
“And I read the messages to my friends who are participating also in the study and 
they didn’t receive any message about this topic and they were sad. And so I had to 
send them all the messages.” id 20114, aged 20, 1 child, no methods acceptable at 
follow-up 
 
"My mother was excited to know the information" id 15848, aged 19, 0 children, at 
least one method acceptable at follow-up 
 
One participant appeared to not receive the intervention messages.  
 
Knowledge  
All participants except for the one that appeared to not receive the intervention said that the 
messages increased their knowledge about contraception. Participants frequently referred to 
misinformation: 
 
“The most important thing is not to accept any random information from anyone 
because it’s not scientific and safe enough. And I have to directly take it just from the 
health providers. When I took the contraception (pills) my mother in law, sister and 
my father used to warn me and scare me to stop using it. My father was totally 
against me using the pills….Through the messages my thoughts totally changed about 
the contraception and I’m convinced that the people are stupid." id 15715, aged 22, 0 
children, at least one method was acceptable at follow-up 
 
“People are thinking that it (OCs) cause infertility especially after having the first 
child. I’m so sorry to say that people don’t know and they don’t believe in science and 
just they are stuck in what they know.” id 20114, aged 20, 1 child, no methods 
acceptable at follow-up 
 
Participants mentioned that they had heard of the IUD and OCs, but for many, the implant 
and patch were new: 
 
“I didn’t know about all the different methods of contraception before the study. I 
had heard about the IUD, pills and the injection before the study, however I only 
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heard about the implant and patch through the messages. Before the study I thought 
that contraception causes infertility. But now I know that it is safe to use it and it is 
actually a way for women to care for their health. In addition, in the past I wasn’t 
sure I would use a family planning method, although I use to think about, but now I 
am certain that I will use contraception in the future, since now I am convinced that it 
is safe.” id 15837, aged 19, 0 children, at least one method acceptable at follow-up 
 
The above quote illustrates how the acquisition of new, accurate information changed the 
participant’s beliefs about contraception and intention to use it.  
 
One participant, while she learned new information, felt that the messages should be more 
detailed: 
  
“Most of the messages I received were about contraceptive methods and I got great 
information from them. All the messages were very important and some of the 
information were new to me but all of them lacked details.” id 18572, aged 19, 0 
children, no methods acceptable at follow-up    
 
Overall, participants felt that they learned a lot of useful information from the messages, 
which piqued their interest in learning more and in using methods either now or in the 
future.  
 
Attitudes  
Participants spoke mainly about how the information that they learned from the messages 
changed their beliefs.  
 
“Before the study I wasn’t convinced to use pills but after I participated in the study 
my information has been corrected and my thinking has changed.” id 15394, aged 24, 
2+ children, at least one method acceptable at follow-up 
 
“I was constantly thinking about contraceptive methods and I encouraged my sister 
to use an effective contraception method. The study enhanced my concepts on this 
issue and my beliefs also changed and encouraged me to use them comfortably in 
the future.” id 15837, aged 19, 0 children, at least one method acceptable at follow-
up 
 
Although, one participant said that her attitudes did not change, because she had a positive 
attitude towards contraception before the study: 
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“Nothing changed because I believed in this issue before I participated in the study. In 
my opinion having one child is enough, having children doesn’t mean we have to 
have many children. The study encouraged me even more to use contraception 
methods in the future and I will use the implant.” id 15592, aged 22, 0 children, at 
least one method acceptable at follow-up 
 
Participants spoke of the messages not only improving their attitudes towards contraception 
but also generating interest and enthusiasm for the topic: 
 
“Before the study I wasn’t interested but now it’s very important. I didn’t have lots of 
information before I participated in this study, but now I have wide knowledge 
regarding the study…this subject was very embarrassing to me but now I accept it 
normally.” id 15361, aged 23, 0 children, at least one method acceptable at follow-up 
 
One participant mentioned feeling that the messages were from a trustworthy source. She 
spoke of feeling fearful about using contraception before the study, because of myths she 
heard in her community: 
 
“Before the study I used to take the information I wanted through the internet. I liked 
the way that I receive the messages through mobile. Now I have all the messages 
saved and I will read them. The most important point, for me is the source of the 
messages was from a trustworthy association… Before the study, my husband and I 
had fears regarding the usage of contraceptive methods such as pills because maybe 
its causes fetal malformations. Also we had fears about the IUD, as we had heard 
from the people that its causes infertility. The environment where I live in, is a lagging 
environment and the people are not educated and most of them are against using 
contraception method.” id 17656, 23, 2+ children, 0 methods acceptable at follow-up 
 
Agency  
Besides the participant who appeared not to have received the messages and the participant 
who said that she had a positive view about contraception before the study, all participants 
said that their confidence regarding contraceptive methods improved. Participants spoke of 
feeling fearful before the study, but after the study feeling confident in using contraception 
and talking to their partners about it: 
 
"Yes, sure my confidence changed a lot. Now the fear to use the contraception 
methods is gone and I’m ready to use them now. In addition I have lot information 
about the methods this is why I’m not afraid to use them. Right now I have a control 
on myself to use the methods, also my husband want me to use these methods. I 
didn’t try to talk with my husband about this issue before the study. But now I talk to 
him smoothly and he accepts the information easily." id 16276, aged 24, 0 children, 
no methods acceptable at follow-up 
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Participants spoke about lack of trust in the methods before the study, stemming from 
misinformation in the community: 
 
“I didn’t trust them before, because I used to hear wrong information about them 
from the people which increased my fear. But after my participation in this study 
everything changed and my trust increased now for using the contraception. Before 
my participation in this study I hadn’t any trust to talk in this topic. But now after the 
I got training and participated in this study I have a wide knowledge and much 
information in this topic, in addition much bravery in discuss it and without any 
hesitate." id 15296, aged 24, 0 children, no methods acceptable at follow-up 
 
The participant who did not receive the intervention messages was the only participant to 
express lack of confidence in using methods: 
 
“I know that all the methods have side effects and I have a fear of use them, and 
because I hear the people around me talking about them." id 15300, aged 24, 1 child, 
no methods acceptable at follow-up 
 
One participant said that her family was encouraging her to use contraception, but she was 
afraid. It was receiving the intervention messages that changed her views: 
 
"Before the study I wasn’t confident in using contraceptives. My mother in law and 
my husband wanted me to take the pills after I gave birth to my first child, but I 
refused because I was afraid if I did I would not be able to become pregnant again. 
Through the discussions with my mother in law and other people I started to consider 
using a contraceptive. It was with me reading the messages that I received that finally 
convinced me that using a contraception was a good choice." id 15394, aged 24, 2+ 
children, at least one method acceptable at follow-up  
 
One participant even said that her participation in the study influenced her personality by 
making her feel less shy and more willing to take part in other activities: 
 
“Before the study I was too shy and didn’t like to participate in any activity. But after I 
participated in this study and I liked it, also my personality started to change. 
Now I’m ready to participate in other activities and be a volunteer at other 
associations and similar associations.” id 16965, aged 18, 0 children, at least one 
method acceptable at follow-up 
 
One participant spoke specifically about her communication self-efficacy improving after the 
study: 
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“Before the study I wasn’t able to discuss and talk about the contraceptive methods 
because I wasn’t sure about my information. Now after the study my confidence 
related to this subject is 100% and I’m able to discuss confidentially without any 
hesitation.” id 15361, aged 23, 0 children, at least one method acceptable at follow-
up 
 
Behaviour and intention  
Many participants said that the messages increased their intention to use contraception in 
the future: 
 
“Before the study I had fears and worries from using the contraceptive methods, but 
after it my confidence increased because I have more information about them, 
moreover I have a strong intention of using them in the future.” id 15362, aged 23, 0 
children, at least one method acceptable at follow-up  
 
Some participants said that the messages had encouraged them to use contraception and 
were currently doing so: 
 
“I went to the clinic and to the pharmacy to use the pills. The messages have 
encouraged me to use the pills with full confidence and without any fears and I 
intend to use the injection in the future.” id 20114, aged 20, 1 child, no methods 
acceptable at follow-up 
  
Participants also spoke about how taking part in the study lead to discussions with their 
partners: 
  
“Before the study I didn’t talk a lot with my husband about using effective 
contraception, only we discussed that probability to use the IUD. Now after I got 
more information and knowledge about the topic and discussed it with my husband 
we reached the result to most likely use the IUD.” id 16373, aged 21, 1 child, no 
methods acceptable at follow-up 
 
They also felt that the messages helped them dispel myths they heard about the methods in 
their communities and families and helped them talk about contraception in general: 
 
“Now I openly talk with my sisters and advise them on using contraceptives. 
Moreover, I’m ready to give advice for anyone I know and correct her/his 
information, especially many people thinking that these methods cause infertility.” id 
15837, aged 19, 0 children, at least one method acceptable at follow-up 
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“I became more courageous and less shy to talk about this topic with my sisters and 
brother’s wife, I can now openly participate in discussion with them about this topic.   
I have also discussed with my friends and colleagues in the institute where I study 
regarding the messages I received.” id 18133, aged 21, 0 children, no methods 
acceptable at follow-up 
 
“I talk about this topic with my colleagues at work. I have a friend and I advised her to 
use the IUD. Now I know the difference about the correct and wrong information 
when talking about the IUD. I discuss as well with my friends and my colleagues 
because some of them use the pills.” id 17656, aged 23, 2+ children, no methods 
acceptable at follow-up 
 
“I have been discussing more with my husband, mother in law and family more 
vigorously and insistently. I’m so insist that I take the decision for me and my 
husband only. And nobody has the right to interfere in my private life. But 
unfortunately, most of their convictions contradict my convictions, and it’s so difficult 
to change their thoughts and believes. For sure in the future I will use the IUD, 
because if I want to use the pills it would be a problem because I’m afraid to forget 
using them at the same time." id 15715, aged 22, 0 children, at least one method 
acceptable at follow-up 
 
In contrast to the positive comments from the other participants, the participant who did not 
receive the messages expressed fear regarding the use of the IUD: 
 
"In the past I was thinking to use the IUD but I heard that he causes problems. So 
now I have a fear to use it because I heard that it has side effects." id 15300, aged 24, 
1 child, no methods acceptable at follow-up 
 
Environment 
A few participants spoke of family members pressuring them to have children: 
 
“All my family is against me and my husband and friends as well, I have 8 sisters all of 
them against me except one who is ten years older than me. And all of them are 
surprised because I don’t want to give birth now. My family is a traditional one 
therefore they like the big family and to keep giving birth and having a lot of children. 
For me it’s enough to have three children and this is what I want. But my family 
wants me to keep giving birth as long as I am able to do that and have no obstacles 
preventing me to keep giving birth." id 15715, aged 22, 0 children, at least one 
method acceptable at follow-up 
 
One participant said that her wider family was unsupportive of her using contraception, but 
her mother was supportive of her and encouraged her to use contraception so that she could 
continue her studies: 
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“There are family members who have always advised me not to use any form of 
contraceptive methods before having another child (second one), and they say that 
using them causes infertility and other problems. On the contrary my mother advised 
me not to have another child before continuing my studies in the University. The 
most important point is what my husband and I agree on about this topic.” id 16373, 
aged 21, 1 child, no methods acceptable at follow-up 
 
However, most participants said that they did not face any environmental obstacles regarding 
family planning: 
 
“I didn’t face any obstacles nor won’t face any in the future preventing me from 
taking care of my sexual and reproductive health.” id 17606, aged 18, 0 children, no 
methods acceptable at follow-up 
 
One participant spoke of societal pressure to have more children, but felt that she could cope 
with it: 
“Nothing prevents me to take care of my health. I wanted to use the IUD after the 
first child but the people and the society pressure advised me to have at least two 
kids and then I can put the IUD. My husband wants more kids but I refused that 
because it’s a huge responsibility and I can’t bear it. Now he accepted my opinion and 
agreed with me to use the IUD for five years and after that we can have more kids.” 
id 18704, aged 23, 2+ children, at least one method acceptable at follow-up 
 
One participant reflected on societal barriers have led to her current situation, which she is 
not satisfied with:  
 
“Having more kids is an obstacle for me in being able to care for my sexual and 
psychological health. I regretted having a second child. Nothing is preventing me 
from taking care of my health and going to receive related services. For a while my 
husband was not working and we could not afford for me to get an IUD, but when he 
got work, I took money from him and went to put the IUD. The society thinking in this 
topic is backward, and all the society needs more awareness. People just keep having 
children without thinking, they just want to have more children. I’m very upset 
because I have no life except my marriage and kids. I want to work because I’m 
educated but my husband doesn’t cooperate with me in that and he objects to me 
working." id 15394, aged 24, 2+ children, at least one method acceptable at follow-up 
 
Recommendations 
Participants in general thought that the messages should provide more details about the 
methods, with many wanting more messages sent over a longer time period.  
 
“More detailed information and increase the number of messages. Extend the period 
of the participation in the study to be more than four months. Send messages for 
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married women and single women, age 16 and above. I think the messages should be 
offered for all young females and males, but more focused on females. As a result, 
early marriage would decrease.” id 17606, aged 18, 0 children, no methods 
acceptable at follow-up 
 
Participants thought that the messages should be sent to a wide range of people, e.g. 
mothers, mothers-in-law, people in rural areas and young people.  
 
“I would like to advice to send these messages to all young people. Because it is a 
really important issue. In addition we have an opportunity to change their ideas and 
concepts about this topic.”  id 18572, aged 19, 0 children, no methods acceptable at 
follow-up 
 
Participants also spoke about the need to send messages to young people in particular 
because of the problem of early marriage in society: 
 
“It would be good to increase the number of the messages…for all youth from age 16-
20 because we have early marriage phenomena.” id 15361, aged 23, 0 children, at 
least one method acceptable at follow-up 
 
“Send the messages to mothers especially who have been married for a long time. 
Publish and circulate such messages in schools and educate students from age 14 to 
avoid early marriage. The messages should go to all young females and males to 
educate about this important topic. Some males don’t know anything about sexual 
reproductive health particularly issues related to women.” id 18081, aged 19, 0 
children, no methods acceptable at follow-up 
 
One participant thought that the messages should include counselling for married women to 
convince their husbands to allow them to use contraception: 
 
“The messages should include psychological counselling for married women to be 
able convince their husband to use the contraception and avoid or prevent repeated 
pregnancies spaced too close together. The prominent masculine society believes 
that the women’s role is only to reproduce.…Our streets do not need any more 
children, one child is enough.” id 15592, aged 22, 0 children, at least one method 
acceptable at follow-up 
 
10.3.3 Bolivia 
I sent instructions with the list of potential participants in which to interview, according to 
randomised arm, as I did with Tajikistan and Palestine. Bolivia returned interviews for four 
intervention participants and 15 control participants, labelled with the interview id as 
requested. Upon reviewing the interviews, it transpired that the opposite discussion guide 
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was used in nine interviews (the control guide was used for two intervention participants and 
the intervention guide was used for seven control participants). In five interview reports with 
control participants, it appeared that they received the intervention messages. There was 
nothing in the trial data, however, that suggested that control participants received the 
intervention messages, so this is most likely a labelling error. One file was named ‘Interview 
ID 67’ but was labelled ‘Interview 6’ within the document. These recording and reporting 
discrepancies meant that I did not have confidence that the reports corresponded to the 
correct participant id. In two interview reports with intervention participants, it appeared 
that they did not receive messages. This is consistent with the trial data that suggested some 
intervention participants did not receive the intervention messages. In addition, the interview 
reports were very sparse and read more like short responses to a questionnaire.  
 
For the reasons above, it was not possible to achieve the aim of the interviews and therefore 
I have not reported them as I have done with the Tajikistan and Palestine interviews. For the 
one interview with an intervention participant where the intervention discussion guide was 
used, and it was clear that they received the messages (id 17535, aged 18, at least one 
method acceptable at follow-up, was not using effective contraception at follow-up), the 
participant said that she did not read the app pages because she did not have time. She 
preferred the intervention messages because they were “short and concrete”. She liked 
receiving the messages because they contained new information. She approved of the 
number of messages and did not have confidentiality concerns. She spoke about learning a 
lot about the IUD, and how this new information changed her thinking. Before she thought 
that the IUD and other methods were harmful but after receiving the messages, she did not 
believe this anymore. The participant also reported that she feels more confident because 
she has more information. She said that she intends to speak with her partner but her 
behaviour, however, did not change. 
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10.4 Discussion 
Overall, from the intervention recipients’ perspective, it appears that the increase in 
knowledge that resulted from the intervention (delivered by the messages in Palestine and 
the messages and app contraception pages in Tajikistan) was the active component. This fits 
with this project’s theoretical model in that knowledge influences attitudes (Figure 4.2). 
Participants in Tajikistan and Palestine were very positive about the intervention content. 
Most did not have concerns about confidentiality and many spoke about how their 
confidence in using contraception improved and how they intend to use it. 
 
A strength of this descriptive report of the interviews in Tajikistan and Palestine is that it 
enriches the understanding of how the intervention affected attitudes, knowledge, agency, 
behaviour and intention among trial participants. The reports provide a qualitative insight 
into the experience of the trial participants. Another strength is that the samples include 
participants that vary demographically, so that the views of a range of participants were 
represented. 
 
There were several limitations of this report. Because I was not able to conduct the 
interviews myself, the interviewees were not probed as often as they would have been, had I 
conducted the interviews. The interviews were not transcribed verbatim and back translated. 
The quotes were the interviewer’s interpretation/translation. The reporting variability in the 
notes between the two countries meant that I have reported the results differently; in 
Palestine, the notes were more like interview transcripts, so I was able to report more 
quotes. In some sections of the Tajikistan notes, it was difficult to tell if the text was the 
interpretation of the interviewer rather than what the interviewee intended. For example, in 
the below excerpt, it was not clear if it was the interviewer’s opinion that the interviewee had 
the ‘wrong interpretation’ or if this was the interviewee’s opinion: 
 
Before the study, as it was already mentioned, he had wrong interpretation regarding 
some kinds of contraception methods. Mostly it has changed because of the 
information he got from the messages and the app contraception page. (id 15550) 
 
Also, the meaning occasionally was not clear as exhibited by the excerpt below: 
 
The participant mentioned that despite the sexual behavior, active or passive, people 
have to talk with each other about contraception. (id 15929) 
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When the meaning was unclear, I would ignore the text rather than attempt to discern what 
was meant, because it was not possible to clarify this with the interviewers.  
 
Despite the limitations, the interviews provide a useful insight into how the participants view 
the effect of the intervention. It was clear that the Tajikistan and Palestine participants were 
very enthusiastic about the intervention messages (and the app itself in Tajikistan). From the 
participants’ point of view, the intervention messages and the app in Tajikistan increased 
knowledge, which led to an improvement in attitudes towards the effective methods, 
intention to use them and confidence in using and communicating with partners about the 
effective methods. Likewise, in Palestine, participants viewed the messages as increasing 
their knowledge about effective contraception, which improved their attitudes towards the 
methods, agency in using and communicating with partners about them, intention to use the 
methods and some participants attributed their use of effective contraception. In Tajikistan, 
the messages sent through the app seemed to serve to remind participants about the app. 
This reminder appeared to boost engagement with the app itself. As intervention content 
was also on the app, participants could have received a greater dose of the intervention 
compared to the Palestine participants because they had the option to read the intervention 
content in an alternative way. 
 
The interviews suggest that the provision of accurate information from a trustworthy source 
in a context where there is none or very little, influenced participants’ beliefs and intention 
and potentially also their behaviour.  
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11 Discussion  
11.1 Summary of the thesis 
In Chapter 1 I introduced the health problem that is the ultimate focus of this thesis, 
(unintended pregnancy), described the origin of the three country-project and outlined my 
thesis. In Chapter 2 I reviewed the literature on the main factors that influence contraceptive 
use in LMIC and describe the context in each country regarding contraceptive and mobile 
phone use. I also reviewed trials of interventions delivered by mobile phone, with a focus on 
the development, theoretical basis and reported efficacy of the interventions. These chapters 
provide a background for the research activities that I described in detail through my 
research papers in Chapters 3 and 5-8. 
 
Chapter 3 consists of the published research paper that details the development of the 
intervention. Intervention Mapping provided a useful guide for theory-based participatory 
intervention development. The results of the intervention development were similar across 
the countries. The process produced an acceptable and highly-specified individual-level 
contraceptive intervention delivered by mobile phone, tailored for each country.  
 
In Chapter 4 I described the Integrated Behavioural Model in more detail, which is the 
theoretical basis of the intervention. Because the evaluation methods were largely similar, I 
combined the three published trial protocols in Chapter 5, highlighting the methodological 
differences. In this chapter I also present additional information that was not included in the 
published protocols on how I constructed the trial outcome measures and how I built the 
baseline and follow-up trial databases.  
 
Chapters 6, 7 and 8 present the trial results in each country. In Tajikistan, intervention 
content was included on the app, causing contamination. There was no evidence that the 
intervention and control groups were different regarding acceptability of effective 
contraception (66% intervention vs 64% control; adjusted OR 1.21 95% CI .80-1.83, p = 0.36). 
Because of the contamination, I conducted a post-hoc analysis of change in acceptability of 
effective contraception from baseline to follow-up using data from all participants who 
completed the primary outcome together, which showed an increase from 2% to 65% (p < 
0.001). The Palestine trial recruited to target, achieved 80% follow-up response for the 
primary outcome acceptability and found that intervention recipients had 2.34 times the 
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odds of finding at least one method acceptable compared to the control group (95% CI 1.48-
3.68, p < 0.001). In Bolivia, recruitment and follow-up was challenging and we did not meet 
our targets. Consequently, the results were equivocal. The odds ratio of 1.19 for use of 
effective contraception (33% in the control and 37% in the intervention) observed in the 
Bolivia trial, however, would be worthwhile, if it were true. While there was a substantial 
increase in self-reported use in both arms, this could be because young women already 
interested in using effective contraception were more likely to take part than those that had 
no interest. When the results of the three trials are considered together, it seems likely that 
the intervention content is effective at increasing acceptability across different contexts. 
 
In Chapter 9 I presented three additional analyses.  The first was a psychometric evaluation of 
the acceptability outcome measure, which indicated that the measure has internal 
consistency and predictive validity. The second was a post-hoc change from baseline to 
follow-up analysis in Bolivia. As in Tajikistan, this analysis showed a large increase in 
acceptability from baseline to follow-up (9% to 67%, p < 0.001). The third was a cost-analysis, 
which provides a financial guide for adapting the intervention to other settings.    
 
Finally, in Chapter 10, I reported my descriptive analysis of the interviews conducted with 
trial participants in each country. Participants in Tajikistan and Palestine were very 
enthusiastic about the intervention content (delivered by SMS in Palestine and by app instant 
message and through the static app pages in Tajikistan). While I was not able to meaningfully 
analyse the Bolivia interviews due to the lack of clarity in the reports overall, the reports were 
consistent with the trial results that indicate that some intervention participants did not 
receive the intervention messages. Drawing on the interviews and trial results in Tajikistan 
and Palestine and the theoretical framework, it is likely that accurate information about 
contraception provided by a trustworthy source changed people’s attitudes by increasing 
their knowledge.  
 
11.2 Challenges and opportunities  
One of the main challenges throughout the course of this project was communicating 
scientific research principles to the local partners so that they were able to conduct the 
research according to protocol. This was the first randomised controlled trial that the local 
partners had been involved in. Adding to this challenge was the fact that my first language 
was not the same as either of the partners’ first language (although in Palestine, the United 
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States-born Finance Director frequently attended meetings, which was an asset). By varying 
degrees, at different points in the project, the language differential made it a challenge to 
ensure mutual understanding. It was this challenge that resulted in the contamination in the 
Tajik trial. Further complicating the language differential was the challenge of managing the 
research remotely. Had I been based locally, I would have had more in-person contact with 
the partners, which would have helped facilitate mutual understanding.  
 
Delivering the interventions to the correct participants by mobile phone was a major 
technical challenge. It took months and many meetings involving the LSHTM systems 
developer and the local platform developers in each country to integrate the application 
programming interface (API) (written by the LSHTM systems developer) that connected the 
LSHTM-based randomisation system to the local platform that sends the messages. After the 
API was integrated, we tested it repeatedly with test mobile numbers in each country, 
making sure that numbers randomised to the control receive the control messages and that 
numbers randomised to the intervention received the intervention messages. We also tested 
the timing of the message delivery, fixing the technical problems as they arose. We did not 
start trial recruitment until I was satisfied that the process was working. Despite this, 
technical problems arose in the Palestine and Bolivia trials after they commenced. In the 
Bolivia trial, I did not become aware of the message delivery problem until I analysed the 
data and discovered that 19% of intervention participants who answered the free text 
question in the follow-up questionnaire said that they did not receive any messages. 
Unfortunately, it was not possible to investigate this problem further at the point of 
discovery.  
 
The technical problems in Palestine, however, were discovered in real time. Because the 
messages were delivered by SMS, we were able to monitor their delivery through the online 
SMS delivery platform. So that I remained masked to allocation, only Dr Palmer had access to 
the online platform. Each week during recruitment, she would extract the mobile numbers 
from the platform. I would then check the mobile numbers against the mobile numbers on 
the LSHTM-based randomisation system. Occasionally, we discovered that there were 
numbers on the LSHTM system that were not on the Palestine platform, meaning that 
baseline data was entered and randomisation occurred, but the information was not received 
by the Palestine platform. In these cases, the LSHTM systems developer pushed the numbers 
from the LSHTM system until they were received. Participants were due to receive the first 
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message the day after their baseline data was submitted. This problem resulted in a delay to 
the start of the messages among some participants.  
 
There was also a technical problem with the delivery of the messages from the local Palestine 
platform. The online delivery platform interface displayed all messages that were scheduled, 
sent and failed. In addition to checking the mobile numbers, Dr Palmer monitored the 
message delivery. About a month into the trial, she noticed that there were a significant 
number of messages that were displaying as “scheduled” to be sent on a day in the past, 
seemingly indicating that the messages had not been sent or failed. After correspondence 
with the local developer, we came to understand that this problem was caused by the 
Microsoft server, however we were unable to ascertain the details. The local developer then 
switched to a new server, which resulted in messages not being sent and, among some 
participants, in receiving many messages at once. A separate problem also occurred later in 
the trial where the local developer stopped the server without warning, because their 
contract with PFPPA ended. This also resulted in some participants not receiving messages. 
The result of these problems was that many intervention participants did not receive the full 
intervention, meaning that the effect estimate in the trial is likely conservative.  
 
These technical problems highlight the importance of monitoring the delivery of the 
intervention to ensure fidelity, which is even more important when interventions are scaled-
up but may not always be possible. Rokicki 2017 also experienced technical problems with 
intervention delivery in their trial and estimated that their intention to treat analysis was 
conservative (140).  
 
It was inevitable that there would be different priorities within the diverse group of people 
that were involved in this project. For our local partners, it is understandable that service 
delivery, rather than the research, was their main priority. Considering this, it is not surprising 
that Bolivia did not want to extend recruitment (this was offered to them as my maternity 
leave would have enabled the recruitment period to continue). They were working to a 
specific timetable and wanted their app to be made widely available in Bolivia as soon as 
possible.  
 
IPPF’s role was to facilitate communication and joint decision making between LSHTM and 
the local partners and to monitor and ensure compliance with the research grant agreement. 
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They also conceived of the aim of the project, including the choice of the three countries. The 
factor that linked the countries when this project was conceived was that each country 
included a mobile phone component in their original proposals. This unconventional 
approach to conceiving of a research project meant that my role was very work-intensive as I 
led three intervention development and evaluation research projects in the time that is 
normally planned for one. Despite the challenges, through frequent remote meetings, email 
correspondences, field visits, humour and complex discussions, the research was conducted 
to a relatively high standard in Tajikistan and Bolivia and a high standard in Palestine. I 
benefitted professionally and personally from the opportunity to work with partners in 
different contexts with a range of backgrounds.  
 
11.3 Limitations 
There are several limitations to this thesis. One is in relation to the self-reported outcome 
measures. Because they are self-reported, they are more likely to be biased than if the 
outcomes were objective, such as clinic verified use of contraception. Sexual activity before 
marriage is stigmatised in all countries and in Tajikistan and Palestine, it was clear from the 
formative work that if young people were sexually active and not-married, they would not 
admit to it. This precluded the option of an objective primary outcome in Tajikistan and 
Palestine. Not-married young people in Bolivia did admit to sexual activity in the formative 
work, therefore we could justify including use as a co-primary outcome in this country.  
 
While the questionnaires were tested with the target groups for face validity, I did not have 
the time or resources to conduct a questionnaire validation study. The additional 
psychometric analysis of the individual method acceptability measures suggests that the 
measure has internal consistency and predictive validity. However, a measure validation 
study is warranted. In deciding how to score the acceptability measure, I decided that it was 
better to avoid false positives; for a method of effective contraception to be acceptable, 
participants had to choose ‘agree’ or ‘strongly agree’ to the positively worded stems and 
‘disagree’ or ‘strongly disagree’ to the negatively worded stems. In other words, for 
participants to score ‘acceptable’ for a method, they must have unequivocally thought the 
method acceptable. An example of a problem with the scoring is that it is possible that an 
individual could believe that a method had unwanted side effects but would still use it 
because they felt that the benefit of using it outweighed the risks (that is, an unintended 
pregnancy is more unwanted than the perceived side effect). This is exemplified by the 
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interviews in Palestine. Quite a few interview participants who did not find at least one 
method acceptable at follow-up indicated that they had positive attitudes and intended to 
use a method. The scoring means that the measurement of acceptability is likely 
underestimated. While this does not have implications regarding the effect of the 
intervention relative to the control, it means that in the samples overall, the true 
acceptability may have been higher at baseline and at follow-up. 
 
Another limitation is the contamination in Tajikistan. Had the contamination not occurred I 
could comment with greater confidence about the efficacy of the intervention across 
different contexts. Related to this, is the low follow-up and under-recruitment in Bolivia. Had 
we been able to produce more precise estimates, I could conclude more about the 
generalisability of the intervention across the three very different contexts.  
 
A further limitation relates to the contexts in which the interventions were delivered. The 
environmental constraints such as societal pressure to marry and start a family early are 
extremely influential and were not targeted by this intervention. The trials were designed to 
evaluate the effect of the intervention on acceptability of effective contraception among 
young people (and on use in Bolivia). In young non-sexually active people, the intervention 
aims to improve their attitudes towards the effective methods so that they have greater 
choice when they want to limit or space their future families. Further work could involve a 
longer follow-up period where we can observe effects of the intervention on desired family 
size.  
 
11.4 Cross-country considerations  
Despite the limitations, there are inferences can be made about the generalisability of the 
intervention when the results of the three trials are considered together. It is very likely that 
the intervention delivered by short messages through a mobile phone improves attitudes 
towards effective contraception across different contexts. The degree to which it does 
however, depends on what is offered as usual care. For example, when the comparator is no 
family planning information, as in the Palestine trial, the intervention more than doubled 
acceptability in the intervention arm. There was also a beneficial effect of the intervention on 
attitudes, knowledge and intention. However, when usual care is standard family planning 
information provided on a mobile app, as in the Tajik and Bolivia trials, the intervention is 
likely to be moderately more effective. In this thesis, the difference however, cannot be 
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precisely estimated, due to the contamination that occurred in Tajikistan and the low 
recruitment and follow-up in Bolivia.  
 
The results of the trials can also help to clarify the components of the intervention were the 
most effective. For example, in the Tajik trial, the large increase in acceptability from baseline 
to follow-up and the lack of evidence of a difference between the groups suggests that the 
intervention content included on the app alone can change attitudes. The Bolivia trial results 
suggest that standard family planning support delivered on app pages may change attitudes 
and that the intervention delivered by instant message through the app may moderately 
boost this effect. The post-hoc change from baseline analysis that I conducted among all trial 
participants in Tajikistan and Bolivia suggests that simply providing accurate information from 
a credible source might be all that is needed to produce dramatic improvements in attitudes 
towards effective contraception.  
 
An alternative explanation for the improvement in attitudes at follow-up across the countries 
could be due to the Hawthorne effect (212). That is, it is possible that participants were more 
likely to report positive attitudes towards effective contraception because they were aware 
that it was the trial’s topic. Participants were aware of the trial’s topic when they completed 
the baseline questionnaire and baseline acceptability was very low (2% in Tajikistan, 8% in 
Palestine and 8% in Bolivia). It is possible that exposure to contraceptive-related content 
during the trial however, primed intervention participants’ awareness of the trial topic. This 
effect could have occurred among control participants in Tajikistan and Bolivia, because the 
app contained contraceptive information. Another contributing factor to the observed 
increase in acceptability could have been that people who chose to participate were people 
already wanting more information about contraception, so they could have been more 
receptive to the intervention than someone who was not seeking information about 
contraception.  
 
While it is likely that the intervention can improve attitudes, changing behaviour (use of 
effective contraception) is more difficult, or at least more difficult to measure objectively. 
According to the project’s theoretical model, the performance of the behaviour requires it to 
be salient and requires the removal of the environmental barriers. Young people may not find 
contraceptive use a salient behaviour if they either are not sexually active or are sexually 
active and want to conceive or feel pressured to conceive. As mentioned in the Limitations 
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section, the environmental barriers, such as pressure to start a family, are not targeted by the 
intervention.  
 
Overall, there was not much difference between the groups regarding the process outcomes 
across the countries. It was clear from the interviews in Palestine and Tajikistan, that 
participants who received the intervention content felt that their agency regarding 
contraceptive use increased and attributed this to the increase in knowledge that they 
received from the intervention. This is also reflected in the theoretical model. Despite this, 
there was no statistically significant difference in agency in any of the countries. One 
explanation for this is that agency is a difficult construct to measure and the scales were not 
validated. In addition, the translation of the behaviour change methods for delivery by mobile 
phone may have resulted in loss of meaning. Likewise, for perceived norms, the lack of 
difference overall could have been due to the non-validated scales. Alternatively, changing 
norms regarding contraception may require more intervention than a mobile phone is able to 
provide.  
 
Intervention infidelity was an issue in Palestine as technical problems were discovered 
through delivery monitoring and in Bolivia as they were discovered through the open ended 
follow-up question data. In Tajikistan, while there was nothing in the open-ended follow-up 
question that indicated that there were intervention delivery problems, we cannot be certain 
that intervention participants received the intervention as intended. With most individual 
level mobile phone interventions, you cannot verify that the intervention has been received 
by the intended recipient, so any beneficial effects observed could be considered 
conservative. Table 11.1 illustrates what the intervention and control group were intended to 
receive in each country and what they received. (N.B. we cannot know what participants 
‘received’ only what was sent or what was included on the app.)  
 
Table 11.1 Intervention and control in each country 
  Tajikistan Palestine  Bolivia 
 
 
Intervention 
intended intervention 
instant messages, 
sent through the 
app 
intervention text 
messages 
intervention 
instant messages, 
sent through the 
app 
received* no indication that 
intervention was 
sent not as 
intended  
40% of 
intervention 
participants were 
sent 90% or more 
at least 19% 
intervention 
participants did 
not receive any 
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of the 
intervention 
messages and 8% 
of intervention 
participants were 
sent less than 
70% of the 
messages 
messages 
(according to 
self-reported 
data) 
 
 
 
 
 
 
 
 
 
Control 
intended access to app 
with standard FP 
information 
 
16 messages 
about trial 
participation 
 
usual care, free 
to seek any other 
support, whether 
existing or new 
 
 
 
 
 
 
16 messages 
about trial 
participation 
 
usual care, free 
to seek any other 
support, whether 
existing or new 
 
access to app 
with standard FP 
information 
 
16 messages 
about trial 
participation 
 
usual care, free 
to seek any other 
support, whether 
existing or new 
 
received* intervention 
content was 
included on the 
app, causing 
contamination 
as intended as intended 
* We cannot know what participants ‘received’ only what was sent or what was included on the app  
 
11.5 Implications  
The implications of the research conducted in this thesis mainly relate to the practical aspects 
of developing and delivering behavioural interventions by mobile phone. The contamination 
in the Tajik trial offered an unintentional insight into what BCMs were effective. The trial 
demonstrated that there was no additional benefit of the nine extra BCMs delivered by the 
messages only, over information and the BCM ‘belief selection’ delivered on the app 
contraception pages. This could have been the result of several factors such as the 
parameters for effectiveness of the methods not being met and the potential loss of meaning 
when adapted for delivery by mobile phone. The no additional benefit of the additional nine 
BCMs, when considered alongside the change from baseline analyses in the Tajik and Bolivia 
trial that showed large increases in acceptability and the favourable results of the Palestine 
trial, implies that providing accurate information plus addressing the beliefs of the target 
group is likely enough to improve attitudes towards effective contraception. In other words, 
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not all the BCMs were needed. What matters most appears to be the needs assessments, 
where the beliefs of the target groups are identified and addressed in the intervention. 
 
This thesis has demonstrated the importance of using theory in the development of 
interventions. In adapting the IBM for this project, based on what was learned from the 
intervention development work, I added knowledge as a fundamental determinant of an 
individual’s beliefs, which influences intention and ultimately behaviour (Figure 4.2). 
Explicating the IBM alongside the development of the intervention, provided a structure from 
which to develop the intervention content. It also enabled me to hypothesise how the 
intervention was expected to work, i.e. by influencing knowledge, attitudes and personal 
agency. When considering the results of the evaluations, it was useful to refer to the IBM, 
which suggested that improving knowledge indeed was necessary to improve people’s 
attitudes towards effective contraception.  
 
The implications regarding the delivery of interventions delivered by mobile phone contrast 
with what is widely assumed about such interventions, that is, that they are cheap and easy 
to deliver. The technical challenges that we encountered demonstrate that thorough and 
dedicated testing and monitoring of the delivery is required, which is neither cheap nor easy. 
LSHTM managed the testing in all three countries and performed the monitoring of the 
intervention delivery in Palestine during this project. These functions would need to be 
performed by trained local staff if the intervention is adapted in different contexts.  
 
Globally, many effective interventions fail to reach the population that can benefit from 
them, due in large part to inadequate knowledge translation of research findings (213). 
Mobile phone-based interventions in particular are often piloted but lack a sufficient 
evidence base to inform implementation (214). PFPPA and I plan to conduct qualitative 
research among young people and environmental agents (e.g. husbands, wives and partners, 
parents, siblings, mothers-in-law, community and religious leaders, teachers, government 
officials, PFPPA staff and health care providers) to understand the barriers to successful 
implementation and adoption of the intervention. We will then make the intervention 
available on their website, and evaluate the implementation by measuring adoption, 
feasibility, fidelity, coverage and sustainability. Ultimately, future research would establish 
the effect of the intervention on unintended pregnancy.  
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Adapting and implementing the intervention for different contexts should be relatively 
straightforward. This is because the cross-country beliefs about contraception identified in 
the intervention development work were similar to the beliefs in the global literature, which 
indicates that the intervention is likely generalizable. In addition, the intervention is well-
specified. Adaptation would only require a few focus groups and interviews with the target 
group in the new context to verify that the local beliefs broadly align with the intervention. 
Minor tailoring for contextual differences and cultural appropriateness would then be 
necessary. 
  
While it is likely that the intervention can improve attitudes towards effective contraception 
in different contexts, it is unclear how this attitudinal change leads to contraceptive use. 
Reflecting on this project’s theoretical model (Figure 4.2) an improvement in attitudes 
towards effective contraception is necessary for use of the methods to increase. Attitudinal 
change then influences intention to perform the behaviour, which is the most proximal 
determinant of the behaviour. Even if there is evidence that the intervention increases 
intention to use contraception (as demonstrated by the Palestine trial), whether or not the 
behaviour is actually performed depends on the presence, absence and overall influence of 
the factors in the model that influence the behaviour directly, i.e. having the skills to perform 
the behaviour, how salient the behaviour is to the individual, habits and the existence of 
environmental constraints. In this project, it was clear that stigma regarding sexual activity 
conducted outside of marriage- whether explicit (e.g. admission of sexual activity) or implicit 
(e.g. clinic attendance)- and the pressure to bear children, are powerful cultural barriers to 
contraceptive uptake in all three countries. It is likely that a broader intervention that targets 
multiple environmental agents (e.g. parents, schools, community organisations/leaders, 
governmental agencies) is needed to create the conditions necessary to facilitate larger 
changes in individual contraceptive use.  
 
11.6 Retrospective consideration of the thesis 
I am fortunate to have had the opportunity to base my PhD on a dynamic project regarding a 
topic that I feel passionately about. It is difficult to consider what I would do differently if I 
had the chance to conduct the project again because there was so much learning involved, on 
everyone’s part, which is valuable. One thing I can say that I would do differently however, is 
that, although I thoroughly explained to the Tajik partner that in a randomised controlled 
trial, control participants do not receive any intervention content, I would say explicitly that 
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none of the intervention messages should be included on the app. I would then insist on 
reviewing the content of the app before the trial began.  
 
Other things that I would do differently require additional funds, which we did not have. For 
example, I would have hired maternity cover staff to monitor the conduct of the interviews in 
Bolivia. I would have also had all interviews transcribed and translated into English. Finally, I 
would not assume that the partners were as motivated by the research as I was.  
 
11.7 Conclusions 
The development of the intervention resulted in a well-specified, theory-based intervention, 
tailored to each country. This work demonstrated that it is feasible to develop an 
intervention delivered by mobile phone for young people in different settings. The thesis also 
takes forward the process of adapting behaviour change methods for delivery by mobile 
phone.  
 
This thesis adds to the body of evidence regarding the efficacy of contraceptive interventions  
delivered by mobile phone, demonstrating that an intervention delivered by  mobile phone 
messaging changed knowledge and acceptability of and intention to use effective 
contraception. The trials in Tajikistan and Bolivia suggest that providing accurate, 
comprehensive information that addresses the beliefs of the target groups, delivered from a 
trustworthy source, may be enough to change attitudes about effective contraception in 
contexts where young people have little accurate information. In addition, my thesis has also 
demonstrated that achieving high fidelity in interventions delivered by mobile phone is not as 
simple as is currently widely assumed. The trials were the first in each country to evaluate an 
intervention of its kind. The clear benefit in Palestine, suggestive benefit in Tajikistan and 
Bolivia and lack of evidence that is associated with negative outcomes, supports the 
implementation of the intervention in each country. Implementation research could 
maximise the benefits of the intervention in each country and the intervention can be 
adapted and delivered in other contexts. 
 
 
  
200 
 
12 References 
1. Bearak J, Popinchalk A, Alkema L, Sedgh G. Global, regional, and subregional trends in 
unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian 
hierarchical model. The Lancet Global health. 2018;6(4):e380-e9. 
2. Hardee K, Eggleston E, Wong EL, Irwanto, Hull TH. Unintended pregnancy and 
women's psychological well-being in Indonesia. Journal of biosocial science. 2004;36(5):617-
26. 
3. Khajehpour M, Simbar M, Jannesari S, Ramezani-Tehrani F, Majd HA. Health status of 
women with intended and unintended pregnancies. Public health. 2013;127(1):58-64. 
4. Gipson JD, Koenig MA, Hindin MJ. The effects of unintended pregnancy on infant, 
child, and parental health: a review of the literature. Studies in family planning. 
2008;39(1):18-38. 
5. Najman JM, Morrison J, Williams G, Andersen M, Keeping JD. The mental health of 
women 6 months after they give birth to an unwanted baby: a longitudinal study. Social 
science & medicine (1982). 1991;32(3):241-7. 
6. Barber JS, Axinn WG, Thornton A. Unwanted childbearing, health, and mother-child 
relationships. Journal of health and social behavior. 1999;40(3):231-57. 
7. Nakku JEM, Nakasi G, Mirembe F. Postpartum major depression at six weeks in 
primary health care: prevalence and associated factors. African health sciences. 
2006;6(4):207-14. 
8. Lau Y, Keung DWF. Correlates of depressive symptomatology during the second 
trimester of pregnancy among Hong Kong Chinese. Social science & medicine (1982). 
2007;64(9):1802-11. 
9. Orr ST, Miller CA. Unintended pregnancy and the psychosocial well-being of pregnant 
women. Women's health issues : official publication of the Jacobs Institute of Women's 
Health. 1997;7(1):38-46. 
10. Cheng D, Schwarz EB, Douglas E, Horon I. Unintended pregnancy and associated 
maternal preconception, prenatal and postpartum behaviors. Contraception. 2009;79(3):194-
8. 
11. Eggleston E. Unintended pregnancy and women's use of prenatal care in Ecuador. 
Social science & medicine (1982). 2000;51(7):1011-8. 
12. Marston C, Cleland J. Do unintended pregnancies carried to term lead to adverse 
outcomes for mother and child? An assessment in five developing countries. Population 
studies. 2003;57(1):77-93. 
13. Kost K, Landry DJ, Darroch JE. Predicting maternal behaviors during pregnancy: does 
intention status matter? Family planning perspectives. 1998;30(2):79-88. 
14. Magadi MA, Madise NJ, Rodrigues RN. Frequency and timing of antenatal care in 
Kenya: explaining the variations between women of different communities. Social science & 
medicine (1982). 2000;51(4):551-61. 
15. Shah PS, Balkhair T, Ohlsson A, Beyene J, Scott F, Frick C. Intention to become 
pregnant and low birth weight and preterm birth: a systematic review. Maternal and Child 
Health Journal. 2011;15(2):205-16. 
16. Mohllajee AP, Curtis KM, Morrow B, Marchbanks PA. Pregnancy intention and its 
relationship to birth and maternal outcomes. Obstetrics and gynecology. 2007;109(3):678-86. 
17. Carson C, Redshaw M, Sacker A, Kelly Y, Kurinczuk JJ, Quigley MA. Effects of 
pregnancy planning, fertility, and assisted reproductive treatment on child behavioral 
problems at 5 and 7 years: evidence from the Millennium Cohort Study. Fertility and sterility. 
2013;99(2):456-63. 
18. Brown SS, Eisenberg L, editors. The Best Intentions: Unintended Pregnancy and the 
Well-Being of Children and Families. Washington D.C.: National Academies Press; 1995. 
  
201 
 
19. Sedgh G, Henshaw S, Singh S, Ahman E, Shah IH. Induced abortion: estimated rates 
and trends worldwide. Lancet (London, England). 2007;370(9595):1338-45. 
20. Unsafe Abortion. Global and regional estimates of the incidence of unsafe abortion 
and associated mortality in 2008. 6th ed. Geneva, Switzerland: World Health Organization; 
2011. 
21. Darroch JE, Woog V, Bankole A, Ashford L. Adding it up: Costs and Benefits of 
Meeting the Contraceptive Needs of Adolescents. Guttmacher Institute, 2016. 
22. Giacaman R, Abu-Rmeileh NME, Mataria A, Wick L. Palestinian women's pregnancy 
intentions: analysis and critique of the Demographic and Health Survey 2004. Health policy 
(Amsterdam, Netherlands). 2008;85(1):83-93. 
23. Hall JA, Benton L, Copas A, Stephenson J. Pregnancy Intention and Pregnancy 
Outcome: Systematic Review and Meta-Analysis. Maternal and child health journal. 
2017;21(3):670-704. 
24. Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 
2012 and recent trends. Studies in family planning. 2014;45(3):301-14. 
25. Bradley SEK, Croft TN, Fishel JD, Westoff CF. Revising unmet need for family planning. 
Calverton, Maryland, USA: ICF International, 2012. 
26. Sedgh G, Ashford L, Hussain R. Unmet Need for Contraception in Developing 
Countries: Examining Women’s Reasons for Not Using a Method. New York: Guttmacher 
Institute, 2016. 
27. Family planning/Contraception: World Health Organization 2016. Available from: 
http://www.who.int/mediacentre/factsheets/fs351/en/. 
28. Cleland J, Ali MM. Reproductive consequences of contraceptive failure in 19 
developing countries. Obstetrics and gynecology. 2004;104(2):314-20. 
29. Trussell J. Contraceptive efficacy. In: Hatcher R, Trussell J, Nelson A, Cates W, Kowal 
D, Policar M, editors. Contraceptive Technology: Twentieth Revised Edition. 20th ed. New 
York NY: Ardent Media; 2011  
30. Trussell J. Contraceptive efficacy: Global library of women's medicine; 2014 [26 
September 2017]. Available from: 
http://www.glowm.com/section_view/heading/Contraceptive%20Efficacy/item/374. 
31. ICT Facts and Figures 2017. United Nations International Telecommunication Union; 
2017. 
32. Free C, Knight R, Robertson S, Whittaker R, Edwards P, Zhou W, et al. Smoking 
cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, 
randomised trial. Lancet. 2011;378(9785):49-55. 
33. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile 
phone short message service on antiretroviral treatment adherence in Kenya (WelTel 
Kenya1): a randomised trial. Lancet. 2010;376(9755):1838-45. 
34. Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, 
et al. Mobile phone technologies improve adherence to antiretroviral treatment in a 
resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 
2011;25(6):825-34. 
35. Zurovac D, Sudoi RK, Akhwale WS, Ndiritu M, Hamer DH, Rowe AK, et al. The effect of 
mobile phone text-message reminders on Kenyan health workers' adherence to malaria 
treatment guidelines: a cluster randomised trial. Lancet. 2011;378(9793):795-803. 
36. Orr JA, King RJ. Mobile phone SMS messages can enhance healthy behaviour: a meta-
analysis of randomised controlled trials. Health psychology review. 2015;9(4):397-416. 
37. Hall CS, Fottrell E, Wilkinson S, Byass P. Assessing the impact of mHealth 
interventions in low- and middle-income countries--what has been shown to work? Global 
health action. 2014;7:25606. 
  
202 
 
38. Aranda-Jan CB, Mohutsiwa-Dibe N, Loukanova S. Systematic review on what works, 
what does not work and why of implementation of mobile health (mHealth) projects in 
Africa. BMC public health. 2014;14:188. 
39. Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P, et al. The Effectiveness of 
Mobile-Health Technology-Based Health Behaviour Change or Disease Management 
Interventions for Health Care Consumers: A Systematic Review. PLoS Med. 
2013;10(1):e1001362. 
40. Head KJ, Noar SM, Iannarino NT, Grant Harrington N. Efficacy of text messaging-
based interventions for health promotion: a meta-analysis. Social science & medicine (1982). 
2013;97:41-8. 
41. Hall AK, Cole-Lewis H, Bernhardt JM. Mobile text messaging for health: a systematic 
review of reviews. Annual review of public health. 2015;36:393-415. 
42. mHealth: New horizons for health through mobile technologies: second global survey 
on eHealth. World Health Organization 2011. 
43. L'Engle KL, Mangone ER, Parcesepe AM, Agarwal S, Ippoliti NB. Mobile Phone 
Interventions for Adolescent Sexual and Reproductive Health: A Systematic Review. 
Pediatrics. 2016;138(3):e20160884. 
44. Bull S, Devine S, Schmiege SJ, Pickard L, Campbell J, Shlay JC. Text Messaging, Teen 
Outreach Program, and Sexual Health Behavior: A Cluster Randomized Trial. American journal 
of public health. 2016;106(S1):S117-S24. 
45. Devine S, Leeds C, Shlay JC, Leytem A, Beum R, Bull S. Methods to assess youth 
engagement in a text messaging supplement to an effective teen pregnancy program. Journal 
of biomedical informatics. 2015;56:379-86. 
46. Devine S, Bull S, Dreisbach S, Shlay J. Enhancing a Teen Pregnancy Prevention 
Program with text messaging: engaging minority youth to develop TOP Plus Text. The Journal 
of adolescent health : official publication of the Society for Adolescent Medicine. 2014;54(3 
Suppl):S78-83. 
47. Ippoliti NB, L'Engle K. Meet us on the phone: mobile phone programs for adolescent 
sexual and reproductive health in low-to-middle income countries. Reproductive health. 
2017;14(1):11. 
48. Deglise C, Suggs LS, Odermatt P. Short message service (SMS) applications for disease 
prevention in developing countries. Journal of medical Internet research. 2012;14(1):e3. 
49. Gurman TA, Rubin SE, Roess AA. Effectiveness of mHealth behavior change 
communication interventions in developing countries: a systematic review of the literature. 
Journal of health communication. 2012;17 Suppl 1:82-104. 
50. McCarthy OL, Wazwaz O, Osorio Calderon V, Jado I, Saibov S, Stavridis A, et al. 
Development of an intervention delivered by mobile phone aimed at decreasing unintended 
pregnancy among young people in three lower middle income countries. BMC public health. 
2018;18(1):576. 
51. McCarthy OL, Leurent B, Edwards P, Tokhirov R, Free C. A randomised controlled trial 
of an intervention delivered by app instant messaging to increase the acceptability of 
effective contraception among young people in Tajikistan: study protocol. BMJ Open. 
2017;7(9). 
52. McCarthy OL, Wazwaz O, Jado I, Leurent B, Edwards P, Adada S, et al. An intervention 
delivered by text message to increase the acceptability of effective contraception among 
young women in Palestine: study protocol for a randomised controlled trial. Trials. 
2017;18(1):454. 
53. McCarthy OL, Osorio Calderon V, Makleff S, Huaynoca S, Leurent B, Edwards P, et al. 
An Intervention Delivered by App Instant Messaging to Increase Acceptability and Use of 
Effective Contraception Among Young Women in Bolivia: Protocol of a Randomized 
Controlled Trial. JMIR research protocols. 2017;6(12):e252. 
  
203 
 
54. McCarthy O, Ahamed I, Kulaeva F, Tokhirov R, Saibov S, Vandewiele M, et al. A 
randomized controlled trial of an intervention delivered by mobile phone app instant 
messaging to increase the acceptability of effective contraception among young people in 
Tajikistan. Reprod Health. 2018;15(1):28. 
55. Bongaarts J, Bruce J. The causes of unmet need for contraception and the social 
content of services. Studies in family planning. 1995;26(2):57-75. 
56. Westoff CF, Bankole A. Unmet need: 1990-1994. Calverton, Maryland, USA: Macro 
International Inc., 1995. 
57. Sedgh G, Hussain R, Bankole A, Singh S. Women with an unmet need for 
contraception in developing countries and their reasons for not using a method. New York: 
Guttmacher Institute, 2007 37. 
58. Glinski A, Sexton M, S P. Understanding the Adolescent Family Planning Evidence 
Base Washington, D.C.: International Center for Research on Women, 2014. 
59. Wells E. Countering myths and misperceptions about contraceptives, 
. Seattle, WA, USA: PATH, 2015. 
60. High-Impact Practices in Family Planning (HIPs). Adolescent-friendly contraceptive 
services: mainstreaming adolescent-friendly elements into existing contraceptive services. 
Washington DC: USAID, 2015. 
61. Darroch JE, Sedgh G, Ball H. Contraceptive Technologies: Responding to Women’s 
Needs. New York: Guttmacher Institute, 2011. 
62. Campbell M, Sahin-Hodoglugil NN, Potts M. Barriers to fertility regulation: a review of 
the literature. Studies in family planning. 2006;37(2):87-98. 
63. Chandra-Mouli V, McCarraher DR, Phillips SJ, Williamson NE, Hainsworth G. 
Contraception for adolescents in low and middle income countries: needs, barriers, and 
access. Reproductive health. 2014;11(1):1. 
64. Cleland J, Bernstein S, Ezeh A, Faundes A, Glasier A, Innis J. Family planning: the 
unfinished agenda. Lancet. 2006;368(9549):1810-27. 
65. Casterline JB, Perez AE, Biddlecom AE. Factors underlying unmet need for family 
planning in the Philippines. Studies in family planning. 1997;28(3):173-91. 
66. Casterline JB, Sathar ZA, ul Haque M. Obstacles to contraceptive use in Pakistan: a 
study in Punjab. Studies in family planning. 2001;32(2):95-110. 
67. Stash S. Explanations of unmet need for contraception in Chitwan, Nepal. Studies in 
family planning. 1999;30(4):267-87. 
68. Link CF. Spousal communication and contraceptive use in rural Nepal: an event 
history analysis. Studies in family planning. 2011;42(2):83-92. 
69. Memmi S. Contraceptive behaviour as a marital responsibility in the occupied 
Palestinian territory: a cross-sectional survey. The Lancet. 2013;382:S26. 
70. Ochako R, Mbondo M, Aloo S, Kaimenyi S, Thompson R, Temmerman M, et al. 
Barriers to modern contraceptive methods uptake among young women in Kenya: a 
qualitative study. BMC Public Health. 2015;15:118. 
71. Sedgh G, Hussain R. Reasons for Contraceptive Nonuse among Women Having Unmet 
Need for Contraception in Developing Countries. Studies in family planning. 2014;45(2):151-
69. 
72. Widman L, Welsh DP, McNulty JK, Little KC. Sexual communication and contraceptive 
use in adolescent dating couples. The Journal of adolescent health : official publication of the 
Society for Adolescent Medicine. 2006;39(6):893-9. 
73. Williamson LM, Parkes A, Wight D, Petticrew M, Hart GJ. Limits to modern 
contraceptive use among young women in developing countries: a systematic review of 
qualitative research. Reproductive health. 2009;6:3. 
  
204 
 
74. Wulifan JK, Brenner S, Jahn A, De Allegri M. A scoping review on determinants of 
unmet need for family planning among women of reproductive age in low and middle income 
countries. BMC women's health. 2016;16:2. 
75. Jarallah Y. Marriage patterns in Palestine. Population Reference Bureau, 2008. 
76. Rashad H, Osman M, Roudi-Fahimi F. Marriage in the Arab World. Washington, D.C.: 
Population Reference Bureau, 2005. 
77. Amado L. Sexual and bodily rights as human rights in the Middle East and North 
Africa. Reproductive health matters. 2004;12(23):125-8. 
78. Family Planning: A Global Handbook for Providers (2011 update). Baltimore and 
Geneva: CCP and WHO.: World Health Organization Department of Reproductive Health and 
Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for 
Communication Programs (CCP), Knowledge for Health Project., 2011. 
79. Moreau C, Bajos N, J B. Question Comprehension and Recall: The Reporting of 
Induced Abortions in Quantitative Surveys on the General Population.  Population (English 
edition). 59ᵉ année2004. p. 439-54. 
80. Jones RK, Kost K. Underreporting of induced and spontaneous abortion in the United 
States: an analysis of the 2002 National Survey of Family Growth. Studies in family planning. 
2007;38(3):187-97. 
81. Ulikpan A, Mirzoev T, Jimenez E, Malik A, Hill PS. Central Asian Post-Soviet health 
systems in transition: has different aid engagement produced different outcomes? Global 
Health Action. 2014;7(1):24978. 
82. Health care in Central Asia. Buckingham: Open University Press; 2002. 
83. Tajikistan Demographic and Health Survey 2012. Dushanbe, Tajikistan, and Calverton, 
Maryland, USA: SA, MOH, and ICF International.: Statistical Agency under the President of the 
Republic of Tajikistan (SA), Ministry of Health [Tajikistan], and ICF International. , 2013. 
84. UNFPA Tajikistan Country Programme 2010-2015 Evaluation Report. United Nations 
Population Fund; 2014. 
85. Country programme document for Tajikistan New York: United Nations Population 
Fund; 2015. 
86. Statistical Agency under the President of the Republic of Tajikistan MoHaSPoPotRoT, 
and ICF. Tajikistan Demographic and Health Survey 2017. Dushanbe, Republic of Tajikistan, 
and Rockville, Maryland, USA: Statistical Agency under the President of the Republic of 
Tajikistan (SA), Ministry of Health and Social Protection of Population of the Republic of 
Tajikistan (MOHSP), and ICF., 2018. 
87. Tajikistan Multiple Indicator Cluster Survey 2005, Final Report. Dushanbe, Tajikistan: 
State Committee on Statistics of the Republic of Tajikistan, 2007. 
88. Giacaman R, Rabaia Y, Nguyen-Gillham V, Batniji R, Punamaki R-L, Summerfield D. 
Mental health, social distress and political oppression: the case of the occupied Palestinian 
territory. Global public health. 2011;6(5):547-59. 
89. Giacaman R, Mataria A, Nguyen-Gillham V, Safieh RA, Stefanini A, Chatterji S. Quality 
of life in the Palestinian context: an inquiry in war-like conditions. Health policy (Amsterdam, 
Netherlands). 2007;81(1):68-84. 
90. Giacaman R, Abu-Rmeileh NME, Husseini A, Saab H, Boyce W. Humiliation: the 
invisible trauma of war for Palestinian youth. Public health. 2007;121(8):563-71; discussion 
72-7. 
91. Bates K, Leone T, Ghandour R, Mitwalli S, Nasr S, Coast E, et al. Women's health in 
the occupied Palestinian territories: Contextual influences on subjective and objective health 
measures. PloS one. 2017;12(10):e0186610. 
92. Leone T, Alburez-Gutierrez D, Gandour R, Coast E, Giacaman R, editors. Maternal and 
child health outcomes and intensity of conflict in the occupied Palestinian territory in 2000-
14: a pseudo longitudinal analysis. Lancet (London, England); 2018. 
  
205 
 
93. Sayej S, Kokian V. Increasing Access of the Underserved Areas in Palestine To SRH 
Services. 2014. 
94. Bosmans M, Nasser D, Khammash U, Claeys P, Temmerman M. Palestinian women's 
sexual and reproductive health rights in a longstanding humanitarian crisis. Reproductive 
health matters. 2008;16(31):103-11. 
95. Sexual and reproductive health: United Nations Population Fund, Palestine;  [cited 
2019 April 18 2019]. Available from: https://palestine.unfpa.org/en/node/22582. 
96. Palestinian Multiple Indicator Cluster Survey 2014: Final Report. Ramallah, Palestine: 
PCBS, 2015. 
97. Courbage Y, Abu Hamad B, Zagha A. Palestine 2030- Demographic change: 
Opportunities for Development. State of Palestine & United Nations Population Fund, 2016. 
98. Final Report of the Palestinian Family Survey 2010. Ramallah, Palestine: PCBS, 2013. 
99. Hammoudeh W. Addressing Family Planning Delivery Gaps in the Palestinian 
Territory. Washington, DC: Population Reference Bureau, 2014. 
100. Imam A, Khatib S, Al-Hajar B, Qaraqra D, Al-Halaweh H, Salim M. Unmet needs for 
modern family planning in state of Palestine. Jerusalem, Palestine: School of Public Health/Al-
Quds University, 2013. 
101. Roudi-Fahimi F, Abdul Monem A, Ashford L, El Adawy M. Women's need for family 
planning in Arab countries. In: Bureau PR, editor. 2012. 
102. Sayej S. Baseline Survey on Safe/Unsafe Abortion In Selected Refugee Camps In West 
Bank  Jerusalem: Palestinian Family Planning and Protection Association 2007. 
103. AlRifai A. Safe and Unsafe Abortion among Palestinian Women in Hebron 
Governorate in Southern West Bank- Palestine. Jerusalem: 2015. 
104. Roudi-Fahimi F, Abdul Monem A. Unintended Pregnancies in the Middle East and 
North Africa. 2010. 
105. Palestinian Family Health Survey 2006: Final Report. Ramallah, Palestine: PCBS, 2007. 
106. Public Health Law #20, Clause 8. 2004. 
107. Shahawy S, Diamond MB. Perspectives on induced abortion among Palestinian 
women: religion, culture and access in the occupied Palestinian territories. Culture, health & 
sexuality. 2018;20(3):289-305. 
108. Country programme document for the Plurinational State of Bolivia. New York United 
Nations Population Fund, 2017. 
109. Bolivia World Development Indicators 2015. Available from: 
http://data.worldbank.org/data-catalog/world-development-indicators. 
110. Indigenous peoples in Latin America: economic opportunities and social networks. 
4227 ed: World Bank Policy Research Working Paper; 2007. 
111. Bertrand J. USAID Graduation from Family Planning Assistance: Implications for Latin 
America Tulane University School of Public Health and Tropical Medicine, 2011. 
112. Encuesta Nacional de Demografía y Salud 2008. 2009. 
113. Encuesta de Demographia y Salud: EDSA 2016. La Paz, Bolivia: Instituto Nacional de 
Estadística; 2017. 
114. Independent Country Programme Evaluation- Bolivia. UNFPA, 2012. 
115. Ponce de Leon RG, Ewerling F, Serruya SJ, Silveira MF, Sanhueza A, Moazzam A, et al. 
Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible 
contraceptives: prevalence and inequalities in 23 countries. The Lancet Global health. 
2019;7(2):e227-e35. 
116. Legal abortion access greatly expanded in Bolivia 2017 [14 September 2018]. 
Available from: http://www.ipas.org/en/News/2017/December/Legal-abortion-access-
greatly-expanded-in-Bolivia.aspx. 
117. Penal Code (1972), Title VIII, Chapter II, Articles 263–269, (1972). 
  
206 
 
118. Mobile cellular subscriptions (country ICT data until 2018). International 
Telecommunications Union, 2018  Contract No.: 01 April 2019. 
119. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and 
evaluating complex interventions: new guidance. Medical Research Council. 
120. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and 
evaluating complex interventions: the new Medical Research Council guidance. International 
journal of nursing studies. 2013;50(5):587-92. 
121. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process 
evaluation of complex interventions: Medical Research Council guidance. BMJ (Clinical 
research ed ). 2015;350:h1258. 
122. Kok G, Gottlieb N, Peters G, Mullen P, Parcel G, Ruiter R, et al. A Taxonomy of 
Behavior Change Methods; an Intervention Mapping Approach. Health Psychology Review. 
2016;10(3):297-312. 
123. Agarwal S, LeFevre AE, Lee J, L'Engle K, Mehl G, Sinha C, et al. Guidelines for reporting 
of health interventions using mobile phones: mobile health (mHealth) evidence reporting and 
assessment (mERA) checklist. BMJ (Clinical research ed ). 2016;352:i1174. 
124. Bartholomew Eldredge LK, Markham C, Ruiter R, Fernandez M, Kok G, Parcel G. 
Planning Health Promotion Programs: An Intervention Mapping Approach, 4th Edition. San 
Francisco, CA: Jossey-Bass; 2016. 
125. Prestwich A, Sniehotta FF, Whittington C, Dombrowski SU, Rogers L, Michie S. Does 
theory influence the effectiveness of health behavior interventions? Meta-analysis. Health 
psychology : official journal of the Division of Health Psychology, American Psychological 
Association. 2014;33(5):465-74. 
126. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and 
evaluating complex interventions: the new Medical Research Council guidance. International 
journal of nursing studies. 2008;50(5):587-92. 
127. Mohr DC, Schueller SM, Montague E, Burns MN, Rashidi P. The Behavioral 
Intervention Technology Model: An Integrated Conceptual and Technological Framework for 
eHealth and mHealth Interventions. J Med Internet Res. 2014;16(6):e146. 
128. Ritterband LM, Thorndike FP, Cox DJ, Kovatchev BP, Gonder-Frederick LA. A behavior 
change model for internet interventions. Annals of behavioral medicine : a publication of the 
Society of Behavioral Medicine. 2009;38(1):18-27. 
129. Fogg BJ. A behavior model for persuasive design.  Persuasive Technology, Fourth 
International Conference; April 26-29, 2009; Claremont, California, USA2009. 
130. Crutzen R. The Behavioral Intervention Technology Model and Intervention Mapping: 
The Best of Both Worlds. J Med Internet Res. 2014;16(8):e188. 
131. Bock BC, Rosen RK, Barnett NP, Thind H, Walaska K, Foster R, et al. Translating 
Behavioral Interventions Onto mHealth Platforms: Developing Text Message Interventions for 
Smoking and Alcohol. JMIR mHealth and uHealth. 2015;3(1):e22. 
132. Behaviour change: individual approaches. In: Excellence NIfC, editor. 2014. 
133. Smith C, Gold J, Ngo TD, Sumpter C, Free C. Mobile phone-based interventions for 
improving contraception use. Cochrane Database of Systematic Reviews. 2015. 
134. Castaño PM, Bynum JY, Andres R, Lara M, Westhoff C. Effect of daily text messages 
on oral contraceptive continuation: a randomized controlled trial. Obstetrics and gynecology. 
2012;119(1):14-20. 
135. Smith C, Ngo TD, Gold J, Edwards P, Vannak U, Sokhey L, et al. Effect of a mobile 
phone-based intervention on post-abortion contraception: a randomized controlled trial in 
Cambodia. Bulletin of the World Health Organization. 2015. 
136. Hou MY, Hurwitz S, Kavanagh E, Fortin J, Goldberg AB. Using daily text-message 
reminders to improve adherence with oral contraceptives: a randomized controlled 
  
207 
 
trial.[Erratum appears in Obstet Gynecol. 2010 Nov;116(5):1224]. Obstetrics & Gynecology. 
2010;116(3):633-40. 
137. Tsur L, Kozer E, Berkovitch M. The effect of drug consultation center guidance on 
contraceptive use among women using isotretinoin: a randomized, controlled study. Journal 
of women's health (2002). 2008;17(4):579-84. 
138. Trent M, Tomaszewski K. 140. Family Planning Appointment Attendance Among 
Urban Youth: Results From the Depotext Trial. Journal of Adolescent Health. 2013;52(2, 
Supplement 1):S88. 
139. Gilliam M, Hebert L, Brown R, Akinola M, Hill B, Whitaker A, et al. Exploring the 
feasibility and effectiveness of a contraceptive counseling waiting room app. Contraception. 
2016;94(4):412. 
140. Rokicki S, Cohen J, Salomon JA, Fink G. Impact of a Text-Messaging Program on 
Adolescent Reproductive Health: A Cluster-Randomized Trial in Ghana. American journal of 
public health. 2017;107(2):298-305. 
141. Sridhar A, Chen A, Forbes ER, Glik D. Mobile application for information on reversible 
contraception: a randomized controlled trial. American journal of obstetrics and gynecology. 
2015;212(6):774.e1-7. 
142. Johnson D, Juras R, Riley P, Chatterji M, Sloane P, Choi SK, et al. A randomized 
controlled trial of the impact of a family planning mHealth service on knowledge and use of 
contraception. Contraception. 2017;95(1):90-7. 
143. Trent M, Thompson C, Tomaszewski K. Text Messaging Support for Urban 
Adolescents and Young Adults Using Injectable Contraception: Outcomes of the DepoText 
Pilot Trial. The Journal of adolescent health : official publication of the Society for Adolescent 
Medicine. 2015;57(1):100-6. 
144. Hebert LE, Hill BJ, Quinn M, Holl JL, Whitaker AK, Gilliam ML. Mobile contraceptive 
application use in a clinical setting in addition to standard contraceptive counseling: A 
randomized controlled trial. Contraception. 2018. 
145. Harrington E. Evaluation of an mHealth SMS dialogue strategy to meet women’s and 
couples’ postpartum contraceptive needs in Kenya (Mobile WACh XY): A randomized 
controlled trial 2018. 
146. Bracken H, Lohr PA, Taylor J, Morroni C, Winikoff B. RU OK? The acceptability and 
feasibility of remote technologies for follow-up after early medical abortion. Contraception. 
2014;90(1):29-35. 
147. Lopez LM, Grey TW, Chen M, Tolley EE, Stockton LL. Theory-based interventions for 
contraception. The Cochrane database of systematic reviews. 2016;11:CD007249. 
148. Oringanje C, Meremikwu MM, Eko H, Esu E, Meremikwu A, Ehiri JE. Interventions for 
preventing unintended pregnancies among adolescents. The Cochrane database of 
systematic reviews. 2016;2:CD005215. 
149. Lopez LM, Stockton LL, Chen M, Steiner MJ, Gallo MF. Behavioral interventions for 
improving dual-method contraceptive use. The Cochrane database of systematic reviews. 
2014;3:CD010915. 
150. Lopez LM, Grey TW, Chen M, Denison J, Stuart G. Behavioral interventions for 
improving contraceptive use among women living with HIV. The Cochrane database of 
systematic reviews. 2016(8):CD010243. 
151. Halpern V, Lopez LM, Grimes DA, Stockton LL, Gallo MF. Strategies to improve 
adherence and acceptability of hormonal methods of contraception. The Cochrane database 
of systematic reviews. 2013;10:CD004317. 
152. Hall KS, Westhoff CL, Castano PM. The impact of an educational text message 
intervention on young urban women's knowledge of oral contraception. Contraception. 
2013;87(4):449-54. 
  
208 
 
153. Akinola M, Hebert LE, Hill BJ, Quinn M, Holl JL, Whitaker AK, et al. Development of a 
Mobile App on Contraceptive Options for Young African American and Latina Women. Health 
education & behavior : the official publication of the Society for Public Health Education. 
2018:1090198118775476. 
154. L'Engle K, Vahdat H, Ndakidemi E, Lasway C, Zan T. Evaluating feasibility, reach and 
potential impact of a text message family planning information service in Tanzania. 
Contraception. 2013;87:251 - 6. 
155. Vahdat HL, L'Engle KL, Plourde KF, Magaria L, Olawo A. There are some questions you 
may not ask in a clinic: providing contraception information to young people in Kenya using 
SMS. International journal of gynaecology and obstetrics: the official organ of the 
International Federation of Gynaecology and Obstetrics. 2013;123 Suppl 1:e2-6. 
156. Smith C, Vannak U, Sokhey L, Ngo TD, Gold J, Free C. Mobile Technology for Improved 
Family Planning (MOTIF): the development of a mobile phone-based (mHealth) intervention 
to support post-abortion family planning (PAFP) in Cambodia. Reprod Health. 2016;13. 
157. Smith C, Vannak U, Sokhey L, Ngo TD, Gold J, Khut K, et al. MObile Technology for 
Improved Family Planning Services (MOTIF): study protocol for a randomised controlled trial. 
Trials. 2013;14:427. 
158. Michie S, van Stralen MM, West R. The behaviour change wheel: A new method for 
characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. 
159. Darroch JE, Audam S., Biddlecom A., Kopplin G., Riley T, Singh S, et al. Adding It Up: 
The Costs and Benefits of Investing in Sexual and Reproductive Health 2017 (Investing in 
Contraception and Maternal and Newborn Health fact sheet). Guttmacher Institute; 2017. 
160. Mobile 4 Reproductive Health- Evidence 2013. Available from: 
http://m4rh.fhi360.org/?page_id=12. 
161. Berenson AB, Rahman M. A randomized controlled study of two educational 
interventions on adherence with oral contraceptives and condoms. Contraception. 
2012;86(6):716-24. 
162. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane 
Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. 
163. McCarthy O, Carswell K, Murray E, Free C, Stevenson F, Bailey JV. What young people 
want from a sexual health website: design and development of Sexunzipped. Journal of 
medical Internet research. 2012;14(5):e127. 
164. Free C, McCarthy O, French R, Wellings K, Michie S, Roberts I, et al. Can text messages 
increase safer sex behaviours in young people? Intervention development and pilot 
randomised controlled trial. Health Technology Assessment. 2016;20(57). 
165. United Nations Department of Economic and Social Affairs. Definition of Youth  [26 
September 2017]. Available from: http://www.un.org/esa/socdev/documents/youth/fact-
sheets/youth-definition.pdf. 
166. Deliver + Enable Toolkit: Scaling-up comprehensive sexuality education (cse) London: 
The International Planned Parenthood Federation; 2016. Available from: 
https://www.ippf.org/resource/deliverenable-toolkit-scaling-comprehensive-sexuality-
education-cse. 
167. Abraham C, Michie S. A taxonomy of behavior change techniques used in 
interventions. Health Psychol. 2008;27(3):379-87. 
168. Lopez LM, Tolley EE, Grimes DA, Chen M, Stockton LL. Theory-based interventions for 
contraception. The Cochrane database of systematic reviews. 2013;8:CD007249. 
169. Gottschalk LB, Ortayli N. Interventions to improve adolescents' contraceptive 
behaviors in low- and middle-income countries: a review of the evidence base. 
Contraception. 2014;90(3):211-25. 
  
209 
 
170. Montaño D, Kasprzyk D. Theory of Reasoned Action, Theory of Planned Behavior, and 
the Integrated Behavioral Model. In: Glanz K, Rimer BK, Viswanath K, editors. Health 
behaviour: Theory, research and practice. 5 ed. San Francisco: Jossey-Bass; 2015. p. 168-222. 
171. Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychological bulletin. 
1992;111(3):455-74. 
172. Fishbein M, Ajzen I. Belief, Attitude, Intention, and Behavior: An Introduction to 
Theory and Research. Reading, MA.: Addison-Wesley; 1975. 
173. Ajzen I. Attitudes, personality and behavior. Chicago, IL.: Dorsey Press; 1988. 
174. Bandura A. Toward a Psychology of Human Agency. Perspectives on psychological 
science : a journal of the Association for Psychological Science. 2006;1(2):164-80. 
175. Bandura A. Social foundations of thought and action: A Social Cognitive Theory. 
Englewood Cliffs, NJ: Prentice Hall; 1986. 
176. Kelder S, Hoelscher D, Perry CL. How individuals, environments and health behaviors 
interact: Social Cognitive Theory. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior: 
Theory, research and practice. 5th ed ed. San Francisco, CA: Jossey-Bass; 2015. p. 285-325. 
177. Ajzen I. The theory of planned behavior. Organizational behavior and human decision 
processes. 1991;50(2):179-211. 
178. Coyle K, Basen-Engquist K, Kirby D, Parcel G, Banspach S, Collins J, et al. Safer choices: 
reducing teen pregnancy, HIV, and STDs. Public health reports (Washington, D C : 1974). 
2001;116 Suppl 1:82-93. 
179. Sieving RE, McRee A-L, McMorris BJ, Beckman KJ, Pettingell SL, Bearinger LH, et al. 
Prime time: sexual health outcomes at 24 months for a clinic-linked intervention to prevent 
pregnancy risk behaviors. JAMA pediatrics. 2013;167(4):333-40. 
180. Schinke SP, Blythe BJ, LD. G. Cognitive-behavioral prevention of adolescent 
pregnancy. Journal of Counseling Psychology. 1981;28(5):451–4. 
181. Canto De Cetina T, Canto P, Ordonez Luna M. Effect of counseling to improve 
compliance in Mexican women receiving depot-medroxyprogesterone acetate. 
Contraception. 2001;63:143 - 6. 
182. Ingersoll KS, Ceperich SD, Nettleman MD, Karanda K, Brocksen S, Johnson BA. 
Reducing alcohol-exposed pregnancy risk in college women: initial outcomes of a clinical trial 
of a motivational intervention. Journal of substance abuse treatment. 2005;29(3):173-80. 
183. Floyd RL, Sobell M, Velasquez MM, Ingersoll K, Nettleman M, Sobell L, et al. 
Preventing alcohol-exposed pregnancies: a randomized controlled trial. American journal of 
preventive medicine. 2007;32(1):1-10. 
184. Peters G. A practical guide to effective behavior change: How to identify what to 
change in the first place. The European Health Psychologist. 2014;16(5). 
185. ICT Facts and Figures 2016. International Telecommunication Union: 
http://www.itu.int/en/ITU-D/Statistics/Documents/facts/ICTFactsFigures2016.pdf, 2016. 
186. Palestinian Family Planning and Protection Association (PFPPA)  [26 September 2017]. 
Available from: http://www.ippf.org/about-us/member-associations/palestine. 
187. Fisher TD, Davis CM, Yarber WL, Davis SL, editors. Handbook of Sexuality-Related 
Measures.2010. 
188. Francis JJ, Eccles MP, Johnston M, Walker A, Grimshaw J, Foy R, et al. Constructing 
questionnaires based on the theory of planned behaviour. A manual for health services 
researchers. 2004;2010:2-12. 
189. Montano DE, Kasprzyk D, Hamilton DT, Tshimanga M, Gorn G. Evidence-based 
identification of key beliefs explaining adult male circumcision motivation in Zimbabwe: 
targets for behavior change messaging. AIDS and behavior. 2014;18(5):885-904. 
190. Encuesta de Evaluación de Salud y Nutrición 2012: Informe de Resultados. Unidad de 
Análisis de Políticas Sociales y Económicas, 2014. 
  
210 
 
191. O'Kelly M, Ratitch B. Clinical trials with missing data: A guide for practitioners. 
Chichester, UK: John Wiley & Sons, Ltd; 2014. 
192. Schulz KF, Altman DG, Moher D, Group C, Altman DG, Barbour V, et al. CONSORT 
2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 
(Clinical research ed ). 2010;340:c332. 
193. European Medicines Agency, Committee for Medicinal Products for Human Use. 
Guideline on adjustment for baseline covariates in clinical trials. London, UK.2015. 
194. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment 
and baseline comparisons in clinical trial reporting: current practice and problems. Statistics 
in medicine. 2002;21(19):2917-30. 
195. Kasenda B, Schandelmaier S, Sun X, von Elm E, You J, Blumle A, et al. Subgroup 
analyses in randomised controlled trials: cohort study on trial protocols and journal 
publications. BMJ (Clinical research ed ). 2014;349:g4539. 
196. Gabler NB, Duan N, Liao D, Elmore JG, Ganiats TG, Kravitz RL. Dealing with 
heterogeneity of treatment effects: is the literature up to the challenge? Trials. 2009;10:43. 
197. Kent DM, Rothwell PM, Ioannidis JPA, Altman DG, Hayward RA. Assessing and 
reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85. 
198. Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup 
analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for 
the interaction test. Journal of clinical epidemiology. 2004;57(3):229-36. 
199. Tsui AO, McDonald-Mosley R, Burke AE. Family planning and the burden of 
unintended pregnancies. Epidemiologic reviews. 2010;32:152-74. 
200. Logan C, Holcombe E, Manlove J, Ryan. S. The consequences of unintended 
childbearing: A white paper. Washington, DC: Child Trends; 2007. 
201. Singh S, Darroch J, Ashford L. Adding It Up: The Costs and Benefits of Investing  in 
Sexual and Reproductive Health 2014. New York: Guttmacher Institute, 2014. 
202. Kirby D, Raine T, Thrush G, Yuen C, Sokoloff A, Potter SC. Impact of an Intervention to 
Improve Contraceptive Use Through Follow-Up Phone Calls to Female Adolescent Clinic 
Patients. Perspectives on Sexual and Reproductive Health. 2010;42(4):251-7. 
203. OL. M. A randomised controlled trial of an intervention delivered by app instant 
messaging to increase the acceptability of effective contraception among young people in 
Tajikistan: statistical analysis plan. Figshare. 
https://doi.org/10.6084/m9.figshare.5314714.v22017. 
204. McCarthy OL, Osorio Calderon V, Makleff S, Huaynoca S, Leurent B, Edwards P, et al. 
An Intervention Delivered by App Instant Messaging to Increase Acceptability and Use of 
Effective Contraception Among Young Women in Bolivia: Protocol of a Randomized 
Controlled Trial. JMIR Res Protoc. 2017;6(12):e252. 
205. Reiss K, Andersen K, Barnard S, Ngo TD, Biswas K, Smith C, et al. Using automated 
voice messages linked to telephone counselling to increase post-menstrual regulation 
contraceptive uptake and continuation in Bangladesh: study protocol for a randomised 
controlled trial. BMC Public Health. 2017;17(1):769. 
206. Bailey JV, Pavlou M, Copas A, McCarthy O, Carswell K, Rait G, et al. The sexunzipped 
trial: optimizing the design of online randomized controlled trials. J Med Internet Res. 
2013;15(12):e278. 
207. Carswell K, McCarthy O, Murray E, Bailey JV. Integrating psychological theory into the 
design of an online intervention for sexual health: the sexunzipped website. JMIR Res Protoc. 
2012;1(2):e16. 
208. McCarthy O. A randomised controlled trial of an intervention delivered by text 
message to increase the acceptability of effective contraception among young women in 
Palestine: statistical analysis plan. Figshare. 
https://doi.org/10.6084/m9.figshare.5578006.v22017. 
  
211 
 
209. McCarthy O. A randomised controlled trial of an intervention delivered by app instant 
messaging to increase acceptability and use of effective contraception among young women 
in Bolivia: statistical analysis plan. Figshare. 
https://doi.org/10.6084/m9.figshare.5578012.v12017. 
210. Ritchie J, Lewis J. Qualitative Research Practice. A Guide for Social Science Students 
and Researchers. London: SAGE Publications Ltd; 2007. 
211. French RS, McCarthy O, Baraitser P, Wellings K, Bailey JV, Free C. Young People’s 
Views and Experiences of a Mobile Phone Texting Intervention to Promote Safer Sex 
Behavior. JMIR mHealth uHealth. 2016;4(2):e26. 
212. McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: 
new concepts are needed to study research participation effects. Journal of clinical 
epidemiology. 2014;67(3):267-77. 
213. Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation of 
research findings. Implementation science : IS. 2012;7:50. 
214. Tomlinson M, Rotheram-Borus MJ, Swartz L, Tsai AC. Scaling up mHealth: where is 
the evidence? PLoS medicine. 2013;10(2):e1001382. 
  
212 
 
13 Appendices 
Appendix 1. Search strategy 
(phone adj3 call*).mp. OR ((cell* or mobile or smart or google or nexus or iphone) adj3 
(phone* or telephone*)).mp. OR smartphone*.mp. OR smart-phone*.mp. OR (blackberr* not 
extract).mp. OR (black-berr* not extract).mp. OR ((mobile adj3 health) not (van* or 
unit*)).mp. OR mhealth.mp OR m-health.mp OR e-health*.mp. OR ehealth*.mp. OR 
(electronic adj health).mp. OR (mobile adj3 technol*).mp. OR ((mobile or smartphone or 
smart-phone or phone or software) adj3 app*).mp. OR MMS.mp. OR multimedia messaging 
service.mp OR SMS.mp. OR short messag* service.mp OR (text* adj messag*).mp. OR text-
messa*.mp. OR voice messag*.mp. OR interactive voice response.mp OR IVR.mp. OR 
Telemedicine/ OR cellular phone/ or text messaging/ 
 
AND 
 
(contracept* or (family adj planning) or (Birth adj control)).mp. OR condom.mp. OR (OC adj 
pill).mp. OR (depot medroxyprogest* or NET EN or Mesigyna or Cyclofem).mp. OR 
(intrauterine system or intra-uterine system or IUS or intrauterine device or intra-uterine 
device or IUD).mp. OR (vasectomy or sterilisation or sterilization or (tubal adj ligation)).mp. 
OR ((vaginal adj ring) or cycletel or cycle-tel or abstain or abstinen* or lactational 
amenorr*).mp OR (pregnan* or abortion).mp OR exp Contraception/ OR exp Contraceptive 
Devices/ OR exp Pregnancy, Unplanned/ OR exp Pregnancy, Unwanted/ OR exp Abortion, 
Induced/ OR (NORPLANT or implanon or Femplant).mp.  
 
limit to (clinical trial or randomized controlled trial or controlled clinical trial) [Limit not valid 
in Global Health,PsycINFO; records were retained] 
 
limit to yr="2017 -Current" 
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Appendix 2. Intervention development publication 
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Appendix 3. Target group discussion guide 
1. Introduction 
 We would like to hear about young people’s experiences and thoughts about contraception so 
that we can best help them 
 We also would like to know what young people about receiving contraceptive support by 
mobile phone 
 Don’t have to take part if you don’t want to 
 There are no right or wrong answers 
 I am here to facilitate the discussion, I’m not an expert on the issues 
 We are interested in a range of views, so it’s ok to disagree with each other 
 Check again that they are ok with audio recording, explain confidentiality and anonymity 
 It will last up to 90 mins (up to 60 mins for interview) 
 You can leave when you want without having to give a reason 
 You don’t have to talk about anything you don’t want to talk about 
 
2. Informed consent  
 Give them two copies of the consent, one is for them and one for CIES 
 Ask them to initial each box, print, sign and date 
 They don’t have to add their number if they don’t want to  
 
3. Demographic questionnaire 
 This information is anonymous, your name won’t be on it 
 It’s so we can describe the kinds of people we’ve talked to 
 
Rules (for focus group): 
 Please respect each other’s confidentiality by not sharing anything with anyone outside the 
group that might identify people in the group 
 Respect each other’s opinions 
 Don’t interrupt 
 Please one person speak at a time so that we can understand the recording 
 Can take phone calls (please leave the room for the conversation) 
 Any questions before I ask you to provide consent and fill out a questionnaire? 
 
4. Game 
 Ideas: each person says their name and then one thing about themselves and then people 
guess if it’s true or false, each person says their name and something about themselves and 
each person has to remember what the people before them have said, another game that you 
may know of 
 
START RECORDER 
 
5. Technology & information 
Aim: to understand patterns of technology use and what tools they use to access information 
(general and contraception) 
 Where do young people get their information from? [If you wanted to find out about 
something, where would you go (e.g. websites, apps, friends, books, friends, parents]? 
 Do you own a phone? [How many? What type? How often do you replace your main phone? 
(if they don’t own one) Do you use someone else's phone?]  
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 Do you share your phone ever? [e.g. with friends or family. If yes, how do you keep things on 
your phone private?] 
 What do you use your phone for? [if apps, which ones?]  
 Do you have access to the internet? [where, how and when?] 
 When do you get information from your phone? [are there times that you can't get info from 
your phone?] 
 [MUST ASK] What would young people think about receiving contraceptive information 
about on their mobile phone?  
 How helpful is contraception support on your phone if someone is not having sex? 
 How would you like to receive contraceptive support on your phone? (e.g. text, app, voice 
message, instant message) 
To change and add for the next group/interview: 
 
6. Knowledge  
Aim: to find out how much they know about the range of methods so we can identify any gaps in 
knowledge  
 What kinds of contraception do young people know about? [show images of different 
methods, ask about traditional methods] 
 What do you know about them (the methods that they named)? [How do you use 
(methods)?] 
 How do young people find out about contraception? [Where would you go to find out more? 
How do your friends learn about it?] 
 Would young people like more information about contraception? [how would you like to 
receive this information?] 
 (F) If you have gone to a reproductive health centre/youth friendly centre, what have the 
providers told you about the different types of contraception? 
 How easy do you think is it for a woman to get pregnant if they are not using any 
contraception?  
 How easy do you think it is for a woman to get pregnant if they are just using condoms?  
To change and add for the next group/interview: 
 
7. Attitudes 
Aim: to identify misconceptions, biases, perceptions and stigma surrounding contraception. 
 What do people in Bolivia think about people who use contraception? [Why do you think this? 
Married/unmarried] 
 What do young people think about contraception? [How many of your friends use it? What 
kinds do they use?] 
 Show images of different methods and ask what they think about each. 
 What concerns (if any) do you have about these different methods? [Do you think any of 
them are harmful? (if yes- which ones? Why do you think this?)] 
 Who should take responsibility for contraception? [you, your partner or both?] 
 What do you think about unmarried young people having sex? [Why? Different for females & 
males?] 
 How does contraception make you feel/would contraception make you feel about sex? [more 
or less pleasurable? Why?] 
To change and add for the next group/interview: 
 
8. Barriers 
Aim: to explore things that may prevent them from using contraception.  
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 How common it is for young people to use contraception? [ones have you/they used? What 
was your/their experience using the different methods? If not common, ask why not] 
 What kinds of problems (if any) do you or other people have with using contraception?  
 How easy is it for young people to get to the clinic/mobile service? [rural/urban] 
 How do you think providers feel about an unmarried person asking for contraception? 
 A young woman in her teens just got married. How acceptable is it for her to wait to get 
pregnant?  
 What role does religion play in how acceptable contraception is? [does this influence how you 
feel about it?] 
 What do you think about women making decisions on their own about contraception? [how 
easy/hard is it for them? Why do you think this?] 
 Does the cost of contraception prevent people from using it? 
 (F) If your partner didn’t approve of contraception, would you use it anyway? [how important 
is it that your partner approves?] 
To change and add for the next group/interview: 
 
9. Communication  
Aim: to understand how confident they are talking to partners and others about their reproductive 
needs and preferences. 
 How confident are young people with talking to their partner about contraception? [what 
would help them feel more confident?] 
 How do young people feel about talking to staff at the clinic about contraception? [F- are 
young women comfortable talking to them on their own? Why/why not?] 
 How confident are young people with talking to their friends about contraception? 
 How confident are young people with talking to their parents about contraception? 
 If a young woman told her partner that she wanted to use contraception but her (male) 
partner said he didn’t want to, what would happen? 
 Imagine a friend of yours is having sex and doesn’t want a pregnancy at this time. What would 
you say to her/him? 
To change and add for the next group/interview: 
 
10. Trying new methods  
Aim: to get a sense for how open they are to trying new methods and how confident they feel about 
trying them. 
 (F) If a young person wanted to try a new method, how confident would they be about trying 
it? [how easy/difficult would it be? What would prevent you from trying it?]  
 (F) What would help young people feel more confident trying new methods? [show images if 
they don’t respond] 
 What would need to change to make people feel more confident in using contraception?  
 What kinds of contraception do you think young people would be interested in trying?  
To change and add for the next group/interview: 
 
11. Intervention content & privacy 
Aim: to find out how the intervention can be supportive & easy to understand.  
 What kinds of messages should we send? [e.g. educational, stories and quotes from other 
people about using contraception, ideas about how to talk about contraception with your 
partner, images, etc.] 
 What kinds of messages should we not send? 
 What concerns would young people have about receiving messages like these on your mobile 
phone? 
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 How many messages should we send each day (if it was delivered by text or instant message)? 
To change and add for the next group/interview: 
 
12. Wrap up 
 Thinking about all that we talked about today, what do you feel is the most important? [why?] 
 What we’ve talked about today will help us provide the best contraceptive support by mobile 
phone  
 LAST QUESTION- if you were part of a study, would you come to the service so that the 
researchers could check your contraceptive use? 
 Any questions or comments? 
 Thank you! (if they want any more information, show our contact details again) 
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Appendix 4. Provider discussion guide 
The interviews with service providers will explore their perceptions of the target group’s knowledge of, 
attitudes towards and barriers to using different contraceptive methods. We will also ask for their 
views of the socio-cultural, socio-economic and structural factors involved in method choice. 
 
1. Introduction 
 We are asking people to help us develop content for a mobile phone contraceptive 
intervention.  
 We’d like to hear about your experiences and thoughts about the service users’ contraceptive 
use.  
 We also would like to know what you think about receiving contraceptive support by mobile 
phone.  
 Check again that they are ok with audio recording, explain confidentiality and anonymity 
 It will last up to 60 mins 
 Can take phone calls if you need to 
 You can leave when you want without having to give a reason. You don’t have to talk about 
anything you don’t want to talk about. Any questions before we start? 
 
2. Informed consent  
 Give them two copies of the consent, one is for them and one for CIES 
 Ask them to initial each box, print, sign and date 
 They don’t have to add their number if they don’t want to  
 
3. Demographic questionnaire 
 This information is anonymous, your name won’t be on it 
 It’s so we can describe the different people we’ve talked to 
 
4. Knowledge 
Aim: to find out their perceptions regarding users’ knowledge about the range of methods 
 What kinds of contraception do you think that the service users know about?  
 What don’t they know about? [why do you think they don’t know about them?] 
 Do you think service users want more information about contraception? [if yes- how would 
they like to receive this information? Why do you think this? If no, why not?] 
 Where do you think users get information in general? [e.g. online web forums, friends, books] 
 Where do they get information about contraception? 
 What do service users think about contraception in general? 
 What do users think about (name each method)? [why do they have these views?] 
 What do users say about different methods? [have they expressed any concerns, e.g. side 
effects?] 
To change and add for the next interview: 
 
5. Attitudes 
Aim: to find out their perceptions regarding user’s attitudes towards contraception 
 What methods do you think are best for young people? [why? Married/unmarried] 
 What methods do you think are not appropriate for young people? [why? 
Married/unmarried] 
 What would you recommend for a young unmarried women who wants contraception? 
[why?] 
 What is the best method for a young woman in a relationship who has never been pregnant 
but wants a family someday? [why?] 
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 Are there any methods that you think are unsafe? Why do you think this? [Is this your 
experience or have you heard this from other people?] 
 How safe are IUDs? [Why do you think this?] 
To change and add for the next interview: 
 
6. Barriers 
Aim: to find out what they think prevents users from using contraception. 
 What prevents service users from using effective contraception?  
 How acceptable is contraception in Bolivia  
 How does (religion, women’s status in society, stigma, social-disapproval in general) influence 
contraception use? [Do you think this can change and if so, how?] 
 What kinds of problems do people have with using contraception? [financial, supply, access, 
language] 
 What influence do parents/friends have on users’ choice? 
 How important is it partner approval in people’s choice?  
 What would need to change to make people feel more confident in using effective 
contraception?  
To change and add for the next interview: 
 
7. Communication 
Aim: to find out what they think about the frequency and quality of users’ communication about 
contraception with partners & providers 
 What kinds of things do you discuss with a person who is looking for contraception? [married 
& not married] 
 What kinds or methods do you suggest for them? [Ask why for each and ask why they do not 
recommend others. How do they respond?] 
 How comfortable to users seem when they talk to you about contraception? 
To change and add for the next interview: 
 
8. Trying new methods 
Aim: to hear providers’ opinions on how open people are to trying new methods 
 What would help young people feel more confident trying new methods? 
To change and add for the next interview: 
 
9. Technology 
Aim: to hear their views on user acceptability of a mobile phone intervention. 
 Do you think young people would like to receive information by mobile phone? [why or why 
not? If yes, what kind of information?] 
 How would you see a mobile phone intervention fitting into the services that you provide?  
To change and add for the next interview: 
 
10. Wrap up 
 Thinking about all that we talked about today, what do you feel is the most important? [why?] 
 What we’ve talked about today will help us provide the best contraceptive support by mobile 
phone  
 Any questions or comments? 
 Thank you! (if they want any more information, show our contact details again) 
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Appendix 5. Matrix of change objectives 
 Determinants 
Performance 
objectives 
    
 Knowledge Attitude Intention Personal agency 
Young people… Behavioral outcome 1: Use effective contraception 
po1.1 Choose a 
method 
k1.1.1 Name the effective 
methods 
 
k1.1.2 Describe how the 
effective methods work 
 
k1.1.3 List the risks & 
benefits of the range of 
effective methods  
 
 
 
a1.1.1 Express positive attitudes towards the 
effective methods 
 
a1.1.2 Recognise that hormonal methods are 
not less healthy than non-hormonal methods  
 
a1.1.3 Differentiate between real potential 
side-effects and misconceptions  
 
a1.1.4 Recognise that an experience of side-
effects in one method may not occur in 
another method 
 
i1.1.1 Assess options 
 
i1.1.2 Express intention to 
choose effective contraception 
pa1.1.0 Express 
personal agency in 
choosing an effective 
method despite fears 
of being judged by 
society (married or not 
married) 
po1.2 Acquire the 
method 
 
k1.2.0 List services that 
provide effective 
contraception 
 
 
a1.2.1/a2.1.1 
Question whether not attending a service 
because of fear of being judged by providers 
is worth the risk of unintended pregnancy 
 
a1.2.2 Question whether not using effective 
contraception because of fear of being judged 
by society (whether married or unmarried) is 
worth the risk of unintended pregnancy 
 
a1.2.3 Recognise that it is better to withhold 
assumptions about the affordability of 
contraception until the price has been 
confirmed by the service 
 
i1.2.0 Express intention to 
acquire effective contraception 
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 Determinants 
Performance 
objectives 
    
 Knowledge Attitude Intention Personal agency 
po1.3 Use the method 
correctly 
k1.3.0 Describe how 
methods are used 
 
 
 i1.3.0 Express intention to use 
effective contraception 
pa1.3.0 Express 
personal agency in 
using methods 
correctly 
 Behavioral outcome 2: Access reproductive health services 
po2.1 Locate a service k1.2.0/2.1.0 List services 
that provide effective 
contraception 
 
a2.1.1/a1.2.1 
Question whether not attending a service 
because of fear of being judge by providers is 
worth the risk of unintended pregnancy 
 
a2.1.2 Understand that it is fundamental to 
providers’ job to maintain confidentiality  
 
(B)a2.1.3 Debate cultural norm of not 
accessing services until something is wrong 
i2.1.0 Express intention to 
locate a service  
 
po2.2 Travel to the 
service  
  i2.2.0 Plan travel to the service 
 
i2.2.1 Recognise that it is 
possible for young people 
(married or not married) to 
travel to services while 
preserving privacy 
pa2.2.0 Express 
personal agency in 
travelling to the 
service 
po2.3 Communicate 
effectively with 
providers  
   pa2.3.0 Express 
personal agency in 
communicating with 
providers 
 Behavioral outcome 3: Communicate with partners about contraception before sex 
po3.1 Initiate 
conversation with 
partner 
 a3.1.1 Question whether refraining from 
initiating a conversation about contraception 
with a partner is worth the risk of unintended 
pregnancy 
i3.1.0 Express intention to 
initiate conversation about 
effective contraception with 
partners 
pa3.1.0 Express 
personal agency in 
initiating a 
conversation about 
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 Determinants 
Performance 
objectives 
    
 Knowledge Attitude Intention Personal agency 
 
(B)a3.1.3 Assess whether having sex without 
using effective contraception is really a “proof 
of love” 
effective contraception 
with partners 
 
po3.2 State own 
fertility preferences 
  i3.2.0 Express intention to 
clearly state own fertility 
preferences with partner 
pa3.2.0 Express 
personal agency in 
clearly stating own 
fertility preferences to 
partner 
po3.3 Listen to 
partner’s fertility 
preferences 
  i3.3.0 Express intention to listen 
to partner’s fertility preferences  
pa3.3.0 Express 
personal agency in 
listening to partners 
talk about their fertility 
preferences 
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Appendix 6. Behaviour change methods 
Method Definition The basis upon which 
the method was 
selected 
Determinant Parameters How the parameters 
were taken into 
account 
Belief selection Using messages 
designed to strengthen 
positive beliefs, weaken 
negative beliefs and 
introduce new beliefs 
Theory of planned 
behaviour, Reasoned 
action approach 
Knowledge, Attitude Requires investigation 
of the current 
attitudinal, normative 
and efficacy beliefs of 
the individual before 
choosing the beliefs on 
which to intervene 
Beliefs targeted were 
identified in the needs 
assessment 
Facilitation Creating an 
environment that makes 
the action easier or 
reduces barriers to 
action 
Social cognitive theory, 
suitability for delivery 
by text message 
Intention, Personal 
agency 
Requires real changes in 
the environment 
instead of perceptions 
of the environment; 
requires the 
identification of barriers 
and facilitators and the 
power for making the 
appropriate changes.  
Cannot produce real 
changes in the 
environment but 
provides advice on how 
they can change their 
environment to remove 
barriers 
 
Anticipated regret Stimulating individuals 
to focus on their 
feelings after 
unintended risky 
behaviour, before any 
losses actually 
materialise 
Theory of planned 
behaviour, Reasoned 
action approach 
Knowledge, Attitude, 
Intention, Personal 
agency 
Stimulation of imagery; 
assumes a positive 
intention to avoid the 
risky behaviour 
 
Cannot be certain that 
the individual intends to 
avoid the behaviour. 
However, the 
intervention aims to 
influence intention. 
 
Guided practice Prompting individuals to 
rehearse and repeat the 
behaviour various 
times, discuss the 
experience and provide 
feedback 
Social cognitive theory Intention, Personal 
agency 
Subskill demonstration, 
instruction and 
enactment with 
individual feedback; 
requires supervision by 
an experienced person 
Cannot provide 
feedback or supervision. 
However, real quotes 
from the target group 
will help participants 
compare themselves 
with an example of a 
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Method Definition The basis upon which 
the method was 
selected 
Determinant Parameters How the parameters 
were taken into 
account 
conversation that went 
well. 
Verbal persuasion Using messages that 
suggest that the 
participant possesses 
certain capabilities 
Social cognitive theory Intention, Personal 
agency 
Credible source Individuals will know 
that the messages are 
coming from the 
organisation and were 
written the 
organisation, the 
University of London 
and young people  
Tailoring Matching the 
intervention or 
components to 
previously measured 
characteristics of the 
participant 
Needs assessment Knowledge Tailoring variable or 
factors related to 
behaviour change (such 
as stage) or to relevance 
(such as culture) 
The intervention is 
based on the needs 
assessment and is 
tailored according to 
marital status and 
gender 
Cultural similarity Using characteristics of 
the target group in 
source, message and 
channel 
Needs assessment Attitude Using surface 
characteristics of the 
target group enhances 
receptivity. Socio-
cultural characteristics 
leads to a more positive 
reception of the 
message. 
Quotes from people in 
the target group are 
used  
 
Arguments Using a set of one or 
more meaningful 
premises and a 
conclusion 
Suitability for delivery 
by text message 
Attitudes, Intention, 
Personal agency 
Arguments need to be 
new  
 
Cannot be certain that 
all arguments were new 
to individuals but they 
might be 
Shifting perspective Encouraging taking the 
perspective of the other 
Needs assessment Personal agency Initiation from the 
perspective of the 
individual; needs 
imaginary competence 
Cannot be certain that 
that the individual has 
imaginary competence. 
The needs assessment 
revealed lack of 
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Method Definition The basis upon which 
the method was 
selected 
Determinant Parameters How the parameters 
were taken into 
account 
confidence in 
communicating with 
providers so this 
method prompts 
individuals to see the 
situation from the 
providers’ perspective. 
Goal setting Prompting planning 
what the person will do, 
including a definition of 
goal-directed 
behaviours that results 
in the target behaviour 
Suitability for delivery 
by text message 
Intention Commitment to the 
goal; goals that are 
difficult but available 
within the individual's 
skill level 
Cannot know if 
individuals are 
committed to the goal 
or if it is within their skill 
level. However, it might 
be. 
Accurate information 
provision 
 Information-Motivation-
Behavioural Skills 
Model; not a method, 
and generally not an 
important predictor of 
behaviour, but in 
contexts where 
knowledge is low, 
providing information 
may influence 
behaviour 
Knowledge   
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Appendix 7. Intervention development ethical approval 
letters 
LSHTM 
 
  
241 
 
 
  
242 
 
Tajikistan 
 
  
243 
 
Palestine 
 
  
244 
 
Bolivia 
  
245 
 
Appendix 8. Tajikistan trial protocol publication 
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Appendix 9. Palestine trial protocol publication 
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Appendix 10. Bolivia trial protocol publication 
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Appendix 11. Trial participant information sheets 
Tajikistan 
We are inviting you to take part in a research study. Before you decide, it is important that you know 
why we are doing the study and what is involved. Please read the following information carefully. 
 
What is the study? 
The study is testing whether sending instant messages providing information and support helps change 
young people’s attitudes towards the most effective methods of contraception. The messages are sent 
through the Tajik Family Planning Alliance’s (TFPA) health promotion app. 
 
Who is organising and funding the study? 
The study is being conducted by TFPA and the London School of Hygiene & Tropical Medicine (LSHTM). 
TFPA provides high quality sexual and reproductive health services in Tajikistan. LSHTM is a world-
leading centre for research and postgraduate education in public and global health. The study is 
funded by the International Planned Parenthood Federation (IPPF). 
 
Why have I been chosen? 
You are aged 16-24, own a personal mobile phone and live in Tajikistan. 
 
Do I have to take part?  
No, you do not have to take part. It is your choice. If you choose not to take part, all the services you 
receive will continue as normal. 
 
What will happen if I take part? 
After you have had all of your questions answered and if you decide to take part, we will ask you to 
complete a consent form. We will then ask you to complete a confidential questionnaire that asks you 
to provide details about yourself, such as name and date of birth. The questionnaire also asks for your 
feelings and attitudes towards contraception. Completing the questionnaire will take 5-10 minutes. 
You can complete the consent and questionnaire on our secure and confidential study website or by 
filling out a paper version. 
 
After you have completed the questionnaire, you will receive a code on your phone to download 
TFPA’s app. An automated computer system will put you into one of two groups by chance 
(randomly):  
 
Group 1: One group will have access to TFPA’s app and receive 0 to 3 instant messages a day 
about contraception over 4 months. 
 
Group 2: The other group will have access to TFPA’s app and will not receive the instant 
messages.  
 
At the end of the study, 4 months after joining, we will ask you to complete the questionnaire again. 
This is to see how things may have changed. You can complete the 4-month questionnaire on our 
secure and confidential study website (this is mobile phone friendly too), by filling out a paper version 
at the service or by providing your answers to the research staff over the phone. 
 
Will you compensate me for taking part? 
Unfortunately, we are not able to offer you something for taking part. You do not have to pay for the 
app. 
 
What are the alternatives? 
You do not have to take part.  
 
What are the possible disadvantages of taking part? 
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Completing the questionnaires will take some of your time. It is possible that the messages that we 
send could be read by someone else. If you are concerned about this, you could lock your phone and 
delete the messages after you read them. You can choose the times that you want to receive the 
messages. 
 
What are the possible advantages of taking part? 
You may find the messages helpful and enjoy the experience of taking part in research. You can add 
your participation in the study to your resume. 
 
What if I do not want to take part anymore? 
You can stop receiving messages by (method to be determined). You can leave the study at any time by 
contacting the Project Coordinator (details below). You do not have to give a reason for wanting to 
leave the study. Leaving the study will not affect the services that you receive.  
 
What if there is a problem? 
You can talk to the Project Coordinator at any time (details below).   
 
Will my taking part be confidential?  
Yes. Your answers to the questionnaires will be stored anonymously and your contact details and will 
be kept confidential and separate from your answers to the questionnaires. You will be assigned a 
unique study number when you join the study. We will not inform your parents, partner or anyone else 
about your involvement in this research. With your permission, will search TFPA records to check for 
any services you may have received during your time in the study.  
 
What will happen with the results of this study? 
We will share the results through publication in journals and through conference presentations. If you 
would like to know the results of the study, please contact the team (details below) and we will share 
them with you. Your name will not be used in the results of this study. 
 
If the results of the study show that the messages have helped, they will be made available to all young 
people in Tajikistan. 
 
Who has reviewed this study? 
The London School of Hygiene & Tropical Medicine Interventions Research Ethics Committee and the 
Tajikistan National Scientific and Research Centre on Paediatrics and Child Surgery (NSRCP&CS).  
 
Thank you for taking the time to consider taking part 
 
Rukhshona Jamoliddinova Ravshan Tokhirov Ona McCarthy 
Project Coordinator Executive Director Principal Investigator 
TFPA, 10 Rudaki Avenue TFPA, 10 Rudaki Avenue LSHTM, Keppel St, WC1E 7HT 
TC 'Sadbarg', 7th floor, Dushanbe TC 'Sadbarg', 7th floor, Dushanbe London, United Kingdom 
tfpa.inpro@gmail.com  ed.tfpa@gmail.com  ona.mccarthy@lshtm.ac.uk 
+992 (918) 69-9925   
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Palestine 
We are inviting you to take part in a research study. Before you decide, it is important that you know 
why we are doing the study and what is involved. Please read the following information carefully. 
 
What is the study? 
The study is testing whether SMS messages providing information and support helps change young 
women’s attitudes towards the most effective methods of contraception.  
 
Who is organising and funding the study? 
The study is being conducted by the Palestinian Family Planning and Protection Association (PFPPA) 
and the London School of Hygiene & Tropical Medicine (LSHTM). PFPPA provides high quality sexual 
and reproductive health services in the Palestinian Authority. LSHTM is a world-leading centre for 
research and postgraduate education in public and global health. The study is funded by the 
International Planned Parenthood Federation (IPPF). 
 
Why have I been chosen? 
You are female, aged 18-24, do not report using effective contraception, own a personal mobile phone 
and live in the West Bank. 
 
Do I have to take part?  
No, you do not have to take part. It is your choice. If you choose not to take part, all the services you 
receive will continue as normal. 
 
What will happen if I take part? 
After you have had all of your questions answered and if you decide to take part, we will ask you to 
complete a consent form. We will then ask you to complete a confidential questionnaire that asks you 
to provide details about yourself, such as name and date of birth. The questionnaire also asks for your 
feelings and attitudes towards contraception. Completing the questionnaire will take 5-10 minutes. 
You can complete the consent and questionnaire on our secure and confidential study website or by 
filling out a paper version. 
 
After you have completed the questionnaire, an automated computer system will put you into one of 
two groups by chance (randomly): 
 
Group 1: One group will receive 0 to 3 text messages a day about contraception over 4 
months.  
 
Group 2: The other group will receive SMS messages that are not about contraception. This 
group will receive one message a month for 4 months.  
 
At the end of the study, 4 months after joining, we will ask you to complete the questionnaire again. 
This is to see how things may have changed. You can complete the 4-month questionnaire on our 
secure and confidential study website, by filling out a paper version at the service or by providing your 
answers to the research staff over the phone. 
 
Will you compensate me for taking part? 
Unfortunately, we are not able to offer you something for taking part. You do not have to pay for the 
messages that you receive. 
 
What are the alternatives? 
You do not have to take part.  
 
What are the possible disadvantages of taking part? 
Completing the questionnaires will take some of your time. It is possible that the messages that we 
send could be read by someone else. If you are concerned about this, you could lock your phone and 
  
282 
 
delete the messages after you read them. You can choose the times that you want to receive the 
messages. 
 
What are the possible advantages of taking part? 
You may find the messages helpful and enjoy the experience of taking part in research. You can add 
your participation in the study to your resume. You can add your participation in the study to your 
resume. 
 
What if I do not want to take part anymore? 
You can stop receiving messages by texting ‘stop’. You can leave the study at any time by contacting 
the Project Coordinator (details below). You do not have to give a reason for wanting to leave the 
study. Leaving the study will not affect the services that you receive.  
 
What if there is a problem? 
You can talk to the Project Coordinator at any time (details below).   
 
Will my taking part be confidential?  
Yes. Your answers to the questionnaires will be stored anonymously and your contact details and will 
be kept confidential and separate from your answers to the questionnaires. You will be assigned a 
unique study number when you join the study. We will not inform your parents, partner or anyone else 
about your involvement in this research. With your permission, will search PFPPA records to check for 
any services you may have received during your time in the study.  
 
What will happen with the results of this study? 
We will share the results through publication in journals and through conference presentations. If you 
would like to know the results of the study, please contact the team (details below) and we will share 
them with you. Your name will not be used in the results of this study. 
 
If the results of the study show that the messages have helped, they will be made available to all young 
people in the West Bank. 
 
Who has reviewed this study? 
The London School of Hygiene & Tropical Medicine Interventions Research Ethics Committee and the 
State of Palestine Ministry of Health.  
 
 
Thank you for taking the time to consider taking part 
 
Ola Wazwaz Amina Stavridis Ona McCarthy 
Project Coordinator Executive Director Principal Investigator 
PFPPA, Industrial Zone, Wadi Al-Joze  PFPPA, Industrial Zone, Wadi Al-Joze  LSHTM, Keppel St, WC1E 7HT 
Jerusalem, Palestinian Territory Jerusalem, Palestinian Territory London, United Kingdom 
ipc@pfppa.org director@pfppa.org ona.mccarthy@lshtm.ac.uk 
+ 9722-6280630   
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Bolivia 
We are inviting you to take part in a research study. Before you decide, it is important that you know 
why we are doing the study and what is involved. Please read the following information carefully. 
 
What is the study? 
The study is testing whether sending instant messages providing information and support helps change 
young people’s attitudes towards the most effective methods of contraception. The messages are sent 
through CIES Salud Sexual - Salud Reproductiva (CIES) sexual and reproductive health promotion app. 
 
Who is organising and funding the study? 
The study is being conducted by CIES and the London School of Hygiene & Tropical Medicine (LSHTM). 
CIES provides high quality sexual and reproductive health services in Bolivia. LSHTM is a world-leading 
centre for research and postgraduate education in public and global health. The study is funded by the 
International Planned Parenthood Federation (IPPF). 
 
Why have I been chosen? 
You are: female, aged 16-24, have had sex in the past 6 months, want to avoid a pregnancy at the 
moment, are not using effective contraception, own a personal android mobile phone and live in El 
Alto or La Paz. 
 
Do I have to take part?  
No, you do not have to take part. It is your choice. If you choose not to take part, all the services you 
receive will continue as normal. 
 
What will happen if I take part? 
After you have had all of your questions answered and if you decide to take part, we will ask you to 
complete a consent form. We will then ask you to complete a confidential questionnaire that asks you 
to provide details about yourself, such as name and date of birth. The questionnaire also asks for your 
feelings and attitudes towards contraception. Completing the questionnaire will take 5-10 minutes. 
You can complete the consent and questionnaire on our secure and confidential study website or by 
filling out a paper version. 
 
After you have completed the questionnaire, you will receive a code on your phone to download CIES’s 
app. An automated computer system will put you into one of two groups by chance (randomly):  
 
Group 1: One group will have access to CIES’s app and receive 0 to 3 instant messages a day 
about contraception over 4 months. 
 
Group 2: The other group will have access to CIES’s app and will not receive the instant 
messages.  
 
At the end of the study, 4 months after joining, we will ask you to complete the questionnaire again. 
This is to see how things may have changed. You can complete the 4-month questionnaire on our 
secure and confidential study website (this is mobile phone friendly too), by filling out a paper version 
at the service or by providing your answers to the research staff over the phone. 
 
Will you compensate me for taking part? 
Unfortunately, we are not able to offer you something for taking part. You do not have to pay for the 
app. 
 
What are the alternatives? 
You do not have to take part.  
 
What are the possible disadvantages of taking part? 
Completing the questionnaires will take some of your time. It is possible that the messages that we 
send could be read by someone else. If you are concerned about this, you could lock your phone and 
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delete the messages after you read them. You can choose the times that you want to receive the 
messages. 
 
What are the possible advantages of taking part? 
You may find the messages helpful and enjoy the experience of taking part in research. You can add 
your participation in the study to your resume.  
 
What if I do not want to take part anymore? 
You can stop receiving messages by (method to be determined). You can leave the study at any time by 
contacting the Project Coordinator (details below). You do not have to give a reason for wanting to 
leave the study. Leaving the study will not affect the services that you receive.  
 
What if there is a problem? 
You can talk to the Project Coordinator at any time (details below).   
 
Will my taking part be confidential?  
Yes. Your answers to the questionnaires will be stored anonymously and your contact details and will 
be kept confidential and separate from your answers to the questionnaires. You will be assigned a 
unique study number when you join the study. We will not inform your parents, partner or anyone else 
about your involvement in this research. With your permission, will search CIES records to check for 
any services you may have received during your time in the study.  
 
What will happen with the results of this study? 
We will share the results through publication in journals and through conference presentations. If you 
would like to know the results of the study, please contact the team (details below) and we will share 
them with you. Your name will not be used in the results of this study. 
 
If the results of the study show that the messages have helped, they will be made available to all young 
people in Bolivia. 
 
Who has reviewed this study? 
The London School of Hygiene & Tropical Medicine Interventions Research Ethics Committee and the 
Bolivian National Research Ethics Committee.  
 
Thank you for taking the time to consider taking part 
 
Maria Eugenia Torrico Dr Jhonny Lopez Ona McCarthy 
Coordinadora de proyecto Executive Director Principal Investigator 
CIES Salud Sexual - Salud Reproductiva CIES Salud Sexual - Salud Reproductiva LSHTM, Keppel St, WC1E 7HT 
Calle 6 de Obrajes Nro. 614 – Casilla 
9935, (591-2) 2788162 
Calle 6 de Obrajes Nro. 614 – Casilla 
9935, (591-2) 2788162 
London, United Kingdom 
ona.mccarthy@lshtm.ac.uk 
maeugenia@cies.org.bo       JLopez@cies.org.bo  
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Appendix 12. Trial consent forms 
 
Tajikistan 
Project Coordinator: Rukhshona Jamoliddinova, the Tajik Family Planning Alliance (TFPA), 10 
Rudaki Avenue, TC 'Sadbarg', 7th floor, Dushanbe, +992 (918) 69-9925,  tfpa.inpro@gmail.com  
 
Principal Investigator: Ona McCarthy, The London School of Hygiene and Tropical Medicine, 
Department of Population Health, Keppel St, WC1E 7HT, London, United Kingdom, 
ona.mccarthy@lshtm.ac.uk    
  
Please initial 
here 
1. I have read the Information sheet for the above study (v1 19.02.16) or it 
has been read to me. I have had the opportunity to consider the 
information in it. 
 
 
 
 
2. I have had the opportunity to ask questions and I am happy with the 
answers that you gave me. 
 
 
 
 
3. I understand that I do not have to take part if I do not want to.  
 
 
 
 
4. I understand that the information that I provide will remain confidential 
and will only be used for this study. Only the research team will have 
access to this information. 
 
 
 
 
 
5. I agree to the study researchers searching TFPA clinic records to check 
for any services that I may have received during my participation in the 
study.  
 
 
6. I understand that I am free to leave the study at any time without 
having to give a reason. I understand that this will not affect the services 
that I receive. 
 
 
 
 
7. I consent to take part in the above study.  
 
 
(optional) I agree to be contacted about taking part in a short interview 
 
 
                     _________ 
             Name of participant (print)     Signature of participant                            Date 
   
Statement by person taking consent 
I confirm that the participant was given an opportunity to ask questions about the study, and all the questions 
asked by the participant have been answered correctly and to the best of my ability. I confirm that the individual 
has not been coerced into giving consent, and the consent has been given freely and voluntarily. A copy of the 
consent form has been given to the participant.  
            ___________ 
  Name of person taking consent (print) Signature of person taking consent           Date
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Palestine 
 
Project Coordinator: Ola Wazwaz, Palestinian Family Planning and Protection Association 
(PFPPA), Industrial Zone, Wadi Al-Joze, Jerusalem, Palestine,  + 9722-6280630, 
ipc@pfppa.org 
 
Principal Investigator: Ona McCarthy, The London School of Hygiene and Tropical Medicine, 
Department of Population Health, Keppel St, WC1E 7HT, London, United Kingdom, 
ona.mccarthy@lshtm.ac.uk    
  
Please initial 
here 
4. I have read the Information sheet for the above study (v2 06.08.16) or it has 
been read to me. I have had the opportunity to consider the information in 
it. 
 
 
 
 
5. I have had the opportunity to ask questions and I am happy with the 
answers that you gave me. 
 
 
 
 
6. I understand that I do not have to take part if I do not want to.  
 
 
 
 
5. I understand that the information that I provide will remain confidential and 
will only be used for this study. Only the research team will have access to 
this information. 
 
 
 
 
 
8. I agree to the study researchers searching PFPPA clinic records to check for 
any services that I may have received during my participation in the study.  
 
 
9. I understand that I am free to leave the study at any time without having to 
give a reason. I understand that this will not affect the services that I receive. 
 
 
 
 
10. I consent to take part in the above study.  
 
 
(optional) I agree to be contacted about taking part in a short interview 
 
 
                     _________ 
             Name of participant (print)     Signature of participant                            Date 
   
Statement by person taking consent 
I confirm that the participant was given an opportunity to ask questions about the study, and all the questions 
asked by the participant have been answered correctly and to the best of my ability. I confirm that the individual 
has not been coerced into giving consent, and the consent has been given freely and voluntarily. A copy of the 
consent form has been given to the participant.  
 
            ___________ 
  Name of person taking consent (print) Signature of person taking consent           Date
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Bolivia 
 
Project Coordinator: Maria Eugenia Torrico, CIES Salud Sexual - Salud Reproductiva, Calle 6 de 
Obrajes Nro. 614 – Casilla 9935, (591-2) 2788162, maeugenia@cies.org.bo     
 
Principal Investigator: Ona McCarthy, The London School of Hygiene and Tropical Medicine, 
Department of Population Health, Keppel St, WC1E 7HT, London, United Kingdom, 
ona.mccarthy@lshtm.ac.uk    
  
Please 
initial 
here 
7. I have read the Information sheet for the above study (v3 02.11.16) or it has 
been read to me. I have had the opportunity to consider the information in it. 
 
 
 
 
8. I have had the opportunity to ask questions and I am happy with the answers 
that you gave me. 
 
 
 
 
9. I understand that I do not have to take part if I do not want to.  
 
 
 
 
6. I understand that the information that I provide will remain confidential and 
will only be used for this study. Only the research team will have access to this 
information. 
 
 
 
 
 
11. I agree to the study researchers searching CIES clinic records to check for any 
services that I may have received during my participation in the study.  
 
 
12. I understand that I am free to leave the study at any time without having to 
give a reason. I understand that this will not affect the services that I receive. 
 
 
 
 
13. I consent to take part in the above study.  
 
 
(optional) I agree to be contacted about taking part in a short interview 
 
 
                     _________ 
             Name of participant (print)     Signature of participant                            Date 
   
Statement by person taking consent 
I confirm that the participant was given an opportunity to ask questions about the study, and all the questions 
asked by the participant have been answered correctly and to the best of my ability. I confirm that the individual 
has not been coerced into giving consent, and the consent has been given freely and voluntarily. A copy of the 
consent form has been given to the participant.  
 
            ___________ 
  Name of person taking consent (print) Signature of person taking consent           Date
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Appendix 13. Baseline questionnaires 
Tajikistan 
  
Using the 
pill… 
      
1 causes 
infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the pill is 
2 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the pill is 
3 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the pill is 
4 is a good way 
to prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the pill is 
5 I would 
recommend 
the pill to a 
friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the pill is 
  
Using the 
IUD… 
      
6 causes 
infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
7 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
8 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
9 is a good way 
to prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
10 I would 
recommend 
the IUD to a 
friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
11 The IUD 
insertion 
would not be 
a problem 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
  
Using the 
injection… 
      
12 causes 
infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the injection is 
13 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the injection is 
14 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the injection is 
15 is a good way 
to prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the injection is 
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16 I would 
recommend 
the injection 
to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the injection is 
  
Using the 
implant… 
      
17 causes 
infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
18 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
19 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
20 is a good way 
to prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
21 I would 
recommend 
the implant 
to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
22 The implant 
insertion 
would not be 
a problem 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
        
        
23 What is your first name? 
24 What is your last name? 
25 What is your mobile number? 
26 What is your email address? 
27 What day 
were you 
born? 
 
Day 
 
Month Year    
28 
Are you? 
Female 
 
 
Male     
29 
Are you? 
Married Not 
married 
 
    
30 How many 
children do 
you have? 
0 1 2+ 
 
   
31 
Are you? 
(check all that 
apply) 
 
Tajik 
 
Russian 
 
Kyrgyz 
 
   
 
Uzbek 
 
Kazak  
 
 
Other 
   
32 
Are you? 
(check all that 
apply) 
At school At 
university 
  
Working Training   
Full time 
parent 
Not 
working 
Long-
term sick 
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33 What is the 
highest level 
of education 
that you have 
completed? 
Primary Secondary University Technical 
education 
  
34 Do you want 
a pregnancy 
now? 
Yes No Unsure Not 
married  
  
35 What method 
of 
contraception 
are you or 
your partner 
using now 
(check all that 
apply)? 
 
None 
Injection Male 
condom 
IUD Not 
married 
 
Implant 
 
Pill Female 
condom 
Calendar-
based 
method 
LAM  
Withdrawal 
 
Patch Ring Other 
method 
  
36 How did you 
find out 
about this 
study? 
 
Facebook OK Youth 
service 
TFPA 
website 
Friend Flyer/poster 
       Other 
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Palestine 
  
Using the 
pill… 
      
1 
causes 
infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the pill 
is 
2 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the pill 
is 
3 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the pill 
is 
4 is a good 
way to 
prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the pill 
is 
5 I would 
recommen
d the pill to 
a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the pill 
is 
  
Using the 
IUD… 
      
6 
causes 
infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the IUD 
is 
7 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the IUD 
is 
8 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the IUD 
is 
9 is a good 
way to 
prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the IUD 
is 
10 I would 
recommen
d the IUD 
to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the IUD 
is 
11 The IUD 
insertion 
would not 
be a 
problem 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the IUD 
is 
  
Using the 
injection… 
      
12 
causes 
infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
injection is 
13 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
injection is 
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14 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
injection is 
15 is a good 
way to 
prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
injection is 
16 I would 
recommen
d the 
injection to 
a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
injection is 
  
Using the 
implant… 
      
17 
causes 
infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
implant is 
18 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
implant is 
19 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
implant is 
20 is a good 
way to 
prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
implant is 
21 I would 
recommen
d the 
implant to 
a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
implant is 
22 The 
implant 
insertion 
would not 
be a 
problem 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
implant is 
  
Using the 
patch… 
      
23 
causes 
infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
patch is 
24 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
patch is 
25 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
patch is 
26 is a good 
way to 
prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
patch is 
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27 I would 
recommen
d the patch 
to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly agree I do not know 
what the 
patch is 
        
        
28 What is your first name? 
29 What is your last name 
30 What is your mobile number? 
31 What is your email address? 
32 What day 
were you 
born? 
 
Day 
 
Month Year    
33 
Are you? 
Married Not married 
 
    
34 How many 
children do 
you have? 
0 1 2 or more 
 
  
35 
Where do 
you live? 
 
City 
 
Village 
 
Camp 
 
 
Bedouin 
 
36 
Are you? 
(check all 
that apply) 
At school At university 
  
Working Training   
Full time 
parent 
Not working Long-term 
sick 
   
37 What is the 
highest 
level of 
education 
that you 
have 
completed
? 
Primary Secondary University Technical 
education 
  
38 Do you 
want a 
pregnancy 
now? 
 
Yes No Unsure Not 
married  
  
39 
What 
method of 
contracepti
on are you 
using now 
(check all 
that 
apply)? 
 
None 
Injection Male 
cond
om 
IUD Not married  
Implant 
 
Pill Fem
ale 
cond
om 
Calendar-
based 
method 
LAM 
 
 
Withdraw
al 
 
Patch Ring Other 
method 
  
40 How did 
you hear 
about this 
study? 
 
Facebook PFPPA 
service 
delivery 
point 
PFPPA 
website 
Friend/family Flyer/poster Othe
r 
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41 How did 
you enrol 
in this 
study? 
 
PFPPA 
Jerusalem 
PFPPA  
Bethlehem 
PFPPA 
Halhoul 
PFPPA 
Hebron 
PFPPA  
Ramallah 
Youth  
friendly  
service 
Online 
42 What times 
do you 
prefer to 
receive 
messages? 
10-2 2-6 10-6  
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Bolivia 
  
Using the pill… 
      
1 
…causes infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the pill is 
2 …causes unwanted side-
effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the pill is 
3 
…is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the pill is 
4 …is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the pill is 
5 I would recommend the 
pill to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the pill is 
  
Using the IUD… 
      
6 
…causes infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the IUD is 
7 …causes unwanted side-
effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the IUD is 
8 
…is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the IUD is 
9 …is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the IUD is 
10 I would recommend the 
IUD to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the IUD is 
11 The IUD insertion would 
not be a problem 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the IUD is 
  
Using the injection… 
      
12 
…causes infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
injection is 
13 
…causes unwanted side-
effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
injection is 
14 
…is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
injection is 
15 
…is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
injection is 
16 
I would recommend the 
injection to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
injection is 
  
Using the implant… 
      
17 
…causes infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
implant is 
18 
…causes unwanted side-
effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
implant is 
19 
…is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
implant is 
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20 
…is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
implant is 
21 
I would recommend the 
implant to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
implant is 
22 
The implant insertion 
would not be a problem 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the 
implant is 
  
Using the patch… 
      
23 
…causes infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the patch 
is 
24 
…causes unwanted side-
effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the patch 
is 
25 
…is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the patch 
is 
26 
…is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the patch 
is 
27 
I would recommend the 
patch to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know 
what the patch 
is 
        
        
28 What is your first name? 
29 What is your last name? 
30 What is your mobile number? 
31 What is your email address? 
32 What day 
were you 
born? 
 
Day 
 
Month Year    
33 
Are you? 
Married Not married 
 
    
34 How many 
children do 
you have? 
0 1 2+ 
 
   
35 You identify 
with some 
indigenous 
origin, mark 
as 
appropriate  
 
Aymara 
 
Quechua 
 
Guarani 
 
 
Ninguno 
 
Otro 
 
36 Are you? 
(check all that 
apply) 
At school At 
university 
  
Working Training Not 
working 
 
37 What is the 
highest level 
of education 
that you have 
completed? 
Primary Secondary University Technical 
education 
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38 Where do 
you live? 
El Alto Norte La Paz Central La 
Paz 
Sur La 
Paz 
  
39 What method 
of 
contraception 
are you or 
your partner 
using now 
(check all that 
apply)? 
 
None 
 Male 
condom 
   
  Female 
condom 
Calendar-
based 
method 
LAM  
Withdrawal 
 
  Other 
method 
  
40 How did you 
find out 
about this 
study? 
 
Facebook CIES El Alto CIES La 
Paz 
CIES 
website 
Friend Flyer/poster 
       Otro 
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Appendix 14. Follow-up questionnaires 
Tajikistan 
FEMALE 
1 
What method of 
contraception are 
you using now 
(check all that 
apply)? 
 
None 
Injection Male condom IUD Not married 
Implant 
 
Pill Female 
condom 
Calendar-
based 
method 
LAM 
Withdrawal 
 
Patch Ring Other 
method 
 
2 
Where did you get 
this method? 
Not 
married 
Not using a 
method 
Reproductive 
health centers 
Health 
centers 
 
Drugstore NGO I do not know   
3  
Do you want a 
pregnancy now? 
Yes No Not sure Not 
married 
No, I am 
currently 
pregnant 
 Using the pill…       
4 
causes infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
5 
causes unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
6 
is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
7 
is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
8 I would 
recommend the 
pill to a friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
  
Using the IUD… 
      
9 
causes infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
10 
causes unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
11 
is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
12 
is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
13 I would 
recommend the 
IUD to a friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
14 The IUD insertion 
would not be a 
problem 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
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Using the 
injection… 
15 
causes infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the 
injection is 
16 
causes unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the 
injection is 
17 
is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the 
injection is 
18 
is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the 
injection is 
19 I would 
recommend the 
injection to a 
friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the 
injection is 
  
Using the 
implant… 
      
20 
causes infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
21 
causes unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
22 
is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
23 
is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
24 
I would 
recommend the 
implant to a friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
25 
The implant 
insertion would 
not be a problem 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
        
26 Have you become 
pregnant since 
joining the study? 
Yes No Not married   
27 
 
Yes No Not sure Not 
married 
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Did you want to 
become pregnant 
during the study? 
28 Have you had a 
termination 
(abortion) since 
joining the study? 
Yes No Not married   
29 
What method of 
contraception 
have you used 
during the study 
(check all that 
apply)? 
 
None 
Injection Male condom IUD Not married 
Implant 
 
Pill Female 
condom 
Calendar-
based 
method 
LAM 
Withdrawal 
 
Patch Ring Other 
method 
 
30 How many times 
have you attended 
a sexual health 
service since you 
joined the study 4 
months ago? 
0 1 2+   
31 How many 
messages did you 
read? 
 
All Most Some  None  
32 Did you stop the 
messages? 
 
Yes No    
33 Do you know 
anyone else in the 
study? 
Yes No    
34 Did they read the 
messages that we 
sent you? 
Yes No I do not know 
anyone in the 
study 
  
35 Did you read the 
messages that we 
sent them? 
Yes No I do not know 
anyone in the 
study 
  
36 Have you 
experienced 
physical violence 
since being in the 
study? 
Yes No    
37 Did anything good or bad happen as a result of receiving the messages? If so, please 
summarise here: 
        
38 
 
Hormonal 
contraception is 
more effective at 
preventing 
pregnancy than 
condoms alone 
Disagree Agree Do not know   
39  
The pill is taken 
once a month 
Disagree Agree Do not know   
40  Disagree Agree Do not know   
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The IUD lasts for 6 
months 
41 The injection is 
given once a year 
 
Disagree Agree Do not know   
42 The implant can 
stay under the skin 
for 10 years 
 
Disagree Agree Do not know   
43 I know where to 
go to get 
contraception 
 
Disagree Agree Do not know   
 
If you are not married, please imagine that you are and try to answer the following questions: 
 
44 My friends would 
use the pill, IUD, 
injection or 
implant if they 
wanted to prevent 
pregnancy. 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
45 My friends would 
talk to their 
husband about 
contraception if 
they wanted to 
prevent a 
pregnancy. 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
       
46 If you wanted to 
use the pill, IUD, 
injection or 
implant, how easy 
would it be for you 
to use it? 
Very 
difficult 
Difficult Not sure Easy Very easy 
47 If you wanted to 
talk to your 
husband about 
contraception, 
how easy would it 
be for you to talk 
to him? 
Very 
difficult 
Difficult Not sure Easy Very easy 
       
48 If you wanted to 
use the pill, IUD, 
injection or 
implant, how 
certain are you 
that you could use 
it? 
Very 
certain I 
could not 
Certain I 
could not 
Not sure Certain I 
could 
Very certain 
I could 
49 If you wanted to 
talk to your 
husband about 
contraception, 
Very 
certain I 
could not 
Certain I 
could not 
Not sure Certain I 
could 
Very certain 
I could 
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how certain are 
you that you could 
talk to him? 
       
50 I intend to use the 
pill, IUD, injection 
or implant 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
 
MALE 
1 
What method of 
contraception is 
your wife using 
now (check all 
that apply)? 
 
None 
Injection Male condom IUD Not 
married 
Implant 
 
Pill Female condom Calendar-
based 
method 
LAM 
Withdrawal 
 
Patch Ring Other 
method 
 
2 Where did your 
wife get this 
method? 
Not married Not using a 
method 
Reproductive 
health center 
Health 
center 
 
Drugstore NGO I do not know   
3 
 
Do you want a 
pregnancy now? 
Yes No Not sure Not 
married 
No, my 
wife is 
currently 
pregnant 
  
 Using the pill…       
4 
causes infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the pill is 
5 causes 
unwanted side-
effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the pill is 
6 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the pill is 
7 is a good way to 
prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the pill is 
8 I would 
recommend the 
pill to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the pill is 
  
Using the IUD… 
      
9 
causes infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
10 causes 
unwanted side-
effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
11 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
12 is a good way to 
prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
13 I would 
recommend the 
IUD to a friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
14 The IUD 
insertion would 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the IUD is 
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not be a 
problem 
  
Using the 
injection… 
      
15 
causes infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the injection is 
16 causes 
unwanted side-
effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the injection is 
17 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the injection is 
18 is a good way to 
prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the injection is 
19 I would 
recommend the 
injection to a 
friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the injection is 
  
Using the 
implant… 
      
20 
causes infertility 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
21 causes 
unwanted side-
effects 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
22 
is easy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
23 is a good way to 
prevent 
pregnancy 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
24 I would 
recommend the 
implant to a 
friend 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
25 The implant 
insertion would 
not be a 
problem 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
I do not know what 
the implant is 
        
26 Has your wife 
become 
pregnant since 
joining this 
study? 
Yes No Not married   
27  
Did she want to 
become 
pregnant during 
the study? 
Yes No Not sure Not 
married 
 
28 Has your wife 
had a 
termination 
(abortion) since 
Yes No Not married   
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joining the 
study? 
29 
What method of 
contraception 
has your wife 
used during the 
study (check all 
that apply)? 
 
None 
Injection Male condom IUD Not 
married 
Implant 
 
Pill Female condom Calendar-
based 
method 
LAM 
Withdrawal 
 
Patch Ring Other 
method 
Unsure 
30 How many 
times have you 
attended a 
sexual health 
service since 
you joined the 
study 4 months 
ago? 
0 1 2+   
31 How many 
messages did 
you read? 
 
All Most Some  None  
32 Did you stop the 
messages? 
 
Yes No    
33 Do you know 
anyone else 
that took part in 
the study? 
 
Yes No  
34 Did they read 
the messages 
that we sent 
you? 
Yes No I do not know 
anyone in the 
study 
35 Did you read 
the messages 
that we sent 
them? 
Yes No I do not know 
anyone in the 
study 
36 Have you 
experienced 
physical 
violence since 
being in the 
study? 
Yes No  
37 Did anything good or bad happen as a result of receiving the messages? If so, please 
summarise here: 
        
38 Hormonal 
contraception is 
more effective 
at preventing 
pregnancy than 
condoms alone 
Disagree Agree Do not know   
39 
 
 
The pill is taken 
once a month 
Disagree Agree Do not know   
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40  
The IUD lasts for 
6 months 
Disagree Agree Do not know   
41  
The injection is 
given once a 
year 
Disagree Agree Do not know   
42  
The implant can 
stay under the 
skin for 10 years 
Disagree Agree Do not know   
43  
I know where to 
get 
contraception 
Disagree Agree Do not know   
If you are not married, please imagine that you are and try to answer the following 
questions: 
44 My female 
friends would 
use the pill, IUD, 
injection or 
implant if they 
wanted to 
prevent 
pregnancy. 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
45 My friends 
would talk to 
their wife about 
contraception if 
they wanted to 
prevent a 
pregnancy. 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
       
46 If you wanted to 
talk to your wife 
about 
contraception, 
how easy would 
it be for you to 
talk to her? 
Very difficult Difficult Not sure Easy Very 
easy 
       
47 If you wanted to 
talk to your wife 
about 
contraception, 
how certain are 
you that you 
could talk to 
her? 
Very certain I 
could not 
Certain I 
could not 
Not sure Certain I 
could 
Very 
certain I 
could 
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Palestine 
 
 
1 
What method 
of 
contraception 
are you using 
now (check 
all that 
apply)? 
 
None 
Injection Male condom IUD Not 
married 
Implant 
 
Pill Female condom Calendar-
based 
method 
LAM 
Withdrawal 
 
Patch Ring Other 
method 
 
2 
 
Where did 
you get this 
method? 
PFPPA 
Jerusalem 
PFPPA  
Bethlehem 
PFPPA  
Halhoul 
PFPPA  
Hebron 
PFPPA 
Ramallah 
MoH clinic UNRWA 
 
Not using a method I do not 
know 
Not 
married 
 
3 
 
Do you want 
a pregnancy 
now? 
Yes No Not sure Not 
married 
 
        
 Using the 
pill… 
 
      
4 
causes 
infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
5 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
6 
is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
7 is a good way 
to prevent 
pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
8 I would 
recommend 
the pill to a 
friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
  
Using the 
IUD… 
      
9 
causes 
infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
10 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
11 
is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
12 is a good way 
to prevent 
pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
13 I would 
recommend 
the IUD to a 
friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
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14 The IUD 
insertion 
would not be 
a problem 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
  
Using the 
injection… 
      
15 
causes 
infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the injection 
is 
16 
causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the injection 
is 
17 
is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the injection 
is 
18 
is a good way 
to prevent 
pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the injection 
is 
19 I would 
recommend 
the injection 
to a friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the injection 
is 
  
Using the 
implant… 
      
20 
causes 
infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
21 
causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
22 
is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
23 
is a good way 
to prevent 
pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
24 I would 
recommend 
the implant 
to a friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
25 The implant 
insertion 
would not be 
a problem 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
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Using the 
patch… 
26 
causes 
infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the patch is 
27 causes 
unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the patch is 
28 
is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the patch is 
29 is a good way 
to prevent 
pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the patch is 
30 I would 
recommend 
the patch to a 
friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the patch is 
       
       
31 Have you 
become 
pregnant 
since joining 
this study? 
Yes No Not married   
32  
Did you want 
to become 
pregnant 
during this 
study? 
Yes No Not sure Not 
married 
 
33 Have you had 
a termination 
(abortion) 
since joining 
this study? 
Yes No Not married   
34 What method 
of 
contraception 
have you 
used during 
this study 
(check all that 
apply)? 
 
None 
Injection Male condom IUD Not 
married 
Implant 
 
Pill Female condom Calendar-
based 
method 
LAM 
Withdrawal 
 
Patch Ring Other 
method 
 
35 How many 
times have 
you attended 
a sexual 
health service 
since you 
joined this 
study 4 
months ago? 
0 1 2 +   
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36 How many 
messages did 
you read? 
 
All Most  Some None  
37 Did you stop 
the 
messages? 
 
Yes No    
38 Do you know 
anyone else 
in the study? 
Yes No    
39 Did they read 
the messages 
that we sent 
you? 
Yes No I do not know 
anyone in the study 
 
40 Did you read 
the messages 
that we sent 
them? 
Yes No I do not know 
anyone in the study 
 
41 Have you 
experienced 
physical 
violence since 
being in the 
study? 
Yes No    
42 Did anything good or bad happen as a result of receiving the messages? If so, please 
summarise here: 
   
43 
 
Hormonal 
contraception 
is more 
effective at 
preventing 
pregnancy 
than 
condoms 
alone 
Disagree Agree Do not know 
44  
The pill is 
taken once a 
month 
Disagree Agree Do not know 
45  
The IUD lasts 
for 6 months 
Disagree Agree Do not know 
46  
The injection 
is given once 
a year 
Disagree Agree Do not know 
47  
The implant 
can stay 
under the 
skin for 10 
years 
Disagree Agree Do not know 
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48 A new patch 
is worn each 
week for 3 
weeks, then 
no patch for 
the 4th week 
Disagree Agree Do not know 
49  
I know where 
to get 
contraception 
Disagree Agree Do not know 
 
If you are not married, please imagine that you are and try to answer the following questions: 
50 My friends would use the pill, IUD, 
injection, implant or patch if they 
wanted to prevent pregnancy. 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
51 My friends would talk to their 
husband about contraception if they 
wanted to prevent a pregnancy. 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
       
52 If you wanted to use the pill, IUD, 
injection, implant or patch, how easy 
would it be for you to use it? 
Very 
difficult 
Difficult Not 
sure 
Easy Very 
easy 
53 If you wanted to talk to your husband 
about contraception, how easy would 
it be for you to talk to him? 
Very 
difficult 
Difficult Not 
sure 
Easy Very 
easy 
       
54 If you wanted to use the pill, IUD, 
injection, implant or patch, how 
certain are you that you could use it? 
Very 
certain I 
could not 
Certain I 
could 
not 
Not 
sure 
Certain 
I could 
Very 
certain I 
could 
55 If you wanted to talk to your husband 
about contraception, how certain are 
you that you could talk to him? 
Very 
certain I 
could not 
Certain I 
could 
not 
Not 
sure 
Certain 
I could 
Very 
certain I 
could 
       
56 I intend to use the pill, IUD, injection, 
implant or patch 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
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Bolivia 
 
 
1 What method of 
contraception are you 
using now (check all that 
apply)? 
 
None 
Injection Male 
condom 
IUD Not 
sexually 
active 
Implant 
 
Pill Female 
condom 
Calendar-
based 
method 
LAM 
Withdrawal 
 
Patch Ring Other 
method 
 
 
2 
Where did you get this 
method? 
CIES El Alto CIES La 
Paz 
Other 
service 
Not using 
a method 
I do not 
know 
 
3 
 
Do you want a pregnancy 
now? 
Yes No Not 
sure 
Not 
sexually 
active 
 
 
 Using the pill…       
4 
…causes infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
5 
…causes unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
6 
…is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
7 
…is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
8 I would 
recommend the pill 
to a friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the pill is 
  
Using the IUD… 
      
9 
…causes infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
10 
…causes unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
11 
…is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
12 
…is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
13 I would 
recommend the 
IUD to a friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
14 The IUD insertion 
would not be a 
problem 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the IUD is 
  
Using the 
injection… 
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15 
…causes infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the 
injection is 
16 
…causes unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the 
injection is 
17 
…is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the 
injection is 
18 
…is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the 
injection is 
19 
I would 
recommend the 
injection to a friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the 
injection is 
  
Using the implant… 
      
20 
…causes infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
21 
…causes unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
22 
…is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
23 
…is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
24 
I would 
recommend the 
implant to a friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
25 
The implant 
insertion would not 
be a problem 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the implant 
is 
  
Using the patch… 
      
26 
…causes infertility 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the patch is 
27 
…causes unwanted 
side-effects 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the patch is 
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28 
…is easy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the patch is 
29 
…is a good way to 
prevent pregnancy 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the patch is 
30 I would 
recommend the 
patch to a friend 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
I do not 
know what 
the patch is 
 
31 Have you become 
pregnant since joining this 
study? 
Yes No Not 
sexually 
active 
  
 
32 
 
Did you want to become 
during this study? 
Yes No Not 
sure 
Not 
sexually 
active 
 
 
 
33 
Have you had a 
termination (abortion) 
since joining this study? 
Yes No Not 
sexually 
active 
  
 
34 
What method of 
contraception have you 
used during this study 
(check all that apply)? 
 
None 
Injection Male 
condom 
IUD Not 
sexually 
active 
Implant 
 
Pill Female 
condom 
Calendar-
based 
method 
LAM 
Withdrawal 
 
Patch Ring Other 
method 
 
35 How many times have you 
attended a sexual health 
service since you joined 
the study 4 months ago? 
0 1 2+   
36 How many messages did 
you read? 
 
All Most Some  None  
37 Did you stop the 
messages? 
 
Yes No    
38 Do you know anyone else 
in the study? 
Yes No    
39 
Did they read the 
messages that we sent 
you? 
Yes No I do not 
know 
anyone 
in the 
study 
  
40 
Did you read the messages 
that we sent them? 
Yes No I do not 
know 
anyone 
in the 
study 
  
41  
Have you experienced 
physical violence since 
being in the study? 
Yes No    
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42 Did anything good or bad happen as a result of receiving the messages? If so, please 
summarise here: 
   
43 
 
Hormonal contraception is 
more effective at 
preventing pregnancy 
than condoms alone 
Disagree Agree Do not 
know 
  
44 The pill is taken once a 
month 
Disagree Agree Do not 
know 
  
45  
The IUD lasts for 6 months 
Disagree Agree Do not 
know 
  
46  
The injection is given once 
a year 
Disagree Agree Do not 
know 
  
47  
The implant can stay 
under the skin for 10 years 
Disagree Agree Do not 
know 
  
48 A new patch is worn each 
week for 3 weeks, then no 
patch for the 4th week 
Disagree Agree Do not 
know 
  
49  
I know where to get 
contraception 
Disagree Agree Do not 
know 
  
 
50 My friends would use the 
pill, IUD, injection, implant 
or patch if they wanted to 
prevent pregnancy. 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
51 My friends would talk to 
their partner about 
contraception if they 
wanted to prevent a 
pregnancy. 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
       
52 If you wanted to use the 
pill, IUD, injection, implant 
or patch, how easy would 
it be for you to use it? 
Very difficult Difficult Not 
sure 
Easy Very easy 
53 If you wanted to talk to 
your partner about 
contraception, how easy 
would it be for you to talk 
to him? 
Very difficult Difficult Not 
sure 
Easy Very easy 
       
54 If you wanted to use the 
pill, IUD, injection, implant 
or patch, how certain are 
you that you could use it? 
Very certain I 
could not 
Certain I 
could 
not 
Not 
sure 
Certain I 
could 
Very 
certain I 
could 
55 If you wanted to talk to 
your partner about 
contraception, how 
certain are you that you 
could talk to him? 
Very certain I 
could not 
Certain I 
could 
not 
Not 
sure 
Certain I 
could 
Very 
certain I 
could 
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56 I intend to use the pill, 
IUD, injection, implant or 
patch 
Strongly 
disagree 
Disagree Not 
sure 
Agree Strongly 
agree 
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Appendix 17. Baseline characteristics by follow-up status (Tajikistan)  
 Primary outcome completers Primary outcome non-completers All participants 
Control 
N = 244 
% (n) 
Intervention 
N = 228 
% (n) 
Control 
N = 54 
% (n) 
Intervention 
N = 47 
% (n) 
Control 
N = 298 
% (n) 
Intervention 
N = 275 
% (n) 
Age mean [sd] 20 [2.44] 20 [2.35] 19.73 [2.29] 19.80 [1.65] 20.00 [2.41] 19.93 [2.24] 
16-19 52.05 (127) 55.70 (127) 57.41 (31) 61.70 (29) 53.02 (158) 56.73 (156) 
20-24 47.95 (117) 44.30 (101) 42.59 (23) 38.30 (18) 46.98 (140) 43.27(119) 
Gender female 43.03 (105) 45.18 (103) 59.26 (32) 57.45 (27) 45.97(137) 47.27 (130) 
male 56.97 (139) 54.82 (125) 40.74 (22) 42.55 (20) 54.03 (161) 52.73 (145) 
Marital status married 7.38 (18) 4.82 (11) 3.70 (2) 10.64 (5) 6.71 (20) 5.82 (16) 
not-married 92.62 (226) 95.18 (217) 96.30 (52) 89.36 (42) 93.29 (278) 94.18 (259) 
Number of children 0 95.49 (233) 97.37 (222) 96.30 (52) 95.74 (45) 95.64 (285) 97.09 (267) 
1 2.05 (5) 1.75 (4) 1.85 (1) 4.26 (2) 2.01 (6) 2.18 (6) 
2 or more 2.46 (6) 0.88 (2) 1.85 (1) 0 (0) 2.35 (7) 0.73 (2) 
Ethnicity Tajik  94.26 (230) 94.30 (215) 85.19 (46) 91.49 (43) 92.62 (276) 93.82 (258) 
Russian 2.05 (5) 0.44 (1) 3.70 (2) 0 (0) 2.35 (7) 0.36 (1) 
Uzbek 3.69 (9) 5.26 (12) 11.11 (6) 6.38 (3) 5.03 (15) 5.45 (15) 
other 0 (0) 0 (0) 0 (0) 2.13 (1) 0 (0) 0.36 (1) 
Occupation school  16.39 (40) 17.54 (40) 24.07 (13) 14.89 (7) 17.79 (53) 17.09 (47) 
university 68.85 (168) 69.30 (158) 66.67 (36) 76.60 (36) 68.46 (204) 70.55 (194) 
working 11.89 (29) 12.28 (28) 5.56 (3) 2.13 (1) 10.74 (32) 10.55 (29) 
training 0.41 (1) 0 (0) 1.85 (1) 0 (0) 0.67 (2) 0 (0) 
parent 0.41 (1) 0 (0) 0 (0) 0 (0) 0.34 (1) 0 (0) 
not working 1.64 (4) 0.88 (2) 1.85 (1) 6.38 (3) 1.68 (5) 1.82 (5) 
university & working 0.41 (1) 0 (0) 0 (0) 0 (0) 0.34 (1) 0 (0) 
Highest level of 
education completed 
primary 12.70 (31) 13.16 (30) 12.96 (7) 12.77 (6) 12.75 (38) 13.09 (36) 
secondary 68.44 (167) 62.28 (142) 55.56 (30) 46.81 (22) 66.11 (197) 59.64 (164) 
university 17.62 (43) 23.68 (54) 27.78 (15) 36.17 (17) 19.46 (58) 25.82 (71) 
other 1.23 (3) 0.88 (2) 3.70 (2) 4.26 (2) 1.68 (5) 1.45 (4) 
Current pregnancy 
intention 
yes 3.69 (9) 3.07 (7) 0 (0) 8.51 (4) 3.02 (9) 4.00 (11) 
no 11.07 (27) 6.14 (14) 18.52 (10) 4.26 (2) 12.42 (37) 5.82 (16) 
unsure 0.41 (1) 0.44 (1) 3.70 (2) 2.13 (1) 1.01 (3) 0.73 (2) 
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 Primary outcome completers Primary outcome non-completers All participants 
Control 
N = 244 
% (n) 
Intervention 
N = 228 
% (n) 
Control 
N = 54 
% (n) 
Intervention 
N = 47 
% (n) 
Control 
N = 298 
% (n) 
Intervention 
N = 275 
% (n) 
(‘Do you want a 
pregnancy now?) 
not married* 84.84 (207) 90.35 (206) 77.78 (42) 85.11 (40) 83.56 (249) 89.45 (246) 
Baseline method none 28.28 (69) 25.88 (59) 48.15 (26) 46.81 (22) 31.88 (95) 29.45 (81) 
male condom 1.64 (4) 1.32 (3) 3.70 (2) 0 (0) 2.01 (6) 1.09 (3) 
IUD** 0.82 (2) 0 (0) 0 (0) 0 (0) 0.67 (2) 0 (0) 
not married* 68.85 (168) 72.37 (165) 48.15 (26) 53.19 (25) 65.10 (194) 69.09 (190) 
LAM*** 0 (0) 0.44 (1) 0 (0) 0 (0) 0 (0) 0.36 (1) 
other 0.41 (1) 0 (0) 0 (0) 0 (0) 0.34 (1) 0 (0) 
At least one effective 
method is acceptable 
yes 2.46 (6) 1.75 (4) 3.70 (2) 2.13 (1) 2.68 (8) 1.82 (5) 
no 97.54 (238) 98.25 (224) 96.30 (52) 97.87 (46) 97.32 (290) 98.18 (270) 
Pill acceptability yes 1.23 (3) 0.44 (1) 1.85 (1) 2.13 (1) 1.34 (4) 0.73 (2) 
no 98.77 (241) 99.56 (227) 98.15 (53) 97.87 (46) 98.66 (294) 99.27 (273) 
IUD acceptability yes 1.23 (3) 0 (0) 1.85 (1) 0 (0) 1.34 (4) 0 (0) 
no 98.77 (241) 100 (228) 98.15 (53) 100 (47) 98.66 (294) 100 (275) 
Injection acceptability yes 0.82 (2) 1.32 (3) 0 (0) 2.13 (1) 0.67 (2) 1.45 (4) 
no 99.18 (242) 98.68 (225) 100 (54) 97.87 (46) 99.33 (296) 98.55 (271) 
Implant acceptability yes 0.41 (1) 0.88 (2) 0 (0) 0 (0) 0.34 (1) 0.73 (2) 
no 99.59 (243) 99.12 (226) 100 (54) 100 (47) 99.66 (297) 99.27 (273) 
*The response ‘not married’ was used as a proxy for not being sexually active 
**IUD = intrauterine device 
***LAM = Lactational amenorrhea method 
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Appendix 18. Baseline characteristics by follow-up status (Palestine) 
 Primary outcome completers Primary outcome non-completers All participants 
Control 
N = 235 
% (n) 
Intervention 
N = 229 
% (n) 
Control 
N = 54 
% (n) 
Intervention 
N = 60 
% (n) 
Control 
N = 289 
% (n) 
Intervention 
N = 289 
% (n) 
Age mean [sd] 21.38 [1.73] 21.18 [1.70] 21.29 [1.97] 21.18 [1.93] 21.36 [1.77] 21.18 [1.75] 
18-19 24.68 (58) 32.75 (75) 31.48 (17) 31.67 (19) 25.95 (75) 32.53 (94) 
20-24 75.32 (177) 67.25 (154) 68.52 (37) 68.33 (41) 74.05 (214) 67.47 (195) 
Marital status married 40.43 (95) 39.74 (91) 40.74 (22) 35.00 (21) 40.48 (117) 38.75 (112) 
not-married 59.57 (140) 60.26 (138) 59.26 (32) 65.00 (39) 59.52 (172) 61.25 (177) 
Number of children 0 73.62 (173) 79.48 (182) 66.67 (36) 80.00 (48) 72.32 (209) 79.58 (230) 
1 13.62 (32) 10.92 (25) 27.78 (15) 10.00 (6) 16.26 (47) 10.73 (31) 
2 or more 12.77 (30) 9.61 (22) 5.56 (3) 10.00 (6) 11.42 (33) 9.69 (28) 
Residence city 48.51 (114) 46.72 (107) 38.89 (21) 51.67 (31) 46.71 (135) 47.75 (138) 
village 47.23 (111) 48.1 (112) 51.85 (28) 38.33 (23) 48.10 (139) 46.71 (135) 
camp  3.40 (8) 3.93 (9) 7.41 (4) 8.33 (5) 4.15 (12) 4.84 (14) 
Bedouin 
community 
0.85 (2) 0.44 (1) 1.85 (1) 1.67 (1) 1.04 (3) 0.69 (2) 
Occupation 
 
 
school  2.13 (5) 0.44 (1) - - 1.73 (5) 0.35 (1) 
university 50.21 (118) 55.02 (126) 40.74 (22) 43.33 (26) 48.44 (140) 52.60 (152) 
working 4.26 (10) 3.06 (7) 9.26 (5) 5.00 (3) 5.19 (15) 3.46 (10) 
training 12.34 (29) 14.85 (34) 25.93 (14) 20.00 (12) 14.88 (43) 15.92 (46) 
parent 22.8 (54) 19.65 (45) 20.37 (11) 21.67 (13) 22.49 (65) 20.07 (58) 
not working 6.38 (15) 6.11 (14) 3.70 (2) 8.33 (5) 5.88 (17) 6.57 (19) 
university & 
working 
0.43 (1) 0.44 (1) - - 0.35 (1) 0.35 (1) 
university & 
parent 
0.85 (2) - - - 0.69 (2) - 
school & parent 0.43 (1) - - 1.67 (1) 0.35 (1) 0.35 (1) 
working, training & 
parent 
- 0.44 (1) - - - 0.35 (1) 
primary 0.43 (1) 0.87 (2) 1.85 (1) - 0.69 (2) 0.69 (2) 
secondary 21.70 (51) 19.21 (44) 27.78 (15) 28.33 (17) 22.84 (66) 21.11 (61) 
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 Primary outcome completers Primary outcome non-completers All participants 
Control 
N = 235 
% (n) 
Intervention 
N = 229 
% (n) 
Control 
N = 54 
% (n) 
Intervention 
N = 60 
% (n) 
Control 
N = 289 
% (n) 
Intervention 
N = 289 
% (n) 
Highest level of 
education 
completed 
university 68.94 (162) 69.00 (158) 53.70 (29) 56.67 (34) 66.09 (191) 66.44 (192) 
technical 8.94 (21) 10.92 (25) 16.67 (9) 15.00 (9) 10.38 (30) 11.76 (34) 
Current pregnancy 
intention 
(‘Do you want a 
pregnancy now?) 
yes 16.60 (39) 20.52 (47) 14.81 (8) 18.33 (11) 16.26 (47) 20.07 (58) 
no 25.53 (60) 26.20 (60) 25.93 (14) 18.33 (11) 25.61 (74) 24.57 (71) 
unsure 4.26 (10) 1.75 (4) 3.70 (2) - 4.15 (12) 1.38 (4) 
not married a 53.62 (126) 51.53 (118) 55.56 (30) 63.33 (38) 53.98 (156) 53.98 (156) 
Baseline method none 41.28 (97) 43.23 (99) 31.48 (17) 35.00 (21) 39.45 (114) 41.52 (120) 
male condom 0.85 (2) 0.87 (2) - - 0.69 (2) 0.69 (2) 
not married a 52.34 (123) 52.84 (121) 59.26 (32) 60.00 (36) 53.63 (155) 54.33 (157) 
calendar 0.85 (2) 0.44 (1) 1.85 (1) - 1.04 (3) 0.35 (1) 
LAM b 2.55 (6) 1.31 (3) 5.56 (3) 1.67 (1) 3.11 (9) 1.38 (4) 
withdrawal 1.70 (4) 0.87 (2) 1.85 (1) 3.33 (2) 2.08 (6) 1.38 (4) 
none-withdrawal 0.43 (1) - - - - - 
other - 0.44 (1) - - - 0.35 (1) 
At least one 
effective method is 
acceptable 
yes 9.36 (22) 5.24 (12)  14.81 (8) 8.33 (5) 10.38 (30) 5.88 (17) 
no 90.64 (213) 94.76 (217) 85.19 (46) 91.67 (55) 89.62 (259) 94.12 (272) 
Pill acceptability yes 3.40 (8) 2.62 (6) 5.56 (3) 5.00 (3) 3.81 (11) 3.11 (9) 
no 96.60 (227) 97.38 (223) 94.44 (51) 95.00 (57) 96.19 (278) 96.89 (280) 
IUD c acceptability yes 4.26 (10) 0.87 (2) 5.56 (3) 5.00 (3) 4.50 (13) 1.73 (5) 
no 95.74 (225) 99.13 (227) 94.44 (51) 95.00 (57) 95.50 (276) 98.27 (284) 
Injection 
acceptability 
yes 1.28 (3) 1.31 (3) 1.85 (1) 1.67 (1) 1.38 (4) 1.38 (4) 
no 98.72 (232) 98.69 (226) 98.15 (53) 98.33 (59) 98.62 (285) 98.62 (285) 
Implant 
acceptability 
yes 2.55 (6) 1.31 (3) 5.56 (3) 3.33 (2) 3.11 (9) 1.73 (5) 
no 97.45 (229) 98.6 (226) 94.44 (51) 96.67 (58) 96.89 (280) 98.27 (284) 
Patch acceptability yes 0.85 (2) 0.44 (1) - - 0.69 (2) 0.35 (1) 
  no 99.15 (233) 99.56 (228) 100 (54) 100 (60) 99.31 (287) 99.65 (288) 
a the response ‘not married’ was used as a proxy for sexual activity 
b LAM Lactational amenorrhea method 
c IUD Intrauterine device 
  
343 
 
Appendix 19. Baseline characteristics by follow-up status (Bolivia) 
 Primary outcome use completers Primary outcome use non-
completers 
All participants 
 Control 
N = 215 
% (n) 
Intervention 
N = 214 
% (n) 
Control 
N = 104 
% (n) 
Intervention 
N = 107 
% (n) 
Control 
N = 319 
% (n) 
Intervention 
N = 321 
% (n) 
Age mean [sd] 20.69 [2.54] 20.32 [2.61] 19.87 [2.50] 20.17 [2.53] 20.42 [2.56] 20.27 [2.58] 
16-19 42.33 (91) 51.40 (110) 56.73 (59) 51.40 (55) 47.02 (150) 51.40 (165) 
20-24 57.67 (124) 48.60 (104) 43.27 (45) 48.60 (52) 52.98 (169) 48.60 (156) 
Marital status married 3.72 (8) 6.07 (13) 5.77 (6) 4.67 (5) 4.39 (14) 5.61 (18) 
not-married 96.28 (207) 93.93 (201) 94.23 (98) 95.33 (102) 95.61 (305)  94.39 (303) 
Number of 
children 
0 91.63 (197) 89.25 (191) 92.31 (96) 88.79 (95) 91.85 (293) 89.10 (286) 
1 5.58 (12) 7.01 (15) 3.85 (4) 5.61 (6) 5.02 (16) 6.54 (21) 
2 or more 2.79 (6) 3.74 (8) 3.85 (4) 5.61 (6) 3.13 (10) 4.36 (14) 
Indigenous origin 
(ethnicity) 
Aymara 59.53 (128) 55.61 (119) 50.96 (53) 56.07 (60) 56.74 (181) 55.76 (179) 
Guarani 0.47 (1) 0.47 (1) - 1.87 (2) 0.31 (1) 0.93 (3) 
Quechua  3.72 (8) 2.34 (5) 4.81 (5) 0.93 (1) 4.08 (13) 1.87 (6) 
other 2.79 (6) 2.80 (6) 3.85 (4) 3.74 (4) 3.13 (10)  3.12 (10) 
none 33.49 (72) 38.79 (83) 40.38 (42) 37.38 (40) 35.74 (114) 38.32 (123) 
Occupation 
 
 
school  15.35 (33) 16.82 (36) 26.92 (28) 20.56 (22) 19.12 (61) 18.07 (58) 
university 57.21 (123) 57.01 (122) 50.96 (53) 55.14 (59) 55.17 (176) 56.39 (181) 
working 9.77 (21) 12.62 (27) 8.65 (9) 8.41 (9) 9.40 (30) 11.21 (36) 
training 5.12 (11) 5.61 (12) 7.69 (8) 4.67 (5) 5.96 (19) 5.30 (17) 
not working 1.40 (3) 0.93 (2) 0.96 (1) 1.87 (2) 1.25 (4) 1.25 (4)  
university & working 8.84 (19) 6.07 (13) 4.81 (5)  9.35 (10) 7.52 (24) 7.17 (23) 
school & working 0.93 (2) 0.47 (1) - - 0.63 (2) 0.31 (1) 
training & working 1.40 (3)  0.47 (1) - - 0.94 (3) 0.31 (1) 
Highest level of 
education 
completed 
primary 4.65 (10) 3.74 (8) 8.65 (9) 4.67 (5) 5.96 (19) 4.05 (13) 
secondary 70.70 (152) 73.36 (157) 72.12 (75) 72.90 (78) 71.16 (227) 73.21 (235) 
university 22.79 (49) 20.56 (44) 18.27 (19) 16.82 (18) 21.32 (68) 19.31 (62) 
technical 1.86 (4) 2.34 (5) 0.96 (1)  5.61 (6) 1.57 (5) 3.43 (11) 
Baseline method none 73.95 (159) 79.44 (170) 77.88 (81) 81.31 (87) 75.24 (240) 80.06 (257) 
male condom 14.88 (32) 10.75 (23) 13.46 (14) 12.15 (13) 14.42 (46) 11.21 (36) 
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 Primary outcome use completers Primary outcome use non-
completers 
All participants 
 Control 
N = 215 
% (n) 
Intervention 
N = 214 
% (n) 
Control 
N = 104 
% (n) 
Intervention 
N = 107 
% (n) 
Control 
N = 319 
% (n) 
Intervention 
N = 321 
% (n) 
female condom 3.26 (7) 1.40 (3) 1.92 (2) 0.93 (1) 2.82 (9) 1.25 (4) 
calendar 1.40 (3) 2.80 (6) - 0.93 (1) 0.94 (3) 2.18 (7) 
withdrawal 0.47 (1) - 0.96 (1) - 0.63 (2) - 
male & female 
condom 
0.93 (2) - - - 0.63 (2) - 
calendar & withdrawal - 0.47 (1) - 0.93 (1) - 0.62 (2) 
other - - 5.77 (6) 3.74 (4) 0.63 (2) - 
At least one 
effective method 
is acceptable 
yes 8.37 (18) 9.35 (20) 7.69 (8) 5.61 (6) 8.15 (26) 8.10 (26) 
no 91.63 (197) 90.65 (194) 92.31 (96) 94.39 (101) 91.85 (293) 91.90 (295) 
Pill acceptability yes 0.93 (2) 1.87 (4) - 0.93 (1) 0.63 (2) 1.56 (5) 
no 99.07 (213) 98.13 (210) 100 (104) 99.07 (106) 99.37 (317) 98.44 (316) 
IUD a acceptability yes 1.40 (3) 1.40 (3) 2.88 (3)  0.93 (1) 1.88 (6) 1.25 (4) 
no 98.60 (212) 98.60 (211) 97.12 (101) 99.07 (106) 98.12 (313) 98.75 (317) 
Injection 
acceptability 
yes 2.70 (6) 1.87 (4) 2.88 (3) 1.87 (2) 2.82 (9) 1.87 (6) 
no 97.21 (209) 98.13 (210) 97.12 (101) 98.13 (105) 97.18 (310) 98.13 (315) 
Implant 
acceptability 
yes 1.86 (4) 3.27 (7) 0.96 (1) 2.80 (3) 1.57 (5) 3.12 (10) 
no 98.14 (211) 96.73 (207) 99.04 (103) 97.20 (104) 98.43 (314) 96.88 (311) 
Patch 
acceptability 
yes 3.72 (8) 2.80 (6) 2.88 (3) 1.87 (2) 3.45 (11) 2.49 (8) 
no 96.28 (207) 97.20 (208) 97.12 (101) 98.13 (105) 96.55 (308) 97.51 (313) 
a IUD = Intrauterine device 
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Appendix 20. Trial interviews: Discussion guides 
Tajikistan-intervention group guide 
Introduction  
• Thank you for agreeing to the interview. The purpose of the interview is to understand how it was 
for you to receive the messages. This is so we can understand better how they may have 
influenced people.  
• Please be as honest as possible. If things have not changed for you, we would like to know that. 
There are no right or wrong answers. 
• You don’t have to talk about anything that you don’t want to talk about.  
• The interview will last up to 60 minutes and you can end the interview at any time.  
• Check again that they are ok with audio recording, explain confidentiality and anonymity 
 
START RECORDER 
 
“Just to clarify that when I ask about the ‘messages’ I mean the instant messages that were sent to 
you though the app.”  
 
Receiving the messages 
1) What was it like to receive the messages?  
2) Did you have any trouble receiving them? [were there any times that the messages couldn’t be 
delivered?] 
3) What did you think about the number of messages you received? [too many/too little/just right? 
Why?]  
4) What did you do when you received a message? [e.g. did you read it right away, save it for a time 
when you were alone, etc.?] 
5) How many of the messages did you read? [All of them, some, none? Why?] 
6) Did you stop the messages? [Why? When did you stop them, i.e. very early on, in what month?] 
7) Did you keep the messages or delete them? [Which ones did you keep or delete? Why?] 
8) Did you re-read any of the messages? [Which ones? Why?]  
 
Confidentiality 
1) Were you concerned about others seeing the text messages? [If yes, how did you deal with it?]  
2) Did anyone else read your messages? [Who was this person? How did you feel about it?] 
3) Did you discuss information in the messages with anyone? [Who was this person? How did you 
feel about this?] 
4) Did anything unwanted happen as a consequence of receiving the messages? 
 
Knowledge 
1) What did you learn from the messages? [what was the most important thing that you learned 
from the messages? Why was this the most important?] 
2) How has what you learned changed how you think & feel about effective contraception (IUD, pill, 
injection, implant)? [How did the messages change your views?] 
 
Attitudes 
1) What did you think about using effective contraception before the study? Have your beliefs 
changed? How have they changed and why? 
2) What did you think about going to a service contraception before the study? Has that changed? 
How has it changed and why? 
3) What did you think about talking to a partner about contraception before the study? Has that 
changed? How has it changed and why? 
  
Agency 
1) How has your confidence in using contraception changed since being in the study? [Why do you 
think it has changed? Do you feel you have control over using contraception?] 
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2) How do you feel about going to a service for contraception now? Has this changed? Why? Do you 
feel like you could go there if you wanted to? Why? 
3) How has your confidence in talking to partners about confidence changed since being in the 
study? Do you feel like you can talk about it if you want to? Why/how? 
4) Did you talk to your partner before about contraception? Have you talked to them now? Do you 
feel that you have control over talking to your partner? 
 
Behaviour and intention 
1) Have the messages influenced your behaviour in any way? [What changed? Why?] 
2) Did you intend to use effective contraception (including the IUD) before the study? Do you intend 
to ever use it? [Why has this changed?] 
3) What about going to a service? Have you been since joining the study? Do you intend to go 
sometime?  
4) And talking to a partner- have you talked about contraception? Do you intend to sometime? 
 
Environment 
1) Is there anything that prevents you from doing what you want to do with regard to your 
reproductive health? How is this a barrier? Can it be overcome? How? 
2) All of these things- using, going to a service, talking to a partner- if you intend to do them, is there 
anything that is preventing you from doing them now? 
 
The app 
1) Did you deinstall the app? [if yes, why?] 
2) What did you think of the app contraception pages? [did you read all, some, most or none of 
them?] 
 
[if they read the app contraception pages]: 
 
3) What did you learn from the app contraception pages? 
4) Did the app contraception pages influence you in any way? [What changed? Why?] 
5) How were the app contraception pages and the messages different? [Did you prefer one over the 
other? Why/why not?] 
 
Wrap up 
• What advice do you have about how we could improve the messages? 
• Would you recommend the messages to other people? [Who? Why?] 
• Do you think that all young people should be offered these messages? Why? 
• Thinking about all that we talked about today, what do you feel is the most important?  
• Anything else to add? 
• Thank you, you’ve been a big help! (if they want any more information, show our contact details 
again) 
 
Tajikistan-control group guide 
Introduction  
• Thank you for agreeing to the interview. The purpose of the interview is to understand how you 
found the app contraception pages.  
• Please be as honest as possible. If things have not changed for you, we would like to know that. 
There are no right or wrong answers. 
• You don’t have to talk about anything that you don’t want to talk about.  
• The interview will last up to 60 minutes and you can end the interview at any time.  
• Check again that they are ok with audio recording, explain confidentiality and anonymity 
•  
START RECORDER 
Having the app on your phone 
1) What was it like to have the app on your phone?  
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2) Did you deinstall the app? [if yes, why?] 
 
Confidentiality 
3) Were you concerned about others seeing the app on your phone? [If yes, how did you deal with 
it?]  
4) Did anyone else look at the app on your phone? [Who was this person? How did you feel about 
it?] 
5) Did you discuss information in the app with anyone? [Who was this person? How did you feel 
about this?] 
6) Did anything unwanted happen as a consequence of having the app on your phone? 
 
Knowledge 
7) Did you read the app contraception pages? [why/why not?] 
 
8) [If they read the app contraception pages]  
9) What did you think of the app contraception pages? [did you read all, some, most or none of 
them?] 
10) What did you learn from the app contraception pages? [what was the most important thing that 
you learned? Why was this the most important?] 
11) How has what you learned changed how you think & feel about effective contraception (IUD, pill, 
injection, implant)? [How did the app change your views?] 
 
Attitudes 
12) What did you think about using effective contraception before the study? Have your beliefs 
changed? How have they changed and why? 
13) What did you think about going to a service contraception before the study? Has that changed? 
How has it changed and why? 
14) What did you think about talking to a partner about contraception before the study? Has that 
changed? How has it changed and why? 
 
Agency 
15) How has your confidence in using contraception changed since being in the study? [Why do you 
think it has changed? Do you feel you have control over using contraception?] 
16) How do you feel about going to a service for contraception now? Has this changed? Why? Do you 
feel like you could go there if you wanted to? Why? 
17) How has your confidence in talking to partners about confidence changed since being in the 
study? Do you feel like you can talk about it if you want to? Why/how? 
18) Did you talk to your partner before about contraception? Have you talked to them now? Do you 
feel that you have control over talking to your partner? 
 
Behaviour and intention 
19) Have the app influenced your behaviour in any way? [What changed? Why?] 
20) Did you intend to use effective contraception (including the IUD) before the study? Do you intend 
to ever use it? [Why has this changed?] 
21) What about going to a service? Have you been since joining the study? Do you intend to go 
sometime?  
22) And talking to a partner- have you talked about contraception? Do you intend to sometime? 
 
Environment 
23) Is there anything that prevents you from doing what you want to do with regard to your 
reproductive health? How is this a barrier? Can it be overcome? How? 
24) All of these things- using, going to a service, talking to a partner- if you intend to do them, is there 
anything that is preventing you from doing them now? 
 
  
348 
 
Wrap up 
• What advice do you have about how we could improve the app? 
• Would you recommend the app to other people? [Who? Why?] 
• Do you think that all young people should be offered the app? Why? 
• Thinking about all that we talked about today, what do you feel is the most important?  
• Anything else to add? 
• Thank you, you’ve been a big help! (if they want any more information, show our contact details 
again) 
 
  
349 
 
Palestine 
Introduction  
• Thank you for agreeing to the interview. The purpose of the interview is to understand how it was 
for you to receive the messages. This is so we can understand better how they may have 
influenced people.  
• Please be as honest as possible. If things have not changed for you, we would like to know that. 
There are no right or wrong answers. 
• You don’t have to talk about anything that you don’t want to talk about.  
• The interview will last up to 60 minutes and you can end the interview at any time.  
• Check again that they are ok with audio recording, explain confidentiality and anonymity 
 
START RECORDER 
Receiving the messages 
1) What was it like to receive the messages?  
2) Did you have any trouble receiving them? [were there any times that the messages couldn’t be 
delivered?] 
3) What did you think about the number of messages you received? [too many/too little/just right? 
Why?]  
4) What did you do when you received a message? [e.g. did you read it right away, save it for a time 
when you were alone, etc.?] 
5) How many of the messages did you read? [All of them, some, none? Why?] 
6) Did you stop the messages? [Why? When did you stop them, i.e. very early on, in what month?] 
7) Did you keep the messages or delete them? [Which ones did you keep or delete? Why?] 
8) Did you re-read any of the messages? [Which ones? Why?]  
 
Confidentiality 
9) Were you concerned about others seeing the text messages? [If yes, how did you deal with it?]  
10) Did anyone else read your messages? [Who was this person? How did you feel about it?] 
11) Did you discuss information in the messages with anyone? [Who was this person? How did you 
feel about this?] 
12) Did anything unwanted happen as a consequence of receiving the messages? 
 
Knowledge 
13) What did you learn from the messages? [what was the most important thing that you learned 
from the messages? Why was this the most important?] 
14) How has what you learned changed how you think & feel about effective contraception (IUD, pill, 
injection, implant, patch)? [How did the messages change your views?] 
 
Attitudes 
15) What did you think about using effective contraception before the study? Have your beliefs 
changed? How have they changed and why? 
16) What did you think about going to a service contraception before the study? Has that changed? 
How has it changed and why? 
17) What did you think about talking to a partner about contraception before the study? Has that 
changed? How has it changed and why? 
 
Agency 
18) Has your confidence change since being in the study? [How has it changed? Why do you think it 
has changed? Do you feel you have control over using contraception?] 
19) How do you feel about going to a service for contraception now? Has this changed? Why? Do you 
feel like you could go there if you wanted to? Why? 
20) Has your confidence in talking to partners about contraception changed since being in the study? 
[How has it changed? Why do you think it has changed? Do you feel like you can talk about it if 
you want to? Why/how?] 
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21) Did you talk to your partner before about contraception? Have you talked to them now? Do you 
feel that you have control over talking to your partner? 
 
Behaviour and intention 
22) Have the messages influenced your behaviour in any way? [What changed? Why?] 
23) Did you intend to use effective contraception (including the IUD) before the study? Do you intend 
to ever use it? [Why has this changed?] 
24) What about going to a service? Have you been since joining the study? Do you intend to go 
sometime?  
25) And talking to a partner- have you talked about contraception? Do you intend to sometime? 
 
Environment 
26) Is there anything that prevents you from doing what you want to do with regard to your 
reproductive health? How is this a barrier? Can it be overcome? How? 
27) All of these things- using, going to a service, talking to a partner- if you intend to do them, is there 
anything that is preventing you from doing them now? 
 
Wrap up 
• What advice do you have about how we could improve the messages? 
• Would you recommend the messages to other people? [Who? Why?] 
• Do you think that all young people should be offered these messages? Why? 
• Thinking about all that we talked about today, what do you feel is the most important?  
• Anything else to add? 
• Thank you, you’ve been a big help! (if they want any more information, show our contact details 
again) 
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Bolivia-intervention group guide 
Introduction  
• Thank you for agreeing to the interview. The purpose of the interview is to understand how it was 
for you to receive the messages. This is so we can understand better how they may have 
influenced people.  
• Please be as honest as possible. If things have not changed for you, we would like to know that. 
There are no right or wrong answers. 
• You don’t have to talk about anything that you don’t want to talk about.  
• The interview will last up to 60 minutes and you can end the interview at any time.  
• Check again that they are ok with audio recording, explain confidentiality and anonymity 
 
START RECORDER 
 
“Just to clarify that when I ask about the ‘messages’ I mean the instant messages that were sent to 
you though the app.”  
 
Receiving the messages 
1) What was it like to receive the messages?  
2) Did you have any trouble receiving them? [were there any times that the messages couldn’t be 
delivered?] 
3) What did you think about the number of messages you received? [too many/too little/just right? 
Why?]  
4) What did you do when you received a message? [e.g. did you read it right away, save it for a time 
when you were alone, etc.?] 
5) How many of the messages did you read? [All of them, some, none? Why?] 
6) Did you stop the messages? [Why? When did you stop them, i.e. very early on, in what month?] 
7) Did you keep the messages or delete them? [Which ones did you keep or delete? Why?] 
8) Did you re-read any of the messages? [Which ones? Why?]  
 
Confidentiality 
9) Were you concerned about others seeing the text messages? [If yes, how did you deal with it?]  
10) Did anyone else read your messages? [Who was this person? How did you feel about it?] 
11) Did you discuss information in the messages with anyone? [Who was this person? How did you 
feel about this?] 
12) Did anything unwanted happen as a consequence of receiving the messages? 
 
Knowledge 
13) What did you learn from the messages? [what was the most important thing that you learned 
from the messages? Why was this the most important?] 
14) How has what you learned changed how you think & feel about effective contraception (IUD, pill, 
injection, implant)? [How did the messages change your views?] 
 
Attitudes 
15) What did you think about using effective contraception before the study? Have your beliefs 
changed? How have they changed and why? 
16) What did you think about going to a service contraception before the study? Has that changed? 
How has it changed and why? 
17) What did you think about talking to a partner about contraception before the study? Has that 
changed? How has it changed and why? 
 
Agency 
18) How has your confidence in using contraception changed since being in the study? [Why do you 
think it has changed? Do you feel you have control over using contraception?] 
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19) How do you feel about going to a service for contraception now? Has this changed? Why? Do you 
feel like you could go there if you wanted to? Why? 
20) How has your confidence in talking to partners about confidence changed since being in the 
study? Do you feel like you can talk about it if you want to? Why/how? 
21) Did you talk to your partner before about contraception? Have you talked to them now? Do you 
feel that you have control over talking to your partner? 
 
Behaviour and intention 
22) Have the messages influenced your behaviour in any way? [What changed? Why?] 
23) Did you intend to use effective contraception (including the IUD) before the study? Do you intend 
to ever use it? [Why has this changed?] 
24) What about going to a service? Have you been since joining the study? Do you intend to go 
sometime?  
25) And talking to a partner- have you talked about contraception? Do you intend to sometime? 
 
Environment 
26) Is there anything that prevents you from doing what you want to do with regard to your 
reproductive health? How is this a barrier? Can it be overcome? How? 
27) All of these things- using, going to a service, talking to a partner- if you intend to do them, is there 
anything that is preventing you from doing them now? 
 
The app 
28) Did you deinstall the app? [if yes, why?] 
29) What did you think of the app contraception pages? [did you read all, some, most or none of 
them?] 
30) [if they read the app contraception pages]: 
31) What did you learn from the app contraception pages? 
32) Did the app contraception pages influence you in any way? [What changed? Why?] 
33) How were the app contraception pages and the messages different? [Did you prefer one over the 
other? Why/why not?] 
 
Wrap up 
• What advice do you have about how we could improve the messages? 
• Would you recommend the messages to other people? [Who? Why?] 
• Do you think that all young people should be offered these messages? Why? 
• Thinking about all that we talked about today, what do you feel is the most important?  
• Anything else to add? 
• Thank you, you’ve been a big help! (if they want any more information, show our contact details 
again) 
 
Bolivia-control group guide 
Introduction  
• Thank you for agreeing to the interview. The purpose of the interview is to understand how you 
found the app contraception pages.  
• Please be as honest as possible. If things have not changed for you, we would like to know that. 
There are no right or wrong answers. 
• You don’t have to talk about anything that you don’t want to talk about.  
• The interview will last up to 60 minutes and you can end the interview at any time.  
• Check again that they are ok with audio recording, explain confidentiality and anonymity 
 
START RECORDER 
Having the app on your phone 
1) What was it like to have the app on your phone?  
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2) Did you deinstall the app? [if yes, why?] 
 
Confidentiality 
3) Were you concerned about others seeing the app on your phone? [If yes, how did you deal with 
it?]  
4) Did anyone else look at the app on your phone? [Who was this person? How did you feel about 
it?] 
5) Did you discuss information in the app with anyone? [Who was this person? How did you feel 
about this?] 
6) Did anything unwanted happen as a consequence of having the app on your phone? 
 
Knowledge 
7) Did you read the app contraception pages? [why/why not?] 
 
8) [If they read the app contraception pages]  
9) What did you think of the app contraception pages? [did you read all, some, most or none of 
them?] 
10) What did you learn from the app contraception pages? [what was the most important thing that 
you learned? Why was this the most important?] 
11) How has what you learned changed how you think & feel about effective contraception (IUD, pill, 
injection, implant)? [How did the app change your views?] 
 
Attitudes 
12) What did you think about using effective contraception before the study? Have your beliefs 
changed? How have they changed and why? 
13) What did you think about going to a service contraception before the study? Has that changed? 
How has it changed and why? 
14) What did you think about talking to a partner about contraception before the study? Has that 
changed? How has it changed and why? 
 
Agency 
15) How has your confidence in using contraception changed since being in the study? [Why do you 
think it has changed? Do you feel you have control over using contraception?] 
16) How do you feel about going to a service for contraception now? Has this changed? Why? Do you 
feel like you could go there if you wanted to? Why? 
17) How has your confidence in talking to partners about confidence changed since being in the 
study? Do you feel like you can talk about it if you want to? Why/how? 
18) Did you talk to your partner before about contraception? Have you talked to them now? Do you 
feel that you have control over talking to your partner? 
 
Behaviour and intention 
19) Have the app influenced your behaviour in any way? [What changed? Why?] 
20) Did you intend to use effective contraception (including the IUD) before the study? Do you intend 
to ever use it? [Why has this changed?] 
21) What about going to a service? Have you been since joining the study? Do you intend to go 
sometime?  
22) And talking to a partner- have you talked about contraception? Do you intend to sometime? 
 
Environment 
23) Is there anything that prevents you from doing what you want to do with regard to your 
reproductive health? How is this a barrier? Can it be overcome? How? 
24) All of these things- using, going to a service, talking to a partner- if you intend to do them, is there 
anything that is preventing you from doing them now? 
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Wrap up 
• What advice do you have about how we could improve the app? 
• Would you recommend the app to other people? [Who? Why?] 
• Do you think that all young people should be offered the app? Why? 
• Thinking about all that we talked about today, what do you feel is the most important?  
• Anything else to add? 
• Thank you, you’ve been a big help! (if they want any more information, show our contact details 
again) 
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Appendix 21. Trial interviews: Participant information 
sheets 
Tajikistan 
We are inviting you to take part in a research study. Before you decide, it is important that you know 
why we are doing the study and what is involved. Please read the following information carefully. 
 
What is the study? 
We would like to ask you what you think about the messages that you received while taking part in the 
randomised controlled trial. We’d like to understand how the messages may have affected you. This 
will help us better understand how and why the intervention may have worked. 
 
Who is organising and funding the study? 
The study is being conducted by TFPA and the London School of Hygiene & Tropical Medicine (LSHTM). 
TFPA provides high quality sexual and reproductive health services in Tajikistan. LSHTM is a world-
leading centre for research and postgraduate education in public and global health. The study is 
funded by the International Planned Parenthood Federation (IPPF). 
 
Why have I been chosen? 
You have taken part in the randomised controlled trial and receive the contraception messages. 
 
Do I have to take part?  
No, you do not have to take part. It is your choice. If you choose not to take part, all the services you 
receive will continue as normal. 
 
What will happen if I take part? 
If you decide to take part, a study researcher will arrange a time for you to come to TFPA at your 
convenience. You will be interviewed by the Project Coordinator. With your permission, the interview 
will be audio recorded. You will not be named on the recording. We will ask you about your 
experiences with receiving the messages and how it may have influenced how you think and feel about 
contraception.  
 
What do I have to do? 
If you decide to take part, we will ask you to complete the consent form.  
 
How long will it take? 
The interview will take up to 60 minutes. You can stop the interview at any time. 
 
Will you compensate me for taking part? 
We will offer transportation reimbursement. 
 
What are the alternatives? 
You do not have to take part.  
 
What are the possible disadvantages of taking part? 
The study will take some of your time. Because the interview is about contraception, we will be talking 
about sexual and reproductive health. You do not have to share anything that you are not comfortable 
sharing. You do not have to give us a reason for not sharing. 
 
What are the possible advantages of taking part? 
You may enjoy taking part in the research, sharing your experiences and knowing that your 
participation can help us understand how best to support young people. You can add your 
participation in the study to your resume. 
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What if I do not want to take part anymore? 
You can end the interview at any time by telling the interviewer that you’d like to stop. You do not 
have to give a reason for ending the interview. Ending the interview will not affect the services that 
you receive.  
 
What if there is a problem? 
You can talk to the Project Coordinator at any time (details below).   
 
Will my taking part be confidential?  
Yes. We will not share any information about you with anyone outside of the research team. Your 
comments will be anonymous (they will be identified by a research number only). The audio recording 
will be kept on a password protected computer. No one else besides the research team will listen to 
the recording. You will not be named in the recording.  
 
What will happen with the results of this study? 
Your name will not be used in the results of this study. Your views will help us understand how the 
intervention may have supported young people. We will share the results through publication in 
journals and through presenting at conferences. If you would like to know the results of the study, 
please contact the team (details below) and we will share them with you. 
 
If the results of the study show that the messages have helped, they will be made available to all young 
people in Tajikistan. 
 
Who has reviewed this study? 
The London School of Hygiene & Tropical Medicine Interventions Research Ethics Committee and the 
Tajikistan National Scientific and Research Centre on Paediatrics and Child Surgery (NSRCP&CS).  
 
Thank you for taking the time to consider taking part 
 
Firuza Kulaeva Ravshan Tokhirov Ona McCarthy 
Project Coordinator Executive Director Principal Investigator 
TFPA, 10 Rudaki Avenue TFPA, 10 Rudaki Avenue LSHTM, Keppel St, WC1E 
7HT 
TC 'Sadbarg', 7th floor, Dushanbe TC 'Sadbarg', 7th floor, Dushanbe London, United Kingdom 
tfpa.inpro@gmail.com  ed.tfpa@gmail.com  ona.mccarthy@lshtm.ac.uk 
+992 (918) 69-9925   
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Palestine 
We are inviting you to take part in a research study. Before you decide, it is important that you know 
why we are doing the study and what is involved. Please read the following information carefully. 
 
What is the study? 
We would like to ask you what you think about the messages that you received while taking part in the 
randomised controlled trial. We’d like to understand how the messages may have affected you. This 
will help us better understand how and why the intervention may have worked. 
 
Who is organising and funding the study? 
The study is being conducted by the Palestinian Family Planning and Protection Association (PFPPA) 
and the London School of Hygiene & Tropical Medicine (LSHTM). PFPPA provides high quality sexual 
and reproductive health services in the Palestinian Authority. LSHTM is a world-leading centre for 
research and postgraduate education in public and global health. The study is funded by the 
International Planned Parenthood Federation (IPPF). 
 
Why have I been chosen? 
You have taken part in the randomised controlled trial and have received the contraception messages. 
 
Do I have to take part?  
No, you do not have to take part. It is your choice. If you choose not to take part, all the services you 
receive will continue as normal. 
 
What will happen if I take part? 
If you decide to take part, a study researcher will arrange a time for you to come to PFPPA at your 
convenience. You will be interviewed by the Project Coordinator. With your permission, the interview 
will be audio recorded. You will not be named on the recording. We will ask you about your 
experiences with receiving the messages and how it may have influenced how you think and feel about 
contraception.  
 
What do I have to do? 
If you decide to take part, we will ask you to complete the consent form.  
 
How long will it take? 
The interview will take up to 60 minutes. You can stop the interview at any time. 
 
Will you compensate me for taking part? 
We will offer transportation reimbursement. 
 
What are the alternatives? 
You do not have to take part.  
 
What are the possible disadvantages of taking part?  
The study will take some of your time. Because the interview is about contraception, we will be talking 
about sexual and reproductive health. You do not have to share anything that you are not comfortable 
sharing. You do not have to give us a reason for not sharing. 
 
What are the possible advantages of taking part? 
You may enjoy taking part in the research, sharing your experiences and knowing that your 
participation can help us understand how best to support young people.  
 
What if I do not want to take part anymore? 
You can end the interview at any time by telling the interviewer that you’d like to stop. You do not 
have to give a reason for ending the interview. Ending the interview will not affect the services that 
you receive.  
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What if there is a problem? 
You can talk to the Project Coordinator at any time (details below).   
 
Will my taking part be confidential?  
Yes. We will not share any information about you with anyone outside of the research team. Your 
comments will be anonymous (they will be identified by a research number only). The audio recording 
will be kept on a password protected computer. No one else besides the research team will listen to 
the recording. You will not be named in the recording.  
 
What will happen with the results of this study? 
Your name will not be used in the results of this study. Your views will help us understand how the 
intervention may have supported young people. We will share the results through publication in 
journals and through presenting at conferences. If you would like to know the results of the study, 
please contact the team (details below) and we will share them with you. 
 
If the results of the study show that the messages have helped, they will be made available to all young 
people in the West Bank. 
 
Who has reviewed this study? 
The London School of Hygiene & Tropical Medicine Interventions Research Ethics Committee and the 
State of Palestine Ministry of Health.  
 
 
Thank you for taking the time to consider taking part 
 
Hanadi Zghayyer Amina Stavridis Ona McCarthy 
Project Coordinator Executive Director Principal Investigator 
PFPPA, Industrial Zone, Wadi 
Al-Joze  
PFPPA, Industrial Zone, Wadi Al-Joze  LSHTM, Keppel St, WC1E 
7HT 
Jerusalem, Palestinian 
Territory 
Jerusalem, Palestinian Territory London, United Kingdom 
ipc@pfppa.org director@pfppa.org ona.mccarthy@lshtm.ac.uk 
+ 9722-6280630   
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Bolivia 
We are inviting you to take part in a research study. Before you decide, it is important that you know 
why we are doing the study and what is involved. Please read the following information carefully. 
 
What is the study? 
We would like to ask you what you think about the messages that you received while taking part in the 
randomised controlled trial. We’d like to understand how the messages may have affected you. This 
will help us better understand how and why the intervention may have worked. 
 
Who is organising and funding the study? 
The study is being conducted by CIES and the London School of Hygiene & Tropical Medicine (LSHTM). 
CIES provides high quality sexual and reproductive health services in Bolivia. LSHTM is a world-leading 
centre for research and postgraduate education in public and global health. The study is funded by the 
International Planned Parenthood Federation (IPPF). 
 
Why have I been chosen? 
You have taken part in the randomised controlled trial and have received the contraception messages. 
 
Do I have to take part?  
No, you do not have to take part. It is your choice. If you choose not to take part, all the services you 
receive will continue as normal. 
 
What will happen if I take part? 
If you decide to take part, a study researcher will arrange a time for you to come to CIES at your 
convenience. You will be interviewed by the Project Coordinator. With your permission, the interview 
will be audio recorded. You will not be named on the recording. We will ask you about your 
experiences with receiving the messages and how it may have influenced how you think and feel about 
contraception.  
 
What do I have to do? 
If you decide to take part, we will ask you to complete the consent form.  
 
How long will it take? 
The interview will take up to 60 minutes. You can stop the interview at any time. 
 
Will you compensate me for taking part? 
We will offer transportation reimbursement. 
 
What are the alternatives? 
You do not have to take part.  
 
What are the possible disadvantages of taking part? 
The study will take some of your time. Because the interview is about contraception, we will be talking 
about sexual and reproductive health. You do not have to share anything that you are not comfortable 
sharing. You do not have to give us a reason for not sharing. 
 
What are the possible advantages of taking part? 
You may enjoy taking part in the research, sharing your experiences and knowing that your 
participation can help us understand how best to support young people. You can add your 
participation in the study to your resume. 
 
What if I do not want to take part anymore? 
You can end the interview at any time by telling the interviewer that you’d like to stop. You do not 
have to give a reason for ending the interview. Ending the interview will not affect the services that 
you receive.  
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What if there is a problem? 
You can talk to the Project Coordinator at any time (details below).   
 
Will my taking part be confidential?  
Yes. We will not share any information about you with anyone outside of the research team. Your 
comments will be anonymous (they will be identified by a research number only). The audio recording 
will be kept on a password protected computer. No one else besides the research team will listen to 
the recording. You will not be named in the recording.  
 
What will happen with the results of this study? 
Your name will not be used in the results of this study. Your views will help us understand how the 
intervention may have supported young people. We will share the results through publication in 
journals and through presenting at conferences. If you would like to know the results of the study, 
please contact the team (details below) and we will share them with you. 
 
If the results of the study show that the messages have helped, they will be made available to all young 
people in Bolivia. 
 
Who has reviewed this study? 
The London School of Hygiene & Tropical Medicine Interventions Research Ethics Committee and the 
Bolivian National Research Ethics Committee.  
 
Thank you for taking the time to consider taking part 
 
Verónica Osorio Calderón Dr Jhonny Lopez Ona McCarthy 
Project Coordinator Executive Director Principal Investigator 
CIES Salud Sexual - Salud 
Reproductiva 
CIES Salud Sexual - Salud Reproductiva LSHTM, Keppel St, WC1E 
7HT 
Calle 6 de Obrajes Nro. 614 
– Casilla 9935, (591-2) 
2788162 
Calle 6 de Obrajes Nro. 614 – Casilla 
9935, (591-2) 2788162 
London, United Kingdom 
ona.mccarthy@lshtm.ac.uk 
vosorio@cies.org.bo   JLopez@cies.org.bo  
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Appendix 22. Trial interviews: Consent forms 
Tajikistan 
Project Coordinator: Firuza Kulaeva, the Tajik Family Planning Alliance (TFPA), 10 Rudaki Avenue, 
TC 'Sadbarg', 7th floor, Dushanbe, +992 (918) 69-9925,  tfpa.inpro@gmail.com  
 
Principal Investigator: Ona McCarthy, The London School of Hygiene and Tropical Medicine, 
Department of Population Health, Keppel St, WC1E 7HT, London, United Kingdom, 
ona.mccarthy@lshtm.ac.uk    
 
 
 
 
Please initial 
here 
10. I have read the Information sheet for the above study (v1 19.02.16) or it has 
been read to me. I have had the opportunity to consider the information in it. 
 
 
 
 
11. I have had the opportunity to ask questions and I am happy with the answers 
that you gave me. 
 
 
 
 
12. I understand that I do not have to take part if I do not want to.  
 
 
 
 
7. I understand that what I say will be written about but my real name will not be 
used. 
 
 
 
 
 
14. I understand that I do not have to talk about anything that I do not want to talk 
about.  
 
 
 
15. I understand that I am free to end the interview at any time without having to 
give a reason. I understand that this will not affect the services that I receive. 
 
 
 
 
16. I consent to take part in the above study.  
 
 
                     _________ 
             Name of participant (print)     Signature of participant                            Date 
   
Statement by person taking consent 
I confirm that the participant was given an opportunity to ask questions about the study, and all 
the questions asked by the participant have been answered correctly and to the best of my ability. I 
confirm that the individual has not been coerced into giving consent, and the consent has been given 
freely and voluntarily. A copy of the consent form has been given to the participant.  
 
            ___________ 
  Name of person taking consent (print) Signature of person taking consent           Date
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Palestine 
Project Coordinator: Hanadi Zghayyer, Palestinian Family Planning and Protection Association 
(PFPPA), Industrial Zone, Wadi Al-Joze, Jerusalem, Palestine,  + 9722-6280630, ipc@pfppa.org 
 
Principal Investigator: Ona McCarthy, The London School of Hygiene and Tropical Medicine, 
Department of Population Health, Keppel St, WC1E 7HT, London, United Kingdom, 
ona.mccarthy@lshtm.ac.uk    
 
 
 
 
Please 
initial 
here 
1. I have read the Information sheet for the above study (v1 19.02.16) or it has 
been read to me. I have had the opportunity to consider the information in it. 
 
 
 
 
2. I have had the opportunity to ask questions and I am happy with the answers 
that you gave me. 
 
 
 
 
3. I understand that I do not have to take part if I do not want to.  
 
 
 
 
4. I understand that what I say will be written about but my real name will not be 
used. 
 
 
 
 
 
5. I understand that I do not have to talk about anything that I do not want to talk 
about.  
 
 
 
6. I understand that I am free to end the interview at any time without having to 
give a reason. I understand that this will not affect the services that I receive. 
 
 
 
 
7. I consent to take part in the above study.  
 
 
                     _________ 
             Name of participant (print)     Signature of participant                            Date 
   
Statement by person taking consent 
I confirm that the participant was given an opportunity to ask questions about the study, and all 
the questions asked by the participant have been answered correctly and to the best of my ability. I 
confirm that the individual has not been coerced into giving consent, and the consent has been given 
freely and voluntarily. A copy of the consent form has been given to the participant.  
 
            ___________ 
  Name of person taking consent (print) Signature of person taking consent           Date 
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Bolivia 
Project Coordinator: Verónica Osorio Calderón, CIES Salud Sexual - Salud Reproductiva, Calle 6 de 
Obrajes Nro. 614 – Casilla 9935, (591-2) 2788162, vosorio@cies.org.bo   
 
Principal Investigator: Ona McCarthy, The London School of Hygiene and Tropical Medicine, 
Department of Population Health, Keppel St, WC1E 7HT, London, United Kingdom, 
ona.mccarthy@lshtm.ac.uk    
 
 
 
 
Please 
initial 
here 
1. I have read the Information sheet for the above study (v1 19.02.16) or it has 
been read to me. I have had the opportunity to consider the information in it. 
 
 
 
 
2. I have had the opportunity to ask questions and I am happy with the answers 
that you gave me. 
 
 
 
 
3. I understand that I do not have to take part if I do not want to.  
 
 
 
 
4. I understand that what I say will be written about but my real name will not be 
used. 
 
 
 
 
 
5. I understand that I do not have to talk about anything that I do not want to talk 
about.  
 
 
 
6. I understand that I am free to end the interview at any time without having to 
give a reason. I understand that this will not affect the services that I receive. 
 
 
 
 
7. I consent to take part in the above study.  
 
 
                     _________ 
             Name of participant (print)     Signature of participant                            Date 
   
Statement by person taking consent 
I confirm that the participant was given an opportunity to ask questions about the study, and all 
the questions asked by the participant have been answered correctly and to the best of my ability. I 
confirm that the individual has not been coerced into giving consent, and the consent has been given 
freely and voluntarily. A copy of the consent form has been given to the participant.  
 
            ___________ 
  Name of person taking consent (print) Signature of person taking consent           Date 
 
